[
  {
    "title": "Effectiveness and safety of sofosbuvir/velpatasvir ± ribavirin vs glecaprevir/pibrentasvir in genotype 3 hepatitis C virus infected patients",
    "url": "https://ejhp.bmj.com/content/27/e1/e41",
    "authors": "Luis Margusino-Framiñán, Purificación Cid-Silva, Sandra Rotea-Salvo, Álvaro Mena-de-Cea, Francisco Suárez-López, Pilar Vázquez-Rodríguez, Manuel Delgado-Blanco, Ana Isabel Sanclaudio-Luhia, Isabel Martín-Herranz, Ángeles Castro-Iglesias",
    "institution": "Pharmacy Service, Universitary Hospital of A Coruña, A Coruña, Spain. Division of Clinical Virology, Biomedical Research Institute of A Coruña (INIBIC), Universitary Hospital of A Coruña (CHUAC), Sergas, University of A Coruña (UDC), A Coruña, Spain. Infectious Diseases Unit. Internal Medicine Service, Universitary Hospital of A Coruña (CHUAC), A Coruña, Spain. Hepatology Unit, Digestive System Service, University Hospital of A Coruña (CHUAC), A Coruña, Spain. Information Systems Department, University Hospital of A Coruña, A Coruña, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-002060",
    "filters": {
      "actSubs": ["Sofosbuvir / Velpatasvir", "Sofosbuvir", "Velpatasvir", "Ribavirin", "Glecaprevir / Pibrentasvir", "Glecaprevir", "Pibrentasvir"],
      "indication": ["Hepatitis C Genotype 3", "Fibrosis (Liver)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Fisher’s Exact Test", "Mann-Whitney U Test", "Real-Time Polymerase Chain Reaction"],
      "studyLength": ["More than 1 year - 2 years"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of the stability of vancomycin solutions at concentrations used in clinical services",
    "url": "https://ejhp.bmj.com/content/27/e1/e87",
    "authors": "Morgane Masse, Stéphanie Genay, Anthony Martin Mena, Natacha Carta, Damien Lannoy, Christine Barthélémy, Bertrand Décaudin, Pascal Odou",
    "institution": "Univ. Lille, CHU Lille, ULR 7365–GRITA–Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-002076",
    "filters": {
      "actSubs": ["Vancomycin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)", "Mann-Whitney U Test"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Long-term stability of ready-to-use norepinephrine solution at 0.2 and 0.5 mg/mL",
    "url": "https://ejhp.bmj.com/content/27/e1/e93",
    "authors": "Sixtine Gilliot, Morgane Masse, Stéphanie Genay, Damien Lannoy, Christine Barthélémy, Bertrand Décaudin, Pascal Odou",
    "institution": "EA 7365–GRITA–Groupe de Recherche sur les formes Injectables et les Technologies Associées, University of Lille, CHU Lille, F-59000 Lille, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-002146",
    "filters": {
      "actSubs": ["Norepinephrine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography Reversed-Phase (RP-HPLC)", "Cochran Test"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Cost efficacy analysis of abiraterone in newly diagnosed high risk metastatic castration sensitive prostate cancer",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A4.1",
    "authors": "A Soares, A Alcobia",
    "institution": "Hospital Garcia De Orta, Pharmacy Department, Almada, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.8",
    "filters": {
      "actSubs": ["Abiraterone"],
      "indication": ["Prostate Cancer (Metastatic Castration Sensitive)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Application of a time slot model in oncology: delivery planning and process optimisation",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A8.2",
    "authors": "C Bertino, M Di Gerardo, A Pirrone, E Dalla Fontana, G Caravella, A Spagnuolo, R Cursano",
    "institution": "Università Degli Studi Di Milano, Scienze Farmaceutiche-Scuola Di Specializzazione Farmacia Ospedaliera, Milano, Italy. Asst Melegnano Martesana, Farmacia, Vizzolo Predabissi, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.18",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": ["pharmacoeconomy"],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Envisioning sustainability in personalised medicine: Fondo AIFA 5% and the Italian example",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A7.2",
    "authors": "F Bocchio, M Tizzoni, M Calvi, A Di Benedetto",
    "institution": "Fondazione Irccs Policlinico San Matteo Pavia, Uoc Farmacia, Pavia, Italy. Universita’ Degli Studi Di Milano, Scuola Di Specializzazione in Farmacia Ospedaliera, Pavia, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.16",
    "filters": {
      "actSubs": ["Venetoclax", "Eltrombopag", "Pembrolizumab", "Ruxolitinib", "Blinatumomab", "Trabectedina", "Cenegermin"],
      "indication": ["Leukaemia (Acute Myeloid)", "Lymphoma (Mantle Cell)", "Pure Red Cell Aplasia", "Lymphoma (Hodgkin)", "Lymphoma (non-Hodgkin)", "Myeloproliferative Neoplasm (BCR/JAK2-Rearranged)", "Leukaemia (Acute Lymphoblastic)", "Graft Versus Host Disease", "Ovarian Carcinoma", "Ovarian Serous Adenocarcinoma", "Neurotrophic Keratitis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["10 - 50"],
      "criteriaMethod": [],
      "studyLength": ["More than 1 year - 2 years"],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": ["personalized"],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Smartphone applications for patients diagnosed with genitourinary tumours: analysis of the quality using the mobile application rating scale",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A6.1",
    "authors": "MÁ Amor, R Collado-Borrell, V Escudero-Vilaplana, A Ribed-Sánchez, A Melgarejo-Ortuño, FJ García-Moreno, S García-Sánchez, Á Narrillos-Moraza, P Ruiz-Briones, A Herranz-Alonso, M Sanjurjo-Sáez",
    "institution": "Servicio De Farmacia, Hospital General Universitario Gregorio Marañón, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.13",
    "filters": {
      "actSubs": [],
      "indication": ["Genitourinary Cancers", "Prostate Cancer", "Cervical Cancer", "Testicular Cancer", "Ovarian Carcinoma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study", "Observational Study", "Descriptive Study"],
      "setting": [],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Mobile Application Rating Scale (MARS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": ["mobileVR"],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Biological drugs for the treatment of moderate and severe plaque psoriasis: a cost analysis and an application of a correlation analysis to investigate cost effectiveness",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A1.2",
    "authors": "N Sagaria, D Mengato, I Corbucci, G Felluga, G Morandell, A Tavella",
    "institution": "School of Hospital Pharmacy, Department of Pharmaceutical Sciences University of Padova, Padova, Italy. Bolzano General Hospital, Hospital Pharmacy Department, Bolzano, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.2",
    "filters": {
      "actSubs": ["Adalimumab", "Infliximab", "Guselkumab"],
      "indication": ["Psoriasis (Moderate to Severe Plaque)"],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Psoriasis Area and Severity Index (PASI)", "Correlation Analysis"],
      "studyLength": ["3 months - 5 months"],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Economic comparison of therapeutic alternatives for firstline treatment of multiple myeloma",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A2.2",
    "authors": "MD Gil-Sierra, S Fenix-Caballero, MDP Briceño-Casado, M Dominguez-Cantero, EJ Alegre-Del Rey",
    "institution": "Hospital Universitario De Puerto Real, Pharmacy, Puerto Real, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.4",
    "filters": {
      "actSubs": ["Daratumumab", "Lenalidomide", "Bortezomib", "Thalidomide", "Melphalan", "Prednisone", "Dexamethasone"],
      "indication": ["Multiple Myeloma (Newly Diagnosed)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "ABC-VEN crosstab analysis: a decision making system for anticancer medicines",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A2.3",
    "authors": "M Fragiadaki, E Rinaki, M Petrongonas, L Tzimis",
    "institution": "Chania General Hospital, Pharmacy, 73300-Chania, Greece",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.5",
    "filters": {
      "actSubs": ["Daratumumab", "Trastuzumab emtansine", "Pantoprazole"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Haematology", "Oncology", "Chemotherapy"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["ABC/Pareto Analysis"],
      "studyLength": ["6 months - 1 year"],
      "country": ["Greece"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Can rivaroxaban become cost saving compared with vitamin K antagonists in the treatment of patients with non-valvular atrial fibrillation in France?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A1.1",
    "authors": "S Robert, F Vincent, S Vengadessane",
    "institution": "Chru Nancy, Pharmacy, Vandoeuvre Les Nancy, France. Hospices Civils De Lyon, Pharmacie, Lyon, France. Université Paris Descartes, Faculté De Pharmacie De Paris, Paris, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.1",
    "filters": {
      "actSubs": ["Rivaroxaban"],
      "indication": ["Nonvalvular Atrial Fibrillation"],
      "statedClass": ["Vitamin K Antagonists", "Novel Oral Anticoagulants"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Cost effectiveness analysis of patient self-administration of medication during hospitalisation in a cardiology unit",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A6.2",
    "authors": "CA Sørensen, A De Thurah, M Lisby, C Olesen, SB Sørensen, U Enemark",
    "institution": "Hospital Pharmacy Central Denmark Region, Clinical Pharmacy-Randers Regional Hospital, Randers Nø, Denmark. Randers Regional Hospital, Medical Department-Cardiology Unit, Randers Nø, Denmark. Aarhus University, Clinical Medicine, Aarhus, Denmark. Aarhus University Hospital, Rheumatology, Aarhus, Denmark. Aarhus University Hospital, Research Centre of Emergency Medicine, Aarhus, Denmark. Hospital Pharmacy Central Denmark Region, Clinical Pharmacy-Aarhus University Hospital, Aarhus, Denmark. Aarhus University, Public Health, Aarhus, Denmark",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.14",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Cardiology"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Denmark"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": ["selfMedication"],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of bispectral index monitoring in general anaesthesia through a health technology assessment method: a possible introduction in clinical practice in an Italian hospital?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A7.1",
    "authors": "E Guido, ME Borghesi, A Saccardi",
    "institution": "University of Milan, Specialisation School in Hospital Pharmacy, Milan, Italy. Asst Carlo Poma-Mantova, Hospital Pharmacy, Mantova, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.15",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": ["preopMedication"],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "National reporting system for drug shortages: classification and trends in reported causes from 2015 to 2018",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A5.2",
    "authors": "A Benhabib, P Maison",
    "institution": "French National Agency for Medicines and Health Products Safety, Health Products Survey, Saint-Denis, France. Strasbourg Faculty of Pharmacy, Hospital Pharmacy, Strasbourg, France. Ea 7379- Paris Est Creteil University Upec and Chic Hospital, Epidemiology Department, Créteil, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.12",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Study of the use of intravenous immunoglobulins during the fourth quarter of 2018 and analysis of its off-label use",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A2.1",
    "authors": "S Izquierdo Muñoz, A Pariente Junquera, A De Frutos Soto",
    "institution": "Hospital Clínico Universitario De Valladolid, Farmacia Hospitalaria, Valladolid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.3",
    "filters": {
      "actSubs": [],
      "indication": ["Neuropathy (Demyelinating)", "Myasthenia Gravis", "Myopathy", "Encephalitis", "Encephalomyelitis", "Morvan Syndrome", "Paraneoplastic Syndrome", "Dermatitis (Atopic)", "Paraneoplastic Dermatomyositis", "Scleroderma", "Antisynthetase Syndrome"],
      "statedClass": ["Immunoglobulin (IVIg)"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effectiveness evaluation of high cost drugs for advanced non-small-cell lung cancer: real world evidence, compliance with clinical practice guidelines and economic evaluation",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A3.1",
    "authors": "A Isoardo, E Grande, MM Ferrero, C Fruttero",
    "institution": "Ao S Croce E Carle, SC Farmacia Ospedaliera, Cuneo, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.6",
    "filters": {
      "actSubs": ["Pemetrexed", "Erlotinib", "Gefitinib", "Afatinib", "Osimertinib", "Crizotinib", "Pembrolizumab", "Nivolumab"],
      "indication": ["Non-Small Cell Lung Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Kaplan-Meier Method"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "New cancer drug approvals in Portugal",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A3.2",
    "authors": "A Alcobia, A Soares",
    "institution": "Hospital Garcia De Orta, Pharmacy Department, Almada, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.7",
    "filters": {
      "actSubs": ["Midostaurin", "Olaparib", "Brentuksimab vedotin", "Vedotin", "Pomalidomide", "Durvalumab", "Venetoclax", "Ixazomib", "Alectinib", "Atezolizumab", "Cabozantinib"],
      "indication": ["Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Budget impact analysis of a natalizumab extended interval dosing regimen",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A4.2",
    "authors": "E Pierobon, A Mastrogiacomo, F Capano, D Ielo",
    "institution": "AOU San Luigi Gonzaga, Pharmacy, Turin, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.9",
    "filters": {
      "actSubs": ["Natalizumab"],
      "indication": ["Progressive Multifocal Leukoencephalopathy", "Multiple Sclerosis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["501 - 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Introduction of rituximab biosimilar: an opportunity to improve health system efficiency?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A4.3",
    "authors": "C Panciroli, L Cervi, D Mazza, G Mangoni, M Dall’aglio, F Ruggiero, ML Medaglia",
    "institution": "Asst Grande Ospedale Metropolitano Niguarda, SC Farmacia, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.10",
    "filters": {
      "actSubs": ["Rituximab"],
      "indication": [],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": ["vigilance"],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Assessment of asthma diagnosed population eligible for new monoclonal antibody therapy and related cost in the Veneto region",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A5.1",
    "authors": "L Degli Esposti, V Perrone, D Sangiorgi, AM Menti, M Andretta",
    "institution": "Clicon SRL-Health-Economics and Outcomes Research, Clicon SRL-Health-Economics and Outcomes Research, Ravenna, Italy. Uoc Hta-Azienda Zero-Regione Veneto, Uoc Hta-Azienda Zero-Regione Veneto, Padova, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.11",
    "filters": {
      "actSubs": ["Theophylline"],
      "indication": ["Asthma (Severe Refractory)"],
      "statedClass": ["Monoclonal Antibodies", "Corticosteroids (Inhaled)", "Long-Acting β Adrenoceptor Agonists", "Antileukotriene Agents", "Anticholinergics", "Corticosteroids (Systemic)"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": [],
      "ward": [],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Impact of supply problems in a hospital pharmacy service",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A8.1",
    "authors": "B Zarate, Á Pieras López, R Menárguez Blanc, A Iglesias Carbajo, C Álvarez Asteinza, A Lozano Blazquez, Á Arias-Martinez, I Maray Mateos, MD Macía Rivas, CL Fernández Laguna",
    "institution": "Hospital Universitario Central De Asturias, Pharmacy, Oviedo, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.17",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Hospital pharmacists aged <45 years: an employment status and job satisfaction survey in Italy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A9.1",
    "authors": "SE Campbell Davies, G Bagaglini, F Brera",
    "institution": "Italian Society of Hospital Pharmacy Sifo, Young Pharmacists, Milano, Italy. Italian Society of Hospital Pharmacy Sifo, Young Pharmacists, Roma, Italy. Italian Society of Hospital Pharmacy Sifo, Young Pharmacists, San Donà Di Piave, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.19",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": ["youngPharma"],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Implementation of home delivery and telepharmacy systems in a third level hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A9.2",
    "authors": "J Cordero-Ramos, Ú Baños-Roldán, JA Fernandez-González-Caballos, C Castillo-Martin, EM Delgado-Cuesta",
    "institution": "Hospital Universitario Virgen Macarena, Hospital Pharmacy, Seville, Spain. Hospital Universitario Virgen Macarena, Primary Care Pharmacy Department, Seville, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.20",
    "filters": {
      "actSubs": [],
      "indication": ["Multiple Sclerosis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Outpatient Clinic"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": ["telepharmacy"],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": ["delivery"],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Improvement in an antimicrobial stewardship programme after implementing a screening alert system",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A10.1",
    "authors": "E Tevar, MJ Castillo Méndez, A Ferrer Machín, ML Padilla Salazar, L Abella Vázquez, J Ode Febles, K Álvarez Tosco, M Hayek Peraza, MÁ Ocaña Gómez, J Merino Alonso",
    "institution": "Hospital Nuestra Señora De La Candelaria, Pharmacy Service, Santa Cruz De Tenerife, Spain. Hospital Nuestra Señora De La Candelaria, Computer Department, Santa Cruz De Tenerife, Spain. Hospital Nuestra Señora De La Candelaria, Internal Medicine, Santa Cruz De Tenerife, Spain. Hospital Nuestra Señora De La Candelaria, Microbiology Service, Santa Cruz De Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.21",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Quasi-Experimental Study"],
      "setting": ["Hospital"],
      "ward": ["Cardiology", "Vascular Surgery", "General Surgery", "Geriatrics", "Internal Medicine", "Neurology", "Traumatology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Economic impact of the introduction of lamivudine plus dolutegravir bitherapy in HIV naive patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A10.2",
    "authors": "L Cantarelli, J Gonzalez Garcia, B Del Rosario Garcia, J Ramos Rodriguez, F Gutierrez Nicolas, J Garcia Cairos, S Garcia Gil, GJ Nazco Casariego",
    "institution": "Complejo Hospitalario Universitario De Canarias, Pharmacy, Santa Cruz De Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.22",
    "filters": {
      "actSubs": ["Dolutegravir", "Abacavir", "Lamivudine", "Emtricitabine", "Tenofovir", "Raltegravir"],
      "indication": ["Acquired Immunodeficiency Syndrome (AIDS)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Efficiency of precision dosing with intravenous immunoglobulins in patients with haematological malignancies",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A11.1",
    "authors": "M Dominguez Cantero, FJ Salmeron-Navas, EM Barreiro-Fernandez, C Moreno-Ramos, MP Briceño-Casado",
    "institution": "Hospital Universitario Puerto Real, Servicio De Farmacia, Cadiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.23",
    "filters": {
      "actSubs": ["Immunoglobulin (IVIg)"],
      "indication": ["Hematologic Malignancy", "Immunodeficiency", "Anemia (Hemolytic)", "Thrombocytopenic Purpura"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Economic analysis of osimertinib in previously untreated EGFR mutant advanced non-small cell lung cancer",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A11.2",
    "authors": "A Ferrer Machín, LG José Arístides, JA Martín Conde, T Betancor García, M Vera Cabrera, S Hernández Rojas, I González García, K Álvarez Tosco, J Merino Alonso",
    "institution": "Hospital Pharmacist, Pharmacy Service, Santa Cruz De Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.24",
    "filters": {
      "actSubs": ["Osimertinib", "Afatinib", "Gefitinib", "Erlotinib"],
      "indication": ["Non-Small Cell Lung Cancer (EGFR-Mutated)"],
      "statedClass": ["Tyrosine Kinase Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Assessment of regorafenib, ramucirumab and cabozantinib as secondline therapy in hepatocarcinoma and alfa-fetoprotein value ≥400 ng/mL",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A12.1",
    "authors": "M Camean-Castillo, S Fenix-Caballero, FJ Salmeron-Navas, M Dominguez-Cantero, JM Borrero-Rubio",
    "institution": "Hospital Universitario Puerto Real, Pharmacy, Puerto Real, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.25",
    "filters": {
      "actSubs": ["Regorafenib", "Ramucirumab", "Cabozantinib", "Sorafenib"],
      "indication": ["Hepatocarcinoma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Meta-Analysis"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Bucher's Method", "Shakespeare Method"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Out of supply of chemotherapy injectable medicines over 9 months: patient impact",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A12.2",
    "authors": "F Charbonneau, Y Brasleret, MA Zilavec, C Naine, J Grimaux, G Svrcek",
    "institution": "Soissons Hospital Centre, Pharmacy Unit, Soissons, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.26",
    "filters": {
      "actSubs": ["Bleomycin", "Mitomycin C", "Docetaxel"],
      "indication": ["Ovarian Carcinoma", "Bladder Cancer", "Squamous Cell Carcinoma of the Rectum", "Prostate Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Impact of French experiment for incentivising etanercept biosimilar use after 10 months",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A12.3",
    "authors": "P Paubel, A Degrassat-Théas, F Bocquet",
    "institution": "Faculté De Pharmacie De Paris, Institut Droit Et Santé- Inserm Umr S 1145, Paris, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.27",
    "filters": {
      "actSubs": ["Etanercept"],
      "indication": [],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital", "Community Pharmacy"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Cost minimisation study of the biological treatment of inflammatory bowel disease: ustekinumab versus vedolizumab",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A13.1",
    "authors": "L Cantarelli, F Gutierrez Nicolas, B Del Rosario Garcia, J Ramos Rodriguez, J Garcia Cairos, JA Morales Barrios, S Garcia Gil, GA Gonzalez De La Fuente, J Gonzalez Garcia, GJ Nazco Casariego",
    "institution": "Complejo Hospitalario Universitario De Canarias, Pharmacy, Santa Cruz De Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.28",
    "filters": {
      "actSubs": ["Ustekinumab", "Vedolizumab"],
      "indication": ["Inflammatory Bowel Disease"],
      "statedClass": ["Tumor Necrosis Factor (TNF) Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": ["pharmacoeconomy"],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Economic impact of switching the administration route of tocilizumab in polyarticular juvenile idiopathic arthritis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A13.2",
    "authors": "M Rodriguez Reyes, F Bossacoma Busquets, M Sanchez Celma, J Arrojo Suarez, A Comes Escoda, C Latre Gorbe, E Iglesias Jimenez, J Anton Lopez",
    "institution": "Hospital Clinic Barcelona, Pharmacy, Barcelona, Spain. Hospital Sant Joan De Déu/Fundació Salut Empordà, Pharmacy, Esplugues De Llobregat, Spain. Hospital Sant Joan De Déu, Pharmacy, Esplugues De Llobregat, Spain. Hospital Sant Joan De Déu, Paediatrics, Esplugues De Llobregat, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.29",
    "filters": {
      "actSubs": ["Tocilizumab"],
      "indication": ["Juvenile Idiopathic Arthritis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Trans-interface gain share programme for biosimilar infliximab",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A14.1",
    "authors": "C Mc Gann, S Cullen, B Love, J Carr",
    "institution": "Connolly Hospital, Pharmacy Department, Blanchardstown, Ireland",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.30",
    "filters": {
      "actSubs": ["Infliximab", "Vedolizumab"],
      "indication": [],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Rheumatology", "Gastroenterology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["6 months - 1 year"],
      "country": ["Ireland"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Cost minimisation study in severe asthma treatment",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A14.2",
    "authors": "J Ramos Rodríguez, S García Gil, L Cantarelli, J González García, C Romero Delgado, J García Cairós, G Calzado Gómez, GA González De La Fuente, B Del Rosario García, GJ Nazco Casariego, F Gutiérrez Nicolás",
    "institution": "Hospital Universitario De Canarias, Pharmacy, San Cristóbal De La Laguna, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.31",
    "filters": {
      "actSubs": ["Omalizumab"],
      "indication": ["Severe Asthma (IgE-Mediated)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Pneumology"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Application of the ABC analysis method for optimising the stock management of medical devices in common use",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A15.1",
    "authors": "M Belhouari, N Nchinech, H Attjioui, N Bouhlala, B Elouadghiri, J Lamsaouri",
    "institution": "Mohammed V Military Training Hospital, Pharmacy, Rabat, Morocco. Mohammed V University-Faculty of Medicine and Pharmacy of Rabat, Chis, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.32",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Universal Kits", "Sterile Gloves", "Infusers", "Plaster Strips", "Guedel Cannulas", "Y Fittings"],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["ABC/Pareto Analysis"],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluating the methodological quality of pivotal clinical trial publications for orphan drugs authorised in 2018. Are they reliable?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A15.2",
    "authors": "R Iglesias Gómez, F Luna, J Moya Sola, M Tordera Baviera, MJ Company Albir, T Palanques Pastor, I Beltran Garcia, JL Poveda Andres",
    "institution": "Hospital Universitario Y Politécnico La Fe De Valencia, Servicio De Farmacia, Valencia, Spain. Hospital General De Agudos Carlos G. Durand, Servicio De Farmacia, Buenos Aires, Argentina",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.33",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain", "Argentina"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": ["orphan"],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Cost of stockout. A growing problem",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A16.1",
    "authors": "G Rodriguez Torne, MJ Sanchez Cuenca, F Burgos Sierra, C Fernandez Oropesa",
    "institution": "Hospital De Baza, Pharmacy Service, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.34",
    "filters": {
      "actSubs": ["Piperacillin / Tazobactam", "Docetaxel", "Paclitaxel", "Levothyroxine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Future distribution models for paid pharmaceuticals: the patient’s perspective",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A16.2",
    "authors": "C Olesen, MN Pedersen, MS Wellner",
    "institution": "Hospital Pharmacy Central Denmark Region, Clinical Pharmacy-Aarhus, Aarhus C, Denmark. Hospital Pharmacy Central Denmark Region, Department of for Paid Pharmaceuticals, Aarhus C, Denmark",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.35",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Denmark"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": ["telepharmacy"],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": ["delivery"],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Impact of the implementation of the falsified medicines directive at the Lisbon Portuguese Institute of Oncology (FG, EPE)",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A16.3",
    "authors": "AC Franco, A Gouveia",
    "institution": "Lisbon Portuguese Institute of Oncology Francisco Gentil Epe, Hospitalar Pharmacy, Lisbon, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.36",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": ["falsified"],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Four year study of drugs shortages in two public hospitals",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A17.1",
    "authors": "A Decoene, S Traore, A Pruvost, I Walbecq, P Mazaud",
    "institution": "Ch De Dunkerque, Pharmacy, Dunkerque, France. Chu De Lille, Pharmacy, Lille, France. Ch De Valenciennes, Pharmacy, Valenciennes, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.37",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Student's T-test"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Four years of shortages regarding the anatomic, therapeutic and chemical classification",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A17.2",
    "authors": "A Decoene, S Traore, I Walbecq, P Mazaud",
    "institution": "Ch De Dunkerque, Pharmacy, Dunkerque, France. Chu De Lille, Pharmacy, Lille, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.38",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Cephalosporins"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Impact of medicine shortages on an outpatient clinic of a general hospital ",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A18.1",
    "authors": "I Puértolas Tena, M Comet Bernad, C Moncín Torres",
    "institution": "Hospital Royo Villanova, Servicio De Farmacia, Zaragoza, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.39",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": ["Outpatient Clinic"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Survey of drug shortages in Hungarian hospitals",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A18.2",
    "authors": "RG Vida, S Sebők, B Nyaka, J Hornyák, L Botz",
    "institution": "University of Pécs Faculty of Pharmacy, Department of Pharmaceutics and Central Clinical Pharmacy, Pécs, Hungary. Semmelweis University, University Pharmacy Department of Pharmacy Administration, Budapest, Hungary",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.40",
    "filters": {
      "actSubs": ["Digoxin", "Sodium Ferric Gluconate", "Phytomenadione", "Immunoglobulin", "Idarubicin", "Amoxicillin / Clavulanic acid"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Hungary"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": ["selection"],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Drug shortages and drug unavailability: analysis from an Italian hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A19.1",
    "authors": "A Zovi, C Inserra, M Piacenza, V Stefania",
    "institution": "Asst Fatebenefratelli Sacco-L Sacco Hospital, Pharmacy, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.41",
    "filters": {
      "actSubs": ["Ampicillin", "Ceftazidime", "Midazolam", "Oxacillin", "Ferrous gluconate", "Glutathione", "Piperacillin / Tazobactam", "Lysine acetylsalicylate", "Hydrocortisone", "Suxamethonium", "Cefepime", "Methylprednisolone", "Heparin", "Atracurium", "Mupirocin", "Chlorphenamine", "Alprostadil", "Etilefrine", "Diazepam", "Lorazepam", "Fructose", "Labetalol", "Danazol", "Sodium nitroprusside"],
      "indication": [],
      "statedClass": ["Antibiotics", "Non-Steroidal Anti-Inflammatory Drugs", "Benzodiazepines", "Antihypertensives", "Dietetics", "Anaesthetics", "Urological Drugs", "Antihistamines", "Adrenergic Drugs"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "How much does falsified medicines directive actually costs? Detailed cost evaluation of serialisation in a representative sample of Hungarian hospital pharmacies",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A19.2",
    "authors": "A Fittler, K Richter, P Vajda, Z Bodrogi, RG Vida, R Bella, S Kovács, A Zemplényi, L Botz",
    "institution": "University of Pécs, Department of Pharmaceutics and Central Clinical Pharmacy, Pécs, Hungary. Szent Borbála Hospital, Department of Pharmacy, Tatabánya, Hungary. University of Pécs, Department of Pharmacoeconomics, Pécs, Hungary",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.42",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Hungary"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": ["falsified"],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Shortages of medicines in hospital: results of a survey on the perception of health workers in the wards VSV real world",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A20.1",
    "authors": "A Zovi, UM Musazzi, F Cilurzo, P Minghetti",
    "institution": "Asst Fatebenefratelli Sacco-L Sacco Hospital, Pharmacy, Milan, Italy. University of Milan, Department of Pharmaceutical Sciences, Milano, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.43",
    "filters": {
      "actSubs": ["Danazol", "Ceftazidime", "Oxacillin", "Lysine acetylsalicylate"],
      "indication": [],
      "statedClass": ["Antibiotics", "Corticosteroids", "Gastroprotectors", "Antihypertensives", "Benzodiazepines", "Psychostimulants", "Nutritional Agents", "Antihistamines", "Blood Products", "Biologicals"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": ["selection"],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Application of hazard vulnerability analysis to evaluate the risk level of medicine shortages",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A20.2",
    "authors": "E Di Martino, D Vinci Leonardi, R Giammona, A Provenzani, P Polidori",
    "institution": "Università Degli Studi Di Palermo, Stebicef, Palermo, Italy. Università Degli Studi Di Messina, Chimica-Biologia-Farmacia-Scienze Ambientali, Messina, Italy. Irccs Ismett, Clinical Pharmacy, Palermo, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.44",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Hazard Vulnerability Analysis"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Management of drug shortages",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A20.3",
    "authors": "MI Bernias Domínguez, M Mañes Sevilla, B Martin Cruz, B Santiago Gallego, I Escribano Valenciano, C Moriel Sánchez",
    "institution": "Hospital Universitario De Móstoles, Hospital Pharmacy, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.45",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Antimetabolites", "Corticosteroids", "Antiarrhythmics", "Antipsychotics"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Economic impact of drug shortages",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A21.1",
    "authors": "C Aparicio Carreño, Y Labeaga Beramendi, B Rodriguez, B Fernández González, A Gándara Ande, FJ Barbazán Vázquez, C Martínez-Múgica Barbosa, C Durán Román",
    "institution": "Cabueñes Hospital University, Pharmacy, Gijón, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.46",
    "filters": {
      "actSubs": ["Piperacillin / Tazobactam", "Alprostadil", "Dexchlorpheniramine", "Magnesium sulphate", "Clorazepate dipotassium", "Metoclopramide", "Sodium chloride", "Doxycycline", "Isoniazid / Pyrazinamide / Rifampicin", "BCG Vaccine (Tice strain)"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital", "Community Pharmacy"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Referencing a midline: how to make a choice?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A21.2",
    "authors": "P Behague, M Debailleul, L Lampe, N Garnier, V Colas, M Raoult, F Cathelineau, N Guenault, V Leclercq, C Canevet, E Floret",
    "institution": "Hôpital Saint Philibert, Service Pharmacie, Lomme, France. Hôpital Saint Philibert, Equipe Opérationnelle D’hygiène, Lomme, France. Hôpital Saint Philibert, Service D’anesthésie, Lomme, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.47",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Midlines"],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": ["youngPharma"],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Compatibility and stability assessment of a sodium glycerophosphate formulation mixed in bags for neonatal total parenteral nutrition",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A22.1",
    "authors": "A Isoardo, E Grande, MM Ferrero, M Viglione, B Rolando, R Fruttero, C Fruttero",
    "institution": "Ao S Croce E Carle, SC Farmacia Ospedaliera, Cuneo, Italy. Università Degli Studi Di Torino, Dipartimento Di Scienza E Tecnologia Del Farmaco, Torino, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.48",
    "filters": {
      "actSubs": ["Sodium glycerophosphate"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": ["incompatibilities"],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Microbiological stability test of 15% topical resorcinol for quality control",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A22.2",
    "authors": "J Cordero-Ramos, M Delgado-Valverde, V Merino-Bohórquez, C Castillo-Martin, FJ Falcón-Rodríguez, M Cameán-Fernández",
    "institution": "Hospital Universitario Virgen Macarena, Hospital Pharmacy, Seville, Spain. Hospital Universitario Virgen Macarena, Microbiology Department, Seville, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.49",
    "filters": {
      "actSubs": ["Resorcinol"],
      "indication": ["Hidradenitis suppurativa"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Terlipressin pH stability for continuous infusion",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A23.1",
    "authors": "A Castro Balado, J González-López, S Blanco-Dorado, EJ Bandín-Vilar, L García-Quintanilla, I Varela-Rey, M Busto Iglesias, M González-Barcia, I Zarra-Ferro",
    "institution": "Complejo Hospitalario Universitario De Santiago De Compostela, Hospital Pharmacist Service, Santiago De Compostela, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.50",
    "filters": {
      "actSubs": ["Terlipressin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Physicochemical stability of cefepime in polypropylene syringes and in elastomeric devices",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A23.2",
    "authors": "E D’huart, H Zenier, J Vigneron, A Charmillon, B Demore",
    "institution": "University Hospital of Nancy, Pharmacy Department, Vandoeuvre Lès Nancy, France. University Hospital of Nancy, Infectious and Tropical Diseases Department, Vandoeuvre Lès Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.51",
    "filters": {
      "actSubs": ["Cefepime"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Polypropylene Syringes", "Elastomeric Devices"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Physicochemical stability of cefazolin in polypropylene syringes and in elastomeric devices",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A24.1",
    "authors": "E D’huart, N Sobalak, J Vigneron, A Charmillon, B Demore",
    "institution": "University Hospital of Nancy, Pharmacy Department, Vandoeuvre Lès Nancy, France. University Hospital of Nancy, Infectious and Tropical Diseases Department, Vandoeuvre Lès Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.52",
    "filters": {
      "actSubs": ["Cefazolin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Polypropylene Syringes", "Elastomeric Devices"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Physicochemical stability of aztreonam in polypropylene syringes at high concentration for intensive care units",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A24.2",
    "authors": "YE Nisse, J Vigneron, F Blaise, E D’huart, A Charmillon, B Demoré",
    "institution": "Chru Nancy, Pharmacy, Vandoeuvre-Lès-Nancy, France. Chru Nancy, Infectious Diseases Department, Vandoeuvre-Lès-Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.53",
    "filters": {
      "actSubs": ["Aztreonam"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Polypropylene Syringes"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Levofloxacin 0.05% eye drops: a case study",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A24.3",
    "authors": "M Martín Marqués, A De Dios López, J Del Estal Jiménez, PA López Broseta, MÁ Roch Ventura, A Sanjuan Belda, S Jornet Montaña, E Esteve Pitarch, M Vuelta Arce, M Mendoza Aguilera, L Canadell Vilarrasa",
    "institution": "Hospital Universitari Joan Xxiii, Pharmacy, Tarragona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.54",
    "filters": {
      "actSubs": ["Levofloxacin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": ["Neonatal Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Intravenous perfusion of ceftolozane–tazobactam using elastomeric infusion pumps",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A25.1",
    "authors": "S Rotea, M García, B Feal, C Fernández, V Giménez, I Martín",
    "institution": "Hospital Pharmacy, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.55",
    "filters": {
      "actSubs": ["Ceftolozane / Tazobactam"],
      "indication": ["Pneumonia (Hospital Acquired)", "Severe Abdominal Infection", "Urinary Infection (Severe)"],
      "statedClass": [],
      "typeOfMedical": ["Elastomeric Infusion Pumps"],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Home Care Unit"],
      "numPatients": ["Less than 10"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": ["homeCare"],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Treatment of recurrent otomycosis with local application of a compounded formulation of voriconazole ear drops: case series",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A25.2",
    "authors": "L Carrasco Piernavieja, E Zhan Zhou, M Dominguez Bachiller, AM Martín De Rosales Cabrera, MS Marcos Salazar, M Perez Encinas",
    "institution": "Hospital Universitario Fundación Alcorcón, Hospital Pharmacy, Alcorcón, Spain. Hospital Universitario Fundación Alcorcón, Otorhinolaryngology, Alcorcón, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.56",
    "filters": {
      "actSubs": ["Voriconazole"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)", "STATA", "McNemar Test"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of the production accuracy and error rate in the automated compounding of cytotoxic preparations by a robot",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A26.1",
    "authors": "BR Kujau, J Raffaelli, C Klaas",
    "institution": "Universitätsklinikum Münster, Zentrale Einrichtung Apotheke, Münster, Germany. Loccioni Deutschland Gmbh, Humancare, Calw, Germany",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.57",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["More than 1000"],
      "criteriaMethod": [],
      "studyLength": ["6 months - 1 year"],
      "country": ["Germany"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Closed system transfer device based on air filtration: the drug vapour challenge",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A26.2",
    "authors": "G Levin",
    "institution": "Simplivia Healthcare, Research and Development, Hod Hasharon, Israel",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.58",
    "filters": {
      "actSubs": ["Cyclophosphamide", "Florourasil (5-FU)"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Closed System Drug-Transfer Device (CSTD)", "Vial Adaptors"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Liquid Chromatography Tandem - Mass Spectrometry (LC–MS/MS)"],
      "studyLength": [],
      "country": ["Israel"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Management of non-administered chemotherapy preparation: an opportunity to minimise drug waste in oncology pharmacy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A27.1",
    "authors": "A El Assil, C Adade, R Issa, H Bechar, A Zedou, A Fassi Fihri, Y Rahali",
    "institution": "Mohamed V University-Faculty of Medecine and Pharmacy, Department of Pharmacy, Rabat, Morocco. National Institute of Oncology-Ibn Sina University Hospital, Department of Pharmacy, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.59",
    "filters": {
      "actSubs": ["Docetaxel"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Centralised Cytotoxic Preparation Unit"],
      "numPatients": [],
      "numPrescriptions": ["51 - 100"],
      "criteriaMethod": [],
      "studyLength": ["6 months - 1 year"],
      "country": ["Morocco"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": ["vigilance"],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": ["incompatibilities"],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Comparative biophysical stability study of ziv-aflibercept (Zaltrap, opened vials) stored at 4°C and room temperature for 2 weeks",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A27.2",
    "authors": "J Hermosilla Fernández, A Salmeron García, J Cabeza, N Navas",
    "institution": "Biomedical Research Institute Ibs Granada, Analytical Chemistry-Science Faculty-University of Granada, Granada, Spain. Biomedical Research Institute Ibs Granada, Clinical Pharmacy-San Cecilio University Hospital, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.60",
    "filters": {
      "actSubs": ["Ziv-Aflibercept"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research", "Comparative Study"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Dynamic Light Scattering", "Size-Exclusion Chromatography (SEC)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Use of cabazitaxel and reduction of waste: the potential of drug day",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A28.1",
    "authors": "L Gasperoni, M Nardelli, A Caraffa, A Colicchio, M Mancini",
    "institution": "Azienda Ospedaliera Ospedali Riuniti Marche Nord, Uoc Farmacia, Pesaro, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.61",
    "filters": {
      "actSubs": ["Cabazitaxel"],
      "indication": ["Prostate Cancer (Metastatic Castration Resistant)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Short term stability of diluted solutions of the monoclonal antibody daratumumab",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A28.2",
    "authors": "G Mangoni, F Selmin, L Camuffo, L Cancanelli, M Piccoli, M Rivano, L Cervi, F Cilurzo, P Minghetti",
    "institution": "Università Degli Studi Di Milano, School of Specialisation in Hospital Pharmacy, Milano, Italy. Università Degli Studi Di Milano, Department of Pharmaceutical Sciences, Milano, Italy. Asst Grande Ospedale Metropolitano Niguarda, SC Farmacia, Milano, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.62",
    "filters": {
      "actSubs": ["Daratumumab"],
      "indication": ["Multiple Myeloma"],
      "statedClass": [],
      "typeOfMedical": ["Low Density Polyethylene (LDPE) Bags"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Size Exclusion Chromatography - High Performance Liquid Chromatography (SEC-HPLC)", "Dynamic Light Scattering", "Nanoparticle Tracking Analysis (NTA)"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Stability of compounded nivolumab solution after pneumatic system transportation",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A29.1",
    "authors": "L Camuffo, F Selmin, F Vasile, M Rivano, M Piccoli, G Mangoni, L Cancanelli, M Fazio, F Cilurzo, P Minghetti",
    "institution": "University of Milan, School in Hospital Pharmacy, Milan, Italy. Humanitas Research Hospital, Pharmacy, Rozzano, Italy. University of Milan, Department of Pharmaceutical Sciences, Milan, Italy. San Raffaele Hospital, Pharmacy, Milan, Italy. University of Milan, Department of Chemistry, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.63",
    "filters": {
      "actSubs": ["Nivolumab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Dynamic Light Scattering", "Nuclear Magnetic Resonance", "Size Exclusion Chromatography - High Performance Liquid Chromatography (SEC-HPLC)"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Increasing pharmacy productivity by expanding the role of the intravenous compounding robot in a comprehensive cancer centre",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A29.2",
    "authors": "M Capilli, M Federici, T Comandone, G Maffeis, F Foglio, L Omini, F Enrico",
    "institution": "University of Turin, Drug Science and Technology-School of Specialisation in Hospital Pharmacy, Turin, Italy. Loccioni, Angeli Di Rosora, Ancona, Italy. University of Turin, Drug Science and Technology, Turin, Italy. Fpo Irccs Candiolo, Hospital Pharmacy, Candiolo, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.64",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Mitomycin C stability according to pH and temperature conditions",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A29.3",
    "authors": "G Miralles Andreu, I Truyols García, M Pomares Bernabeu, L Soriano Irigaray, L Peral Ballester, A Navarro Ruiz",
    "institution": "Hospital General Universitario De Elche, Hospital Pharmacy Department, Elche, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.65",
    "filters": {
      "actSubs": ["Mitomycin C"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "In use physicochemical and microbiological stability of diluted solutions of the monoclonal antibody nivolumab",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A30.1",
    "authors": "M Rivano, F Selmin, L Camuffo, L Cancanelli, G Mangoni, MA Piccoli, G Longobardo, F Cilurzo, P Minghetti",
    "institution": "University of Milan, School of Hospital Pharmacy, Milan, Italy. University of Milan, Department of Pharmaceutical Sciences, Milan, Italy. Irccs San Raffaele, Pharmacy, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.66",
    "filters": {
      "actSubs": ["Nivolumab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Dynamic Light Scattering", "Size Exclusion Chromatography - High Performance Liquid Chromatography (SEC-HPLC)", "Gel Electrophoresis"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": ["flatDoses"],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Physicochemical stability of 25 mg/mL pemetrexed diarginine in partially used vials and 3 and 12 mg/mL diluted in dextrose 5% in polyolefin bag",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A30.2",
    "authors": "YE Nisse, J Vigneron, N Sobalak, B Demoré",
    "institution": "Chru Nancy, Pharmacy, Vandoeuvre-Lès-Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.67",
    "filters": {
      "actSubs": ["Pemetrexed"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Storage of nivolumab pembrolizumab and daratumumab for 14 days after compounding in the hospital pharmacy: a microbiological stability study",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A31.1",
    "authors": "L Cancanelli, F Selmin, L Camuffo, G Mangoni, M Piccoli, M Rivano, F Cilurzo, P Minghetti",
    "institution": "Università Degli Studi Di Milano, Department of Pharmaceutical Sciences, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.68",
    "filters": {
      "actSubs": ["Nivolumab", "Pembrolizumab", "Daratumumab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Particulate quality of a controlled atmosphere area. Compliance with good manufacturing practices at rest and during activity, highlighting factors impacting on contamination",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A31.2",
    "authors": "M Pottier, M Naveau, A Villain, G Strobbe, I Sakji, F Feutry, G Marliot",
    "institution": "Centre Oscar Lambret, Pharmacy, Lille, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.69",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Development and validation of a discriminative method for anthracyclines used in oncology by visible spectrometer",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A32.1",
    "authors": "CA Adade, A El Orche, H Attjioui, A Cheikh, H Mefetah, M El Karbane, M Bouatia",
    "institution": "Mohamed V University-Faculty of Medicine and Pharmacy, Analytical Chemistry Laboratory, Rabat, Morocco. University of Sultan Moulay Slimane Beni-Mellal, Faculty of Science and Technology, Beni-Mellal, Morocco. Abulcasis University of Health Sciences, Faculty of Pharmacy, Rabat, Morocco. Paediatric Hospital, Pharmacy, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.70",
    "filters": {
      "actSubs": ["Daunorubicin", "Doxorubicin", "Epirubicin"],
      "indication": [],
      "statedClass": ["Anthracyclines"],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": ["Paediatric Haematology – Oncology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Partial Least Squares Discriminant Analysis (PLS-DA)", "Ultraviolet – Visible Spectrophotometry"],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "The effects of freeze–thaw cycling on the stability of the adalimumab biosimilar SB5",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A32.2",
    "authors": "H Ebbers, J Kim, J Yun, D Park, SJ Hwang, SJ Park",
    "institution": "Biogen International GmbH, Scientific Affairs, Baar, Switzerland. Samsung Bioepis Co Ltd, Qc Group, Incheon, Korea South",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.71",
    "filters": {
      "actSubs": ["Adalimumab"],
      "indication": [],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": ["Prefilled Syringes"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Size Exclusion Chromatography - High Performance Liquid Chromatography (SEC-HPLC)", "Capillary Electrophoresis - Sodium Dodecyl Sulfate (CE-SDS) (non-reducing)", "Fluorescence Resonance Energy Transfer (FRET)"],
      "studyLength": [],
      "country": ["Switzerland", "South Korea"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": ["coldChain"],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Magistral formulation for a patient with multiple food allergy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A33.1",
    "authors": "Y Jiménez López, E Pérez Cano, M Merino Almazán, R Claramunt García, MI Sierra Torres, I Caba Porras",
    "institution": "Hospital Universitario De Jaén, Pharmacy Service, Jaén, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.72",
    "filters": {
      "actSubs": ["Iron", "Zinc", "Sirolimus"],
      "indication": ["Multiple Food Allergy (MFA)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Formulation and galenic characterisation of a tacrolimus adhesive gel for treatment of ulcerative proctitis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A33.2",
    "authors": "MF Pérez Almagro, C Perelló Alomar, MM Santandreu Estelrich, M Ortiz González, M Gómez Zamora, E Rodríguez Campos, B García García, FJ Cámara Aguilera, O Delgado Sánchez",
    "institution": "Hospital Universitario Son Espases, Hospital Pharmacy, Palma De Mallorca, Spain. Hospital Universitario Son Espases, Laboratory Medicine Department, Palma De Mallorca, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.73",
    "filters": {
      "actSubs": ["Tacrolimus"],
      "indication": ["Ulcerative Proctitis"],
      "statedClass": [],
      "typeOfMedical": ["Luer-Lock Syringes", "Rectal Cannulas"],
      "studyDesign": [],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Long term stability of a ready to use topical anaesthetic gel kit",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A34.1",
    "authors": "E Dijkers, H Polonini, A Ferreira, C Zander",
    "institution": "Global Innovation Project Manager, Fagron Bv, Rotterdam, The Netherlands. Ortofarma Analytical Services, Ortofarma Analytical Services, Matias Barbosa, Brazil. Fagron Inc, Fagron Inc, Saint Paul, USA",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.74",
    "filters": {
      "actSubs": ["Lidocaine hydrochloride", "Epinephrine bitartrate", "Tetracaine hydrochloride", "Sodium metabisulfite"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Prefilled Syringes"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High-Performance Liquid Chromatography - Ultraviolet (HPLC-UV)"],
      "studyLength": [],
      "country": ["Netherlands", "Brazil", "USA"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Compounding an oral liquid formulation of diazepam alcohol free",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A34.2",
    "authors": "R Barbosa, A Capela, C Sampaio, S Fraga, T Soares, J Campos, D Ferreira, P Costa, L Bighinati",
    "institution": "Centro Hospitalar E Universitário São João- Epe, Pharmacy, Oporto, Portugal. Faculdade De Farmácia Da Universidade Do Porto, Ucibio- Requimte-Pharmaceutical Tecnology, Oporto, Portugal. Universitá Degli Studi Di Modena E Reggio Emilia, Chimica E Tecnologia Farmaceutiche, Modena, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.75",
    "filters": {
      "actSubs": ["Diazepam"],
      "indication": ["Epilepsy"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["Portugal", "Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Paediatric drug resistant epilepsy: nitrazepam 1 mg/mL solutions to avoid clinical therapeutic error",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A35.1",
    "authors": "MA Berardi, GB Ortenzi, V Moretti, E Adresciani, AMF Garzone, S Cappanera, C Polidori, A Pompilio",
    "institution": "Università Degli Studi Di Camerino ‘Scuola Di Scienze Del Farmaco E Dei Prodotti Della Salute’, Facoltà Di Farmacia, Camerino, Italy. Ospedali Riuniti Di Ancona, Sod Farmacia Pediatrica Ospedale Pediatrico G Salesi, Ancona, Italy. Ospedali Riuniti Ancona, Sod Neuropsichiatria Infantile, Ancona, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.76",
    "filters": {
      "actSubs": ["Nitrazepam", "Levetiracetam", "Clobazam", "Topiramate"],
      "indication": ["Epilepsy (Drug-Resistant)", "Lennox–Gastaut Syndrome"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["International League Against Epilepsy Criteria", "High-Performance Liquid Chromatography - Ultraviolet (HPLC-UV)", "Triple Quadrupole Mass Spectrometer (QqQ MS)"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Analytical method validation to carry out physicochemical stability studies of methadone oral solutions",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A35.2",
    "authors": "EA Álvaro Alonso, MP Lorenzo García, FJ Rupérez Pascualena, A Aguilar Ros, P Tejedor Prado, A Lázaro Cebas, I Cañamares Orbis, S Esteban Casado, A Such Díaz, I Escobar Rodríguez",
    "institution": "Hospital Universitario Infanta Leonor, Pharmacy, Madrid, Spain. Universidad Ceu San Pablo, Pharmacy, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.77",
    "filters": {
      "actSubs": ["Methadone"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High-Performance Liquid Chromatography - Ultraviolet (HPLC-UV)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Current state of the anti-infective ophthalmic compounding formulation in pharmacy services: a national survey",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A36.1",
    "authors": "A Castro Balado, L Garcia-Quintanilla, C Mondelo-García, M González-Barcia, I Zarra-Ferro, A Fernández-Ferreiro",
    "institution": "Complejo Hospitalario Universitario De Santiago De Compostela, Hospital Pharmacist Service, Santiago De Compostela, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.78",
    "filters": {
      "actSubs": ["Vancomycin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Autologous tissue adhesive in ophthalmological surgery",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A36.2",
    "authors": "S Berisa, M Medina Persinal, N Vazquez, M Chacon, J Merayo-Lloves, A Meana, L Fernandez-Vega Cueto-Felgueroso",
    "institution": "Instituto Oftalmológico Fernández Vega, Farmacia, Oviedo, Spain. Instituto Oftalmológico Fernández-Vega, Advanced Therapies and Regenerative Medicine, Oviedo, Spain. Instituto Universitario Fernández Vega, Advanced Therapies and Regenerative Medicine, Oviedo, Spain. Instituto Universitario Fernández Vega, Ophthalmology, Oviedo, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.79",
    "filters": {
      "actSubs": ["Human fibrinogen / Human thrombin"],
      "indication": [],
      "statedClass": ["Autologous Fibrin Tissue Adhesive"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Intracameral and intrastromal voriconazole administration in fusarium keratitis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A37.1",
    "authors": "S Gutiérrez Palomo, IM Moreno Escudero, A Rochina Astorga, A Quesada Asencio, L Peral Ballester, A Navarro Ruiz",
    "institution": "Hospital General Universitario De Elche, Pharmacy, Elche, Spain. Hospital General Universitario De Elche, Ophthalmology, Elche, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.80",
    "filters": {
      "actSubs": ["Voriconazole"],
      "indication": ["Fusarium Keratitis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Content uniformity of extemporaneous compounded suspensions",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A37.2",
    "authors": "E Dijkers, H Polonini, A Ferreira",
    "institution": "Global Innovation Project Manager, Fagron Bv, Rotterdam, The Netherlands. Ortofarma Analytical Services, Ortofarma Analytical Services, Matias Barbosa, Brazil",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.81",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Oral Liquid Vehicle Range"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High-Performance Liquid Chromatography - Ultraviolet (HPLC-UV)"],
      "studyLength": [],
      "country": ["Netherlands", "Brazil"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "93% oxygen self-production: experience in an Italian hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A38.1",
    "authors": "M Lecis, E Viglione, S Strobino, G Ceravolo",
    "institution": "Asl To3, Hospital Pharmacy, Rivoli, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.82",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Randomized Controlled Trial"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Case study: development of an ointment according to the Pharmaceutical Inspection Convention guideline",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A38.2",
    "authors": "L Pascual Masiá, E Rizkallal, M Machetti, C Lacasa, MI Calvo, F Martínez-Galán",
    "institution": "University of Navarra, Department of Pharmaceutical Technology and Chemistry, Pamplona, Spain. University of Navarra, Pharmacy Services-Clínica Universitaria De Navarra, Pamplona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.83",
    "filters": {
      "actSubs": ["Phenylephrine hydrochloride", "Lidocaine hydrochloride", "Hydrocortisone"],
      "indication": ["Haemorrhoid"],
      "statedClass": ["Vasoconstrictors", "Local Anaesthetics", "Glucocorticoids"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Laboratory", "Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Sterility of single use vials when accessed using a closed system transfer device",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A39.1",
    "authors": "JA Schoenenberger Arnaiz, M Nevot-Blanc, A Moroba-Estor, M Gonzalez-Garcia, M Martinez-Sogues, M Gilabert-Sotoca",
    "institution": "Hospital Universitari Arnau De Vilanova, Pharmacy, Lleida, Spain. Hospital Universitari Santa Maria, Pharmacy, Lleida, Spain. Irblleida, Clinical Trials, Lleida, Spain. Hospital Universitari Arnau De Vilanova, Microbiology, Lleida, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.84",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Single Use Vials", "Closed System Drug-Transfer Device (CSTD)"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Physicochemical stability of the bevacizumab biosimilar, ABP 215, in intravenous bags after preparation and storage",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A39.2",
    "authors": "J Seckute, I Castellanos, S Bane",
    "institution": "Amgen, Process Development, Cambridge, Massachusetts, USA",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.85",
    "filters": {
      "actSubs": ["Bevacizumab"],
      "indication": [],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Size-Exclusion Chromatography (SEC)", "Capillary Electrophoresis", "Cation Exchange Chromatography", "Subvisible Particle Testing"],
      "studyLength": [],
      "country": ["USA"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Optimisation of mixing an oral powder mixture of codeine prepared in the hospital pharmacy for filling into hard capsules",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A40.1",
    "authors": "L Bouz, S Klovrzová, L Matysová",
    "institution": "Institute for Clinical and Experimental Medicine, Hospital Pharmacy, Prague, Czech Republic. Charles University-Faculty of Pharmacy, Department of Analytical Chemistry, Hradec Králové, Czech Republic",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.86",
    "filters": {
      "actSubs": ["Codeine"],
      "indication": ["Diarrhoea (Chronic)", "Irritable Bowel Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Spectrophotometry", "Relative Standard Deviation (RSD)"],
      "studyLength": [],
      "country": ["Czech Republic"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Galenic validation of a dexamethasone 0.01% mouthwash solution to prevent everolimus related stomatitis ",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A40.2",
    "authors": "J Vicente Valor, JL Herrero Revuelta, MS Pernia López, A Herranz Alonso, M Sanjurjo Sáez",
    "institution": "Gregorio Marañón University General Hospital, Pharmacy Service, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.87",
    "filters": {
      "actSubs": ["Everolimus", "Dexamethasone"],
      "indication": ["Stomatitis", "Breast Cancer (HR Positive / HER2 Negative Metastatic)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Surface contamination with cytotoxic drugs in European hospital wards",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A41.1",
    "authors": "E Korczowska, H Jankowiak-Gracz, M Crul, J Tuerk, D Arnold, K Meier",
    "institution": "University Hospital of Lord’s Transfiguration, Hospital Pharmacy, Poznan, Poland. Amsterdam University Medical Centre, Department of Clinical Pharmacology and Pharmacy, Amsterdam, The Netherlands. Institute of Energy and Environmental Technology, Iuta, Duisburg, Germany. Department of Medical Oncology, Klinik Für Tumorbiologie, Freiburg, Germany. Institute For Applied Healthcare Sciences, Ifahs, Hamburg, Germany",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.88",
    "filters": {
      "actSubs": ["Cyclophosphamide", "Florourasil (5-FU)", "Paclitaxel", "Gemcitabine"],
      "indication": [],
      "statedClass": ["Platinum Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Liquid Chromatography Tandem - Mass Spectrometry (LC–MS/MS)", "Inductively Coupled Plasma Mass Spectrometry (ICP-MS)"],
      "studyLength": [],
      "country": ["Poland", "Netherlands", "Germany"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "The significance of pharmacy preparation in paediatrics: making individual therapies for critically ill children possible",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A41.2",
    "authors": "B Verdino, K Nemec",
    "institution": "Donauspital, Hospital Pharmacy, Vienna, Austria",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.89",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Neonatal Intensive Care", "Paediatric Intensive Care"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Austria"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": ["personalized"],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Hazardous drugs: impact of measures for safe handling",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A42.1",
    "authors": "S Buendía-Bravo, C Gastalver-Martin, AM Iglesias-Bolaños, C Capilla-Montes, T Cruz-Cruz",
    "institution": "Hospital Universitario Del Sureste, Pharmacy, Arganda Del Rey, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.90",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "In use physicochemical stability of pembrolizumab under the dilution condition required for use in a day hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A42.2",
    "authors": "M Piccoli, F Selmin, G Mangoni, L Camuffo, L Cancanelli, M Rivano, C Jemos, F Cilurzo, E Omodeo Salè",
    "institution": "Università Degli Studi Di Milano, Pharmaceutical Sciences, Milano, Italy. Istituto Europeo Di Oncologia, Hospital Pharmacy, Milano, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.91",
    "filters": {
      "actSubs": ["Pembrolizumab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Polyolefin Infusion Bags"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Dynamic Light Scattering", "Size Exclusion Chromatography - High Performance Liquid Chromatography (SEC-HPLC)", "Nanoparticle Tracking Analysis (NTA)"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": ["flatDoses"],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Impact of the preparation of a clinical solution of rituximab 1.0 mg/mL on the particulates (aggregation) measured by dynamic light scattering: sodium chloride and glucose concentration, and agitation effect",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A43.1",
    "authors": "N Natalia-Iglesias, J Hermosilla, J Exposito, A Salmerón-Garcia, J Cabeza",
    "institution": "Science Faculty-Institute for Biomedical Research-University of Granada, Analytical Chemistry, Granada, Spain. San Cecilio University Hospital/Institute for Biomedical Research, Clinical Pharmacy, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.92",
    "filters": {
      "actSubs": ["Rituximab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Dynamic Light Scattering"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Parenteral nutrition admixtures: review of the microbiological sampling plan",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A43.2",
    "authors": "C Sampaio, A Capela, R Barbosa, S Fraga, T Soares, M Ribeiro, C Teixeira",
    "institution": "Centro Hospitalar Universitário São João, Pharmacy, 4200–319 Porto, Portugal. Centro Hospitalar Universitário São João, Clinical Pathology, 4200–319 Porto, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.93",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Study of the Trigon depot allergy test (triamcinolone and excipients: carboxymethylcellulose, polysorbate 80) developed in the pharmacy department",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A44.1",
    "authors": "P Pacheco, N Manresa-Ramón, MA Meroño-Saura, MÁ Carvajal-Sánchez, S Clavijos-Bautista, TM Rodríguez-Martínez, C Fernández-Zamora, J Ibañez-Caturla, AM Mora-González",
    "institution": "Hospital General Universitario Morales Meseguer, Pharmacy, Murcia, Spain. Hospital General Universitario Morales Meseguer, Allergology, Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.94",
    "filters": {
      "actSubs": ["Triamcinolone", "Docetaxel"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Importance of non-sterile formulation in a paediatric hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A44.2",
    "authors": "D Gavrus Ion, JM Català Foguet, M Sanchez Celma, JA Cuartero Lozano, M Villaronga Flaqué, R Farre Riba, F Bossacoma Busquets",
    "institution": "Hospital Sant Joan De Déu, Pharmacy, Esplugues De Llobregat, Spain. Hospital Sant Joan De Déu/Fundació Salut Empordà, Pharmacy, Esplugues De Llobregat, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.95",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Digestive System and Metabolism Drugs", "Blood and Haematopoietic Derivatives", "Cardiovascular Drugs", "Dermatological Drugs", "Hormonal Drugs", "Anti-Infective Drugs", "Antineoplastics and Immunomodulators", "Musculoskeletal System Drugs", "Nervous System Drugs", "Antiparasitics", "Respiratory System Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Imipenem–cilastatin fortified eye drops for the treatment of corneal ulcers caused by contact lenses: development and characterisation",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A45.1",
    "authors": "P Pacheco, N Manresa-Ramón, MÁ Carvajal-Sánchez, T Rodríguez-Martínez, MA Meroño-Saura, S Clavijos-Bautista, C Fernández-Zamora, J Ibañez-Caturla",
    "institution": "Hospital General Universitario Morales Meseguer, Pharmacy, Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.96",
    "filters": {
      "actSubs": ["Imipenem / Cilastatin"],
      "indication": ["Ulcer (Corneal)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": ["Emergency Department", "Ophthalmology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Importance of compounding in the paediatric hospital pharmacy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A45.2",
    "authors": "JM Català Foguet, D Gavrus Ion, M Sánchez Celma, M Villaronga Flaqué, R Farré Riba, F Bossacoma Busquets",
    "institution": "Hospital Sant Joan De Déu, Pharmacy, Esplugues De Llobregat, Spain. Hospital Sant Joan De Déu/Fundació Salut Empordà, Pharmacy, Esplugues De Llobregat, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.97",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Circuit to prepare and condition oral hazardous medicines",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A46.1",
    "authors": "A Benito Reyes, C Otero Villalustre, D Dorta Vera, D Fernández Vera, MÁ Perez Cruz, J Montoya Matellanes, E Dolz Bubbi, M Lobardero Pin",
    "institution": "Complejo Hospitalario Universitario Insular Materno Infantil, Pharmacy, Las Palmas De Gran Canaria, Spain. Hospital Universitario Araba Sede Txagorritxu, Pharmacy, Alava, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.98",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],  
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Hazardous medicines in a paediatric hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A46.2",
    "authors": "D Gavrus Ion, JM Català Foguet, A Diaz Cambron, MA Romo Murillo, J Vinent Genestar, R Farré Riba, F Bossacoma Busquets",
    "institution": "Hospital Sant Joan De Déu, Pharmacy Department, Esplugues Del Llobregat Barcelona, Spain. Hospital Sant Joan De Déu/Fundació Salut Empordà, Pharmacy Department, Esplugues Del Llobregat Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.99",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Impact of serialisation on reception of medicines and activity smoothing",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A47.1",
    "authors": "P Lacassagne",
    "institution": "Intern in Pharmacy, 31270, Cugnaux, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.100",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Sodium benzoate suspension in non-ketotic hyperglycinaemia: a case report",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A47.2",
    "authors": "S Inmaculada, F Valiente Borrego, M Muros, N Lucas, MA Sarabia, MA Rodriguez, J Ramos, I Alarcon",
    "institution": "Hospital De La Vega Lorenzo Guirao, Pharmacy, Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.101",
    "filters": {
      "actSubs": ["Sodium benzoate"],
      "indication": ["Nonketotic Hyperglycinemia"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": ["orphan"],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Magistral formulation of 10% sucralfate enemas in proctitis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A37.2",
    "authors": "A Gascón Villacampa, M Pio, M Marin, N Alzueta, D Perez, M Castresana",
    "institution": "Hospital Reina Sofia- Tudela, Pharmacy, Tudela, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.82",
    "filters": {
      "actSubs": ["Sucralfate"],
      "indication": ["Proctitis", "Prostate Cancer", "Rectal Neoplasia", "Endometrial Neoplasia", "Anemia", "Diarrhoea"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["Less than 10"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Preliminary results on the use of oral rehydration solution in the form of gelato for rehydration of children with acute gastroenteritis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A38.1",
    "authors": "G Zvigule Neidere, A Barzdina, G Laizane, I Sviestina, K Gross",
    "institution": "Riga Stradins University, Paediatrics, Riga, Latvia. Riga Stradins University, Anaesthesiology and Intensive Care, Riga, Latvia. Children’s Clinical University Hospital, Infectology, Riga, Latvia. Children’s Clinical University Hospital, Pharmacy, Riga, Latvia. Riga Technical University, Faculty of Materials Science and Applied Chemistry, Riga, Latvia",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.83",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Latvia"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Weight-lowering pseudoephedrine-based prescriptions: monitoring patient feedback after update of national price list of medicines and magistral preparation",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A38.2",
    "authors": "A Pirrone, V Marangon, AA Nisic, F Panzeri, L Cavallo, AL Manfredi, G Palmieri, MG Pizzonia, M Avantaggiato",
    "institution": "Universita Degli Studi di Milano, Scienze Farmaceutiche – Scuola di Specializzazione in Farmacia Ospedaliera, Milano, Italy. ATS Brianza, Pharmacy Service, Monza, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.84",
    "filters": {
      "actSubs": ["Pseudoephedrine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Community Pharmacy"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": ["More than 1000"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "What happens when insulin aspart is diluted in dextrose?",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A38.3",
    "authors": "LH Préta, H Henry, M Masse, N Carta, M Kouach, C Foulon, JF Goossens, D Lannoy, S Genay, B Decaudin, P Odou",
    "institution": "Université de Lille, EA 7365 – Grita – Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Lille, France. Université de Lille- Chu de Lille, EA 7365 – Grita – Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Lille, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.85",
    "filters": {
      "actSubs": ["Insulin aspart"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High-Performance Liquid Chromatography - Ultraviolet (HPLC-UV)", "High Performance Liquid Chromatography - Mass Spectrometry Detection (HPLC-MS)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Stability study of a 10% sodium benzoate oral solution",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A39.1",
    "authors": "A Castro Balado, A Bayón Fernández, I Adán Barrientos, JM Giráldez Montero, I Varela Rey, A Fernández Ferreiro, M González Barcia, I Zarra Ferro",
    "institution": "Clinical University Hospital Santiago de Compostela Sergas, Hospital Pharmacy Department, Santiago de Compostela, Spain. Faculty of Pharmacy- University of Santiago de Compostela USC, Pharmacy and Pharmaceutical Technology Department, Santiago de Compostela, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.86",
    "filters": {
      "actSubs": ["Sodium benzoate"],
      "indication": ["Urea Cycle Defects (UCD)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Spectrophotometry"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Analysis of the regimens established at the pharmacy service for total parenteral nutrition and the use of glutamine as a source of nitrogen",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A39.2",
    "authors": "O Montero Pérez, P Selvi Sabater, A Peláez Bejarano, D Yáñez Feria, E Sánchez Gómez",
    "institution": "Hospital Juan Ramón Jiménez, Pharmacy Service, Huelva, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.87",
    "filters": {
      "actSubs": ["Glutamine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Critical Care Unit"],
      "numPatients": [],
      "numPrescriptions": ["More than 1000"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Implementation and quality control of a 5% fructose and 10% glycerol sterile solution for digestive endoscopy",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A40.1",
    "authors": "M Roche, D Lannoy, C Nassar, F Bourdon, C Berneron, J Branche, P Odou",
    "institution": "CHRU Lille, Pharmacie, Lille Cedex, France. CHRU Lille, Maladies de L’Appareil Digestif, Lille Cedex, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.88",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High-Performance Liquid Chromatography - Ultraviolet (HPLC-UV)", "Kinetic Chromogenic Method", "Light Obscuration"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Physicochemical stability of norepinephrine bitartrate in polypropylene syringes at high concentrations for intensive care units",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A40.2",
    "authors": "E D’Huart, J Vigneron, B Demoré",
    "institution": "University Hospital of Nancy, Pharmacy, Vandoeuvre Lès Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.89",
    "filters": {
      "actSubs": ["Norepinephrine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Polypropylene Syringes"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)", "Spectrophotometry"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Successful treatment of hamartoma in child syndrome after 30 months with topical administration of simvastatin/cholesterol cream: a case report",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A41.1",
    "authors": "H Crametz, D Lannoy, B Catteau, V Foulon, C Nassar, M Roche, P Odou",
    "institution": "CHRU Lille, Pharmacie, Lille Cedex, France. CHRU Lille, Dermatologie, Lille Cedex, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.90",
    "filters": {
      "actSubs": ["Simvastatin / Cholesterol (TFSC)"],
      "indication": ["Epidermical Hamartoma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Stability of chlorhexidine 0.05% eye drops compounding drug",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A41.2",
    "authors": "S Berisa, L Macia, A Fernández, FJ Otero, X García",
    "institution": "Instituto Oftalmológico Fernández Vega, Pharmacy, Oviedo, Spain. Santiago de Compostela University, Pharmacy, Santiago de Compostela, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.91",
    "filters": {
      "actSubs": ["Chlorhexidine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": ["preopMedication"],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effectiveness of 3% topical imiquimod in off-label use for oral florida papillomatosis: a case report",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A42.1",
    "authors": "L Rendón de Lope, P Ruiz Huertas, C Donoso-Rengifo, M Murillo Izquierdo, C Castillo Martin, J Cordero Ramos, MD Alvarado Fernandez, M Fernandez Gonzalez, ML Moya Martin",
    "institution": "Hospital Universitario Virgen Macarena, Pharmacy, Seville, Spain. Hospital Universitario Virgen Macarena, Oral and Maxilofacial Surgery, Seville, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.92",
    "filters": {
      "actSubs": ["Imiquimod"],
      "indication": ["Papillomatosis (Oral Florid)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Topical cidofovir compounding cream for the treatment of disseminated infection by molluscum contagiosum",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A42.2",
    "authors": "R Barbosa, M Vieira, P Carinha, C Lisboa, N Gomes, M Costa-Silva",
    "institution": "Centro Hospitalar e Universitário São João- Epe, Pharmacy, Oporto, Portugal. Centro Hospitalar e Universitário São João- Epe, Dermatology Service, Oporto, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.93",
    "filters": {
      "actSubs": ["Cidofovir"],
      "indication": ["Molluscum Contagiosum", "Erythroderma (Severe)"],
      "statedClass": [],
      "typeOfMedical": ["Luer-Lock Syringes"],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Portugal"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Feedback from a feasibility study of allergy test preparations in day hospitalisation",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A42.3",
    "authors": "A Leleux, S Tombelle, F Danicourt",
    "institution": "Dunkerque Hospital Center, Pharmacy, Dunkerque, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.94",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Antibiotics", "Analgesics", "Local Anaesthetics", "Iodinated Contrast Products", "Non-Steroidal Anti-Inflammatory Drugs"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Dermatology", "Paediatrics", "Pneumology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Stability of 1 mg/ml and 4 mg/ml hydrocortisone solium succinate solutions in 0.9% sodium chloride and 5% glucose",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A43.1",
    "authors": "K Mihovec, R Roškar, &Zcaron; Temova Rakuša, EE Gaal",
    "institution": "UKC Ljubljana, Pharmacy, Ljubljana, Slovenia. University of Ljubljana- Faculty of Pharmacy, Biopharmaceutics and Pharmacokinetics, Ljubljana, Slovenia",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.95",
    "filters": {
      "actSubs": ["Hydrocortisone"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["Slovenia"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Physicochemical stability of cefotaxime in polypropylene syringes at high concentrations for intensive care units",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A43.2",
    "authors": "E D’Huart, J Vigneron, F Blaise, A Charmillon, B Demoré",
    "institution": "University Hospital of Nancy, Pharmacy, Vandoeuvre Lès Nancy, France. University Hospital of Nancy, Infectious and Tropical Diseases Service, Vandoeuvre Lès Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.96",
    "filters": {
      "actSubs": ["Cefotaxime"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Polypropylene Syringes"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Physicochemical stability of vancomycin hydrochloride in polypropylene syringes at high concentrations for intensive care units",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A44.1",
    "authors": "E D’Huart, J Vigneron, A Charmillon, B Demoré",
    "institution": "University Hospital of Nancy, Pharmacy, Vandoeuvre Lès Nancy, France. University Hospital of Nancy, Infectious and Tropical Diseases Service, Vandoeuvre Lès Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.97",
    "filters": {
      "actSubs": ["Vancomycin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Polypropylene Syringes"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Physical compatibility of intravenous anti-infective drugs with medications commonly used in intensive care units",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A44.2",
    "authors": "E D’Huart, J Vigneron, B Demoré",
    "institution": "University Hospital of Nancy, Pharmacy, Vandoeuvre Lès Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.98",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Anti-Infective Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study", "Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Ultraviolet – Visible Spectrophotometry", "Turbidimetry"],
      "studyLength": ["Less than 3 months"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": ["incompatibilities"],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Implementation of quality control of paediatric cytotoxic drug preparations: pilot trial with etoposide",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A45.1",
    "authors": "M Alami Chentoufi, I Bennani, M Benabbes, S Bennis, L Yachi, M Bouatia",
    "institution": "Mohamed V University, Faculty of Medicine and Pharmacy, Rabat, Morocco. Mohamed V University- Faculty of Medicine and Pharmacy, IBN Sina Hospital University Centre- Paediatric Hospital, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.99",
    "filters": {
      "actSubs": ["Etoposide"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Ultraviolet – Visible Spectrophotometry"],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Risk management of cross-contamination of paediatric anti-cancer preparations using failure mode and effects criticality analysis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A45.2",
    "authors": "M Alami Chentoufi, M Benabbes, S Bennis, L Yachi, I Bennani, A Cheikh, H Meftah, M Bouatia",
    "institution": "Mohamed V University, Faculty of Medicine and Pharmacy, Rabat, Morocco. Abulcasis University, Faculty of Pharmacy, Rabat, Morocco. Paediatric Hospital, IBN Sina Hospital University Centre, Rabat, Morocco. IBN Sina Hospital University Centre- Paediatric Hospital, University Mohamed V- Faculty of Pharmacy, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.100",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Failure Mode, Effects and Criticality Analysis (FMECA)"],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Nivolumab weight-based dosing vs flat dose economic analysis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A45.3",
    "authors": "C Bianconi, G Gandini, G Zanotti, M Dall’Ara, E Sterzi, R Barbazza, P Marini",
    "institution": "Azienda Ospedaliera Universitaria Integrata Verona, Hospital Pharmacy, Verona, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.101",
    "filters": {
      "actSubs": ["Nivolumab"],
      "indication": ["Melanoma", "Renal Cell Cancer", "Non-Small Cell Lung Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": ["flatDoses"],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Impact of a centralised intravenous additive service in patients and healthcare workers risk reduction",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A46.1",
    "authors": "Á Marcos Fendián, A Sancho Artés, P Llopis Salvia, M Climente Martí",
    "institution": "Hospital Universitario Doctor Peset, Pharmacy, Valencia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.102",
    "filters": {
      "actSubs": ["Valproic acid"],
      "indication": [],
      "statedClass": ["Antibiotics", "Antiepileptics", "Analgesics", "Proton-Pump Inhibitors", "Corticosteroids"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Centralised Intravenous Additive Service"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": ["personalized"],
      "nutrition": ["nutrition"],
      "highRisk": ["highRisk"],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Preliminary microbiological study of injectable chemotherapy dose-banding",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A46.2",
    "authors": "G Dozias, C Lambert, H Hugerot, B Rey-Rubio, C Loeuillet, N Mugnier, V Cogulet",
    "institution": "CHRU Brest, Pharmacy, Brest, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.103",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Turbidimetry"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": ["flatDoses"],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "A risk analysis method to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients’ safety",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A47.1",
    "authors": "B Marzal Alfaro, CG Rodríguez-González, V Escudero-Vilaplana, JL Revuelta-Herrero, S Ibáñez-Garcia, E García Martín, E González-Haba, I Iglesias-Peinado, A Herranz, M Sanjurjo-Saez",
    "institution": "Hospital General Universitario Gregorio Marañon, Pharmacy, Madrid, Spain. College of Pharmacy- Complutense University, Pharmacology Department, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.104",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Comparative Risk Assessment", "Failure Mode, Effects and Criticality Analysis (FMECA)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "The validation of control method: the gravimetric analysis in cytotoxic drug preparation",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A47.2",
    "authors": "L Nicolas, C Blanc, C Fercocq, L Baillet, R Linossier, JL Pons",
    "institution": "Centre Hospitalier Victor Dupouy, Pharmacy, Argenteuil, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.105",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Gravimetric Analysis"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Optimisation of compounding organisation after implementing a robotic system for automated preparation of oncologic drugs",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A48.1",
    "authors": "P Silimbani, M Tontini, L Moriconi, D Paolucci, M Federici, C Masini",
    "institution": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRST IRCCS, Oncology Pharmacy Unit, Meldola FC, Italy. Loccioni, Loccioni Humancare, Moie di Maiolati- Ancona AN, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.106",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "What is the best chemical decontamination solution for conventional anti-neoplastic drugs in a hospital compounding unit?",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A48.2",
    "authors": "N Simon, P Odou, B Decaudin, P Bonnabry, S Fleury-Souverain",
    "institution": "CHRU de Lille, Institut de Pharmacie, Lille Cedex, France. Hopitaux Universitaires de Geneve, Pharmacie, Geneve, Switzerland",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.107",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France", "Switzerland"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Productivity analysis of an automated compounding system for intravenous chemotherapy",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A49.1",
    "authors": "AC Riestra, MJ Tames, O Olariaga, G Cajaraville",
    "institution": "Onkologikoa, Pharmacy, San Sebastián, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.108",
    "filters": {
      "actSubs": ["Paclitaxel"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Dose-banding gemcitabine and standardisation of chemotherapy protocols production",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A49.2",
    "authors": "C Tirone, S Bertoli, M Galassi, C Della Costanza, V Ladisa",
    "institution": "Fondazione Irccs Istituto Nazionale dei Tumori, Pharmacy, Milano, Italy. Universita’ Degli Studi di Milano, School of Hospital Pharmacy, Milano, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.109",
    "filters": {
      "actSubs": ["Gemcitabine", "Bevacizumab", "Carboplatinum", "Cisplatinum", "Dacarbazine", "Docetaxel", "Oxaliplatinum"],
      "indication": ["Ovarian Carcinoma", "Cervical Cancer", "Endometrial Neoplasia", "Breast Cancer", "Non-Small Cell Lung Cancer", "Mesothelioma", "Biliopancreatic Cancer", "Uterine Leiomyosarcoma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Gynaecology", "Oncology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": ["flatDoses"],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Quality of gemcitabine ready to administer preparations",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A50.1",
    "authors": "R Trittler, H Reinhardt, MJ Hug",
    "institution": "University Medical Centre, Pharmacy, Freiburg, Germany. University Medical Centre, Haematology, Freiburg, Germany. University Medical Centre, Apotheke, Freiburg, Germany",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.110",
    "filters": {
      "actSubs": ["Gemcitabine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography with Diode-Array Detection (HPLC-DAD)", "Liquid Chromatography Mass Spectrometry (LC-MS)"],
      "studyLength": [],
      "country": ["Germany"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": ["flatDoses"],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Physical, chemical and microbiological stability of sirolimus 0.4% in topical formulations",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A50.2",
    "authors": "C Cortell, MA Martinez, C Molina, AC Cercos, M Climente, V Merino",
    "institution": "Hospital Doctor Peset, Pharmacy, Valencia, Spain. Universidad de Valencia, Pharmaceutical Technology, Valencia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.111",
    "filters": {
      "actSubs": ["Sirolimus"],
      "indication": ["Facial Angiofibroma", "Tuberous Sclerosis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High-Performance Liquid Chromatography - Ultraviolet (HPLC-UV)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "The transition from the use of bupivacaine to ropivacaine in the delivery room, in order to achieve a better analgesic effect",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A51.1",
    "authors": "S Hadad, A Ataba, P Abecassis",
    "institution": "Rambam – Health Care Campus, Pharmaceutical Services – Pharmacy Director, Haifa, Israel. Rambam Medical Centre, Pharmacy Department, Haifa, Israel. Rambam Medical Centre, Anaesthesiolgy Department, Haifa, Israel",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.112",
    "filters": {
      "actSubs": ["Ropivacaine", "Bupivacaine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Israel"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": ["preopMedication"],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Low-dose morphine solution for spinal anaesthesia – ready to use to improve patient safety in drug therapy",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A51.2",
    "authors": "K Lämmle, A Kirchhoff, P Hoffmann, S Amann",
    "institution": "München Klinik, Hospital Pharmacy, München, Germany. München Klinik, Klinik für Anästhesiologie- Operative Intensivmedizin und Schmerztherapie, München, Germany",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.113",
    "filters": {
      "actSubs": ["Morphine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography Reversed-Phase (RP-HPLC)"],
      "studyLength": [],
      "country": ["Germany"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": ["preopMedication"],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Labelling without strength for a pharmaceutical preparation used in a blinded dosage adjustment of clozapine",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A51.3",
    "authors": "C Giraudeau, J Jost, M Strumia, G Arnaud, P Brosset, V Ratsimbazafy",
    "institution": "Dupuytren University Hospital, Pharmacy, 87000 Limoges, France. Mother and Child Hospital, Paediatry, 87000 Limoges, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.114",
    "filters": {
      "actSubs": ["Clozapine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Imipenem-fortified eye drops for the treatment of bacterial keratitis: development and characterisation",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A52.1",
    "authors": "A Castro Balado, X García Otero, I Zarra Ferro, M González Barcia, FJ Otero Espinar, A Fernández Ferreiro",
    "institution": "Clinical University Hospital Santiago de Compostela Sergas, Hospital Pharmacy Department, Santiago de Compostela, Spain. Health Research Institute of Santiago de Compostela Idis, Clinical Pharmacology Group, Santiago Compostela, Spain. Faculty of Pharmacy- University of Santiago de Compostela USC, Pharmacology- Pharmacy and Pharmaceutical Technology Department, Santiago de Compostela, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.115",
    "filters": {
      "actSubs": ["Imipenem"],
      "indication": ["Bacterial Keratitis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Spectrophotometry"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Galenic formulations for ophtalmologists: new formulations, prescribing pathways and patient information",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A52.2",
    "authors": "S Manzini, F Gradellini, C Polidori, G Borciani, L Fares",
    "institution": "Azienda Unità Sanitaria Locale – Irccs di Reggio Emilia, Hospital Pharmacy, Reggio Emilia, Italy. University of Camerino, Pharmacology, Camerino, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.116",
    "filters": {
      "actSubs": ["Amphotericin", "Cyclosporine", "Chlorhexidine", "Fluconazole", "Mitomycin C", "Tacrolimus", "Tobramycin", "Vancomycin", "Voriconazole"],
      "indication": [],
      "statedClass": ["Antibiotics", "Antimycotics", "Immune-Suppressors", "Immune-Modulators", "Oncologic Drugs"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Comparison of metabolite levels in serum and tears: implications for the dilution of autologous-serum-eye-drops",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A53.1",
    "authors": "D Wandel, C Steuer, JP Sigle, L Bernasconi, R Egger",
    "institution": "Kantonsspital Aarau, Pharmacy, Aarau, Switzerland. Kantonsspital Aarau, Clinical Chemistry and Clinical Immunology, Aarau, Switzerland. Stiftung Blutspende, SRK Aargau-Solothurn, Aarau, Switzerland",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.117",
    "filters": {
      "actSubs": [],
      "indication": ["Dry Eye Syndrome"],
      "statedClass": ["Autologous Serum Eye Drops"],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Liquid Chromatography Tandem - Mass Spectrometry (LC–MS/MS)"],
      "studyLength": [],
      "country": ["Switzerland"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Development of virtual drug information centre for pharmacy compounding area",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A53.2",
    "authors": "JA Montero Delgado, A Ferrer Machín, M Vera Cabrera, MC Jordán de Luna, L Díaz Díaz, I González García, MA Navarro Dávila, R Mesa Exposito, E Tevar Alfonso, MÁ Ocaña Gomez, FJ Merino Alonso",
    "institution": "Hospital Universitario Nuestra Señora de Candelaria, Hospital Pharmacy Department, Santa Cruz de Tenerife, Spain. Instituto Catalán de Oncología, Pharmacy Department, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.118",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": ["mobileVR"],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Stability study of (99MTC)dotatoc and (68GA)dotatoc in syringes",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A54.2",
    "authors": "S Chaïb, F Hallouard, C Darcissac, P Chennell, V Sautou, M Fraysse",
    "institution": "Groupe Hospitalier Sud-Hospices Civils de Lyon, Unité de Radiopharmacie- Service de Pharmacie, Pierre-Bénite, France. Université de Clermont Auvergne – CHU Clermont-Ferrand, CNRS- Sigma Clermont- ICCF, Clermont-Ferrand, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.120",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Nuclear Medicine"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": ["radiopharmaceuticals"],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Health hazards of raw materials used in the compounding of pharmaceuticals formulations",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A55.1",
    "authors": "EA Álvaro Alonso, P Tejedor Prado, E Izquierdo Garcia, A Such Diaz, A Lazaro Cebas, S Esteban Casado, I Cañamares Orbis, C Esteban Alba, A Santiago Perez, I Escobar Rodriguez",
    "institution": "Hospital Universitario Infanta Leonor, Pharmacy, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.121",
    "filters": {
      "actSubs": ["Atenolol", "Budesonide", "Diltiazem", "Spironolactone", "Phenobarbital", "Furosemide", "Phenol", "Boric Acid", "Dexamethasone", "Disodium tetraborate", "Triamcinolone", "Clobetasol", "Captoril"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Automation of parenteral nutrition compounding: results of gravimetric quality control before and after its implementation",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A55.2",
    "authors": "R Barbosa, S Nogueira, T Soares, S Fraga, A Silva, P Carinha",
    "institution": "Centro Hospitalar e Universitário São João- EPE, Pharmacy, Oporto, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.122",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Gravimetric Analysis"],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "A science- and risk-based strategy to qualify sterilised prefilled syringes as primary packaging material in a hospital pharmacy",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A56.1",
    "authors": "K Beld, A Kuiper, S Van Berkel, H Robben, R Wijnsma, K Taxis, E Frijlink",
    "institution": "ISALA Hospital, Clinical Pharmacy, Zwolle, The Netherlands. University of Groningen, Unit of Pharmacotherapy- -Epidemiology and Pharmacoeconomics PTE2- Groningen Research Institute of Pharmacy, Groningen, The Netherlands. University of Groningen, Department of Pharmaceutical Technology and Biopharmacy, Groningen, The Netherlands",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.123",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Prefilled Syringes", "Cyclic Olefin Polymer (COP) Syringe"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Netherlands"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "New formulation of norepinephrine solution in prefilled cyclic olefin sterilised syringes",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A56.2",
    "authors": "K Beld, S Van Berkel, R Wijnsma, K Taxis, E Frijlink",
    "institution": "ISALA Hospital, Clinical Pharmacy, Zwolle, The Netherlands. University of Groningen, Unit of Pharmacotherapy- -Epidemiology and Pharmacoeconomics Pte2- Groningen Research Institute Of Pharmac, Groningen, The Netherlands. University of Groningen, Department of Pharmaceutical Technology and Biopharmacy, Groningen, The Netherlands",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.124",
    "filters": {
      "actSubs": ["Norepinephrine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Prefilled Syringes", "Cyclic Olefin Polymer (COP) Syringe"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography with Diode-Array Detection (HPLC-DAD)"],
      "studyLength": [],
      "country": ["Netherlands"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": ["incompatibilities"],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Paraffin oil-based emulsion: influence of gum arabic and the mixing rate on emulsion stability",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A56.3",
    "authors": "M Benabbes, M Alami Chentoufi, L Abdelkader",
    "institution": "Faculty of Medicine and Pharmacy- Mohammed V University of Rabat, Team of Formulation and Quality Control of Health Products- Faculty of Medicine and Pharmacy, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.125",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["The Hydrophilic-Lipophilic Balance (HLB)"],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Formulation and stability study of extemporaneous oral liquid dosage forms containing flecainide acetate 2 mg/ml for paediatric use",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A57.1",
    "authors": "A Casiraghi, S Loiacono, S Bordignon, R Puzziferri, F Cilurzo, P Minghetti",
    "institution": "University of Milan, Department of Pharmaceutical Sciences- Specialisation School in Pharmacy, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.126",
    "filters": {
      "actSubs": ["Flecainide acetate"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Study of stability of two liquid formulations of omeprazole elaborated in the pharmaceutical service",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A57.2",
    "authors": "E Conesa Nicolás, AM Chica Marchal, AC Viney, S Nuñez Bracamonte, C Juez Santamaría, A Lloret Llorca, B Fernández-Lobato, CN García Matillas, M Martinez Penella",
    "institution": "Hospital General Universitario Santa Lucía, Servicio de Farmacia, Cartagena- Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.127",
    "filters": {
      "actSubs": ["Omeprazole"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of the effectiveness and satisfaction of the master suspension formula for mucositis elaborated in a tertiary hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A58.1",
    "authors": "E Conesa Nicolás, AM Chica Marchal, AC Viney, S Nuñez Bracamonte, A Lloret Llorca, C Juez Santamaría, CN García Matillas, MS Garcia Simón, MDM Sanchez Catalicio",
    "institution": "Hospital General Universitario Santa Lucía, Servicio de Farmacia, Cartagena- Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.128",
    "filters": {
      "actSubs": ["Nystatin", "Methylprednisolone", "Mepivacaine", "Gentamicin"],
      "indication": ["Mucositis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Oral mucoadhesive dexamethasone 0.1% (m/m) gel: a strategy for motor inhibitors mucositis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A58.2",
    "authors": "AF Cosme Silva, A Castro, A Ferreira, H Luna Pais, V Rodrigues, JP Cruz, A Duarte, S Simões, C Eleuterio, AJ Almeida, J Marto",
    "institution": "Hospital de Santa Maria, Pharmacy and Paediatrics, Lisbon, Portugal. iMed Ulisboa, Pharmaceutics, Lisbon, Portugal. Hospital de Santa Maria, Pharmacy, Lisbon, Portugal. Hospital de Santa Maria, Oncology, Lisbon, Portugal. Hospital de Santa Maria, Pharmacy- Head of Department, Lisbon, Portugal. Faculdade de Farmácia da Universidade de Lisboa, Microbiology, Lisbon, Portugal. Faculdade de Farmácia da Universidade de Lisboa, Faculdade de Farmácia da Universidade de Lisboa, Lisbon, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.129",
    "filters": {
      "actSubs": ["Dexamethasone"],
      "indication": ["Mucositis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["6 months - 1 year"],
      "country": ["Portugal"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Mobile applications related to parenteral nutrition: qualitative and quantitative analysis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A59.1",
    "authors": "JT de Pourcq, JA Montero Delgado, M Gomis Pastor, C Fraile Clemente, FJ Merino Alonso",
    "institution": "Hospital de la Santa Creu I Sant Pau, Pharmacy Service, Barcelona, Spain. Hospital Universitario Nuestra Señora de Candelaria, Pharmacy Service, Santa Cruz de Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.130",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Mobile Application Rating Scale (MARS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": ["mobileVR"],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Application of hazard vulnerability analysis to evaluate potential risks of pharmacy compounding",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A59.2",
    "authors": "R Giammona, P Polidori",
    "institution": "IRCCS ISMETT, Clinical Pharmacy, Palermo, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.131",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Hazard Vulnerability Analysis"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Impact of ophthalmological preparations in the pharmacy service of a reference hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A60.1",
    "authors": "I Salar Valverde, N Manresa Ramon, M Gil Candel, M Onteniente Candela, C Pastor Mondejar, C Caballero Requejo, C Iniesta Navalon, M Garcia Coronel, E Urbieta Sanz",
    "institution": "Hospital General Universitario Reina Sofia, Hospital Pharmacy, Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.132",
    "filters": {
      "actSubs": ["Cyclosporine", "Vancomycin", "Ceftazidime", "Cefuroxime", "Aflibercept", "Bevacizumab"],
      "indication": [],
      "statedClass": ["Ophthalmological Medicines"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Chemical disinfectants vs sterile water and composite fibre: the effect of cleaning methods on microbial contamination in a class a pharmaceutical compounding environment",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A60.2",
    "authors": "E Gleditsch",
    "institution": "Sykehusapotekene HF – Oslo Hospital Pharmacy, Manufacturing, Oslo, Norway",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.133",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Norway"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "New formulations for the treatment of anti-neoplastic and radiotherapy-induced mucosites",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A61.1",
    "authors": "G Borciani, F Gradellini, C Polidori, S Manzini, G Sommese, L Fares",
    "institution": "Azienda Unità Sanitaria Locale – IRCCS di Reggio Emilia, Hospital Pharmacy, Reggio Emilia, Italy. University of Camerino, Pharmacology, Camerino, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.134",
    "filters": {
      "actSubs": ["Lidocaine hydrochloride", "Methylprednisolone", "Misoprostole", "Benzydamine", "Doxepin"],
      "indication": ["Mucositis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Added value from an information and communication technology- assisted intervention in a total parenteral unit of a paediatric hospital pharmacy",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A61.2",
    "authors": "K Perdikouri, L Kouri, K Nikou, G Pegkas, D Gennimata",
    "institution": "Spiliopoulio Hospital, Hospital Pharmacy, Athens, Greece. Paediatric Hospital ‘Aglaia Kyriakou’, Hospital Pharmacy, Athens, Greece. General Hospital of Chest Diseases ‘Sotiria’, Hospital Pharmacy, Athens, Greece. Korgialeneio-Benakio Red Cross General Hospital, Hospital Pharmacy, Athens, Greece",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.135",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Greece"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Cytotoxic agents: skin tests for the diagnosis of drug hypersensitivity",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A61.3",
    "authors": "P Legendre, AC Bonnaure, R Bellay, MA Lester, PN Boivin",
    "institution": "CHU Rennes, Pharmacie, Rennes, France. CH Guillaume Regnier, Pharmacie, Rennes, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.136",
    "filters": {
      "actSubs": ["Docetaxel", "Pertuzumab", "Trastuzumab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Performance analysis of a fully automated oncology pharmacy production: a 2018 update",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A62.1",
    "authors": "S Leoni, MS de Meo, A Ortenzi, S Guglielmi, LL Borgiani, M Federici, D Paolucci, A Marinozzi",
    "institution": "Ospedali Riuniti Ancona, Hospital Pharmacy, Ancona, Italy. Loccioni Group, Humancare, Ancona, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.137",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Gravimetric Analysis", "Photographic Recognition"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Economic impact after the implementation of a risk matrix in the preparation of chemotherapy",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A62.2",
    "authors": "L López Esteban, M Hijazi-Vega, R Diez-Fernández, R Gardón-Pérez, MÁ Esteban-Pérez, I Bueno-Florido, A Cidoncha-Berlanga, M Labrador-Paniagua, T Molina-García",
    "institution": "Hospital Universitario de Getafe, Pharmacy Department, Getafe Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.138",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Risk Management Assessment Matrix"],
      "studyLength": ["Less than 3 months"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Robotic compounding: safety and productivity achievements in the preparation of hazardous drugs",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A63.1",
    "authors": "C Lopez-Cabezas, AM Marín, G Riu, C Codina, D Soy",
    "institution": "Hospital Clinic, Pharmacy, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.139",
    "filters": {
      "actSubs": ["Carboplatinum", "Cyclophosphamide", "Doxorubicin", "Epirubicin", "Florourasil (5-FU)", "Gemcitabine", "Irinotecan", "Oxaliplatinum", "Paclitaxel"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Failure Mode, Effects and Criticality Analysis (FMECA)", "Gravimetric Analysis"],
      "studyLength": ["6 months - 1 year"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Use of extemporaneous oral suspensions of oxybutinin and prazosine in neonates",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A63.2",
    "authors": "R Claramunt García, CL Muñoz Cid, I Caba Porras, AM López-López, M Merino Almazán, Y Jimenez López, E Perez Cano, JF Marín Pozo",
    "institution": "Complejo Hospitalario de Jaén, Servicio de Farmacia, Jaén, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.140",
    "filters": {
      "actSubs": ["Oxybutinin", "Prazosine"],
      "indication": ["Primary Bladder Neck Obstruction"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Paediatrics"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Hot-melt ram extrusion 3D printing: a smart method for compounding orodispersible films in hospital pharmacies",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A64.1",
    "authors": "P Minghetti, UM Musazzi, F Selmin, GM Khalid, S Franzé, F Cilurzo",
    "institution": "University of Milan, Department of Pharmaceutical Sciences, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.141",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": ["personalized"],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": ["Printing3D"],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Optimisation of intracameral cefuroxime consumption in the prevention of postoperative endophtalmitis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A64.2",
    "authors": "J Poquet Jornet, JM del Moral-Sanchez, FJ Carrera-Hueso, C Cuesta-Grueso, A Munilla-Das",
    "institution": "Hospital of Denia, Pharmacy Department, Denia Alicante, Spain. Hospital DR. Moliner, Pharmacy Department, Serra Valencia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.142",
    "filters": {
      "actSubs": ["Cefuroxime"],
      "indication": ["Endophtalmitis"],
      "statedClass": [],
      "typeOfMedical": ["Prefilled Syringes"],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Galenic preparation of 40% dextrose gel: new approach to management of neonatal hypoglycaemia",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A65.2",
    "authors": "M Rivano, C Veneziano, G Longobardo, M Albrecht",
    "institution": "IRCCS Ospedale San Raffaele, Pharmacy, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.144",
    "filters": {
      "actSubs": ["Dextrose"],
      "indication": ["Hypoglycaemia"],
      "statedClass": [],
      "typeOfMedical": ["Enteral Feeding Syringes"],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Newborn Intensive Care"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["6 months - 1 year"],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Feedback from lean management in a sterilisation unit",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A65.3",
    "authors": "H Roux, J Cantoni, MP Ponrouch, B Thaunay, A Giraudo, A Nguyen, A Jalabert",
    "institution": "Service de Stérilisation Centrale, Centre Hospitalier Universitaire de Montpellier, Montpellier, France. Service de Pharmacie, Centre Hospitalier de Montpellier, Montpellier, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.145",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Sterilisation Unit"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Kanban Board"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Orodispersible films – an interesting dosage form!",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A66.1",
    "authors": "S Sauer, L Kohl, L Veitinger, V Zink, T Hoppe-Tichy",
    "institution": "University Hospital Heidelberg, Pharmacy Department, Heidelberg, Germany",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.146",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Germany"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "PT-smell test: a novel hospital compounding and its clinical validation to diagnose olfactory dysfunction",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A66.2",
    "authors": "C Tovar Chaves, J Marto, M Santos, F Duarte-Ramos, R Bronze, L Antunes, A Alcobia, H Ribeiro",
    "institution": "Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal. Research Institute for Medicine and Pharmaceutical Science iMED.ULisboa, Faculdade de Farmácia- Universidade de Lisboa, Lisbon, Portugal. Hospital Garcia de Orta- E.P.E., Serviço de Otorrinolaringologia, Almada, Portugal. Faculdade de Farmácia da Universidade de Lisboa, Departamento de Sócio-Farmácia, Lisbon, Portugal. IBET, Apartado 12- 2781–901, Oeiras, Portugal. Hospital Garcia de Orta- E.P.E., Serviços Farmacêuticos, Almada, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.147",
    "filters": {
      "actSubs": [],
      "indication": ["Olfactory Dysfunction"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Fragrance Identification", "Barcelona Smell Test"],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Experience with the new direct acting antiviral agents in a third level hospital in 2018",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A47.3",
    "authors": "S Nuñez Bracamonte, MH García Lagunar, E Conesa Nicolás, A Lloret Llorca, C Juez Santamaría, CN García Matillas, I Fernández Martínez, JM Montoya Egea",
    "institution": "Hospital General Universitario Santa Lucía, Farmacia Hospitalaria, Cartagena, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.102",
    "filters": {
      "actSubs": ["Glecaprevir / Pibrentasvir", "Glecaprevir", "Pibrentasvir", "Elbasvir / Grazoprevir", "Elbasvir", "Grazoprevir", "Sofosbuvir / Velpatasvir", "Sofosbuvir", "Velpatasvir", "Ribavirin", "Ledipasvir / Sofosbuvir", "Ledipasvir", "Sofosbuvir / Velpatasvir / Voxilaprevir", "Voxilaprevir"],
      "indication": ["Hepatitis C (Chronic)"],
      "statedClass": ["Direct Acting Antivirals"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": ["pharmacogenetics"],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Anticholinergic burden in constipated patient admitted to an emergency department",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A48.1",
    "authors": "A Plaza Diaz, J Ruiz Ramos, A Juanes Borrego, M Blazquez Andion, L Lopez Vinardell, MA Mangues Bafalluy",
    "institution": "Hospital Sant Pau, Pharmacy, Barcelona, Spain. Hospital Sant Pau, Emergency Department, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.103",
    "filters": {
      "actSubs": [],
      "indication": ["Constipation", "Intestinal Obstruction"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Anticholinergic Risk Scale", "STATA"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Liraglutide in chronic intestinal failure: overview and case report",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A48.2",
    "authors": "M Scaldaferri, E Castellana, M Ippolito, FD Merlo, U Aimasso, A De Francesco, F Cattel",
    "institution": "AOU Citta’ Della Salute E Della Scienza Di Torino, Pharmacy, Turin, Italy. AOU Citta’ Della Salute E Della Scienza Di Torino, Internal Medicine 3 U, Turin, Italy. AOU Citta’ Della Salute E Della Scienza Di Torino, Dietetics and Clinical Nutrition, Turin, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.104",
    "filters": {
      "actSubs": ["Liraglutide"],
      "indication": ["Short Bowel Syndrome with Intestinal Failure (SBS-IF)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of the use of hydrocortisone, vitamin C and thiamine for the treatment of septic shock",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A49.1",
    "authors": "M Martín Cerezuela, E Sancho Ferrando, I Beltran Garcia, M Centelles Oria, E Villarreal Tello, M Gordon Sahuquillo, A Castellanos Ortega, P Ramirez Galleymore, JL Poveda Andres",
    "institution": "Hospital Universitario Y Politécnico La Fe, Pharmacy, Valencia, Spain. Hospital Universitario Y Politécnico La Fe, Icu, Valencia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.105",
    "filters": {
      "actSubs": ["Hydrocortisone", "Thiamine", "Vitamin C"],
      "indication": ["Septic Shock"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Cohort Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["STATA"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Risk factors for persistence and tolerance of cow’s milk allergy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A49.2",
    "authors": "JM Giraldez Montero, G Duran Piñeiro, I Varela Rey, R Leis Trabazo, I Zarra Ferro",
    "institution": "Complejo Hospitalario Universitario De Santiago De Compostela, Pharmacy Department, Santiago De Compostela, Spain. Complejo Hospitalario Universitario De Santiago De Compostela, Paediatric Department, Santiago De Compostela, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.106",
    "filters": {
      "actSubs": [],
      "indication": ["Cow's Milk Protein Allergy"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Gastroenterology", "Nutrition Unit"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Logistic Regression Analysis"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Use of ammonium tetrathiomolybdate in Wilson disease",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A50.1",
    "authors": "M Pomares Bernabeu, A Gonzalez Fernandez, M Ibañez Carrillo, AC Murcia Lopez, C Matoses Chirivella, A Navarro Ruiz",
    "institution": "Hospital General Universitario De Elche, Pharmacy, Elche, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.107",
    "filters": {
      "actSubs": ["Ammonium tetrathiomolybdate", "Trientine", "Zinc"],
      "indication": ["Wilson Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": ["orphan"],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Pharmaceutical care as a means of prevention against drug iatrogenesis: case of oral anticoagulants",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A50.2",
    "authors": "D Andre, C Chatain, MC Chaumais, A Rieutord, S Roy",
    "institution": "Antoine Béclère, 92140 Clamart, Clamart, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.108",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Oral Anticoagulants"],
      "typeOfMedical": [],
      "studyDesign": ["Interventional Study", "Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["6 months - 1 year"],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Risk factors associated with readmission to the emergency department in patients with previous gastrointestinal haemorrhage secondary to oral anticoagulant therapy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A51.1",
    "authors": "L López Vinardell, J Ruiz Ramos, A Juanes Borrego, M Puig-Campmany, MA Mangues Bafalluy",
    "institution": "Hospital De La Santa Creu I Sant Pau, Pharmacy, Barcelona, Spain. Hospital De La Santa Creu I Sant Pau, Emergency Department, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.109",
    "filters": {
      "actSubs": [],
      "indication": ["Haemorrhage", "Chronic Kidney Disease", "Coagulation Disorder"],
      "statedClass": ["Direct Oral Anticoagulants", "Vitamin K Antagonists"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Multivariate Analysis"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Duration of dual antiplatelet therapy in coronary artery disease: is pharmacist intervention necessary to improve patient safety?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A51.2",
    "authors": "A Revuelta Amallo, M Alonso Diez, M Alvarez Lavin, E Ruiz De Velasco Artaza, J Fernandez Uria, A Aguirrezabal Arredondo",
    "institution": "Hospital Universitario De Basurto, Pharmacy, Bilbao, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.110",
    "filters": {
      "actSubs": [],
      "indication": ["Coronary Artery Disease", "Acute Coronary Syndrome"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["PRECISE-DAPT Score"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Safety and efficacy of low molecular weight heparins in patients with portal vein thrombosis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A52.1",
    "authors": "M Scaldaferri, E Rolle, C Zurlo, E Castellana, GM Saracco, F Cattel",
    "institution": "Citta’ Della Salute E Della Scienza Di Torino, Pharmacy, Turin, Italy. Citta’ Della Salute E Della Scienza Di Torino, Gastroenterology, Turin, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.111",
    "filters": {
      "actSubs": ["Nadroparin", "Enoxaparin", "Parnaparin"],
      "indication": ["Thrombosis (Portal Vein)", "Cirrhosis", "Portal Hypertension", "Congestive Gastropathy", "Hepatocarcinoma", "Cavernoma", "Thrombocytopenia"],
      "statedClass": ["Low Molecular Weight Heparins"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Prescription analysis of direct acting oral anticoagulants",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A52.2",
    "authors": "I Soto, B Rubio, M Mañes, J Solis, B Bertran De Lis, EP Gómez, E Maroto, MI Bernias, I Sollano, I Morona, C Moriel",
    "institution": "Hospital Universitario De Móstoles, Hospital Pharmacy, Móstoles, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.112",
    "filters": {
      "actSubs": ["Apixaban", "Rivaroxaban", "Dabigatran", "Acenocoumarol"],
      "indication": ["Atrial Fibrillation", "Thrombosis (Deep Vein)", "Pulmonary Thromboembolism", "Gastritis"],
      "statedClass": ["Direct Oral Anticoagulants"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Longitudinal Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": ["Cardiology", "Internal Medicine", "Geriatrics"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["6 months - 1 year"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Audit of oral anticoagulant prescribing; what has changed in 4 years?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A52.3",
    "authors": "J Tuthill, M Kieran, P Ging, C Meegan",
    "institution": "Mater Misericordiae University Hospital, Pharmacy Department, Dublin, Ireland",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.113",
    "filters": {
      "actSubs": ["Warfarin", "Apixaban", "Edoxaban", "Dabigatran", "Rivaroxaban"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Ireland"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effect of 2 mg intravenous phytonadione treatment on international normalised ratio in the hospitalised adult",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A53.1",
    "authors": "N Ramon, M Rosado Ancin, A Santaolalla Sanchez, C Valdazo Martin, A Larrabeiti Echevarria, JJ Garcia Albás, R Hernanz Chaves, C Martinez",
    "institution": "Hua, Service of Pharmacy, Vitoria-Gasteiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.114",
    "filters": {
      "actSubs": ["Phytonadione"],
      "indication": ["Elevated International Normalised Ratio"],
      "statedClass": ["Vitamin K Antagonists"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["STATA", "Pearson Correlation Coefficient"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Clinical and assisted impact of ischaemic ictus in patients treated with oral anticoagulants",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A53.2",
    "authors": "J Ruiz1, A Juanes Borrego, L López Vinardell, A Plaza Diaz, M Puig Campmany, MA Mangues Bafalluy",
    "institution": "Hospital Santa Creu I Sant Pau, Pharmacy, Barcelona, Spain. Hospital Santa Creu I Sant Pau, Emergency Department, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.115",
    "filters": {
      "actSubs": [],
      "indication": ["Atrial Fibrillation", "Stroke (Thromboembolic)", "Stroke (Cardioembolic)"],
      "statedClass": ["Oral Anticoagulants", "Vitamin K Antagonists", "Direct Oral Anticoagulants"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Modified Rankin Scale", "National Institutes of Health Stroke Scale"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Situational analysis of postoperative iron supplementation prescriptions in a plastic surgery department",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A54.1",
    "authors": "S Cesbron, P Gendre, P Nizet, C Letort, JF Huon, N Serandour, J Moquard, E Corbineau, AS Fanuel Remoue",
    "institution": "University Hospital, Pharmacy, Nantes, France. University Hospital, Plastic Surgery Department, Nantes, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.116",
    "filters": {
      "actSubs": ["Iron", "Ferric carboxymaltose", "Ferrous fumarate", "Ferrous sulphate"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Plastic Surgery"],
      "numPatients": [],
      "numPrescriptions": ["51 - 100"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": ["preopMedication"],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Inappropriate use of human albumin in a teaching hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A54.2",
    "authors": "A Ben Cheikh Brahim, A Abbassi, R Khaireddine, E Bokri, H Dridi, Z Ouahchi",
    "institution": "Charles Nicolle Hospital of Tunis-Tunisia, Pharmacy, Tunis, Tunisia. ",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.117",
    "filters": {
      "actSubs": ["Human albumin"],
      "indication": ["Albuminaemia", "Nephrotic Syndrome"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Gastroenterology", "Paediatrics"],
      "numPatients": [],
      "numPrescriptions": ["101 - 500"],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Tunisia"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Efficacy and safety of tolvaptan in the treatment of polycystic kidney disease",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A55.1",
    "authors": "L Majuelos Aicart, L Lopez Bouzo, RM Damas Fuentes, C Otero Villalustre, L Oliva Hernandez, V Quesada Marques, DF Fernandez Vera",
    "institution": "Pharmacist, Hospital Pharmacy, Las Palmas De Gran Canaria, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.118",
    "filters": {
      "actSubs": ["Tolvaptan"],
      "indication": ["Polycystic Kidney Disease (Autosomal Dominant)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["STATA"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Efficacy of urea in the treatment of hyponatraemia in syndrome of inappropriate antidiuretic hormone secretion",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A55.2",
    "authors": "CY Perez, I Plasencia García, MÁ Ocaña Gómez, A Ferrer Machín, K Álvarez Tosco, J Merino Alonso, L Díaz Díaz, I González García, R Mesa Expósito, E Tévar Alfonso, M Vera Cabrera",
    "institution": "Hospital Universitario Nuestra Señora De La Candelaria, Farmacia Hospitalaria, San Cristobal De La Laguna, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.119",
    "filters": {
      "actSubs": ["Urea"],
      "indication": ["Hyponatraemia", "Inappropriate Antidiuretic Hormone Secretion"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Quasi-Experimental Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Shapiro–Wilk Test", "Analysis of Variance (ANOVA)", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Alirocumab and evolocumab: effectiveness after 3 years of follow-up in a real world setting",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A55.3",
    "authors": "C Alonso Martinez, P Sanchez-Sanchez, M Larrosa-Garcia, S Garcia-Garcia, M Miarons-Font, M Gomez-Domingo, I Cardona-Pascual, J Vidal-Otero, M Gorgas-Torner, C Alerany Pardo",
    "institution": "Vall D’hebron University Hospital, Pharmacy Service, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.120",
    "filters": {
      "actSubs": ["Alirocumab", "Evolocumab", "Atorvastatin", "Rosuvastatin", "Fluvastatin", "Pitavastatin", "Ezetimibe"],
      "indication": [],
      "statedClass": ["Proprotein Convertase Subtilisin / Kexin Type 9 Enzyme (PCSK9) Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Use, efficacy and adherence to treatment with PCKS9 inhibitors in real clinical practice",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A56.1",
    "authors": "R Claramunt García, CL Muñoz Cid, A Sánchez Ruiz, AM López, E Pérez Cano, Y Jimenez López, J Jerez Rojas",
    "institution": "Hospital Universitario De Jaén, Pharmacy, Jaén, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.121",
    "filters": {
      "actSubs": ["Evolocumab", "Alirocumab"],
      "indication": ["Hypercholesterolaemia", "Cardiovascular Disease"],
      "statedClass": ["Proprotein Convertase Subtilisin / Kexin Type 9 Enzyme (PCSK9) Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Medication Possession Ratio"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Alirocumab and evolocumab: results in clinical practice",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A56.2",
    "authors": "M Domínguez Bachiller, MI Barcia Martin, AM Gomez Pedrero, M Perez Encinas",
    "institution": "Hospital Universitario Fundación Alcorcon, Hospital Pharmacy, Alcorcon, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.122",
    "filters": {
      "actSubs": ["Alirocumab", "Evolocumab", "Ezetimibe"],
      "indication": ["Hyperlipidaemia"],
      "statedClass": ["Proprotein Convertase Subtilisin / Kexin Type 9 Enzyme (PCSK9) Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Framingham Risk Score"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "PCSK9 inhibitors: evaluation of effectiveness in our centre in relation to the official clinical endpoints",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A57.1",
    "authors": "G Polito, F Ferrante, M Folcarelli, S Crescenzi",
    "institution": "Ospedale ‘F. Spaziani’, UO Farmacia, Frosinone, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.123",
    "filters": {
      "actSubs": ["Evolocumab", "Alirocumab"],
      "indication": ["Dyslipidaemia"],
      "statedClass": ["Proprotein Convertase Subtilisin / Kexin Type 9 Enzyme (PCSK9) Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Cohort Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Long term efficacy, safety and adherence to alirocumab in patients with dyslipidaemia from a tertiary hospital cohort",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A57.2",
    "authors": "A Rodriguez, C Lopez, E González-Colominas, S Luque, L Recasens, J Pedro-Botet, A Oliveras, R Gonzalez, L Tarason, S Grau",
    "institution": "Hospital Del Mar, Pharmacy, Barcelona, Spain. Hospital Del Mar, Cardiology, Barcelona, Spain. Hospital Del Mar, Endocrinology, Barcelona, Spain. Hospital Del Mar, Nephrology, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.124",
    "filters": {
      "actSubs": ["Alirocumab"],
      "indication": ["Dyslipidaemia"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Common Terminology Criteria for Adverse Events", "Medication Possession Ratio"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effectiveness of anti-interleukin-17 drugs in psoriasis in clinical practice",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A58.1",
    "authors": "A Retamero Delgado, C Seguí Solanes, V Charques Trallero, S Mendiola Garcia, N Rudi Sola, D Ferrandez Martí",
    "institution": "Consorci Sanitari De L’anoia, Pharmacy, Igualada, Spain. Hospital General De Granollers, Pharmacy, Granollers, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.125",
    "filters": {
      "actSubs": ["Secukinumab", "Ixekizumab", "Methotrexate", "Acitretin", "Ciclosporin"],
      "indication": ["Psoriasis"],
      "statedClass": ["Anti-Interleukin-17 Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Psoriasis Area and Severity Index (PASI)", "Dermatology Life Quality Index", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Dupilumab in the treatment of moderate to severe atopic dermatitis: case reports",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A58.2",
    "authors": "C Palomo-Palomo, MM Romero Alonso, D Guerra Estevez, M Barrera Ledesma, J Estaire Gutierrez",
    "institution": "Hospital Infanta Elena, Hospital Pharmacy, Huelva, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.126",
    "filters": {
      "actSubs": ["Dupilumab", "Cyclosporine", "Methotrexate"],
      "indication": ["Dermatitis (Atopic)"],
      "statedClass": ["Glucocorticoids", "Antihistamines"],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Eczema Area and Severity Index"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Dalbavancin off-label use: effectiveness and safety",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A59.1",
    "authors": "M Arrieta, JM Caro-Teller, S Ortiz-Pérez, C Rosas-Espinoza, MD Canales-Siguero, F Martínez De La Torre, JM Ferrari-Piquero",
    "institution": "Hospital Universitario 12 De Octubre, Pharmacy, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.127",
    "filters": {
      "actSubs": ["Dalbavancin"],
      "indication": ["Bacteraemia", "Endocarditis", "Osteomyelitis", "Septic Arthritis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Antibiotic therapy reassessment and its documentation: can virtual tools improve practices?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A59.2",
    "authors": "M Bonsergent, C Humbert, L Escaut, D Osman, A Barrail-Tran",
    "institution": "Chu Bicêtre, Pharmacy, 94270 Kremlin-Bicêtre, France. Chu Bicêtre, Infectious Diseases, 94270 Kremlin-Bicêtre, France. Chu Bicêtre, Medical Reanimation, 94270 Kremlin-Bicêtre, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.128",
    "filters": {
      "actSubs": ["Amoxicillin / Clavulanic acid"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": ["mobileVR"],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Experience of ceftaroline use in a third level hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A60.1",
    "authors": "D Canales, JM Caro Teller, F Martínez De La Torre, M Arrieta Loitegui, C Rosas, S Ortiz Pérez, JM Ferrari Piquero",
    "institution": "Hospital 12 De Octubre, Servicio De Farmacia, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.129",
    "filters": {
      "actSubs": ["Ceftaroline"],
      "indication": ["Bacteraemia", "Complicated Skin and Skin Structure Infections", "Pneumonia (Community Acquired)", "Catheter Associated Infections", "Endocarditis", "Pneumonia (Hospital Acquired)", "Osteomyelitis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Preliminary results of an antimicrobial stewardship programme in an oncology department",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A60.2",
    "authors": "C Castillo-Martin, A Martínez-Suarez, P Retamar-Gentil, S Sandoval-Fernandez Del Castillo, M Murillo-Izquierdo",
    "institution": "Hospital Universitario Virgen Macarena, Pharmacy, Seville, Spain. Hospital Universitario Virgen Macarena, Infectious Diseases, Seville, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.130",
    "filters": {
      "actSubs": ["Piperacillin / Tazobactam", "Amoxicillin / Clavulanic acid", "Ceftriaxone", "Levofloxacin", "Fluconazole"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Oncology"],
      "numPatients": [],
      "numPrescriptions": ["51 - 100"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Incidence and risk factors for prosthetic joint infection within 90 days after hemiarthroplasty for femoral neck fractures in the elderly",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A61.1",
    "authors": "P Declercq, L Vanden Broeck, L Moons, I Du Bois, D Scherrenberg, I Spriet, A Sermon, WJ Metsemakers",
    "institution": "University Hospitals Leuven, Pharmaceutical and Pharmacological Sciences, Leuven, Belgium. University Hospitals Leuven, Department of Traumatology, Leuven, Belgium",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.131",
    "filters": {
      "actSubs": ["Cefazolin", "Clindamycin"],
      "indication": ["Bone and/or Prosthetic Infections", "Femoral Neck Fractures"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["501 - 1000"],
      "numPrescriptions": [],
      "criteriaMethod": ["Cox Proportional Hazards Regression Analysis"],
      "studyLength": [],
      "country": ["Belgium"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": ["antibioticProphylaxis"],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Audit of antibiotic prophylaxis practice in visceral surgery in an African country",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A61.2",
    "authors": "DA Fiogbe, AM Dohou, CL Yehouenou, FMD Dossou, F Van Bambeke, O Dalleur",
    "institution": "Louvain Drug Research Institute Ldri-Université Catholique De Louvain Uclouvain, Clinical Pharmacy Research Group Clip, Brussels, Belgium. Université D’abomey Calavi Uac, Faculté Des Sciences De La Santé Fss, Cotonou, Benin. Centre National Hospitalier Et Universitaire De Pneumo-Phtisiologie De Cotonou, Laboratoire De Référence Des Mycobactéries Lrm, Cotonou, Benin. Centre Hospitalo-Universitaire Départementale Ouémé Plateau, Chirurgie, Porto-Novo, Benin. Louvain Drug Research Institute Ldri-Université Catholique De Louvain Uclouvain, Pharmacologie Cellulaire Et Moléculaire, Brussels, Belgium. Université Catholique De Louvain Uclouvain, Pharmacie-Clinique Universitaire Saint-Luc, Brussels, Belgium",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.132",
    "filters": {
      "actSubs": ["Ceftriaxone"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Visceral Surgery"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": ["3 months - 5 months"],
      "country": ["Belgium", "Benin"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": ["antibioticProphylaxis"],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Antibiotic prescription through motivated request: clinical pharmacy tool to improve appropriateness and limit resistant bacterial strains. A follow-up after a year of monitoring in a local hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A62.1",
    "authors": "L Gambitta, S Campbell Davies, E Galfrascoli, E Calzavara, V Curci",
    "institution": "Asst Fatebenefratelli-Sacco-Fatebenefratelli and Ophthalmic Hospital, Hospital Pharmacy Operative Unit, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.133",
    "filters": {
      "actSubs": ["Ceftolozane / Tazobactam"],
      "indication": ["Urinary Tract Infection", "Respiratory Tract Infection", "Sepsis", "Surgical Site Infection"],
      "statedClass": ["Carbapenems"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Off-label use of nebulised aztreonam lysine in patients with chronic gram negative bacterial lung colonisation",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A62.2",
    "authors": "S Garcia Garcia, I Cardona Pascual, E Revilla López, M Larrosa García, C Alonso Martinez, J Vidal Otero, C Alerany Pardo, L Cantos Gil, P Granollers Rabal, MR Gomez Domingo, JB Montoro Ronsano",
    "institution": "Vall D’hebron University Hospital, Hospital Pharmacy Department, Barcelona, Spain. Vall D’hebron University Hospital, Pneumology Department, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.134",
    "filters": {
      "actSubs": ["Aztreonam", "Tobramycin", "Colistin"],
      "indication": ["Fibrosis (Cystic)", "Bronchiectasis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Analysis of Variance (ANOVA)", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Is it possible to rationalise antibiotic use among hospitalised patients by clinical pharmacist activity?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A63.1",
    "authors": "Z Haleder, H Takács, G Soós",
    "institution": "Semmelweis University, University Pharmacy Department of Pharmacy Administration, Budapest, Hungary. Semmelweis University, Department of Dermatology-Venereology and Dermatooncology, Budapest, Hungary",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.135",
    "filters": {
      "actSubs": ["Ceftriaxone", "Piperacillin / Tazobactam", "Metronidazole", "Clarithromycin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Hungary"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Clinical pharmacokinetics of vancomycin in neutropenic patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A63.2",
    "authors": "M Hijazi Vega, F Fernández-Fraga, I Gumiel-Baena, ME Martínez-Núñez, T Molina-García",
    "institution": "Hospital Universitario De Getafe Madrid, Pharmacy, Getafe, Spain. Hospital Universitario Puerta De Hierro Madrid, Pharmacy, Majadahonda, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.136",
    "filters": {
      "actSubs": ["Vancomycin"],
      "indication": ["Neutropenia"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Cockcroft–Gault Creatinine Clearance"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Pharmaceutical interventions in a small hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A64.1",
    "authors": "L Jimenez, E Lobo-Leon, C Puivecino-Moreno, R Gazquez-Perez, A Varas-Perez",
    "institution": "Hospital San Juan Grande, Pharmacy Hospital, Jerez De La Frontera Cadiz, Spain. Hospital San Juan Grande, Pharmacy Hospital, Cadiz, Spain. Hospital Sas Jerez, Pharmacy Hospital, Cadiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.137",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["6 months - 1 year"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Clinical outcome in paediatric intensive care unit patients treated with vancomycin",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A64.2",
    "authors": "A Khangtragool, K Sunkonkit, A Lucksiri, S Seetaboot",
    "institution": "Division of Pharmacy, Faculty of Medicine-Chiang Mai University, Chiang Mai, Thailand. Division of Pulmonary and Critical Care, Department of Paediatrics-Faculty of Medicine-Chiang Mai University, Chiang Mai, Thailand. Department of Pharmaceutical Care, Faculty of Pharmacy-Chiang Mai University, Chiang Mai, Thailand",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.138",
    "filters": {
      "actSubs": ["Vancomycin"],
      "indication": ["Septic Shock"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Paediatric Intensive Care"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Pediatric Index of Mortality (PIM) 2 Score"],
      "studyLength": [],
      "country": ["Thailand"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Stability to high temperatures of the antimicrobials used in outpatient parenteral antimicrobial therapy programmes",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A65.1",
    "authors": "M Mejias Trueba, L Herrera Hidalgo, JL Pérez Blanco, MV Gil Navarro, LE López Cortés, JM Carmona Caballero, R Luque Márquez",
    "institution": "Hospital Universitario Virgen Del Rocío, Hospital Pharmacy, Sevilla, Spain. Instituto De Biomedicina De Sevilla Ibis, Clinical Unit of Infectious Diseases-Microbiology and Preventive Medicine, Sevilla, Spain. Hospital Universitario Virgen Del Rocío, Pharmacy, Sevilla, Spain. Hospital Universitario Virgen Del Rocío, Clinical Unit of Infectious Diseases-Microbiology and Preventive Medicine, Sevilla, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.139",
    "filters": {
      "actSubs": ["Acyclovir", "Cefazolin", "Gentamicin", "Voriconazole", "Aztreonam", "Ampicillin", "Cefepime", "Ceftazidime", "Ceftriaxone", "Clindamycin", "Daptomycin", "Meropenem", "Piperacillin / Tazobactam", "Penicillin G", "Tobramycin", "Vancomycin", "Amphotericin", "Cloxacillin", "Ertapenem", "Foscarnet", "Fluconazole", "Ganciclovir", "Sulbactam", "Teicoplanin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Nosocomial infection by multiresistant pathogens in kidney transplant patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A65.2",
    "authors": "MJ Morales Lara, R Tamayo Bermejo, A Luna Higuera",
    "institution": "Hospital Regional Universitario Carlos Haya, Pharmacy, Malaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.140",
    "filters": {
      "actSubs": ["Basiliximab", "Mycophenolate", "Tacrolimus", "Thymoglobulin", "Ceftazidime", "Ciprofloxacin", "Ceftriaxone", "Meropenem", "Levofloxacin", "Piperacillin / Tazobactam", "Ceftazidime / Avibactam", "Avibactam"],
      "indication": ["Nosocomial Infection", "Urinary Tract Infection"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Adequacy of antibiotic prescriptions in a nursing home",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A66.1",
    "authors": "MR Cantudo Cuenca, BM Muñoz Cejudo, L Dani Ben Abdel-Lah, MA Mora Mora, JE Martínez De La Plata",
    "institution": "Hospital San Agustín Área De Gestión Sanitaria Norte De Jaén, Pharmacy, Linares, Spain. Agencia Pública Empresarial Sanitaria Hospital De Poniente, Pharmacy, El Ejido, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.141",
    "filters": {
      "actSubs": ["Amoxicillin / Clavulanic acid", "Fosfomycin", "Cloxacillin"],
      "indication": ["Urinary Tract Infection", "Skin and Soft Tissue Infection", "Respiratory Tract Infection (Lower)"],
      "statedClass": ["Quinolones", "Cephalosporins"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Charlson Comorbidity Index"],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": ["endOfLife"],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": ["antibioticProphylaxis"],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Pharmacist led antimicrobial stewardship programme",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A66.2",
    "authors": "MR Cantudo Cuenca, L Dani Ben Abdel-Lah, JE Martínez De La Plata, BM Muñoz Cejudo, M Mora Mora",
    "institution": "Hospital San Agustín Área De Gestión Sanitaria Norte De Jaén, Pharmacy, Linares, Spain. Agencia Pública Empresarial Sanitaria Hospital De Poniente, Pharmacy, Linares, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.142",
    "filters": {
      "actSubs": ["Cloxacillin", "Cefazolin"],
      "indication": [],
      "statedClass": ["Carbapenems", "Quinolones", "Antifungals (Systemic)", "Anti-MRSA (Methicillin-Resistant Staphylococcus aureus) Agents"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": ["antibioticProphylaxis"],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Pharmacist’s mission in infection management: evaluation of improvement actions",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A67.1",
    "authors": "C Muziotti, L Dol, MF Texier, S Chadapaud",
    "institution": "Centre Hospitalier D’hyeres, Hospital Pharmacy, Hyeres, France. Centre Hospitalier D’hyeres, Operational Hygiene Team, Hyeres, France. Centre Hospitalier D’hyeres, Infectious Disease Service, Hyeres, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.143",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effectiveness of a new internal protocol for dosage of vancomycin in neonates",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A67.2",
    "authors": "M Ibáñez Carrillo, G Miralles Andreu, S Gutierrez Palomo, AM Sánchez García, AC Murcia López, A Navarro Ruiz",
    "institution": "Hospital General Universitario De Elche, Servicio De Farmacia, Elche, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.144",
    "filters": {
      "actSubs": ["Vancomycin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "The routine use of antibiotics after insertion of a cardiac implantable electronic device (CIED): evidence and current practice",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A68.1",
    "authors": "S Omran, O Mukhtar, S Mousa",
    "institution": "King Salman Armed Forces Hospital-Nwafh, Adult Intensive Care Unit, Tabuk, Saudi Arabia",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.145",
    "filters": {
      "actSubs": [],
      "indication": ["Postoperative Infection", "Complete Heart Block", "Bacteraemia"],
      "statedClass": [],
      "typeOfMedical": ["Cardiac Implantable Electronic Device", "Permanent Pacemaker"],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Fisher’s Exact Test"],
      "studyLength": [],
      "country": ["Saudi Arabia"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Cost effectiveness analysis of meropenem dose optimisation in critical patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A68.2",
    "authors": "AI Idoate, A Aldaz, I Aquerreta, A Ortega",
    "institution": "Clinica Universidad De Navarra, Pharmacy, Pamplona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.146",
    "filters": {
      "actSubs": ["Meropenem"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Propensity Score Matching"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Monitoring the prescription of new antibiotics: the work of the antimicrobial stewardship team in a third level hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A68.3",
    "authors": "E Sánchez-Yáñez, M Gómez Delgado, JL Ortiz Latorre, MR Mora-Santiago, I Moya-Carmona",
    "institution": "Hospital Universitario Virgen De La Victoria, Servicio De Farmacia, Málaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.147",
    "filters": {
      "actSubs": ["Ceftaroline", "Ceftolozane / Tazobactam", "Ceftazidime / Avibactam", "Avibactam", "Dalbavancin", "Tedizolid", "Isavuconazole"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["10 - 50"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Assessing the impact of antimicrobial stewardship programmes in hospitals: the role of pharmacists",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A69.1",
    "authors": "M Jaume Gaya, R Pérez Senoff, MS Sanz Parras, JM Saurina Gomila, A Rey Ferrin, Á García Álvarez, J Martinez Sotelo, PJ Siquier Homar, F Fernandez Cortes, A Vanrell Ballestero, M Pinteño Blanco",
    "institution": "Hospital Comarcal D’inca, Clinical Pharmacy, Inca, Spain. Hospital Comarcal D’inca, Intensive Care, Inca, Spain. Hospital Comarcal D’inca, Infectious Disease, Inca, Spain. Hospital Comarcal D’inca, Clinical Microbiology, Inca, Spain. Primary Care, Clinical Pharmacy, Inca, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.148",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["More than 2 years - 5 years"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Beta-lactam antibiotics in critical ill patients: are we dosing our patients correctly?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A69.2",
    "authors": "M Núñez-Núñez, R Morón-Romero, R Álvarez-Sánchez, J García Villanova, N Chueca, S Portillo-Haro, E Yuste-Ossorio, J Cabeza-Barrera",
    "institution": "Farmacia Hospital San Cecilio, Pharmacy, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.149",
    "filters": {
      "actSubs": ["Meropenem", "Piperacillin"],
      "indication": [],
      "statedClass": ["Beta-Lactam Antibiotics"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Underdosing with high dose piperacillin/tazobactam administered via continuous infusion in outpatient parenteral antimicrobial therapy: a stability or viscosity problem?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A70.1",
    "authors": "C Quintens, I Spriet",
    "institution": "University Hospitals Leuven, Hospital Pharmacy, Leuven, Belgium",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.150",
    "filters": {
      "actSubs": ["Piperacillin / Tazobactam"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Elastomeric Infusion Pumps"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Spectrophotometry"],
      "studyLength": [],
      "country": ["Belgium"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Conformity of antibiotic therapy duration in patients with febrile neutropenia, hospitalised in the haematology department of a university hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A70.2",
    "authors": "M Ravey, S Robert, S Henard, B Demore",
    "institution": "Chru De Nancy, Pharmacie À Usage Intérieur, Vandoeuvre Les Nancy, France. Chru De Nancy, Maladies Infectieuses Et Tropicales, Vandoeuvre Les Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.151",
    "filters": {
      "actSubs": ["Cefepime", "Piperacillin / Tazobactam"],
      "indication": ["Neutropenia (Febrile)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Haematology"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Antibiotics in the emergency department: is it possible to improve prescriptions for infectious respiratory diseases in ambulatory patients?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A71.1",
    "authors": "P Ruiz Briones, R García Sánchez, C Ortega Navarro, MÁ Amor García, F García Moreno, A Melgarejo Ortuño, S García Sánchez, Á Narrillos Moraza, A Herranz Alonso, M Sanjurjo Saez",
    "institution": "Hospital General Universitario Gregorio Marañón, Pharmacy Department, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.152",
    "filters": {
      "actSubs": [],
      "indication": ["Respiratory Tract Infection"],
      "statedClass": ["Antibiotics", "Quinolones", "Antibiotics (High Spectrum)"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of piperacillin/tazobactam dosage in septic patients attending the emergency department",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A71.2",
    "authors": "J Ruiz, A Juanes Borrego, L López Vinardell, A Plaza Diaz, MA Mangues Bafalluy, M Puig Campmany",
    "institution": "Hospital Santa Creu I Sant Pau, Pharmacy, Barcelona, Spain. Hospital Santa Creu I Sant Pau, Emergency Department, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.153",
    "filters": {
      "actSubs": ["Piperacillin / Tazobactam"],
      "indication": ["Sepsis", "Bacteraemia (Gram Negative)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Simulation Study"],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Monte Carlo Simulation"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Antimicrobial stewardship programme in an intensive care unit",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A72.1",
    "authors": "E Sánchez Yañez, M Valera-Rubio, I Moya-Carmona, MR Mora-Santiago, C Pérez-López",
    "institution": "Hospital Clinico Virgen De La Victoria, Pharmacy Department, Malaga, Spain. Hospital Clinico Virgen De La Victoria, Infectious Disease, Malaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.154",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Carbapenems", "Antifungals"],
      "typeOfMedical": [],
      "studyDesign": ["Interventional Study", "Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["More than 1 year - 2 years"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "A multidisciplinary and educational approach to antimicrobial stewardship programmes in the emergency department",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A72.2",
    "authors": "I Plo Seco, L Moreno Nuñez, S Sanz Márquez, E Zhan Zhou, J Valverde Canovas, Francisco, E Pérez Fernández, M Pérez Encinas",
    "institution": "Hospital Universitario Fundacion Alcorcón, Hospital Pharmacy, Alcorcon, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.155",
    "filters": {
      "actSubs": ["Meropenem", "Levofloxacin", "Amoxicillin / Clavulanic acid"],
      "indication": ["Pneumonia (Community Acquired)", "Respiratory Tract Infection", "Urinary Tract Infection"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Interventional Study"],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of use, effectiveness and safety of isavuconazol",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A73.1",
    "authors": "CA Alonso Peralta, CM Valencia Soto, A Illaro Uranga, RM Gonzalez Franco, B Rogado Vegas, J Casanova Vázquez, P Del Rio Ortega, M Rioja Carrera, I Aragon Gracia, L Perez-Periañez Orillo, M Valero Domínguez",
    "institution": "Hospital Universitario Marqués De Valdecilla, Farmacia Hospitalaria, Santander, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.156",
    "filters": {
      "actSubs": ["Isavuconazole", "Voriconazole"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Proper use of antifungals: implementation of operational multidisciplinary teams dedicated to antifungals",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A73.2",
    "authors": "P Audureau, F Meyer, A Charmillon, S Henard, B Demore",
    "institution": "University Hospital Nancy-Brabois Adults Hospital, Pharmacy Department, Vandoeuvre-Lès-Nancy, France. University Hospital Nancy-Brabois Adults Hospital, Infectious and Tropical Diseases Department, Vandoeuvre-Lès-Nancy, France. Lorraine University, Ea 4360 Apemac, Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.157",
    "filters": {
      "actSubs": ["Caspofungin", "Posaconazole"],
      "indication": ["Candidiasis (Invasive)", "Aspergillosis (Pulmonary)"],
      "statedClass": ["Antifungals"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Haematology"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": ["501 - 1000"],
      "criteriaMethod": [],
      "studyLength": ["6 months - 1 year"],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Therapeutic drug monitoring of voriconazole",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A74.1",
    "authors": "S Ruiz Boy, N Socoro-Yuste, C Bastida, D Soy-Muner",
    "institution": "Hospital Clínic, Pharmacy, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.158",
    "filters": {
      "actSubs": ["Voriconazole"],
      "indication": ["Invasive Fungal Infection", "Candidaemia"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Management of the hospitalised patient with flu",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A74.2",
    "authors": "M Mañes Sevilla, B Santiago-Gallego, I Soto-Baselga, C Moriel-Sánchez",
    "institution": "Hospital Universitario Mostoles, Pharmacy Department, Móstoles Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.159",
    "filters": {
      "actSubs": ["Oseltamivir", "Levofloxacin", "Ceftriaxone", "Amoxicillin / Clavulanic acid"],
      "indication": ["Influenza (Flu)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine", "Pneumology"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Strategy for change in antiretroviral therapy: looking for better results",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A75.1",
    "authors": "P Barriga, P Pérez, S Arnaiz, C Caba, P Tena, JJ Duque, JA Sánchez, AM Dobrito, MR Garrido, LC Fernández",
    "institution": "Complejo Hospitalario Universitario De Cáceres, Hospital Pharmacy, Cáceres, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.160",
    "filters": {
      "actSubs": ["Emtricitabine", "Tenofovir disoproxil", "Rilpivirine", "Tenofovir alafenamide"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Prescription analysis of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in a third level hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A75.2",
    "authors": "A Caraffa, A Colicchio, L Gasperoni, G Selvetti, I Tommasini, E Zuccarini, M Mancini",
    "institution": "Azienda Ospedaliera Ospedali Riuniti Marche Nord, Uoc Farmacia, Pesaro, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.161",
    "filters": {
      "actSubs": ["Tenofovir disoproxil", "Tenofovir alafenamide", "Emtricitabine", "Elvitegravir", "Cobicistat", "Rilpivirine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["More than 1000"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Adherence to antiretroviral treatment as a function of the complexity of the treatment",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A76.1",
    "authors": "J Romero, A Soria Martin, J Garcia Marin, M Fages, JR Avila Alvarez",
    "institution": "Hospital Punta De Europa, Pharmacy, Cadiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.162",
    "filters": {
      "actSubs": ["Emtricitabine", "Tenofovir disoproxil", "Efavirenz"],
      "indication": ["Acquired Immunodeficiency Syndrome (AIDS)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Chi-Square (χ2) Test"],
      "studyLength": ["6 months - 1 year"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Patients with darunavir/cobicistat/emtricitabine/tenofovir alafenamide treatment in a third level hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A76.2",
    "authors": "R Gracia, JM Vinuesa, I Sanjoaquin, T Salvador, MDP Pardo, MA Alcácera, A Apesteguia, MJ Crusells, S Letona, M Gimeno-Gracia",
    "institution": "Hospital Clinico Universitario Lozano Blesa, Farmacia Hospitalaria, Zaragoza, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.163",
    "filters": {
      "actSubs": ["Darunavir / Cobicistat / Emtricitabine / Tenofovir alafenamide", "Darunavir", "Cobicistat", "Emtricitabine", "Tenofovir alafenamide"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["HIVTSQ - HIV Treatment Satisfaction Questionnaire"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Use of oseltamivir in the treatment of influenza A",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A76.3",
    "authors": "A Murgadella Sancho, B Gracia Garcia, L Losa Lopez, A Puebla Villaescusa, O Carrascosa Piquer, MT Barrera Puigdollers, N San Juan Martínez",
    "institution": "Hospital Moisès Broggi, Pharmacy, Sant Joan Despí, Spain. Hospital Dos De Maig, Pharmacy, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.164",
    "filters": {
      "actSubs": ["Oseltamivir"],
      "indication": ["Influenza A"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Adherence to antiretroviral treatment in patients with HIV",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A77.1",
    "authors": "C Notario Dongil, A Perez Fácila, B Proy Vega, MM Alañón Pardo, P Araque Arroyo, JC Valenzuela Gámez",
    "institution": "Hospital General La Mancha Centro, Servicio De Farmacia, Alcazar De San Juan, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.165",
    "filters": {
      "actSubs": [],
      "indication": ["Acquired Immunodeficiency Syndrome (AIDS)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Switching to equivalent alternatives: antiretroviral optimisation strategy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A77.2",
    "authors": "B Proy Vega",
    "institution": "Hospital La Mancha Centro, Hospitalary Pharmacy, Alcazar De San Juan Ciudad Real, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.166",
    "filters": {
      "actSubs": ["Dolutegravir", "Abacavir", "Lamivudine", "Lamivudine / Abacavir", "Abacavir / Dolutegravir / Lamivudine", "Emtricitabine", "Tenofovir disoproxil", "Rilpivirine", "Emtricitabine / Tenofovir disoproxil / Rilpivirine", "Emtricitabine / Tenofovir disoproxil"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Changing from cobicistat to a ritonavir boosted regimen in HIV positive patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A78.1",
    "authors": "L Quesada-Muñoz, M Rodríguez Marín, M Vélez-Díaz-Pallarés, B Montero Llorente, T Gramage Caro, MÁ Rodríguez Sagrado, N Vicente Oliveros, S Sanz Merino, MT Bermejo Vicedo",
    "institution": "Ramón Y Cajal Hospital, Pharmacy, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.167",
    "filters": {
      "actSubs": ["Cobicistat", "Ritonavir", "Calcifediol", "Atorvastatin", "Omeprazole"],
      "indication": ["Acquired Immunodeficiency Syndrome (AIDS)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Analysis of usage of direct acting antivirals for the treatment of hepatitis C",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A78.2",
    "authors": "MÁ Roch Ventura, J Del Estal Jiménez, A Sanjuan Belda, M Mendoza Aguilera, PA López Broseta, E Esteve Pitarch, M Martín Marqués, S Jornet Montaña, M Vuelta Arce, L Canadell Vilarrasa",
    "institution": "Hospital Universitari Joan Xxiii, Pharmacy, Tarragona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.168",
    "filters": {
      "actSubs": ["Glecaprevir / Pibrentasvir", "Glecaprevir", "Pibrentasvir", "Sofosbuvir / Velpatasvir", "Sofosbuvir", "Velpatasvir", "Elbasvir / Grazoprevir", "Grazoprevir", "Elbasvir", "Ombitasvir / Paritaprevir / Ritonavir", "Ombitasvir", "Paritaprevir", "Ritonavir", "Dasabuvir", "Ledipasvir / Sofosbuvir", "Ledipasvir", "Sofosbuvir / Velpatasvir / Voxilaprevir", "Voxilaprevir"],
      "indication": ["Hepatitis C"],
      "statedClass": ["Direct Acting Antivirals"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effectiveness of dolutegravir and lamivudine therapy in a two drug regimen in a third level hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A79.1",
    "authors": "C Fernández Zamora, T Rodríguez Martínez, MA Meroño Saura, S Clavijos Bautista, J Plaza Aniorte, P Pacheco López, MÁ Carvajal Sánchez, J Ibáñez Caturla, MD Nájera Pérez",
    "institution": "Hospital Morales Meseguer, Farmacia Hospitalaria, Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.169",
    "filters": {
      "actSubs": ["Dolutegravir", "Lamivudine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of palivizumab as prophylaxis against respiratory syncytial virus infection",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A79.2",
    "authors": "F Fernandez Fraga, P Lopez Mendez, A Lopez Garcia, N Ibañez Heras, T Molina Garcia",
    "institution": "Hospital Universitario De Getafe, Farmacia, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.170",
    "filters": {
      "actSubs": ["Palivizumab"],
      "indication": ["Respiratory Syncytial Virus Infection", "Respiratory Tract Infection"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Analysis of the use of non-specific intravenous immunoglobulins in a tertiary hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A80.1",
    "authors": "Z Rodríguez Fernández, E Martínez Álvarez, X Casas Fernández, A Vélez Blanco, N Álvarez Nuñez, JJ Ortiz De Urbina González",
    "institution": "León University Hospital, Hospital Pharmacy, León, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.171",
    "filters": {
      "actSubs": [],
      "indication": ["Immunodeficiency - Common Variable", "Immunodeficiency - Secondary", "Thrombocytopenic Purpura", "Polyneuropathy", "Myasthenia Gravis"],
      "statedClass": ["Immunoglobulin (IVIg)"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Analysis of effectiveness: use of pertuzumab and trastuzumab in neoadjuvant treatment in patients with HER2 positive breast cancer and its correlation with plasma levels of trastuzumab",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A80.2",
    "authors": "R Álvarez Ambite, F Gutierrez Nicolas, I Ceballos Lezna, IJ Expósito Afonso, J González García, R Ramos Díaz, J Cruz Jurado, GJ Nazco Casariego",
    "institution": "Hospital Universitario De Canarias, Oncología Médica, Santa Cruz De Tenerife, Spain. Hospital Universitario De Canarias, Farmacia Hospitarlaria, Santa Cruz De Tenerife, Spain. Hospital Universitario De Canarias, Oncología Medica, Santa Cruz De Tenerife, Spain. Hospital Universitario De Canarias, Anatomia Patológica, Santa Cruz De Tenerife, Spain. Hospital Universitario De Canarias, Farmacia Hospitalaria, Santa Cruz De Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.172",
    "filters": {
      "actSubs": ["Pertuzumab", "Trastuzumab", "Adriamycin", "Cyclophosphamide"],
      "indication": ["Breast Cancer (HER2 Positive)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["ELISA Immunoassay"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Comparison of immune checkpoint inhibitors (nivolumab, pembrolizumab, atézolizumab and durvalumab) in the treatment of non-small cell lung cancer: tolerance and financial impact",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A81.1",
    "authors": "F Badibouidi, L Dupont, M Benchaabane, S Loutski",
    "institution": "Ghpso, Pharmacy, Creil, France. Ghpso, Oncology, Creil, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.173",
    "filters": {
      "actSubs": ["Nivolumab", "Pembrolizumab", "Atezolizumab", "Durvalumab"],
      "indication": ["Non-Small Cell Lung Cancer", "Pneumonitis"],
      "statedClass": ["Immune Checkpoint Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["More than 1 year - 2 years"],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effectiveness and safety of platin/permetrexed combination in non-small cell lung cancer",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A81.2",
    "authors": "EM Barreiro Fernandez, C Martinez-Diaz, FJ Salmeron-Navas, M Dominguez-Cantero, S Fenix-Caballero",
    "institution": "Hospital Universitario Puerto Real, Servicio De Farmacia, Cadiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.174",
    "filters": {
      "actSubs": ["Platin", "Pemetrexed", "Cisplatinum", "Carboplatinum"],
      "indication": ["Non-Small Cell Lung Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Kaplan-Meier Method", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Cyclin dependent kinase 4/6 inhibitors in breast cancer: potential drug interactions",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A81.3",
    "authors": "MI Bernias Domínguez, M Mañes Sevilla, PM Bernias Domínguez, MJ Vazquez Castillo, C Moriel Sánchez",
    "institution": "Hospital Universitario De Móstoles, Hospital Pharmacy, Madrid, Spain. Fremap, Medicine, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.175",
    "filters": {
      "actSubs": ["Palbociclib", "Ribociclib"],
      "indication": ["Breast Cancer"],
      "statedClass": ["Cyclin-Dependent Kinases 4/6 Inhibitors", "Statins", "Proton-Pump Inhibitors", "Antidepressants", "Pyrazolones"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Ibrutinib associated atrial fibrillation: incidence and management in the real life clinical setting",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A82.1",
    "authors": "S Blanco-Dorado, A Mosquera-Torre, E López-Montero, M Touris-Lores, B Bernardez Ferran, I Zarra-Ferro",
    "institution": "Complejo Hospitalario Universitario De Santiago De Compostela, Pharmacy Department, Santiago De Compostela, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.176",
    "filters": {
      "actSubs": ["Ibrutinib", "Apixaban", "Rivaroxaban", "Amiodarone"],
      "indication": ["Atrial Fibrillation", "Arrhythmia"],
      "statedClass": ["Low Molecular Weight Heparins", "Beta-Blockers"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Indirect comparison between pembrolizumab monotherapy and pembrolizumab chemotherapy regimens in squamous lung cancer",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A82.2",
    "authors": "MDP Briceño Casado, MD Gil-Sierra, S Fenix-Caballero, M Dominguez-Cantero, EJ Alegre-Del Rey",
    "institution": "Hospital Universitario Puerto Real, Hospital Pharmacy, Cadiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.177",
    "filters": {
      "actSubs": ["Pembrolizumab"],
      "indication": ["Non-Small Cell Lung Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Bucher's Method"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Detection and communication of concomitant use of capecitabine and proton pump inhibitors",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A83.1",
    "authors": "AB Guisado Gil, IM Carrión Madroñal, E Sánchez Gómez, MD Santos Rubio",
    "institution": "Hospital Juan Ramón Jiménez, Ugc Farmacia, Huelva, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.178",
    "filters": {
      "actSubs": ["Capecitabine", "Omeprazole", "Pantoprazole", "Esomeprazole", "Rabeprazole"],
      "indication": ["Colorectal Cancer", "Gastric Cancer", "Oesophageal Cancer", "Breast Cancer", "Pancreatic Cancer"],
      "statedClass": ["Proton-Pump Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effectiveness and safety of eribulin for advanced breast cancer treatment",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A83.2",
    "authors": "I Cavada Carranza, M Carrasco Gomariz, M Moreno Garcia, R Diez Fernandez, T Molina Garcia",
    "institution": "Hospital Universitario De Getafe, Pharmacy Department, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.179",
    "filters": {
      "actSubs": ["Eribulin"],
      "indication": ["Breast Cancer (Advanced)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Sequencing of ibrutinib, idelalisib and venetoclax in chronic lymphocytic leukaemia: experience in a tertiary hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A84.1",
    "authors": "R García-Fumero, C Alarcón-Payer, A Jiménez-Morales, MDM García-Valdés, JM Puerta-Puerta, R Claramunt García",
    "institution": "Hospital Universitario Virgen De Las Nieves, Pharmacy, Granada, Spain. Hospital Universitario De Jaén, Pharmacy, Jaén, Spain. Hospital Universitario Virgen De Las Nieves, Haematology, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.180",
    "filters": {
      "actSubs": ["Ibrutinib", "Idelalisib", "Venetoclax"],
      "indication": ["Leukaemia (Chronic Lymphocytic)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Real life tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukaemia",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A84.2",
    "authors": "C Alarcon-Payer1, JM Puerta Puerta2, A Jiménez Morales3, R Claramunt García, F Horno Ureña",
    "institution": "Hospital Universitario De Jaén, Servicio De Farmacia, Jaén, Spain. Hospital Universitario Virgen De Las Nieves, Servicio De Haematología, Granada, Spain. Hospital Universitario Virgen De Las Nieves, Servicio De Farmacia, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.181",
    "filters": {
      "actSubs": ["Imatinib", "Nilotinib", "Dasatinib"],
      "indication": ["Leukaemia (Chronic Myeloid)"],
      "statedClass": ["Tyrosine Kinase Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Real-Time Polymerase Chain Reaction"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Gefitinib in non-small cell lung cancer: effectiveness and safety",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A85.1",
    "authors": "JC Del Río Valencia, A Henares López, R Tamayo Bermejo, I Muñoz Castillo",
    "institution": "Hospital Regional Universitario Malaga, Servicio De Farmacia, Malaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.182",
    "filters": {
      "actSubs": ["Gefitinib"],
      "indication": ["Non-Small Cell Lung Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Response Evaluation Criteria In Solid Tumours (RECIST)", "Kaplan-Meier Method"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": ["pharmacogenetics"],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Risk of myelotoxicity in non-cancer patients treated with chemotherapy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A85.2",
    "authors": "R Diez Fernandez, I Cavana Carranza, M Carrasco Gomariz, M Moreno Garcia, T Molina Garcia",
    "institution": "Hospital Universitario Getafe, Pharmacy, Madrid, Spain. Hospital Universitario De Getafe, Pharmacy, Getafe, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.183",
    "filters": {
      "actSubs": ["Cyclophosphamide"],
      "indication": ["Myelotoxicity", "Systemic Lupus Erythematosus", "Neutropenia", "Thrombocytopenia"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Common Terminology Criteria for Adverse Events"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Safety and tolerability of palbociclib in clinical practice in a tertiary hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A86.1",
    "authors": "J Fernández Fradejas, L Quesada-Muñoz, M Vélez-Díaz-Pallarés, E Vida Navas, A Cortés Salgado, A Cabello Bravo, T Bermejo Vicedo",
    "institution": "Hospital Universitario Ramón Y Cajal, Pharmacy, Madrid, Spain. Hospital Universitario Ramón Y Cajal, Oncology, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.184",
    "filters": {
      "actSubs": ["Palbociclib", "Fulvestrant"],
      "indication": [],
      "statedClass": ["Aromatase Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Cohort Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Common Terminology Criteria for Adverse Events", "Eastern Cooperative Oncology Group (ECOG) Performance Status"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Anthracycline dosage in paediatric obese patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A86.2",
    "authors": "B Fernandez Garcia, C Fraile Rodriguez, X Abasolo Tamayo, I Herrero Corell, M Serrano Alonso, MÁ García-Del-Barrio",
    "institution": "Clinica Universidad De Navarra, Pharmacy, Pamplona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.185",
    "filters": {
      "actSubs": ["Daunorubicin", "Doxorubicin", "Epirubicin", "Idarubicin"],
      "indication": [],
      "statedClass": ["Anthracyclines"],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Improved access to chemotherapeutic treatment in patients with multiple myeloma",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A87.1",
    "authors": "EG Fernández López, MM Viña Romero, J Merino Alonso, JA De Leon Gil, I Gonzalez Perera, JA Martin Conde",
    "institution": "Hospital Nuestra Señora De Candelaria, Hospital Pharmacy, Santa Cruz De Tenerife, Spain. Santa Cruz De Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.186",
    "filters": {
      "actSubs": ["Bortezomib", "Thalidomide", "Prednisone", "Melphalan", "Dexamethasone", "Daratumumab", "Lenalidomide"],
      "indication": ["Multiple Myeloma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Imatinib dose optimisation through therapeutic monitoring in chronic myeloid leukaemia as part of pharmaceutical care",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A87.2",
    "authors": "C Fernandez Oliveira, E Fernández Gabriel, M Outeda Macías, MS Noya Pereira, I Martín Herranz",
    "institution": "Complexo Hospitalario Universitario A Coruña, Pharmacy Service, A Coruna, Spain. Complexo Hospitalario Universitario A Coruña, Haematology Service, A Coruna, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.187",
    "filters": {
      "actSubs": ["Imatinib"],
      "indication": ["Leukaemia (Chronic Myeloid)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Optimisation of resources in the use of immunotherapy: nivolumab and pembrolizumab weight based dosing instead of flat dose",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A88.1",
    "authors": "I Lomares Manzano, MJ Martinez Bautista, A Ganfornina Andrades, MV Manzano Martin",
    "institution": "Hospital Universitario Puerta Del Mar, Servicio De Farmacia Hospitalaria, Cádiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.188",
    "filters": {
      "actSubs": ["Nivolumab", "Pembrolizumab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": ["flatDoses"],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Checkpoint inhibitors in non-microcytic lung cancer: results in common clinical practice",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A88.2",
    "authors": "A Magallon Martinez, MJ Agustín Ferrández, A Pinilla Rello, A Escolano Pueyo, O Pereira Blanco, L Cazorla Poderoso, M Perez Moreno, A Casajús Navasal, R Abaz Sazatornil",
    "institution": "Universitary Miguel Servet Hospital, Hospital Pharmacy, Zaragoza, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.189",
    "filters": {
      "actSubs": ["Nivolumab", "Pembrolizumab", "Atezolizumab", "Pemetrexed", "Carboplatinum"],
      "indication": ["Non-Small Cell Lung Cancer", "Adenocarcinoma", "Squamous Cell Carcinoma", "Large Cell Carcinoma"],
      "statedClass": ["Immune Checkpoint Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Eastern Cooperative Oncology Group (ECOG) Performance Status", "Kaplan-Meier Method"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Comparative effectiveness of nintedanib plus docetaxel versus docetaxel monotherapy in adenocarcinoma non-small cell lung cancer",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A89.1",
    "authors": "M Merino Almanzan, JM Duarte Perez, JF Marin Pozo, R Claramunt Garcia, CL Muñoz Cid, I Caba Porras",
    "institution": "Complejo Hospitalario Jaen, Hospital Pharmacy, Jaén, Spain. University of Granada, Pharmacology, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.190",
    "filters": {
      "actSubs": ["Nintedanib", "Docetaxel"],
      "indication": ["Adenocarcinoma", "Non-Small Cell Lung Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Kaplan-Meier Method", "Cox Proportional Hazards Regression Analysis", "Eastern Cooperative Oncology Group (ECOG) Performance Status"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Efficacy and safety of erlotinib in non-small cell lung cancer",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A89.2",
    "authors": "E Monteagudo Santolaya, M Prieto Castello, L Cebrián Lara, R Colom Moreno, A Sánchez Alcaraz",
    "institution": "Hospital Universitario De La Ribera, Clinical Pharmacy, Alzira, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.191",
    "filters": {
      "actSubs": ["Erlotinib"],
      "indication": ["Non-Small Cell Lung Cancer (EGFR-Mutated)", "Adenocarcinoma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Karnofsky Performance Status Scale"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of aggressiveness of cancer care near the end of life in patients with pancreatic cancer",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A89.3",
    "authors": "S Martínez-Pérez, M Llinares-Esquerdo, G Miralles-Andreu, S Gutierrez-Palomo, A Garcia-Monsalve, A Navarro Ruiz",
    "institution": "Hospital General Universitario De Elche, Pharmacy, Elche, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.192",
    "filters": {
      "actSubs": [],
      "indication": ["Pancreatic Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Oncology", "Intensive Care", "Palliative Care"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Eastern Cooperative Oncology Group (ECOG) Performance Status"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": ["endOfLife"],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of aggressiveness of cancer care near the end of life in patients with metastatic non-microcytic lung cancer",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A90.1",
    "authors": "M Llinares-Esquerdo, S Martínez-Pérez, M Pomares-Bernabeu, IP Jiménez-Pulido, L Sorian-Irigaray, A Navarro Ruiz",
    "institution": "Hospital General Universitario De Elche, Pharmacy, Elche, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.193",
    "filters": {
      "actSubs": [],
      "indication": ["Non-Small Cell Lung Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Palliative Care", "Intensive Care"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Eastern Cooperative Oncology Group (ECOG) Performance Status"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": ["endOfLife"],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effectiveness of dexamethasone mouthwash 0.1 mg/mL for prevention of everolimus related stomatitis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A90.2",
    "authors": "S Martínez-Pérez, M Llinares-Esquerdo, S Gutierrez-Palomo, IP Jimenez-Pulido, A Garcia-Monsalve, A Navarro Ruiz",
    "institution": "Hospital General Universitario De Elche, Pharmacy, Elche, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.194",
    "filters": {
      "actSubs": ["Dexamethasone", "Everolimus", "Exemestane"],
      "indication": ["Stomatitis", "Breast Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Characterisation of potential drug–drug interactions in oncological patients treated with oral anticancer drugs",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A91.1",
    "authors": "M Pomares Bernabeu, G Miralles Andreu, S Martinez Perez, A Garcia Monsalve, C Matoses Chirivella, A Navarro Ruiz",
    "institution": "Hospital General Universitario De Elche, Pharmacy, Elche, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.195",
    "filters": {
      "actSubs": ["Allopurinol"],
      "indication": [],
      "statedClass": ["Corticosteroids", "Proton-Pump Inhibitors", "Antiplatelet Agents", "Oral Anticoagulants"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Reviewing the latest clinical research for treating advanced non-small cell lung cancer: selection of randomised controlled trials published in 2018",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A91.2",
    "authors": "R García-Fumero, C Fernández-López, J Expósito-Hernández, S Portillo-Haro, MÁ Calleja-Hernández",
    "institution": "Hospital Universitario Virgen De Las Nieves, Department of Pharmacy, Granada, Spain. Biosanitary Institute of Granada Ibs Granada, Sas-Universidad De Granada, Granada, Spain. Catalan Institute of Oncology, Department of Pharmacy, Barcelona, Spain. Hospital Universitario Virgen De Las Nieves, Department of Oncology, Granada, Spain. Hospital Universitario San Cecilio, Department of Pharmacy, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.196",
    "filters": {
      "actSubs": ["Alectinib", "Crizotinib", "Osimertinib", "Pembrolizumab", "Anlotinib", "Dulanermin", "Atezolizumab"],
      "indication": ["Non-Small Cell Lung Cancer"],
      "statedClass": ["Epidermal Growth Factor Receptor (EGFR) Inhibitors", "Anaplastic Lymphoma Kinase (ALK) Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of clinical pharmacy services in a haematology outpatient setting",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A92.1",
    "authors": "R Gavira Moreno, V Vázquez Vela, P Gomez Germá, C Puivecino Moreno, A Varas Pérez, JF Sierra Sánchez",
    "institution": "Area De Gestion Sanitaria Norte De Cadiz-Hospital De Jerez, Pharmacy, Jerez De La Frontera, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.197",
    "filters": {
      "actSubs": ["Lenalidomide", "Ibrutinib"],
      "indication": ["Multiple Myeloma", "Leukaemia (Chronic Lymphocytic)", "Leukaemia (Chronic Myeloid)"],
      "statedClass": ["Statins"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": ["Haematology"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["More than 1 year - 2 years"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Secondline treatment of metastatic non-small cell lung cancer with immune checkpoint inhibitors",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A92.2",
    "authors": "FJ Salmeron Navas, C Martinez-Diaz, EM Barreiro-Fernandez, M Dominguez Cantero, S Fenix-Caballero",
    "institution": "Hospital Universitario Puerto Real, Servicio De Farmacia, Cadiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.198",
    "filters": {
      "actSubs": ["Atezolizumab", "Nivolumab", "Pembrolizumab"],
      "indication": ["Non-Small Cell Lung Cancer"],
      "statedClass": ["Immune Checkpoint Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Kaplan-Meier Method"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Indirect treatment comparisons of ibrutinib–obinotuzumab versus venetoclax–obinotuzumab in naive chronic lymphocytic leukaemia",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A93.1",
    "authors": "P Selvi, O Montero-Perez, S Portilo-Haro",
    "institution": "Hospital Minas De Riotinto, Pharmacy, Riotinto, Spain. Hospital Juan Ramón Jiménez, Pharmacy, Huelva, Spain. Hospital Parque Tecnologico De La Salud, Pharmacy, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.199",
    "filters": {
      "actSubs": ["Ibrutinib", "Obinotuzumab", "Venetoclax", "Chlorambucil"],
      "indication": ["Leukaemia (Chronic Lymphocytic)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Real world evidence of pembrolizumab as monotherapy in non-small cell lung cancer: effectiveness and safety study",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A93.2",
    "authors": "R Tamayo Bermejo, JC Del Río Valencia, B Mora Rodríguez, I Muñoz Castillo",
    "institution": "Hospital Regional Universitario De Málaga, Pharmacy, Málaga, Spain. Vithas Hospital Xanit Internacional, Pharmacy, Málaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.200",
    "filters": {
      "actSubs": ["Pembrolizumab"],
      "indication": ["Non-Small Cell Lung Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Response Evaluation Criteria In Solid Tumours (RECIST)", "Kaplan-Meier Method"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Anthracycline dosing in obese adult patients: a systematic review",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A94.1",
    "authors": "B Tapia, A Casas, B Torroba, C Fraile, A Gutierrez, B Fernandez, M Serrano-Alonso, MA García Del Barrio",
    "institution": "Clinica Universidad De Navarra, Hospital Pharmacy, Pamplona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.201",
    "filters": {
      "actSubs": ["Doxorubicin", "Epirubicin", "Idarubicin", "Daunorubicin"],
      "indication": [],
      "statedClass": ["Anthracyclines"],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Trifluridine–tipiracil for metastatic colorectal cancer: real world data experience",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A94.2",
    "authors": "M Tonelli, M Scaldaferri, S Bustreo, L Fanchini, G Ritorto, P Racca, F Cattel",
    "institution": "AOU Citta’ Della Salute E Della Scienza Di Torino, Pharmacy, Turin, Italy. AOU Citta’ Della Salute E Della Scienza Di Torino, Colorectal Cancer Unit, Turin, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.202",
    "filters": {
      "actSubs": ["Trifluridine / Tipiracil", "Trifluridine", "Tipiracil", "Raltitrexed", "Regorafenib", "Mitomycin C"],
      "indication": ["Colorectal Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Influence of palbociclib toxicity in real world clinical practice",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A95.1",
    "authors": "L Ulacia Epelde, D Tejada Marín, P Aldave Cobos, G Pinilla Lebrero, A Rodríguez Esquíroz, JA Illodo Becerra, J Polo Garcia, M Calvo Arbeloa, R Juanbeltz Zurbano, N Larrea Goñi, JJ Elizondo Armendariz",
    "institution": "Complejo Hospitalario De Navarra, Farmacia, Pamplona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.203",
    "filters": {
      "actSubs": ["Palbociclib"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Is there a role for the pharmacist in screening for metabolic syndrome?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A95.2",
    "authors": "R Aladawi, K Prabhu, D Stewart, C Ryan, H Abdelaziz, M El Edrisi, M Izham, M Steinhoff, A Jochebeth, S Kuttikrishnan, SU Khan, M Young, M Steinhoff, A Tonna",
    "institution": "Hamad Medical Corporation-Doha-Qatar, Pharmacy-Clinical Pharmacy, Doha, Qatar. Hamad Medical Corporation-Doha-Qatar, Interim Translational Research Institute Itri, Doha, Qatar. Qatar University, Academic Quality, Doha, Qatar. Trinity College Dublin, The School of Pharmacy and Pharmaceutical Sciences, Dublin, Ireland. Hamad Medical Corporation-Doha-Qatar, Internal Medicine, Doha, Qatar. Qatar University, Medical and Health Sciences Office, Doha, Qatar. Hamad Medical Corporation-Doha-Qatar, Metabolic Institute, Doha, Qatar. Hamad Medical Corporation-Doha-Qatar, I Interim Translational Research Institute Itri, Doha, Qatar. Robert Gordon University, Pharmacy and Life Sciences, Aberdeen, UK",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.204",
    "filters": {
      "actSubs": [],
      "indication": ["Metabolic Syndrome"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Longitudinal Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Qatar", "Ireland", "United Kingdom"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Switching oral antiandrogenic treatment in patients with castrate metastatic prostate cancer: an analysis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A96.1",
    "authors": "C Valdazo Martín, JJ García Albás, MÁ Andrés Moralejo, H Ayerra Pérez, M Rosado Ancín, A Santaolalla Sánchez, N Ramón Rigau, A Larrabeiti Echevarria, C Martínez Martínez",
    "institution": "Hospital Universitario Araba, Hospital Pharmacy, Vitoria-Gasteiz, Spain. Hospital Universitario Araba, Urology, Vitoria-Gasteiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.205",
    "filters": {
      "actSubs": ["Abiraterone", "Enzalutamide", "Prednisone"],
      "indication": ["Prostate Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Tolerance profile to antithymocyte immunoglobulin treatment and its relation to infectious parameters in paediatric patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A96.2",
    "authors": "A Ferrada Gascó, G Gómez Silva, E Martínez Chillaron, I Beltran García, P Escobar Cava, C Fuentes Socorro, JM Fernández Navarro, JL Poveda Andrés",
    "institution": "Hospital Universitari I Politècnic La Fe, Farmacia, Valencia, Spain. Hospital Clínico Universitario, Oncohematología Pediatrica, Santiago De Compostela, Spain. Hospital Universitari I Politècnic La Fe, Pediatria, Valencia, Spain. Hospital Universitari I Politècnic La Fe, Unidad De Trasplante Pediatrico, Valencia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.206",
    "filters": {
      "actSubs": ["Antithymocyte Globulin (Rabbit)"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Analysis of the prescription and safe drug administration of ocrelizumab",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A97.1",
    "authors": "JI García Soler, V Arocas Casañ, L Menendez Naranjo, E Gonzalez Lozano, A Laorden Carrasco, M Diaz Ramon, JA Cano Molina, C Ramirez Roig, M Valderrey Pulido, S Vicente Sánchez",
    "institution": "Hospital Clinico Universitario Virgen De La Arrixaca, Pharmacy Service, Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.207",
    "filters": {
      "actSubs": ["Ocrelizumab"],
      "indication": ["Multiple Sclerosis (Primary Progressive)"],
      "statedClass": ["Disease Modifying Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Common Terminology Criteria for Adverse Events"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Impact of a tool in the electronic clinical history for the optimisation of biologic drugs in rheumatology",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A97.2",
    "authors": "M Mañes Sevilla, EP Gómez-Caballero, B Bertran De Lis-Bartolome, I Soto Baselga, C Moriel-Sánchez",
    "institution": "Hospital Universitario Mostoles, Pharmacy Department, Móstoles Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.208",
    "filters": {
      "actSubs": ["Etanercept", "Infliximab", "Adalimumab", "Certolizumab", "Golimumab", "Tocilizumab", "Abatacept", "Secukinumab", "Baricitinib", "Tofacitinib", "Ustekinumab"],
      "indication": [],
      "statedClass": ["Biologicals"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Rheumatology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "A review of infliximab biosimilar to biosimilar switch: Remsima to Flixabi",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A98.1",
    "authors": "R O’neill, S Singh, R Luber",
    "institution": "Guy’s and St Thomas’s NHS Foundation Trust, Pharmacy, London, UK. Guy’s and St Thomas’s NHS Foundation Trust, Gastroenterology, London, UK",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.209",
    "filters": {
      "actSubs": ["Infliximab"],
      "indication": ["Inflammatory Bowel Disease"],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["United Kingdom"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Analysis of changes in disease modifying treatment in the management of patients with multiple sclerosis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A98.2",
    "authors": "A Arancón Pardo, C Sobrino Jiménez, E Rodríguez Martín, C Bilbao Gómez-Martino, E Villamañán Bueno, I Jiménez-Nácher, F Moreno Ramos, MÁ González Fernández, M Moreno Palomino, M García-Trevijano, A Herrero Ambrosio",
    "institution": "Hospital Universitario La Paz, Pharmacy Department, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.210",
    "filters": {
      "actSubs": ["Interferon Beta", "Teriflunomide", "Dimethylfumarate", "Natalizumab"],
      "indication": ["Multiple Sclerosis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Vedolizumab: outcomes and therapeutic drug monitoring in inflammatory bowel disease",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A99.1",
    "authors": "O Ballesta-López, M Centelles-Oria, A Ferrada-Gascó, T Palanques-Pastor, I Beltrán-García, R Iglesias-Gómez, MR Marqués-Miñana, P Nos-Mateu, JL Poveda-Andrés",
    "institution": "Hospital Universitario Y Politécnico La Fe, Pharmacy, Valencia, Spain. Hospital Universitario Y Politécnico La Fe, Gastroenterology, Valencia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.211",
    "filters": {
      "actSubs": ["Vedolizumab"],
      "indication": ["Inflammatory Bowel Disease", "Ulcerative Colitis", "Crohn’s Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["The Mayo Score for Ulcerative Colitis", "Harvey-Bradshaw Index (HBI) for Crohn's Disease", "Enzyme Immunoassay"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Clinical and economic impact of infliximab biosimilar Inflectra in rheumatoid arthritis, psoriatic arthropathy and ankylosing spondylitis naïve and switched patients: 5 years of follow-up",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A99.2",
    "authors": "J Borras, A Gracia-Pérez, A Valcuende Rosique, MDe Castera, JD Rosique, FJ Abad",
    "institution": "Hospital Sagunto, Pharmacy Service, Sagunto, Spain. Hospital De Sagunto, Rheumatology Section, Sagunto, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.212",
    "filters": {
      "actSubs": ["Infliximab"],
      "indication": ["Rheumatoid Arthritis", "Psoriatic Arthropathy", "Ankylosing Spondylitis"],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Adherence to adalimumab, golimumab and ustekinumab therapy in inflammatory bowel disease",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A100.1",
    "authors": "M Calvo Arbeloa, A Arrondo Velasco, A Rodriguez Esquiroz, J Polo García, G Pinilla Lebrero, D Tejada Marín, J Elizondo Armendáriz, M Sarobe Carricas",
    "institution": "Complejo Hospitalario De Navarra, Pharmacy Department, Pamplona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.213",
    "filters": {
      "actSubs": ["Adalimumab", "Golimumab", "Ustekinumab"],
      "indication": ["Inflammatory Bowel Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Transversal Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Morisky – Green Questionnaire", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Inotuzumab–ozogamizin for the treatment of relapse B precursor acute lymphoblastic leukaemia in an adult patient: a case report",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A100.2",
    "authors": "JC Del Río Valencia, C Ortega De La Cruz, T Chinchilla Alarcón, I Muñoz Castillo",
    "institution": "Hospital Regional Universitario Malaga, Servicio De Farmacia, Malaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.214",
    "filters": {
      "actSubs": ["Inotuzumab / Ozogamicin"],
      "indication": ["Leukaemia (Acute Lymphoblastic)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series", "Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Beliefs about medication and quality of life in multiple sclerosis patients treated with natalizumab",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A100.3",
    "authors": "L Carrasco Piernavieja, M Dominguez Bachiller, MI Barcia Martín, E Zhan Zhou, AM Martín De Rosales Cabrera, L Borrega Canelo, M Perez Encinas",
    "institution": "Hospital Universitario Fundación Alcorcón, Hospital Pharmacy, Alcorcón, Spain. Hospital Universitario Fundación Alcorcón, Neurology, Alcorcón, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.215",
    "filters": {
      "actSubs": ["Natalizumab"],
      "indication": ["Multiple Sclerosis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Expanded Disability Status Scale", "EuroQol-5D", "Visual Analogue Scale", "Statistical Package for the Social Sciences (SPSS)", "Multivariate Analysis"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Therapeutic drug monitoring of etanercept biosimilar in psoriatic patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A101.1",
    "authors": "L Elberdin Pazos, RM Fernández Torres, E Blanco Castro, M Outeda Macias, C Fernandez Oliveira, E Fonseca Capdevila, I Martin Herranz",
    "institution": "Complexo Hospitalario Universitario De A Coruña Chuac-Sergas, Instituto De Investigación Biomédica De A Coruña Inibic, Universidade Da Coruña Udc-Spain, Department of Pharmacy, A Coruña, Spain. Complexo Hospitalario Universitario De A Coruña Chuac-Sergas, Instituto De Investigación Biomédica De A Coruña Inibic, Universidade Da Coruña Udc-Spain., Department of Dermatology, A Coruña, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.216",
    "filters": {
      "actSubs": ["Etanercept", "Methotrexate", "Ciclosporin"],
      "indication": ["Psoriasis (Moderate to Severe Plaque)"],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["ELISA Immunoassay", "Psoriasis Area and Severity Index (PASI)", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Ten years of expertise in ustekinumab use for the treatment of moderate to severe plaque psoriasis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A101.2",
    "authors": "S Esteban-Casado, C Esteban Alba, I Cañamares Orbis, P Tejedor Prado, E Izquierdo Garcia, A Such Díaz, EA Alvaro Alonso, A Lazaro Cebas, A Santiago Perez, I Escobar Rodriguez",
    "institution": "Hospital Universitario Infanta Leonor, Pharmacy, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.217",
    "filters": {
      "actSubs": ["Ustekinumab"],
      "indication": ["Psoriasis (Moderate to Severe Plaque)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Psoriasis Area and Severity Index (PASI)", "Kaplan-Meier Method"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Case report: usefulness of therapeutic drug monitoring of vedolizumab in managing acute graft versus host disease",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A102.1",
    "authors": "R Fernandez Caballero, N Martin-Gutierrez, G Sanchez-Hernandez, S Jimenez-Cabrera, A Navarro-Bailón, B Rey-Búa, M Martin-Gil, D Peña-Lorenzo, L Pedraza-Nieto, MJ Otero-López",
    "institution": "University Hospital of Salamanca, Pharmacy Service, Salamanca, Spain. University Hospital of Salamanca, Haematology Service, Salamanca, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.218",
    "filters": {
      "actSubs": ["Vedolizumab"],
      "indication": ["Graft Versus Host Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Bayesian Population Pharmacokinetic Approach"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": ["personalized"],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Real clinical impact of drug–drug interactions of immunosuppressants in transplant patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A102.2",
    "authors": "AI Gago-Sanchez, M Cardenas, MD Aumente, P Font, JR Del Prado, MA Calleja",
    "institution": "Reina Sofia Universitary Hospitalimibic/University, Pharmacy, Cordoba, Spain. Reina Sofia Universitary Hospitalimibic/University, Rheumatology, Cordoba, Spain. Macarena Universitary Hospital, Pharmacy, Sevilla, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.219",
    "filters": {
      "actSubs": ["Tacrolimus", "Nifedipine"],
      "indication": [],
      "statedClass": ["Immune-Suppressors", "Antifungal Azoles"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": ["More than 1 year - 2 years"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "‘Real world’ experience of tofacitinib and baricitinib in the treatment of rheumatoid arthritis: effectiveness and safety evaluation",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A103",
    "authors": "S Garcia Garcia, I Cardona Pascual, M Larrosa Garcia, JB Montoro Ronsano, R Caparros Ruiz, C Alonso Martinez, J Vidal Otero, S Gamarra Calvo, MR Gomez Domingo, C Alerany Pardo",
    "institution": "Vall D’hebron University Hospital, Hospital Pharmacy Department, Barcelona, Spain. Vall D’hebron University Hospital, Rheumatology Department, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.220",
    "filters": {
      "actSubs": ["Tofacitinib", "Baricitinib", "Methotrexate", "Leflunomide", "Hydroxychloroquine", "Sulfasalazine"],
      "indication": ["Rheumatoid Arthritis"],
      "statedClass": ["Janus Kinase Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Disease Activity Score-28 for Rheumatoid Arthritis with ESR (DAS28-ESR)", "Analysis of Variance (ANOVA)", "Chi-Square (χ2) Test", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Ten year analysis of the use of infliximab in ulcerative colitis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A104.1",
    "authors": "G Gonzalez De La Fuente, F Gutierrez Nicolas, J Gonzalez Garcia, B Del Rosario Garcia, L Cantarelli, J Ramos Rodriguez, GJ Nazco Casariego",
    "institution": "Hospital Universitario De Canarias, Pharmacy, La Laguna, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.221",
    "filters": {
      "actSubs": ["Infliximab"],
      "indication": ["Ulcerative Colitis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of cost and efficacy of eculizumab in complement mediated thrombotic microangiopathy in the clinical setting",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A104.2",
    "authors": "M Larrosa García, P Sanchez-Sancho, BJ Montoro Ronsano, N Ramos Terrada, C Alerany Pardo, S Garcia Garcia",
    "institution": "Vall D´Hebron University Hospital, Clinical Pharmacy, Barcelona, Spain. Vall D´Hebron University Hospital, Clinical Nephrology, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.222",
    "filters": {
      "actSubs": ["Eculizumab"],
      "indication": ["Complement-Mediated Thrombotic Microangiopathy"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["Less than 10"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Potential optimisation of treatment with ustekinumab in Crohn’s disease",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A105.1",
    "authors": "M Llinares-Esquerdo, S Martínez-Pérez, G Miralles-Andreu, M Pomares-Bernabeu, IP Jiménez-Pulido, A Navarro Ruiz",
    "institution": "Hospital General Universitario De Elche, Pharmacy, Elche, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.223",
    "filters": {
      "actSubs": ["Ustekinumab"],
      "indication": ["Crohn’s Disease"],
      "statedClass": ["Biologicals"],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": ["Digestive Medicine"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of adherence to oral disease modifying therapies in patients with relapsing–remitting multiple sclerosis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A105.2",
    "authors": "MP Ortega-Garcia, M Zaragozá-González, I Toledo-Guasp, P Pérez-Villalón, P Blasco-Segura",
    "institution": "Consorcio Hospital General Universitario De Valencia, Service of Pharmacy, Valencia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.224",
    "filters": {
      "actSubs": ["Fingolimod", "Teriflunomide", "Dimethylfumarate"],
      "indication": ["Multiple Sclerosis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Adherence to selective immunosuppressive drug treatments in patients with inflammatory immune mediated diseases",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A106.1",
    "authors": "PA López Broseta, J Del Estal Jiménez, MÁ Roch Ventura, A Sanjuan Belda, S Jornet Montaña, M Martín Marqués, M Mendoza Aguilera, E Esteve Pitarch, M Vuelta Arce, L Canadell Vilarrasa",
    "institution": "Hospital Universitari Joan Xxiii, Pharmacy, Tarragona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.225",
    "filters": {
      "actSubs": ["Adalimumab", "Etanercept"],
      "indication": ["Immune-Mediated Inflammatory Disease", "Rheumatoid Arthritis", "Psoriatic Arthropathy", "Psoriasis", "Crohn’s Disease", "Ulcerative Colitis", "Spondyloarthropathy"],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Medication Possession Ratio", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Acceptance of pharmacokinetic recommendations for everolimus in renal transplant patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A106.2",
    "authors": "A Rochina, S Gutiérrez, A González, A García, L Soriano, A Navarro",
    "institution": "Hospital General Universitario Elche, Hospital Pharmacist, Elche, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.226",
    "filters": {
      "actSubs": ["Everolimus"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Nephrology"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": ["personalized"],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "A population pharmacokinetic model of adalimumab in a cohort of paediatric patients with inflammatory bowel disease: a preliminary analysis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A106.3",
    "authors": "M Miarons Font, JG Sánchez Hernandez, JS Pérez Blanco, S Clemente Bautista, N Rebollo Diaz, O Segarra Cantón, MJ Cabañas Poy, R Torres Peral, MQ Gorgas, MJ Otero",
    "institution": "Hospital Universitario Vall D’hebron, Pharmacy Department, Barcelona, Spain. Complejo Asistencial Universitario De Salamanca, Pharmacy Department, Salamanca, Spain. University of Salamanca, Department of Pharmaceutical Sciences, Salamanca, Spain. Hospital Universitario Vall D’hebron, Paediatric Gastroenterology Unit, Barcelona, Spain. Complejo Asistencial Universitario De Salamanca, Paediatric Gastroenterology Unit, Salamanca, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.227",
    "filters": {
      "actSubs": ["Adalimumab"],
      "indication": ["Inflammatory Bowel Disease", "Ulcerative Colitis", "Crohn’s Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["First-Order Conditional Estimation with Interaction (FOCEI)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Economic impact of intensification regimens in inflammatory bowel disease",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A107",
    "authors": "L Ulacia Epelde, A Arrondo Velasco, J Polo Garcia, G Pinilla Lebrero, JA Illodo Becerra, M Calvo Arbeloa, A Rodríguez Esquíroz, D Tejada Marín, P Aldave Cobos, MT Sarobe Carricas, JJ Elizondo Armendariz",
    "institution": "Complejo Hospitalario De Navarra, Farmacia, Pamplona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.228",
    "filters": {
      "actSubs": ["Adalimumab", "Golimumab", "Ustekinumab", "Vedolizumab", "Infliximab"],
      "indication": ["Inflammatory Bowel Disease"],
      "statedClass": ["Biologicals"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["501 - 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Liver transplant and diabetes mellitus",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A108.1",
    "authors": "M Vera Cabrera, I Plasencia García, A Ferrer Machín, I Gonzalez García, T Betancor García, L Díaz Díaz, R Mesa Exposito, S Hernandez Rojas, K Alvarez Tosco, C Perez Martin, J Merino Alonso",
    "institution": "Hospital Nuestra Señora La Candelaria, Hospital Pharmacy, Santa Cruz of Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.229",
    "filters": {
      "actSubs": [],
      "indication": ["Diabetes Type II (Mellitus)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Pilot study to survey the attitude, supplement use and storage conditions of drug products among patients receiving biological therapy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A108.2",
    "authors": "RG Vida, A Somogyi-Végh, M Mayer, D Kiss, N Schaadt, R Rajj, B Molnár, L Botz",
    "institution": "University of Pécs Faculty of Pharmacy, Department of Pharmaceutics and Central Clinical Pharmacy, Pécs, Hungary",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.230",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Biologicals"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Hungary"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "One in a million: a TNF receptor-1 associated syndrome resistant to anti-TNF-alpha therapy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A108.3",
    "authors": "BC Sánchez Lerma, MÁ Pérez Cruz, Y Hernández Gago, MP González Joyanes, AL García Silva, MA Velaz Suarez",
    "institution": "Hospital Pharmacist, Hospital Pharmacy Department. Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas De Gran Canaria, Spain. Hospital Pharmacist, Hospital Pharmacy, Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas De Gran Canaria, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.231",
    "filters": {
      "actSubs": ["Etanercept", "Anakinra", "Prednisone"],
      "indication": ["Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS)"],
      "statedClass": ["Tumor Necrosis Factor (TNF) Inhibitors", "Glucocorticoids"],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": ["orphan"],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effectiveness of nusinersen in paediatric patients SMA1 and SMA2",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A109.1",
    "authors": "GB Ortenzi, G Palmas, E Andresciani, AMF Garzone, MA Berardi, S Siliquini, L Porfiri, MS Demeo, S Guglielmi, C Polidori, A Pompilio",
    "institution": "AO Ospedali Riunti Di Ancona, Sod Farmacia, Ancona, Italy. AO Ospedali Riuniti Ancona, Sod Clinica Pediatrica, Ancona, Italy. Università Degli Studi Di Camerino, Scuola Di Scienze Del Farmaco E Dei Prodotti Della Salute’ Facoltà Di Farmacia, Camerino, Italy. AO Ospedaliriunti Ancona, Sod Neuropsichiatria Infantile, Ancona, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.232",
    "filters": {
      "actSubs": ["Nusinersen"],
      "indication": ["5q-Spinal Muscular Atrophy (SMA)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND)", "Hammersmith Infant Neurological Examination (HINE)", "Hammersmith Functional Motor Scale-Expanded (HFMSE)"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": ["orphan"],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Indirect treatment comparison of anti-calcitonin gene related peptide pathway antibodies in chronic migraine",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A109.2",
    "authors": "MDP Briceño Casado, S Fenix-Caballero, MD Gil-Sierra, M Dominguez Cantero, EJ Alegre-Del Rey",
    "institution": "Hospital Universitario Puerto Real, Hospital Pharmacy, Cadiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.233",
    "filters": {
      "actSubs": ["Erenumab", "Fremanezumab", "Glacanezumab", "Eptinezumab"],
      "indication": ["Migraine"],
      "statedClass": ["CGRP Receptor Antagonists"],
      "typeOfMedical": [],
      "studyDesign": ["Meta-Analysis"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Bucher's Method"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Is paracetamol a real alternative in the management of patent ductus arteriosus in preterm infants?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A110",
    "authors": "AA Garcia Robles, R Iglesias Gómez, P Pérez Huertas, A Parra Llorca, B Torres García, A Gimeno Navarro, M Vento Torres, JL Poveda Andrés, M Aguar Carrascosa",
    "institution": "Hospital Universitari I Politècnic La Fe, Pharmacy-Neonatology, Valencia, Spain. Hospital Universitari I Politècnic La Fe, Pharmacy, Valencia, Spain. Hospital Universitari I Politècnic La Fe, Neonatology, Valencia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.234",
    "filters": {
      "actSubs": ["Paracetamol", "Ibuprofen"],
      "indication": ["Patent Ductus Arteriosus"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Cohort Study"],
      "setting": ["Hospital"],
      "ward": ["Neonatal Intensive Care"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": ["orphan"],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Prevalence analysis of patients treated with triptans at risk of developing medication overuse headache and development of a prescription optimisation strategy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A111.1",
    "authors": "MT Brieva Herrero, E Marquez-Fernández, N Sánchez-Devicente",
    "institution": "Hospital Antequera, Hospital Pharmacist, Antequera, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.235",
    "filters": {
      "actSubs": [],
      "indication": ["Medication Overdose Headache"],
      "statedClass": ["Triptans"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": ["deprescribing"],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Perphenazine and propranolol poisoning: a case report",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A111.2",
    "authors": "CA Alonso Peralta, T Gimenez Poderós, D Gómez, RM González Franco, B Rogado Vegas, J Casanova Vázquez, M Rioja Carrera, P Del Rio Ortega, L Perez-Periañez Orrillo, I Aragon Gracia, M Valero Domínguez",
    "institution": "Hospital Universitario Marqués De Valdecilla, Farmacia Hospitalaria, Santander, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.236",
    "filters": {
      "actSubs": ["Perphenazine", "Propranolol", "Dobutamine", "Glucagon", "Naloxone"],
      "indication": [],
      "statedClass": ["Benzodiazepines"],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Glasgow Coma Scale"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Dexmedetomidine treatment for the sedation of preterm neonates",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A112.1",
    "authors": "R Escrig-Fernández, AA Garcia Robles, O Ballesta-López, MJ Company-Albir, A Gimeno-Navarro, JL Poveda-Andrés, I Izquierdo-Macián",
    "institution": "Hospital Universitario Y Politécnico La Fe, Neonatology, Valencia, Spain. Hospital Universitario Y Politécnico La Fe, Neonatology/Pharmacy, Valencia, Spain. Hospital Universitario Y Politécnico La Fe, Pharmacy, Valencia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.237",
    "filters": {
      "actSubs": ["Dexmedetomidine", "Fentanyl"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Neonatal Intensive Care"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Review of 3 month prescriptions containing drugs inducing QT prolongation and torsade de pointe",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A112.2",
    "authors": "A Cappe, S Membre, M Moussour, M Compagnon, D Pons",
    "institution": "Ch Philippe Pinel, Pharmacy, Amiens, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.238",
    "filters": {
      "actSubs": ["Escitalopram", "Hydroxyzine", "Domperidone"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["501 - 1000"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "An observational retrospective study on treatment adherence of long acting injectable antipsychotics",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A113.1",
    "authors": "AM Fernández Varela, LM Martínez Agulleiro, B Salazar Laya, D Núñez Arias, I Rodríguez Penín",
    "institution": "Hospital Arquitecto Marcide, Farmacia Hospitalaria, Ferrol-A Coruña, Spain. Hospital Arquitecto Marcide, Psiquiatría, Ferrol-A Coruña, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.239",
    "filters": {
      "actSubs": [],
      "indication": ["Schizophrenia", "Delusional Disorder", "Personality Disorder"],
      "statedClass": ["Antipsychotics (Long Acting Injectable)"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Psychotropic drug usage in octogenarian and nonagenarian complex chronic patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A113.2",
    "authors": "A Perez Contel, S Ortonobes Roig, N Soler Blanco, G Diestre Ortin, P Miralles-Albors, S Fernández-Molina, A Barragán Muñoz, M Gómez-Valent",
    "institution": "Consorci Corporacio Sanitaria Parc Tauli, Pharmacy, Sabadell, Spain. Consorci Corporacio Sanitaria Parc Tauli, Psychogeriatrics, Sabadell, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.240",
    "filters": {
      "actSubs": ["Trazodone", "Sertraline", "Quetiapine", "Risperidone", "Gabapentin"],
      "indication": [],
      "statedClass": ["Hypnotics", "Benzodiazepines", "Antidepressants", "Neuroleptics", "Mood Stabilisers"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Acute Geriatric Unit"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Pfeiffer Test", "Mann-Whitney U Test", "STATA"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Current status of clinical trials for Alzheimer’s disease",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A113.3",
    "authors": "A Rodriguez, ME Navarrete-Rouco, P Acin, M Ponce, M Jorques, O Ferrandez-Quirante, M Espona",
    "institution": "Hospital Del Mar, Pharmacy, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.241",
    "filters": {
      "actSubs": [],
      "indication": ["Alzheimer’s Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Neuropsychology"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effectiveness of immunotherapy in severe uncontrolled asthma",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A114.1",
    "authors": "M Bitlloch Obiols, L Perez Cordon, J Delgado Rodriguez, A Sanchez Ulayar, V Aguilera Jimenez, M Pujal Herranz, T Gurrera Roig, D Lopez Faixo, C Agusti Maragall, L Campins Bernadas",
    "institution": "Hospital De Mataró, Pharmacy, Mataró, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.242",
    "filters": {
      "actSubs": ["Omalizumab", "Mepolizumab", "Reslizumab", "Benralizumab"],
      "indication": ["Asthma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effectiveness and safety of anti-IL-5 biologic agents in severe eosinophilic asthma",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A114.2",
    "authors": "M Calvo Arbeloa, G Pinilla Lebrero, E Lacalle Fabo, J Polo García, L Ulacia Epelde, J Illodo Becerra, D Fresán Restituto, P Aldave Cobos, J Elizondo Armendáriz, M Sarobe Carricas",
    "institution": "Complejo Hospitalario De Navarra, Pharmacy Department, Pamplona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.243",
    "filters": {
      "actSubs": ["Mepolizumab", "Reslizumab", "Benralizumab"],
      "indication": ["Asthma"],
      "statedClass": ["Anti-Interleukin-5 Monoclonal Antibodies"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Asthma Control Test"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Treatment of asthma and chronic obstruction pulmonary disease: are our hospital nurses and physicians ready to treat and educate inpatients?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A115.1",
    "authors": "R Guimaraes, PF Rogliano, L Durand, N Bouzou, S Saad, S Le Poole",
    "institution": "Ch Rives De Seine, Pharmacy, Neuilly-Sur-Seine, France. Ch Rives De Seine, Internal Medicine, Neuilly-Sur-Seine, France. Ch Rives De Seine, Geriatrics, Neuilly-Sur-Seine, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.244",
    "filters": {
      "actSubs": [],
      "indication": ["Asthma", "Chronic Obstructive Pulmonary Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Safety and effectiveness of reduced dose omalizumab for chronic idiopathic urticaria",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A115.2",
    "authors": "M Alonso Moreno, M Soriano Martinez, B Fernandez Rubio, M Mejias Trueba",
    "institution": "Hospital Universitario Virgen Del Rocío, Farmacia, Sevilla, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.245",
    "filters": {
      "actSubs": ["Omalizumab", "Ciclosporin", "Montelukast"],
      "indication": ["Chronic Idiopathic Urticaria"],
      "statedClass": ["Antihistamines"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": ["Allergy", "Dermatology"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Urticaria Activity Score (UAS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of a pharmaceutical care programme for patients being treated with omalizumab",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A116.1",
    "authors": "R Mesa Expósito, I Plasencia Garcia, MA Ocaña Gomez, A De Leon Gil, E Tevar Alonso, A Ferrer Machin, M Vera Cabrera, KI Alvarez Tosco, CY Perez Martin, JA Martin Conde, FJ Merino Alonso",
    "institution": "Hospital Nuestra Señora De La Candelaria, Pharmacy, Santa Cruz De Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.246",
    "filters": {
      "actSubs": ["Omalizumab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": ["selfMedication"],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effectiveness and safety of omalizumab in the treatment of severe uncontrolled asthma",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A116.2",
    "authors": "L Portillo Horcajada, C Garcia Yubero, B Garcia De Santiago, E Lopez Aspiroz, E Garcia Martin, Y Larrubia Marfil, JP Barro Ordovas, J Llorente Gutierrez, A Martinez Hernandez",
    "institution": "University Hospital Infanta Sofía, Pharmacy Department, San Sebastián De Los Reyes, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.247",
    "filters": {
      "actSubs": ["Omalizumab"],
      "indication": ["Asthma"],
      "statedClass": ["Corticosteroids"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Asthma Control Test"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Therapeutic positioning and use of intravitreal ranibizumab and aflibercept",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A117.1",
    "authors": "S García Sánchez, A Ribed-Sánchez, I Herrero-Durán, MJ Aparicio Hernández-Lastras, A Melgarejo-Ortuño, FJ García-Moreno, MÁ Amor-García, P Ruiz-Briones, Á Narrillos-Moraza, A Herranz-Alonso, M Sanjurjo-Sáez",
    "institution": "ospital General Universitario Gregorio Marañón, Pharmacy, Madrid, Spain. Hospital General Universitario Gregorio Marañón, Ophthalmology, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.248",
    "filters": {
      "actSubs": ["Ranibizumab", "Aflibercept", "Bevacizumab"],
      "indication": ["Age Related Macular Degeneration", "Diabetic Macular Oedema"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Clinical evaluation and satisfaction of patients treated with PRGF-Endoret (plasma rich in growth factors)",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A117.2",
    "authors": "S Gea Navarrete, M Montero Hernández, M Belló Crespo, L Rubio Alonso, Á Santiuste Román, E Soler Company",
    "institution": "Hospital Arnau De Vilanova-Llíria, Pharmacy, Valencia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.249",
    "filters": {
      "actSubs": ["Plasma (Rich In Growth Factors)"],
      "indication": ["Keratitis", "Ulcer (Corneal)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Initial therapy for neovascular age related macular degeneration: are the guidelines met in clinical practice?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A118.1",
    "authors": "M Hernando Verdugo, E Queipo García, A Pariente Junquera, MI López Gálvez, MT Sánchez Sánchez",
    "institution": "Hospital Clinico Universitario De Valladolid, Pharmacy, Valladolid, Spain. Hospital Clinico Universitario De Valladolid, Ophthalmology, Valladolid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.250",
    "filters": {
      "actSubs": ["Ranibizumab", "Bevacizumab", "Aflibercept"],
      "indication": ["Age Related Macular Degeneration"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Ophthalmology"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Assessment of burden of disease in terms of health related quality of life in patients with multiple myeloma not eligible for autologous stem cell transplantation",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A118.2",
    "authors": "O Delgado Sanchez, A Domingo, J De La Rubia, A García, A López, C Seguí, L Rumi, A Mengual, G Lostaunau, MV Mateos",
    "institution": "Hospital Son Espases, Pharmacy Department, Palma De Mallorca, Spain. Hospital General De Granollers, Haematology, Granollers, Spain. Hospital Dr Peset, Haematology, Valencia, Spain. Hospital Arnau De Vilanova De Lleida, Haematology, Lleida, Spain. Hospital Arnau De Vilanova De Valencia, Haematology, Valencia, Spain. Hospital General De Granollers, Pharmacy Department, Granollers, Spain. Hospital Arnau De Vilanova De Lleida, Clinical Trials Unit, Lleida, Spain. Hospital Arnau De Vilanova De Valencia, Pharmacy Department, Valencia, Spain. Celgene Slu, Medical Affairs, Madrid, Spain. Hospital Universitario Salamanca, Haematology, Salamanca, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.251",
    "filters": {
      "actSubs": ["Lenalidomide", "Bortezomib"],
      "indication": ["Multiple Myeloma", "Dyspnoea"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["EuroQol-5D"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "The impact of an integrated electronic medical record on therapeutic drug monitoring",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A119.1",
    "authors": "P Firman",
    "institution": "Royal Brisbane and Women’s Hospital, Pharmacy Department, Royal Brisbane Hospital, Australia",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.252",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["10 - 50"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Australia"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Analysis of pharmaceutical interventions in the exchange of therapeutic equivalents",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A119.2",
    "authors": "S Nuñez Bracamonte, MC González Pérez-Crespo, E Conesa Nicolás, C Juez Santamaría, A Lloret Llorca, CN García Matillas, I Fernández Martínez, JM Montoya Egea",
    "institution": "Hospital General Universitario Santa Lucía, Farmacia Hospitalaria, Cartagena, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.253",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Intensification in biological treatment in ulcerative colitis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A120.1",
    "authors": "A Pintado, R Asensi Diez, A Linares, I Muñoz Castillo",
    "institution": "Hospital Regional Universitario Malaga, Farmacia Hospitalaria, Malaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.254",
    "filters": {
      "actSubs": ["Infliximab", "Adalimumab", "Vedolizumab", "Ustekinumab", "Tofacitinib"],
      "indication": ["Ulcerative Colitis"],
      "statedClass": ["Biologicals"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Potentially inappropriate medication for elderly hospitalised patients in a trauma and orthopaedic surgery department",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A120.2",
    "authors": "MM Alañon Pardo, MT Gómez Lluch, MC Conde García, B Proy Vega, ML Moreno Perulero, JC Valenzuela Gámez",
    "institution": "Hospital General La Mancha-Centro, Pharmacy, Alcázar De San Juan, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.255",
    "filters": {
      "actSubs": [],
      "indication": ["Hip Fracture", "Osteoporosis"],
      "statedClass": ["Proton-Pump Inhibitors", "Benzodiazepines"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Traumatology", "Orthopaedic Surgery"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["STOPP/START Criteria", "Binary Logistic Regression Analysis"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Real life experience of home care administration of 5-azacitidine and domiciliary management of patients with myelodysplastic syndrome",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A121.1",
    "authors": "C Alarcon-Payer, I Elósegui Horno, JE Martínez De La Plata, CL Muñoz Cid, A Jiménez Morales",
    "institution": "Hospital Universitario De Jaén, Servicio De Farmacia, Jaén, Spain. Hospital San Agustín, Servicio De Farmacia, Linares, Spain. Hospital De Poniente-El Ejido, Servicio De Farmacia, Almería, Spain. Hospital Universitario Virgen De Las Nieves, Servicio De Farmacia, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.256",
    "filters": {
      "actSubs": ["5-azacitidine"],
      "indication": ["Myelodysplastic Syndrome"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["More than 2 years - 5 years"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": ["homeCare"],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Analysis of the effectiveness and safety of daratumumab in monotherapy in adult patients with relapsed refractory multiple myeloma",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A121.2",
    "authors": "C Alarcon-Payer, AM López López, F Gómez-De Rueda, R Claramunt García, MJ Barbero Hernández, A Jiménez Morales",
    "institution": "Hospital Universitario De Jaén, Servicio De Farmacia, Jaén, Spain. Hospital Universitario Virgen De Las Nieves, Servicio De Farmacia, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.257",
    "filters": {
      "actSubs": ["Daratumumab", "Montelukast"],
      "indication": ["Multiple Myeloma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["More than 2 years - 5 years"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Intravenous biosimilar prescribing trends in a third level Spanish hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A121.3",
    "authors": "JM Vinuesa Hernando, R Gracia Piquer, R Fresquet Molina, FJ Campos Montellano, M Galindo Allueva, MJ Nebot Villacampa, M Arenere Mendoza, I Varela Martínez, T Salvador Gómez, MA Alcacera Lopez",
    "institution": "Hospital Clínico Universitario Lozano Blesa, Pharmacy, Zaragoza, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.258",
    "filters": {
      "actSubs": ["Infliximab", "Rituximab", "Trastuzumab"],
      "indication": ["Rheumatoid Arthritis", "Inflammatory Bowel Disease", "Hematologic Malignancy", "Systemic Lupus Erythematosus", "Breast Cancer", "Gastric Cancer"],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Prescribing trends of adalimumab and etanercept biosimilar drugs in a third level hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A122.1",
    "authors": "JM Vinuesa Hernando, R Gracia Piquer, FJ Campos Montellano, R Fresquet Molina, M Galindo Allueva, O Horna Oreja, A Frutos Perez-Surio, MA Alcacera Lopez, T Salvador Gómez, M Gimeno Gracia",
    "institution": "Hospital Clínico Universitario Lozano Blesa, Pharmacy, Zaragoza, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.259",
    "filters": {
      "actSubs": ["Adalimumab", "Etanercept"],
      "indication": ["Spondyloarthropathy", "Rheumatoid Arthritis", "Psoriatic Arthropathy", "Psoriasis", "Inflammatory Bowel Disease"],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["501 - 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Management of community acquired pneumonia at a tertiary care teaching hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A122.2",
    "authors": "M Alomar, A Mayet, A Alsuwayegh, N Alkhayyat, D Almuqbel",
    "institution": "Clinical Pharmacist Specialist-Internal Medicine, Clinical Pharmacy, Riyadh, Saudi Arabia. King Saud University Medical City, Clinical Pharmacy, Riyadh, Saudi Arabia",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.260",
    "filters": {
      "actSubs": [],
      "indication": ["Pneumonia (Community Acquired)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Saudi Arabia"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Management of drugs in patients with swallowing difficulties in a public residential care home: role of the hospital pharmacist",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A123.1",
    "authors": "N Ferreras López, MA González, N Álvarez Núñez, D López Suarez, E Martínez Álvarez, Z Rodríguez Fernández, B Matilla Fernández, JJ Ortiz De Urbina, C Guindel Jiménez",
    "institution": "Complejo Asistencial Univeristario De León, Hospital Pharmacy, León, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.261",
    "filters": {
      "actSubs": [],
      "indication": ["Dysphagia"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Longitudinal Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": ["endOfLife"],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Pharmacist interventions in a hospital at home unit",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A123.2",
    "authors": "A Brito, A Simoes, A Alcobia",
    "institution": "Hospital Garcia De Orta, Pharmacy, Almada, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.262",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": ["homeCare"],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": ["deprescribing"],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Pharmaceutical interventions in drugs provided to the outpatient hospital pharmacy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A124.1",
    "authors": "A Brito, A Fernandes, L Lourenço, S Domingos, A Alcobia",
    "institution": "Hospital Garcia De Orta, Pharmacy, Almada, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.263",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Longitudinal Study"],
      "setting": ["Hospital"],
      "ward": ["Infectious Disease", "Oncology", "Gastroenterology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Clinical pharmacist residence in an intensive care unit: scope and relevance",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A124.2",
    "authors": "T Cabeças, J Cardoso, R Oliveira, M Pereira",
    "institution": "Cuf Infante Santo, Pharmacy, Lisboa, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.264",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "A safe handling hazardous drugs strategy to improve the safety of health professionals: reducing exposure by medical prescription review in nursing homes",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A124.3",
    "authors": "I Cañamares Orbis, F Apolo Carvajal, M Gonzalez Martinez, E Capilla Santamaria, N Martinez Casanova, I Mayorga Bajo, B Caliz Hernandez, MT Llanos Garcia, A Escudero Brocal, H Hernandez Ovejero, A Aranguren Oyarzabal",
    "institution": "Servicio Madrileño De Salud, Subdirección General De Farmacia Y Productos Sanitarios, Consejería De Sanidad., Madrid, Spain. Consejería De Políticas Sociales-Familias-Igualdad Y Natalidad, Agencia Madrileña De Atencion Social, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.265",
    "filters": {
      "actSubs": ["Risperidone", "Acenocoumarol", "Valproic acid", "Clonazepam", "Spironolactone", "Carbamazepine", "Paroxetine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": ["endOfLife"],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Analysis of antibiotic consumption in a nursing home",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A125.1",
    "authors": "R Sánchez Del Moral, AB Guisado Gil, ÁMVillalba Moreno, IM Carrión Madroñal",
    "institution": "Hospital Juan Ramón Jiménez, Ugc Farmacia, Huelva, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.266",
    "filters": {
      "actSubs": ["Amoxicillin / Clavulanic acid", "Fosfomycin"],
      "indication": [],
      "statedClass": ["Quinolones"],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["More than 1 year - 2 years"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": ["endOfLife"],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Analysis of the maintenance rate of long acting injectable antipsychotic treatment in outpatients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A125.2",
    "authors": "A Castro Balado, E Echarri-Arrieta, L García-Quintanilla, FJ Martínez-Bahamonde, EJ Bandín-Vilar, I Varela-Rey, M Busto-Iglesias, I Zarra-Ferro",
    "institution": "Complejo Hospitalario Universitario De Santiago De Compostela, Hospital Pharmacist Service, Santiago De Compostela, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.267",
    "filters": {
      "actSubs": ["Aripiprazole", "Paliperidone"],
      "indication": ["Schizophrenia", "Substance Related Disorders", "Intellectual Disability", "Personality Disorder"],
      "statedClass": ["Antipsychotics (Long Acting Injectable)"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of pharmaceutical interventions: improvement plans",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A126.1",
    "authors": "L Martinez-Dueñas Lopez-Marin, T Vilchez Medina, R Claramunt García, CL Muñoz Cid, AM Lopez, Y Jimenez Lopez, E Perez Cano, N Garcia Gomez",
    "institution": "Hospital Universitario De Jaén, Pharmacy, Jaén, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.268",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine", "Pneumology", "Neurology", "Cardiology", "Digestive Medicine", "Oncology", "Infectious Disease", "Traumatology", "Psychiatry"],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Development of a Belgian classification system for clinical pharmacy activities",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A126.2",
    "authors": "S Verheyen, S Wuyts, H Collier, PJ Cortoos",
    "institution": "Uz Brussel, Pharmacy, Brussels, Belgium",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.269",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Fleiss' Kappa"],
      "studyLength": [],
      "country": ["Belgium"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effect of abiraterone versus enzalutamide on prostate specific antigen levels in metastatic castration resistant prostate cancer",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A127.1",
    "authors": "B Del Rosario García, F Gutiérrez Nicolás, GA González De La Fuente, L Cantarelli, R Ramos Díaz, R García Marrero, A Plata Bello, GJ Nazco Casariego",
    "institution": "Complejo Hospitalario Universitario De Canarias, Pharmacy, San Cristóbal De La Laguna, Spain. Complejo Hospitalario Universitario De Canarias, Oncology, San Cristóbal De La Laguna, Spain. Complejo Hospitalario Universitario De Canarias, Urology, San Cristóbal De La Laguna, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.270",
    "filters": {
      "actSubs": ["Abiraterone", "Enzalutamide"],
      "indication": ["Prostate Cancer (Metastatic Castration Resistant)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Student's T-test", "Gleason Grading System"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Analysis and evaluation of pharmaceutical interventions performed in the emergency department of a tertiary hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A127.2",
    "authors": "I Plo Seco, S Álvarez Atienza, M Domínguez Bachiller, J Martínez Simón, Javier, S Sanz Márquez, M Renilla Sánchez, Esther, M Pérez Encinas",
    "institution": "Hospital Universitario Fundacion Alcorcón, Hospital Pharmacy, Alcorcon, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.271",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Interventional Study"],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": ["highRisk"],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Pharmacists at the health centre",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A128.1",
    "authors": "A Falk, M Dahl",
    "institution": "Region Kronoberg, Drug Department, Växjö, Sweden",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.272",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["6 months - 1 year"],
      "country": ["Sweden"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Off-label use of intralesional cidofovir in recurrent respiratory papillomatosis: a case report",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A128.2",
    "authors": "A Ganfornina Andrades, MDC Jiménez De-Juan, A Salguero Olid, MJ Fernández Anguita",
    "institution": "Puerta Del Mar University Hospital, Pharmacy, Cádiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.273",
    "filters": {
      "actSubs": ["Cidofovir"],
      "indication": ["Papillomatosis (Recurrent Respiratory)"],
      "statedClass": [],
      "typeOfMedical": ["Luer-Lock Syringes"],
      "studyDesign": ["Case Reports / Series", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": ["orphan"],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Role of the pharmacist in the multidisciplinary management of osteomyelitis: from medication reconciliation to support in clinical decision making",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A129.1",
    "authors": "P Gendre, P Nizet, S Cesbron, J Mocquard, JF Huon, N Serandour, E Corbineau",
    "institution": "University Hospital, Pharmacy, Nantes, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.274",
    "filters": {
      "actSubs": [],
      "indication": ["Osteomyelitis"],
      "statedClass": ["Antibiotics (Systemic)"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Orthopaedic Surgery"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Facilitators and barriers to performing comprehensive medication reviews and follow-up in older hospitalised patients by multiprofessional ward teams including a clinical pharmacist",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A129.2",
    "authors": "T Kempen, A Kälvemark, M Sawires, D Stewart, U Gillespie",
    "institution": "Uppsala University Hospital, Hospital Pharmacy Department, Uppsala, Sweden. Uppsala University, Department of Medical Sciences, Uppsala, Sweden. Uppsala University, Department of Pharmaceutical Biosciences, Uppsala, Sweden. Qatar University, Qatar University Health -College of Pharmacy, Doha, Qatar",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.275",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine", "Geriatrics"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Consolidated Framework for Implementation Research"],
      "studyLength": [],
      "country": ["Sweden", "Qatar"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evolution of antimicrobial consumption in a trauma intensive care unit using defined daily doses per 100 occupied bed days",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A130.1",
    "authors": "L Gómez-Ganda, P Lalueza-Broto, ÁG Arévalo-Bernabé, A Rey-Pérez, J Baena-Caparrós, L Domenech-Moral, M Baguena-Martínez",
    "institution": "Vall D’hebron University Hospital, Pharmacy Service, Barcelona, Spain. Vall D’hebron University Hospital, Trauma Intensive Care Service, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.276",
    "filters": {
      "actSubs": ["Amoxicillin / Clavulanic acid", "Piperacillin / Tazobactam", "Meropenem", "Daptomycin", "Linezolid", "Fluconazole", "Ceftolozane / Tazobactam"],
      "indication": ["Trauma"],
      "statedClass": ["Penicillins", "Cephalosporins", "Quinolones", "Carbapenems", "Aminoglycosides", "Glycopeptides", "Antifungals"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Trauma Intensive Care"],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Electrolyte disturbances in premature infants with intrauterine growth restriction receiving parenteral nutrition",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A130.2",
    "authors": "L Gómez-Ganda1, CJ Parramón-Teixidó1, B Garcia-Palop1, M Linés-Palazón2, F Castillo-Salinas2, A Blanco-Grau3, JB Montoro-Ronsano1, S Clemente-Bautista1",
    "institution": "Vall D’hebron University Hospital, Pharmacy Service, Barcelona, Spain. Vall D’hebron University Hospital, Neonatology Service, Barcelona, Spain. Vall D’hebron University Hospital, Clinical Laboratory, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.277",
    "filters": {
      "actSubs": [],
      "indication": ["Intrauterine Growth Restriction", "Hypophosphataemia", "Hypercalcaemia"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Neonatal Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Logistic Regression Analysis", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Comparative study of patient profiles and initial antiretroviral treatment in 2014 versus 2018",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A131.1",
    "authors": "T Gonzalez Furelos, A Casas Martínez, I Rodríguez Penín",
    "institution": "Xerencia Xestión Integrada Ferrol, Pharmacy Service, Ferrol, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.278",
    "filters": {
      "actSubs": ["Tenofovir disoproxil", "Emtricitabine", "Emtricitabine / Tenofovir disoproxil", "Abacavir", "Lamivudine", "Lamivudine / Abacavir", "Efavirenz", "Rilpivirine", "Darunavir", "Ritonavir", "Darunavir / Ritonavir", "Raltegravir", "Tenofovir alafenamide", "Cobicistat", "Dolutegravir", "Elvitegravir"],
      "indication": [],
      "statedClass": ["Nucleoside Reverse Transcriptase Inhibitors", "Non-Nucleoside Reverse Transcriptase Inhibitors", "Protease Inhibitors", "Integrase Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Transcription of supportive medication for inpatient chemotherapy by designated oncology ward pharmacists",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A131.2",
    "authors": "C Imaz, E Smith, A Fox, D Wright, L Carson",
    "institution": "University Hospital Southampton NHS Foundation, Pharmacy, Southampton, UK. University Hospital Southampton NHS Foundation, Southampton Pharmacy Research Centre, Southampton, UK. Queen’s University Belfast, School of Pharmacy, Belfast, UK",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.279",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Oncology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Student's T-test", "Chi-Square (χ2) Test", "Welch's T-Test"],
      "studyLength": [],
      "country": ["United Kingdom"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "The wide review of polypharmacy in the frail older person",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A132.1",
    "authors": "C Kinahan, H Heery",
    "institution": "Portiuncula University Hospital, Pharmacy Department, Co Galway, Ireland. Portiuncula University Hospital, Pharmacy Department, Ballinasloe, Ireland",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.280",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Cohort Study"],
      "setting": ["Hospital", "Community Pharmacy"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["STOPP/START Criteria", "Medication Appropriateness Index", "PRISMA-7 Questionnaire"],
      "studyLength": ["Less than 3 months"],
      "country": ["Ireland"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": ["deprescribing"],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "From evidence based medicine to practice: gum chewing for postoperative recovery of gastrointestinal function after colorectal surgery with interprofessional teamwork",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A132.2",
    "authors": "YN Lin, CL Chuan, CS Tsai",
    "institution": "Tainan Municipal Hospital managed by Show Chwan Medical Care Corporation, Pharmacy, Tainan, Taiwan ROC. Tainan Municipal Hospital managed by Show Chwan Medical Care Corporation, Nutrition and Dietetics, Tainan, Taiwan ROC. Tainan Municipal Hospital managed by Show Chwan Medical Care Corporation, Internal Medicine, Tainan, Taiwan ROC",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.281",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["PICO (Patient, Intervention, Comparison And Outcome) - Procedure", "Analysis of Covariance (ANCOVA)"],
      "studyLength": [],
      "country": ["Taiwan"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Budgetary impact of biosimilar prescription in the treatment of rheumatic diseases",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A133.1",
    "authors": "A Linares, C Fernandez Cuerva, R Asensi Diez, I Muñoz Castillo",
    "institution": "Hru Carlos Haya, Pharmacy, Malaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.282",
    "filters": {
      "actSubs": ["Etanercept", "Adalimumab", "Golimumab", "Tocilizumab", "Infliximab", "Certolizumab", "Abatacept", "Ustekinumab", "Rituximab", "Anakinra"],
      "indication": ["Rheumatological Diseases"],
      "statedClass": ["Biologicals", "Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Rheumatology"],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Preliminary design of hospital telepharmacy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A133.2",
    "authors": "K Nikou, V Papandreou, AA Volakaki, SA Koufopoulou, C Allagianni, D Makridaki",
    "institution": "General Hospital of Chest Diseases ‘Sotiria’, Pharmacy, Athens, Greece. Evangelismos Hospital, Pharmacy, Athens, Greece. Panarkadiko Hospital, Pharmacy, Tripoli, Greece. Naxos Hospital, Pharmacy, Naxos, Greece. General Hospital of Attica ‘Sismanoglio-Amalia Fleming’, Pharmacy, Athens, Greece",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.283",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Greece"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": ["youngPharma"],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Selection of a population pharmacokinetic model of adalimumab in patients with inflammatory bowel disease suitable for therapeutic drug monitoring",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A134.1",
    "authors": "P Mas-Serrano, R Nalda-Molina, A Ramón-López, S Marquez-Megías, M Díaz-González, J Selva, A Gutiérrez, C Colomer",
    "institution": "Hospital General Universitario De Alicante, Clinical Pharmacokinetic Unit-Pharmacy Department, Alicante, Spain. Miguel Hernández University, Division of Pharmacy and Pharmaceutics, Alicante, Spain. Hospital General Universitario De Alicante, Digestive Department, Alicante, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.284",
    "filters": {
      "actSubs": ["Adalimumab"],
      "indication": ["Inflammatory Bowel Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Nonlinear Mixed Effects Modelling", "Bayesian Population Pharmacokinetic Approach"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of a clinical pharmacy service on an inpatient ward in an acute hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A134.2",
    "authors": "C Mc Gann, B Love, J Carr, E Dolan, M O’Connor",
    "institution": "Connolly Hospital, Pharmacy Department, Blanchardstown, Ireland. Connolly Hospital, Medicine for the Elderly, Blanchardstown, Ireland",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.285",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Eadon Scoring Criteria"],
      "studyLength": ["Less than 3 months"],
      "country": ["Ireland"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Administration of oral anticancer drugs for patients with swallowing difficulties",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A135.1",
    "authors": "N Meca, A Manzaneque, G Castells, G Garreta, C Sebastián, I Parés, P Arcenillas, J Nicolás",
    "institution": "Hospital Universitari Mutua De Terrassa, Pharmacy, Terrassa, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.286",
    "filters": {
      "actSubs": ["Ruxolitinib", "Palbociclib", "Vismodegib", "Nilotinib", "Ibrutinib", "Sorafenib", "Vemurafenib", "Crizotinib", "Lenalidomide", "Imatinib", "Lenvatinib", "Sunitinib"],
      "indication": [],
      "statedClass": ["Oral Anticancer Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Description of pharmaceutical interventions in an intensive care unit",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A135.2",
    "authors": "M Muñoz Burgos, S Escalona Rodriguez, E Prado Mel, M Mejias Trueba",
    "institution": "Hospital Universitario Virgen Del Rocio, Hospital Pharmacy, Seville, Spain. Hospital Universitario Virgen Del Rocio, Intensive Medicine, Seville, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.287",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Prognostic value of haematological inflammatory markers in patients with metastatic non-small cell lung cancer treated with pembrolizumab",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A136.1",
    "authors": "R Jimenez-Galan, L Abdel-Kader-Martin, M Mejias Trueba, MD Vega-Coca, S Flores-Moreno",
    "institution": "Hospital Universitario Virgen Del Rocío, Pharmacy, Seville, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.288",
    "filters": {
      "actSubs": ["Pembrolizumab"],
      "indication": ["Non-Small Cell Lung Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Ambispective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Kaplan-Meier Method", "Multivariate Analysis"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Pharmaceutical intervention to reduce the anticholinergic burden in older hospitalised patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A136.2",
    "authors": "M Mensa Vendrell, A Rizo Gómez, R Romero Dominguez, G Ballesteros Cabañas, M Barrantes González, D Soy Muner",
    "institution": "Hospital Plató, Pharmacy Department, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.289",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Anxiolytics", "Antidepressants", "Antipsychotics", "Opioids", "Antiepileptics"],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Drug Burden Index Score"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": ["deprescribing"],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": " Fall incidents in nursing home patients: development of a predictive clinical rule (finder)",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A137.1",
    "authors": "V Milosevic, B Winkens, B Oijen, K Hurkens, A Linkens, C Mestres-Gonzalvo, H Kuy",
    "institution": "Zuyderland Mc, Clinical Pharmacy and Toxicology, Sittard-Geleen, The Netherlands. Maastricht University, Methodology and Statistics, Maastricht, The Netherlands. Zuyderland Mc, Internal Medicine Section of Geriatric Medicine, Sittard-Geleen, The Netherlands. Mumc, Clinical Pharmacy and Toxicology, Maastricht, The Netherlands. Erasmus Mc, Clinical Pharmacy and Toxicology, Rotterdam, The Netherlands",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.290",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Cohort Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": ["Multiple Linear Regression Analysis"],
      "studyLength": [],
      "country": ["Netherlands"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": ["endOfLife"],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of a new clinical pharmacy service within a newly launched surgical admission process",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A137.2",
    "authors": "K Kreundl, K Koch, C Sablatschan, M Klems, K Kirchdorfer, R Lemmens, D Mueller",
    "institution": "University of Vienna, Department for Pharmacology and Toxicology, Vienna, Austria. Hanusch-Hospital, Pharmacy Department, Vienna, Austria",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.291",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["More than 1000"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Austria"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": ["preopMedication"],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Pharmaceutical interventions in a medication reconciliation programme on admission in surgical patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A138.1",
    "authors": "L Martinez-Dueñas Lopez-Marin, T Vilchez Medina, CL Muñoz Cid, R Claramunt García, AM Lopez Lopez, E Perez Cano, Y Jimenez Lopez, N Garcia Gomez",
    "institution": "Hospital Universitario De Jaén, Pharmacy, Jaén, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.292",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["General Surgery", "Urology"],
      "numPatients": ["501 - 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": ["preopMedication"],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Estimating the survival prognosis of patients with advanced gastrointestinal malignancy on home parenteral nutrition: a retrospective, monocentre study",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A138.2",
    "authors": "J Neefs, I Spriet, L De Pourcq, P Declercq",
    "institution": "University Hospitals Leuven, Hospital Pharmacy, Leuven, Belgium",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.293",
    "filters": {
      "actSubs": [],
      "indication": ["Gastric Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Multivariate Logistic Regression Analysis", "Karnofsky Performance Status Scale", "Glasgow Prognostic Score"],
      "studyLength": [],
      "country": ["Belgium"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": ["homeCare"],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Measuring the impact of hospital pharmacist prescription reviewing in an oncology setting on the pharmacovigilance reporting in a comprehensive cancer centre",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A139.1",
    "authors": "E Omodeo Salè, D Pezzella, M Piccoli, M Milani, C Jemos, D Malengo, F Carrara, D Cimino",
    "institution": "Ieo-European Institute of Oncology Irccs-Milan, Clinical Pharmacy, Milano, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.294",
    "filters": {
      "actSubs": ["Paclitaxel", "Cyclophosphamide", "Carboplatinum", "Epirubicin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": ["vigilance"],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "The underreporting rate as a pharmacovigilance process indicator in a comprehensive cancer centre",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A139.2",
    "authors": "E Omodeo Salè, D Pezzella, M Piccoli, M Milani, C Jemos, D Malengo, F Carrara, D Cimino",
    "institution": "Ieo-European Institute of Oncology Irccs-Milan, Clinical Pharmacy, Milano, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.295",
    "filters": {
      "actSubs": ["Paclitaxel"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": ["vigilance"],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Pharmaceutical interventions in parenteral nutrition for critically ill patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A139.3",
    "authors": "M Gonzalez-Padilla, A Jurado-Romero, M Valera-Rubio, JL Ortiz Latorre, I Moya-Carmona",
    "institution": "Hospital Universitario Virgen De La Victoria, Servicio De Farmacia, Málaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.296",
    "filters": {
      "actSubs": [],
      "indication": ["Pancreatitis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Stability of lipid emulsion in paediatric parenteral nutrition with high electrolytic load",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A140",
    "authors": "L Otero Millan, N Lago Rivero, JL Legido Soto, C Vázquez López, A Blanco Rodicio, G Piñeiro Corrales",
    "institution": "Hospital Álvaro Cunqueiro, Pharmacy, Vigo, Spain. University of Vigo, Applied Physics, Vigo, Spain. Hospital Álvaro Cunqueiro, Emergency, Vigo, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.297",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Aggregation Number", "Laser Diffraction Analysis", "Student's T-test"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Monitoring of off-label use: analysis of prescriptions in the pharmacy’s antiblastic drugs unit",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A141.1",
    "authors": "C Panciroli, L Cervi, D Mazza, L Cavallo, G Mangoni, F Corru’, M Dall’aglio, F Ruggiero, MLA Medaglia",
    "institution": "Asst Grande Ospedale Metropolitano Niguarda, SC Farmacia, Milano, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.298",
    "filters": {
      "actSubs": ["Rituximab", "Mitomycin C", "5-azacitidine", "Bendamustine", "Cyclophosphamide", "Decitabine", "Brentuksimab vedotin", "Pembrolizumab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Antiblastic Drugs Unit", "Haematology", "Nephrology", "Ophthalmology", "Oncology"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Results of a medication reconciliation programme in complex chronic patients at hospital discharge",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A141.2",
    "authors": "L Perez Cordon, J Delgado Rodriguez, M Bitlloch Obiols, S Marin Rubio, C Agusti Maragall, D Lopez Faixo, A Sanchez Ulayar, L Campins Bernadas, T Gurrera Roig, M Miarons Font",
    "institution": "Hospital De Mataró, Pharmacy, Mataró, Spain. Hospital Universitari Dexeus, Pharmacy, Barcelona, Spain. Hospital Universitari Vall D’hebron, Pharmacy, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.299",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Pharmaceutical interventions in haemodialysis patients: a 2 year overview",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A142.1",
    "authors": "C Pinto, J Godinho, L Fernandes, P Vieira, AI Ferreira, I Sousa, C Vieira",
    "institution": "Nephrocare Portugal-SA, Pharmaceutical Services, Lisboa, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.300",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Hypertensive Agents", "Vitamin Supplements", "Phosphate Binders"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": ["renal"],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Differences in allelic frequencies of relevant pharmacogenetic polymorphisms may lead to local gene panel development",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A142.2",
    "authors": "X Díaz-Villamarín, AE Fernández-Gómez, P García-Navas, S Portillo-Haro, A Antúnez-Rodríguez, CL Dávila-Fajardo",
    "institution": "Hospital Universitario San Cecilio, Pharmacy, Granada, Spain. Pfizer-University of Granada-Junta De Andalucía Centre for Genomics and Oncological Research Genyo, Genomics Unit, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.301",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": ["Kompetitive Allele Specific PCR (KASP)", "Chi-Square (χ2) Test", "Fisher’s Exact Test"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": ["pharmacogenetics"],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Identification of hazardous drugs and process in a university hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A143.1",
    "authors": "C Mora Herrera, C Cuadros Martinez, C Puivecino Moreno, V Vazquez Vela",
    "institution": "Hospital Universitario Jerez De La Frontera, Servicio De Farmacia Hospitalaria, Jerez De La Frontera, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.302",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Antineoplastic Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Nutritional risk evaluation in institutionalised elderly patients in a public nursing home",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A143.2",
    "authors": "C Puivecino Moreno, V Vazquez-Vela, A Varas-Perez, V Sanchez-Matamoros Piazza, C Mora Herrera",
    "institution": "Hospital Universitario Jerez De La Frontera, Pharmacy Service, Jerez De La Frontera-Cádiz, Spain. Hospital Universitario Jerez De La Frontera, Pharmacy Service, Jerez De La Frontera, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.303",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Mini Nutritional Assessment – Short Form (MNA-SF)"],
      "studyLength": ["Less than 3 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": ["endOfLife"],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Nurses: what do you think about a pharmaceutical presence in the emergency ward?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A143.3",
    "authors": "N Ranjit, G Decreau-Gaillon, LM Joly",
    "institution": "Chru De Rouen, Pharmacy, Rouen, France. Chru De Rouen, Emergency Ward, Rouen, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.304",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Medicine reconciliation at hospital discharge",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A144.1",
    "authors": "I Martinez Aguirre, A Revuelta Amallo, JA Domínguez Menéndez, U Blazquez Urtizberea, M Alonso Diez, E Fernández Díaz, A Aguirrezabal Arredondo",
    "institution": "Hospital De Basurto, Pharmacy Department, Bilbao, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.305",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine", "Cardiology", "Oncology"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Assessment of the palatability of antibiotic oral suspensions: a literature review",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A144.2",
    "authors": "S Robert, YE Nisse, D Béatrice",
    "institution": "Chru Nancy, Pharmacy, Vandoeuvre Les Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.306",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Antibiotics (Oral)"],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Visual Analogue Scale"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Impact of medication reconciliation in complex chronic patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A145.1",
    "authors": "C Rodriguez Bernuz, A Morales Triadó, L Vilaró Jaques, A Martín Val, RA Fernàndez Fernàndez, A Vilariño Seijas, S Cervero Corbella, C Oliveras Simón, C Quiñones Ribas",
    "institution": "Hospital Universitari Germans Trias I Pujol, Pharmacy, Badalona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.307",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["General Surgery", "Gastrointestinal Surgery", "Angiology", "Vascular Surgery", "Urology", "Nephrology", "Rheumatology"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["STATA"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Treatment adequacy in domiciliary care programme patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A145.2",
    "authors": "C Salom, C Campabadal, I Muiño, C Carrillo, F Bejarano, N Marco, J Del Estal, MP Muniain, MÁ Roch, L Palacios, L Canadell",
    "institution": "Dap Camp De Tarragona-Ics, Pharmacy, Tarragona, Spain. Ap Camp De Tarragona-Ics, Eap Salou, Tarragona, Spain. Dap Camp De Tarragona-Ics, Computing, Tarragona, Spain. Hospital Joan Xxiii, Pharmacy, Tarragona, Spain. Dap Camp De Tarragona-Ics, Management, Tarragona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.308",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Longitudinal Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": ["homeCare"],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Nutritional support in oncology: a cross sectional study among cancer patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A146.1",
    "authors": "Y Samouh, A Benider, S Derfoufi",
    "institution": "Faculty of Medicine and Pharmacy-Hassan Ii University-Casablanca-Morocco, Laboratory of Drug Science-Biomedical Research and Biotechnology-Faculty of Medicine and Pharmacy-Hassan Ii University-Casablanca-Morocc, Casablanca, Morocco. Faculty of Medicine and Pharmacy-Hassan Ii University-Casablanca-Morocco, Mohammed Vi Centre for the Treatment of Cancers-Ibnrochd University Hospital Centre-Casablanca-Morocco, Casablanca, Morocco. Faculty of Medicine and Pharmacy-Hassan Ii University-Casablanca-Morocco, Pharmacy Unit of Ibn Rochd University Hospital Centre-Casablanca-Morocco, Casablanca, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.309",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study", "Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": ["Oncology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "An exploration into a pharmacist-led medicines reconciliation service in an acute hospital setting",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A146.2",
    "authors": "C Shine, M Kieran, C Meegan",
    "institution": "Mater Misericordiae University Hospital, Pharmacy Department, Dublin 7, Ireland. MMUH, Pharmacy, Dublin, Ireland. Mater Misericordiae University Hospital, Pharmacy, Dublin, Ireland",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.310",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Ireland"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Pharmacists’ communication with foreign language speaking patients in a foreigner settlement area, Japan",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A147.1",
    "authors": "E Takahashi, Y Takahashi, H Sato, K Obayashi, Y Takechi, K Takahashi",
    "institution": "Takasaki University of Health and Welfare, Faculty of Pharmacy, Takasaki-Gunma, Japan. Pharma Mirai Co Ltd, Kyoso-Mirai Kakezuka Pharmacy, Isesaki-Gunma, Japan. Hoshino Pharmacy, Tsunatori Branch, Isesaki-Gunma, Japan. Gunma Pharmaceutical Association, Gunma Pharmaceutical Association, Maebashi-Gunma, Japan. Teikyo University Graduate School of Public Health, Department of Global Community Health, Itabashi-Tokyo, Japan",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.311",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Community Pharmacy"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Japan"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Adherence and interactions in patients treated with abiraterone and enzalutamide",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A147.2",
    "authors": "MV Tarazona Casany, P Perez, E Monte, MJ Cuellar",
    "institution": "Hospital Pharmacy Hospital Universitario Y Politécnico La Fe Valencia Spain, Hospital Pharmacy, Valencia, Spain. Hospital Universitario Y Politécnico La Fe Valencia Spain, Hospital Pharmacy, Valencia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.312",
    "filters": {
      "actSubs": ["Abiraterone", "Enzalutamide", "Amiodarone", "Enzalutamide", "Atorvastatin", "Simvastatin", "Omeprazole", "Esomeprazole"],
      "indication": ["Prostate Cancer (Metastatic Castration Resistant)"],
      "statedClass": ["Lipid Lowering Agents", "Proton-Pump Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Morisky – Green Questionnaire"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Healthcare providers’ views of pharmacy team involvement in the preparation and administration of medicines on inpatients wards: an exploratory study",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A147.3",
    "authors": "EM Vella, A Cutajar, P Lewis",
    "institution": "The University of Manchester, School of Health Sciences, Manchester, UK. Mater Dei Hospital, Department of Pharmacy-Clinical Pharmacy Practice Unit, Msida, Malta",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.313",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["General Surgery", "Critical Care Unit", "Emergency Department"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Framework Analysis"],
      "studyLength": ["3 months - 5 months"],
      "country": ["United Kingdom", "Malta"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Patient perceptions of generic medicines 20 years after the right of substitution by pharmacists",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A148.1",
    "authors": "M Vergano, F Badibouidi",
    "institution": "Ghpso, Pharmacy, Creil, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.314",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Computer Assisted Web Interviewing (CAWI)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Improving intravenous to oral switch by identifying and tackling barriers perceived by physicians and nurses",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A148.2",
    "authors": "S Von Winckelmann, E Boey, V Verheyen",
    "institution": "Imelda Hospital, Hospital Pharmacy, Bonheiden, Belgium",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.315",
    "filters": {
      "actSubs": ["Acetaminophen"],
      "indication": [],
      "statedClass": ["Antibiotics"],
      "typeOfMedical": [],
      "studyDesign": ["Interventional Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Orthopaedics", "Geriatrics"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Belgium"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "The impact of clinical pharmacist driven interventions on patient safety in hospitalised patients: preliminary results of a point prevalence study",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A149.1",
    "authors": "S Wilkes, R Zaal, A Abdulla, N Hunfeld",
    "institution": "Erasmus Mc-University Medical Centre Rotterdam, Department of Hospital Pharmacy, Rotterdam, The Netherlands",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.316",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Point Prevalence Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) Index"],
      "studyLength": [],
      "country": ["Netherlands"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Promotion of the quality of drug education for patients using nasogastric tube feeding before discharge",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A149.2",
    "authors": "SC Yeh, YH Liang",
    "institution": "Taipei City Hospital, Pharmacy, Taipei City, Taiwan ROC",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.317",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["Taiwan"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": ["homeCare"],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "A comparative study of the satisfaction of clients with the services of an outpatient pharmacy in a tertiary hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A200.1",
    "authors": "AC Viney, CN García Matillas, S Núñez Bracamonte, E CONESA NICOLÁS, A Lloret Llorca, C Juez Santamaría, MC Mira Sirvent, IG Pérez Pérez, MS García Simón, MDM Sánchez Catalicio, MH García Lagunar",
    "institution": "Hospital General Universitario Santa Lucia de Cartagena, Servicio de Farmacia Hospitalaria, Cartagena, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.430",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Comparative Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Binary logistic regression analysis to evaluate the influence of different basal factors on the effectiveness of ledipasvir/sofosbuvir",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A201.2",
    "authors": "JC del Río Valencia, R Asensi Diez, R Tamayo Bermejo, I Muñoz Castillo",
    "institution": "Hospital Regional Universitario Malaga, Servicio Farmacia, Malaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.433",
    "filters": {
      "actSubs": ["Ledipasvir / Sofosbuvir", "Ledipasvir", "Sofosbuvir"],
      "indication": ["Hepatitis C (Chronic)"],
      "statedClass": ["Direct Acting Antivirals"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Binary Logistic Regression Analysis", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": ["pharmacogenetics"],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Impact of a multidisciplinary team in reducing polypharmacy and treatment complexity in home care patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A186.1",
    "authors": "N Pagès-Puigdemont, M Rovira-Illamola, L Gené, I Garrell, L GUerrero, A Lascorz, E Martínez, M Ortega, A Silva, M Sans, D Soy",
    "institution": "Hospital Clínic, Pharmacy Department, Barcelona, Spain. Capsbe, Cap Comte Borrell, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.400",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Interventional Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Medication Regimen Complexity Index"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": ["homeCare"],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": ["deprescribing"],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Pharmacy intervention and drug prescription regulations in a tertiary hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A196.2",
    "authors": "P Stathopoulou, V Papandreou, V Papadopoulou, G Chatzidimitriou, A Sakka, M Vlachou",
    "institution": "General Hospital ‘Evaggelismos’, Pharmacy Department, Athens, Greece",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.422",
    "filters": {
      "actSubs": ["Ferric carboxymaltose", "Human albumin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Greece"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": ["deprescribing"],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Determining the necessary components of a pharmaceutical care complexity screening tool: an E-delphi study",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A161.2",
    "authors": "M Alshakrah, D Steinke, M Tully, S Williams, P Lewis",
    "institution": "University of Manchester, Division of Pharmacy and Optometry, Manchester, UK",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.346",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Delphi Method", "Likert Scale"],
      "studyLength": [],
      "country": ["United Kingdom"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Analysis of adverse reaction reports before and after the use of equivalent imatinib in a tertiary hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A196.1",
    "authors": "E Specogna, MT Chiarelli, C Naddeo, M Bettio, M Mazzucchelli, F Venturini",
    "institution": "Scuola di Specializzazione in Farmacia Ospedaliera – Universita’ Degli Studi di Milano, Dipartimento di Scienze Farmaceutiche, Milano, Italy. Fondazione Irccs ca’ Granda Ospedale Maggiore Policlinico, U.O.C. Farmacia, Milano, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.421",
    "filters": {
      "actSubs": ["Imatinib"],
      "indication": ["Leukaemia (Chronic Myeloid)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["6 months - 1 year"],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": ["vigilance"],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Prescription and administration of oral medication through the jejunostomy and the nasogastric tube in an intensive care unit: impact of good practices guidelines on clinical practice",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A168.1",
    "authors": "P Cavagna, C Zulian, C Chirk, AC Cuquel, J Perreux, E Houillez, C Sanchez, C Fernandez, T Lescot, S Bizet, M Antignac",
    "institution": "Saint-Antoine Hospital- HUEP- AP-HP, Pharmacy, Paris, France. Saint-Antoine Hospital- HUEP- AP-HP, Surgical Intensive Care Unit – Department of Anaesthesiology and Critical Care Medicine, Paris, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.361",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": ["101 - 500"],
      "criteriaMethod": ["Chi-Square (χ2) Test"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Clinical management of malignant mesothelioma in an asbestos-endemic area",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A176.1",
    "authors": "M Hijazi Vega, P López Méndez, L López Esteban, R Diez Fernández, AM Sánchez Peña, T Molina García",
    "institution": "Hospital Universitario de Getafe Madrid, Pharmacy, Getafe, Spain. Hospital Universitario de Getafe Madrid, Oncology, Getafe, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.378",
    "filters": {
      "actSubs": ["Pemetrexed", "Platin", "Raltitrexed", "Gemcitabine", "Irinotecan", "Vinorelbine"],
      "indication": ["Mesothelioma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Dealing with iatrogenic cardiac arrest in psychiatry, do not overlook monitoring!",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A152.1",
    "authors": "S Wise, C Kowal, B Pignon, K Richard, S Vanhulst, A Pelissolo, M Dalle-Pecal, M Paul, C Divine",
    "institution": "Albert Chenevier Hospital – Henri Mondor Hospital Group – AP-HP, Pharmacy Department, Creteil, France. Albert Chenevier Hospital – Henri Mondor Hospital Group – AP-HP, Psychiatric Department, Creteil, France. Albert Chenevier Hospital – Henri Mondor Hospital Group – AP-HP, Cardiac Rehabilitation Department, Creteil, France. Henri Mondor Hospital – Henri Mondor Hospital Group – AP-HP, Pharmacy Department, Creteil, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.326",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Torsadogenic Drugs"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Psychiatry"],
      "numPatients": [],
      "numPrescriptions": ["51 - 100"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "A new multidisciplinary model with the clinical pharmacist for medication reconciliation in the patient with advanced renal disease",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A141.2",
    "authors": "S Masucci, G Soragna, E Cerutti, M Riba, MC Azzolina, C Vitale, A Gasco",
    "institution": "Mauriziano Hospital, Hospital Pharmacy, Torino, Italy. Mauriziano Hospital, Nephrology Department, Torino, Italy. Universitad de Barcelona, Biochemistry and Physiology Department, Barcellona, Spain. Mauriziano Hospital, Health Management Unit, Torino, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.304",
    "filters": {
      "actSubs": [],
      "indication": ["Chronic Kidney Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["STOPP/START Criteria", "Beers Criteria"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": ["renal"],
      "errors": ["errors"],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Cobicistat interactions with chronic treatments",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A113.2",
    "authors": "M Vélez-Díaz-Pallarés, T Gramage Caro, Má Rodríguez Sagrado, C Palomar Fernández, A Moreno Zamora, MJ Vivancos Gallego, E Ilies, M Carreter Garnica, M Atienza Martín, T Bermejo Vicedo",
    "institution": "Hospital Ramon y Cajal, Pharmacy, Madrid, Spain. Hospital Ramon y Cajal, Infectious Diseases, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.246",
    "filters": {
      "actSubs": ["Cobicistat", "Elvitegravir", "Emtricitabine", "Tenofovir alafenamide", "Budesonide", "Fluticasone"],
      "indication": ["Acquired Immunodeficiency Syndrome (AIDS)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["501 - 1000"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Use of specific drugs for dementia in people at the end of life in nursing homes",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A152.3",
    "authors": "A Zurutuza, I Beobide, B Miró, A Ferro",
    "institution": "Donostia University Hospital, Pharmacy, San Sebastian, Spain. Ricardo Bermingham Hospital Matia Foundation, Pharmacy, San Sebastian, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.328",
    "filters": {
      "actSubs": ["Memantine"],
      "indication": ["Dementia", "Alzheimer’s Disease"],
      "statedClass": ["Acetylcholinesterase Inhibitors", "Anti-Dementia Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": ["Global Impairment Scale (GDS-FAST)", "Barthel Index", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": ["endOfLife"],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Oral anticoagulant prescription practice after an ischaemic stroke",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A73.1",
    "authors": "J Leraut, S Drouot, S Raspaud, O Chassin, C Denier",
    "institution": "CHU De Bicêtre, Val-de-Marne, Kremlin Bicêtre, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.162",
    "filters": {
      "actSubs": [],
      "indication": ["Atrial Fibrillation"],
      "statedClass": ["Oral Anticoagulants", "Vitamin K Antagonists", "Direct Oral Anticoagulants"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "High input in patient safety – documentation of cardiovascular system drugs",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A77.2",
    "authors": "B Laszloffy, D Haider",
    "institution": "Sozialmedizinisches Zentrum Sued KFJ, Pharmacy, Wien, Austria. Sozialmedizinisches Zentrum Sued KFJ, Pharmacy, Vienna, Austria",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.171",
    "filters": {
      "actSubs": ["Nicorandil", "Amlodipin", "Carvedilol"],
      "indication": ["Cardiovascular Disease"],
      "statedClass": ["Cardiovascular Drugs", "Statins", "Beta-Blockers", "Diuretics", "Calcium Channel Blockers", "Angiotensin Converting Enzyme (ACE) Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Tropical Medicine and Infectious Disease"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Austria"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Analysis of antibiotic administration in surgical prophylaxis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A91.1",
    "authors": "P Domecký, L Hauschke, P Neumann, V Cerny, J Kolar, J Maly",
    "institution": "Faculty of Pharmacy in Hradec Kralove- Charles University, Department of Social and Clinical Pharmacy, Hradec Kralove, Czech Republic. Regional Health Corporation, Department of Clinical Pharmacy, Usti Nad Labem, Czech Republic. Na Homolce Hospital, Department of Clinical Pharmacy, Prague, Czech Republic. Masaryk Hospital in Usti Nad Labem- Regional Health Corporation, Clinic Of Anaesthesiology- Perioperative Medicine And Intensive Care Unit, Usti Nad Labem, Czech Republic. Hospital Pharmacy- Motol University Hospital, Department of Clinical Pharmacy, Prague, Czech Republic",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.199",
    "filters": {
      "actSubs": ["Cefazolin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["Czech Republic"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": ["preopMedication"],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": ["antibioticProphylaxis"],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Shortage of drugs era: impact of piperacilin/tazobactam shortage",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A101.1",
    "authors": "C Raga Jimenez, L Belles Medall, S Conde Giner, T Cebolla Beltran, M Tripiana Rallo, J Maiques Llacer, R Ferrando Piqueres",
    "institution": "Hospital General Universitario de Castellón, Castellón, Castellón de la Plana, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.220",
    "filters": {
      "actSubs": ["Piperacillin / Tazobactam", "Meropenem", "Ertapenem", "Imipenem"],
      "indication": [],
      "statedClass": ["Carbapenems"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Regulatory validation of prescriptions at a teaching hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A182.1",
    "authors": "M Mseddi, K Myriam, A Hamdi, T Manel",
    "institution": "Faculty of Pharmacy- University of Monastir, Pharmacology Department, Monastir, Tunisia. Teaching Hospital Hedi Chaker, Pharmacy Department, Sfax, Tunisia",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.391",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Haematology", "Cardiology", "Endocrinology"],
      "numPatients": [],
      "numPrescriptions": ["501 - 1000"],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)", "Multivariate Analysis"],
      "studyLength": ["Less than 3 months"],
      "country": ["Tunisia"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Does platelet-rich plasma composition matter in hip osteoarthritis?",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A199.2",
    "authors": "MDM Villanova Lopez, M Nunez-Nunez, M Murillo-Izquierdo, J Donaire, R Alvarez-Sanchez, M Camean-Fernandez, S Sandoval",
    "institution": "Hospital Hospiten, Traumatology, Malaga, Spain. Hospital San Cecilio- Granada, Pharmacy, Granada, Spain. Hospital Macarena, Pharmacy, Sevilla, Spain. Hospital La Línea, Traumatology, Cadiz, Spain. Hospital San Cecilio, Pharmacy, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.429",
    "filters": {
      "actSubs": ["Plasma (Platelet Rich)"],
      "indication": ["Hip Osteoarthritis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cohort Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)", "Harris Hip Score", "Visual Analogue Scale", "Multivariate Analysis", "Univariate Analysis", "Statistical Package for the Social Sciences (SPSS)", "Kellgren-Lawrence Classification System"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Efficacy and safety of cobimetinib used in monotherapy for erdheim–chester disease",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A125.1",
    "authors": "M Muñoz Burgos, T Desongles Corrales",
    "institution": "Hospital Universitario Virgen del Rocio, Hospital Pharmacy, Seville, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.271",
    "filters": {
      "actSubs": ["Cobimetinib"],
      "indication": ["Erdheim–Chester Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["Less than 10"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Persistence and safety of apremilast in psoriasis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A83.2",
    "authors": "AM López-López, R Claramunt García, CL Muñoz Cid, J Jerez Rojas, Y Jimenez López, E Perez Cano, M Merino Almazan, MJ Barbero Hernández",
    "institution": "Complejo Hospitalario de Jaén, Servicio de Farmacia, Jaén, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.184",
    "filters": {
      "actSubs": ["Apremilast"],
      "indication": ["Psoriasis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Kaplan-Meier Method"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Experience of nab-paclitaxel and gemcitabine use in metastatic pancreatic cancer",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A123.3",
    "authors": "E Mateos Egido, M Lombardero Pin, A Álamo Medina, C García Piernavieja, D Dorta Vera",
    "institution": "Complejo Hospitalario Universitario Insular-Materno Infantil, Pharmacy, Las Palmas de Gran Canaria, Spain. Complejo Hospitalario Universitario Insular-Materno Infantil, Oncology, Las Palmas de Gran Canaria, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.268",
    "filters": {
      "actSubs": ["Nab-paclitaxel", "Gemcitabine"],
      "indication": ["Pancreatic Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Kaplan-Meier Method", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Chemotherapy near the end of life in onco-haematological adult patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A128.2",
    "authors": "M Sanchez Cuervo, L Garcia Basas, C Pueyo Lopez, E Gomez de Salazar Lopez de Silanes, T Bermejo Vicedo",
    "institution": "Ramon y Cajal University Hospital, Pharmacy, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.278",
    "filters": {
      "actSubs": [],
      "indication": ["Lung Cancer", "Breast Cancer", "Colorectal Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Oncology", "Haematology"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": ["endOfLife"],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Use of antimicrobial agents in the emergency department in a third-level hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A93.1",
    "authors": "S Gonzalez Suarez, C Blázquez Romero, H Quirós Ambel, AA García Sacristan, A Dominguez Barahona, R López Álvarez, AR Rubio Salvador, P Moya Gómez",
    "institution": "Hospital Virgen de la Salud, Hospital Pharmacy, Toledo, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.203",
    "filters": {
      "actSubs": [],
      "indication": ["Respiratory Tract Infection (Lower)", "Urinary Tract Infection", "Intra-abdominal Infection", "Pneumonitis", "Chronic Obstructive Pulmonary Disease"],
      "statedClass": ["Antimicrobial Agents"],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effectiveness of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A109.2",
    "authors": "C Burgui, R Juanbeltz, J Castilla, B Larrayoz, M Sarobe, JM Zozaya, M Gracia-Ruiz de Alda, R San Miguel",
    "institution": "Ciber Epidemiologia y Salud Publica Ciberesp, Hospital Pharmacy, Pamplona, Spain. Instituto de Salud Publica de Navarra-Idisna- Ciber Epidemiología y Salud Pública Ciberesp, Transmissible Disease and Vaccination, Pamplona, Spain. Navarra Hospital Complex-Idisna, Hospital Pharmacy, Pamplona, Spain. Navarra Hospital Complex-Idisna, Gastroenterology and Hepatology, Pamplona, Spain. Navarra Hospital Complex, Infectious Disease, Pamplona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.237",
    "filters": {
      "actSubs": ["Glecaprevir / Pibrentasvir", "Glecaprevir", "Pibrentasvir"],
      "indication": ["Hepatitis C (Chronic)", "Acquired Immunodeficiency Syndrome (AIDS)"],
      "statedClass": ["Direct Acting Antivirals"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": ["pharmacogenetics"],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Pharmaceutical interventions in antimicrobial treatment in a 150-bed hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A89.1",
    "authors": "R Gázquez Pérez, LE Lobo León, MJ Lorente Galisteo, L Jiménez Pichardo, A Alcala Soto, C Puivecino Moreno, A Varas Pérez, V Sánchez-Matamoros Piazza",
    "institution": "Hospital Universitario Jerez de La Frontera, Pharmacy Service, Jerez de La Frontera Cádiz, Spain. Hospital San Juan Grande, Pharmacy Service, Jerez De La Frontera Cádiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.195",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["More than 1 year - 2 years"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Identifying medication history errors at hospital admission using the lund integrated medicines management model",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A159.1",
    "authors": "E Abood, T Eriksson, H Al Temimi",
    "institution": "Uppsala University, Department of Pharmaceutical Biosciences, Uppsala, Sweden. Lund University, Department of Clinical Pharmacology, Lund, Sweden. Medical City, Department of Clinical Pharmacy, Baghdad, Iraq",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.341",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Cardiovascular Drugs", "Non-Steroidal Anti-Inflammatory Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study"],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Logistic Regression Analysis"],
      "studyLength": [],
      "country": ["Sweden", "Iraq"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Prevalence of nutritional complications according to the requested hospitalisation service of total parenteral nutrition",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A72.3",
    "authors": "A Ferrer Machín, MA Navarro Dávila, M Vera Cabrera, C Fraile Clemente, E Tévar Alfonso, R Mesa Expósito, J Merino Alonso",
    "institution": "Hospital Universitario Nuestra Señora la Candelaria, Pharmacy Service, Santa Cruz de Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.161",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Catheters"],
      "studyDesign": ["Descriptive Study"],
      "setting": ["Hospital"],
      "ward": ["Oncology", "Surgical Unit"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Chi-Square (χ2) Test", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of patients’, doctors’ and community pharmacists’ satisfaction concerning pharmaceutical consultations for patients receiving oral anti-cancer drugs",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A189.2",
    "authors": "C Renard, G Dozias, B Rey-Rubio, G Larhantec, N Mugnier, M Perennes",
    "institution": "CHRU Brest, Pharmacy, Brest, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.408",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Oral Anticancer Drugs"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital", "Community Pharmacy"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Measurement of health outcomes of pomalidomide, cyclophosphamide and dexamethasone combination in adult patients with relapsed and refractory multiple myeloma",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A116.1",
    "authors": "C Alarcon-Payer, S Cano Domínguez, A Jiménez Morales, R Ríos Tamayo, M Jurado Chacón",
    "institution": "Hospital Universitario Virgen de las Nieves, Servicio de Farmacia, Granada, Spain. Hospital Universitario Virgen de las Nieves, Servicio de Haematología, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.251",
    "filters": {
      "actSubs": ["Pomalidomide", "Dexamethasone", "Cyclophosphamide"],
      "indication": ["Multiple Myeloma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["More than 2 years - 5 years"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "The effect of an enhancing medication adherence programme for a type 2 diabetes mellitus network",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A187.3",
    "authors": "T Pholchai",
    "institution": "Rayong Hospital, Opd Pharmacy, Rayong, Thailand",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.404",
    "filters": {
      "actSubs": [],
      "indication": ["Diabetes Type II (Mellitus)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["6 months - 1 year"],
      "country": ["Thailand"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Study of patient satisfaction with pharmaceutical interview in an outpatient oncology medical unit",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A179.2",
    "authors": "A Maire, L Porcher, C Moulin, P Gueneau, M Boutet, M Boulin, P Pistre",
    "institution": "Dijon University Hospital, Oncology Medical Unit, Dijon, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.386",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Oncology"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Outcomes research on new tyrosine kinase inhibitors for non-small cell lung cancer",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A166.3",
    "authors": "P Cardoso, M Capoulas, T Lobo, C Matos, M Felizardo, R Oliveira, C Santos",
    "institution": "Hospital Beatriz Ângelo, Hospital Pharmacy, Loures, Portugal. Hospital Beatriz Ângelo, Pneumology, Loures, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.358",
    "filters": {
      "actSubs": ["Erlotinib", "Gefitinib", "Crizotinib"],
      "indication": ["Non-Small Cell Lung Cancer"],
      "statedClass": ["Tyrosine Kinase Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Chemotherapy pharmaceutical consultation: pharmaceutical interventions after 18 months of implementation",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A140.1",
    "authors": "E Gerardin, E Protesti, R Cohen-Valensi, S Martinez, T Berod",
    "institution": "Centre Hospitalier de Martigues, Pharmacy, Martigues, France. Centre Hospitalier de Martigues, Haematology, Martigues, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.301",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital", "Community Pharmacy"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["More than 1 year - 2 years"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": ["nursesReccomend"],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Impact of the establishment of assisted electronic prescription on the improvement of the unit-dose drug dispensation system",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A172.2",
    "authors": "C Pastor Mondejar, M Gil Candel, I Salar Valverde, M Onteniente Candela, C Caballero Requejo, C Iniesta Navalon, E Urbieta Sanz",
    "institution": "Hospital General Universitario Reina Sofia, Pharmacy Hospital, Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.371",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Inhaled colistin as chronic suppressor therapy in patients with bronchiectasias with non-cystic fibrosis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A104.1",
    "authors": "G Arrufat Goterris, F Company Bezares, A Oliver Noguera, M Vilanova Bolto",
    "institution": "Hospital Son Llàtzer, Pharmacy Department, Palma, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.226",
    "filters": {
      "actSubs": ["Colistin", "Ciprofloxacin", "Levofloxacin", "Imipenem", "Azithromycin"],
      "indication": ["Bronchiectasis", "Fibrosis (Cystic)", "Chronic Obstructive Pulmonary Disease", "Pneumonitis"],
      "statedClass": ["Quinolones"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Galenic preparations and rare diseases: guanidinoacetate methyltransferase deficiency: experience in a local hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A157.1",
    "authors": "L Gambitta, E Togliardi, E Strada, L Zampogna, G Lo Cricchio, A Bezzi, D Di Benedetto",
    "institution": "ASST Santi Paolo E Carlo- San Carlo Borromeo Hospital, Hospital Pharmacy Operative Unit, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.337",
    "filters": {
      "actSubs": [],
      "indication": ["Guanidinoacetate Methyltransferase Deficiency"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Paediatrics"],
      "numPatients": ["Less than 10"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": ["personalized"],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": ["orphan"],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Feasibility of pharmacy follow-up of antibiotic re-evaluation in a university hospital: day-2 or/and day-7?",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A89.2",
    "authors": "H Benoist, R Baveux, G Saint-Lorant",
    "institution": "Caen University Hospital, Pharmacy, Caen, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.196",
    "filters": {
      "actSubs": ["Linezolid", "Imipenem / Cilastatin", "Ceftazidime", "Levofloxacin", "Cefepime"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": ["51 - 100"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Treatment of follicular lymphoma in routine clinical practice",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A120.1",
    "authors": "A Ferrer Machín, MM Viña Romero, I González Pérez, F Gutiérrez Nicolás, E Ramos Santana, E Gómez Melini, S Hernández Rojas, M Vera Cabrera, R Mesa Expósito, J Merino Alonso",
    "institution": "Hospital Pharmacist, Pharmacy Service, Santa Cruz de Tenerife, Spain. Hospital Nuestra Señora la Candelaria, Pharmacy Service, Santa Cruz de Tenerife, Spain. Hospital Universitario de Canarias, Pharmacy Service, la Laguna, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.260",
    "filters": {
      "actSubs": ["Rituximab", "Cyclophosphamide", "Doxorubicin", "Vincristine", "Prednisone", "Bendamustine"],
      "indication": ["Follicular Lymphoma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": ["Oncology", "Haematology"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Follicular Lymphoma International Prognostic Index (FLIPI)", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Vemurafenib-induced stevens–johnson syndrome in a patient with metastatic melanoma: a case report",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A122.2",
    "authors": "M Lavandeira Pérez, P de Juan-García Torres, I Fernández-Rañada, MA Vega Castro, AM Horta Hernández",
    "institution": "Hospital Universitario de Guadalajara, Hospital Pharmacy, Guadalajara, Spain. Hospital Universitario de Guadalajara, Medical Oncology, Guadalajara, Spain. Hospital Universitario de Guadalajara, Allergology, Guadalajara, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.265",
    "filters": {
      "actSubs": ["Vemurafenib", "Nivolumab", "Cobimetinib", "Dabrafenib"],
      "indication": ["Stevens–Johnson Syndrome", "Melanoma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series", "Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": ["Allergy"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Naranjo Algorithm (Adverse Drug Reaction Probability Scale)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Nephrogenic diabetes insipidus induced by liposomal amphotericin B: a case report",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A106.2",
    "authors": "S Sadyrbaeva, B Cancela-Diez, M Sanchez-Argaiz, A Jimenez-Morales",
    "institution": "Virgen de las Nieves University Hospital, Pharmacy, Granada, Spain. San Agustin Hospital, Pharmacy, Linares Jaen, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.231",
    "filters": {
      "actSubs": ["Amphotericin", "Cyclosporine", "Micophenolate", "Sirolimus", "Methylprednisolone", "Beclametasone", "Meropenem", "Acyclovir", "Levofloxacin", "Cotrimoxazole", "Caspofungin", "Voriconazole", "Posaconazole", "Desmopressin", "Hydrochlorothiazide", "Spironolactone"],
      "indication": ["Diabetes Insipidus (Nephrogenic)", "Graft Versus Host Disease", "Hypokalaemia"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Naranjo Algorithm (Adverse Drug Reaction Probability Scale)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": ["antibioticProphylaxis"],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Study on daptomycin use as a first step towards an antimicrobial stewardship programme",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A92.2",
    "authors": "S García Sánchez, FJ García-Moreno, C Rodríguez-González, E Chamorro-De Vega, E García-Martín, M Valerio Minero, P Muñoz-García De Paredes, E Bouza-Santiago, A Herranz-Alonso, M Sanjurjo-Sáez",
    "institution": "Hospital General Universitario Gregorio Marañón, Pharmacy Department, Madrid, Spain. Hospital General Universitario Gregorio Marañón, Microbiology and Infectious Diseases, Madrid, Spain. Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.202",
    "filters": {
      "actSubs": ["Daptomycin"],
      "indication": ["Skin and Soft Tissue Infection", "Endocarditis", "Osteoarticular Infection"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Charlson Comorbidity Index"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "From the surveillance of antibiotics prescriptions to limitation of multidrug resistant bacteria strains: the role of the hospital pharmacy in defining a carbapenem-sparing-strategy",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A92.1",
    "authors": "L Gambitta, E Galfrascoli, E Calzavara, V Curci, MLA Medaglia",
    "institution": "ASST Fatebenefratelli-Sacco- Fatebenefratelli and Ophthalmic Hospital, Hospital Pharmacy Operative Unit, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.201",
    "filters": {
      "actSubs": ["Tigecycline", "Ceftolozane / Tazobactam", "Ceftazidime / Avibactam", "Avibactam", "Colistin", "Teicoplanin"],
      "indication": ["Urinary Tract Infection", "Respiratory Tract Infection", "Sepsis", "Surgical Site Infection"],
      "statedClass": ["Carbapenems", "Quinolones"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "The choice of antiepileptic drug treatment after status epilepticus",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A149.1",
    "authors": "L Horváth, I Fekete, S Márton, K Fekete",
    "institution": "University of Debrecen, Department of Pharmaceutical Surveillance and Economics, Debrecen, Hungary. University of Debrecen, Department of Neurology, Debrecen, Hungary. University of Debrecen, Faculty of Art- Institute of Political Science and Sociology, Debrecen, Hungary",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.320",
    "filters": {
      "actSubs": ["Carbamazepine", "Valproic acid", "Levetiracetam", "Oxcarbazepine", "Lamotrigine", "Lacosamide"],
      "indication": ["Status Epilepticus"],
      "statedClass": ["Antiepileptics"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["101 - 500"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Hungary"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Potential drug-drug interactions involving tyrosine kinase inhibitors in patients with chronic myeloid leukaemia treated at a university hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A119.1",
    "authors": "N Dewulf, ACF Modesto, NA Sousa",
    "institution": "Pharmacy School – Federal University of Goias, Research Laboratory in Health Teaching and Services, Goiânia, Brazil. Clinical Hospital of Federal University of Goiás, Pharmacy Division, Goiânia, Brazil",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.258",
    "filters": {
      "actSubs": ["Imatinib", "Domperidone", "Levothyroxine", "Dasatinib"],
      "indication": ["Leukaemia (Chronic Myeloid)"],
      "statedClass": ["Tyrosine Kinase Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Multivariate Logistic Regression Analysis", "Poisson Regression"],
      "studyLength": [],
      "country": ["Brazil"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Palivizumab off label use in tertiary referral hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A114.2",
    "authors": "A Gasso, V Gimeno Ballester, P Olier Martinez, I Larrode Leciñena, O Pereira Blanco, MR Abad Sazatornil",
    "institution": "Hospital Universitario Miguel Servet, Pharmacy, Zaragoza, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.248",
    "filters": {
      "actSubs": ["Palivizumab"],
      "indication": ["Fibrosis (Cystic)", "Myopathy", "Respiratory Disorders"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Antimicrobial stewardship programme implementation in the gulf cooperation council states: a systematic review",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A197.2",
    "authors": "N Hashad, A Tonna, D Perumal, D Stewart",
    "institution": "Fatima College of Health Sciences and Robert Gordon University, Pharmacy, Al Ain, United Arab Emirates. Robert Gordon University, Pharmacy and Life Sciences, Aberdeen, UK. Fatima College of Health Sciences, Pharmacy, Abu Dhabi, United Arab Emirates",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.425",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["United Kingdom", "United Arab Emirates"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Extensively pandrug-resistant pseudomonas aeruginosa infections: analysis and outcomes",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A87.2",
    "authors": "M Achaques-Rodriguez, F Fernandez-Fraga, ME Martinez-Nuñez, T Molina-Garcia",
    "institution": "Hospital Universitario de Getafe, Pharmacy, Getafe, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.192",
    "filters": {
      "actSubs": ["Colistin", "Meropenem"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Longitudinal Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Charlson Comorbidity Index", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "The role of clinical pharmacists monitoring regarding the effectiveness and tolerance of expensive drugs prescribed off-label",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A174.1",
    "authors": "C Guillot, L Gutermann, L Djoudi, I Lopez, R Batista, O Conort",
    "institution": "Cochin Hospital, Clinical Pharmacy, Paris, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.374",
    "filters": {
      "actSubs": ["Tocilizumab", "Adalimumab", "Infliximab", "Immunoglobulin (IVIg)", "Canakinumab"],
      "indication": ["Behcet Disease", "Horton Disease", "Hypogammaglobulinaemia", "Sarcoidosis", "Inflammatory Arthritis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine", "Rheumatology"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Clinical benefit of infliximab monitoring in inflammatory bowel disease",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A143.1",
    "authors": "M Llinares, S Martínez Pérez, G Miralles Andreu, L Peral Ballester, AC Murcia López, A Navarro Ruiz",
    "institution": "Hospital General Universitario de Elche, Hospital Pharmacist, Elche, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.307",
    "filters": {
      "actSubs": ["Infliximab"],
      "indication": ["Inflammatory Bowel Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Bayesian Population Pharmacokinetic Approach"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Determining factors affecting patients’ clarity on dispensed medication instructions: a case study at copperbelt university health facility in kitwe, zambia",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A188.2",
    "authors": "K Ponshano",
    "institution": "The Copperbelt University, Health Services, Kitwe, Zambia",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.406",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["Zambia"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Medication use evaluation of edoxaban in a tertiary hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A76.1",
    "authors": "J Park, JH You, SM Lee, YS Lee, HK Lee, JM Kim",
    "institution": "Samsung Medical Centre, Department of Pharmacy, Seoul, South Korea",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.168",
    "filters": {
      "actSubs": ["Edoxaban", "Warfarin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["South Korea"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "A systematic review of meta-analyses of the efficacy of oral antipsychotic lurasidone for the treatment of adult patients with schizophrenia",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A151.2",
    "authors": "C Inserra, A Zovi, M Piacenza, G Zerega",
    "institution": "ASST Fatebenefratelli Sacco – Ospedale L.Sacco, Pharmacy, Milan, Italy. ASST Fatebenefratelli Sacco – L.Sacco Hospital, Pharmacy, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.325",
    "filters": {
      "actSubs": ["Lurasidone"],
      "indication": ["Schizophrenia"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review", "Meta-Analysis"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Positive and Negative Syndrome Scale (PANSS)", "Brief Psychiatric Rating Scale (BPRS)"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Development of a stratification model for ambulatory oncology pharmacy patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A127.2",
    "authors": "JL Revuelta Herrero, MB Marzal-Alfaro, V Escudero-Vilaplana, R Collado-Borrell, A de Lorenzo-Pinto, E González Haba-Peña, R García-Sánchez, MN Sánchez-Fresneda, A Herranz-Alonso, M Sanjurjo-Saéz",
    "institution": "Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón Iisgm, Pharmacy Department, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.276",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Oral Anticancer Drugs"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": ["highRisk"],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Adequacy of nivolumab and pembrolizumab in non-small-cell lung cancer",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A128.1",
    "authors": "E Rosón Sánchez, C González-Pérez, MP Pacheco Ramos, MD Zamora Barrios, AE Areñaza Peña, JC Tallón Martínez, I Larrosa Espejo, G Hernando Llorente, M Molinero Muñoz, JM Martínez Sesmero",
    "institution": "Clínico San Carlos Hospital, Pharmacy Service, Madrid, Spain. Hospital Clínico San Carlos, Pharmacy Service, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.277",
    "filters": {
      "actSubs": ["Nivolumab", "Pembrolizumab"],
      "indication": ["Non-Small Cell Lung Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Kaplan-Meier Method", "Eastern Cooperative Oncology Group (ECOG) Performance Status"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Prevalence of vancomycin-related neutropaenia, thrombocytopaenia and acute kidney injury",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A95.2",
    "authors": "J Landa Alberdi, L Lombera Saez, I Aldalur Uranga, A Zurutuza Lopez, D García Echeverría, T Gonzalez Fernandez, MJ Gayan Lera, P Pascual Gonzalez, MP Bachiller Cacho, MP Carmona Oyaga",
    "institution": "Hospital Universitario Donostia, Pharmacy Department, Donostia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.209",
    "filters": {
      "actSubs": ["Vancomycin"],
      "indication": ["Neutropenia", "Thrombocytopenia", "Acute Kidney Injury"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Analysis of pharmaceutical interventions in an emergency department",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A171.2",
    "authors": "AB Fernandez Roman, C Mariño Martinez, M Martin Lopez, N Herrero Muñoz, MDM Garcia Gutierrez, M Garcia Gil",
    "institution": "Hospital of Fuenlabrada, Pharmacy, Fuenlabrada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.368",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Cardiovascular Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Influence of the route and pharmaceutical preparation in intra-patient variability of tacrolimus serum levels in the liver transplant patient",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A139.2",
    "authors": "S Garcia Garcia, C Dopazo Taboada, MB Aller Hernández, I Bilbao Aguirre, E Pericas Bosch, JB Montoro Ronsano",
    "institution": "Vall d’Hebron Hospital, Pharmacy Service, Barcelona, Spain. Vall d’Hebron Hospital, Hepatolobiliar Surgery Service, Barcelona, Spain. Vall d’Hebron Hospital, Artificial Intelligence Information Service, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.300",
    "filters": {
      "actSubs": ["Tacrolimus"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)", "Kruskal-Wallis H Test"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Bone metastasis treatment in prostate cancer: efficacy and safety",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A145.2",
    "authors": "FJ Salmeron Navas, C Martinez-Diaz, M Camean-Castillo, S Fenix-Caballero, MP Briceño-Casado, MD Gil-Sierra, E Rios-Sanchez, J Diaz-Navarro, EJ Alegre-Del Rey, JM Borrero-Rubio",
    "institution": "Hospital Universitario Puerto Real, Servicio de Farmacia, Cadiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.312",
    "filters": {
      "actSubs": ["Denosumab", "Zoledronic acid"],
      "indication": ["Prostate Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Common Terminology Criteria for Adverse Events"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Encouraging the responsible use of antibiotics: awareness and understanding among a university student population of a community pharmacy public health campaign in scotland",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A103.2",
    "authors": "A Tonna1, A Weidmann, I Donat, J Sneddon, A Cockburn, D Stewart",
    "institution": "Robert Gordon University, School of Pharmacy and Life Sciences, Aberdeen, UK. NHS Healthcare Improvement Scotland, Scottish Antimicrobial Prescribing Group, Glasgow, UK. NHS Lothian Antimicrobial Management Team, Regional Infectious Diseases Unit-Western General Hospital, Edinburgh, UK",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.225",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Likert Scale", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["United Kingdom"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": ["youngPharma"],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Adjuvant chemotherapy and relapse-associated prognostic factors in operable breast cancer",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A135.1",
    "authors": "B François, A Benider, S Housbane, H Chorouk, Z Lhoussaine, S Derfoufi",
    "institution": "IBN Rochd University Hospital Centre, Pharmacy Service, Casablanca, Morocco. Medical and Pharmaceutical College – University Hassan II, Laboratory of Drug Sciences- Biomedical Research and Biotechnology, Casablanca, Morocco. IBN Rochd University Hospital Centre, Mohammed VI Centre for the Treatment of Cancers, Casablanca, Morocco. Medical and Pharmaceutical College-University Hassan II, Laboratory of Medical Informatics, Casablanca, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.291",
    "filters": {
      "actSubs": ["Tamoxifen"],
      "indication": ["Breast Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["501 - 1000"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)", "Kaplan-Meier Method", "Logistic Regression Analysis", "Log Rank Test"],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": ["pharmacogenetics"],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Anticoagulant therapy in chronic complex patients with atrial fibrillation",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A173.1",
    "authors": "M Soria-Soto, A Gomez-Gil, M Pascual-Barrriga, N de Bejar-Riquelme, MA Meroño-Saura, T Rodriguez-Martinez, MT Alonso-Dominguez, C Fernandez-Zamora, MD Najera-Perez, MA Page-Del Pozo",
    "institution": "Hospital Morales Meseguer, Pharmacy, Murcia, Spain. Hospital Morales Meseguer, Internal Medicine, Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.372",
    "filters": {
      "actSubs": ["Apixaban", "Dabigatran", "Rivaroxaban", "Edoxaban"],
      "indication": ["Atrial Fibrillation", "Hypertension", "Dyslipidaemia", "Diabetes Type II (Mellitus)", "Heart Failure"],
      "statedClass": ["Direct Oral Anticoagulants", "Vitamin K Antagonists"],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Charlson Comorbidity Index", "CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk", "HAS-BLED Score for Major Bleeding Risk"],
      "studyLength": ["6 months - 1 year"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of broad-spectrum beta-lactam prescriptions (except carbapenems) in the military hospital of instruction mohammed V rabat",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A97.2",
    "authors": "Y Moutaouakkil, Y Tadlaoui, Y Atbib, B Adouani, A Bennana, Y Cherrah, J Lamsaouri, Y Bousliman",
    "institution": "Pharmacy Pole-Military Hospital of Instruction Mohammed V Rabat, Department of Pharmacology – Toxicology- University Mohammed V- Faculty of Medicine and Pharmacy-, Rabat, Morocco. Pharmacy Pole-Military Hospital of Instruction Mohammed V Rabat, Department of Pharmacy Clinic- University Mohammed V- Faculty of Medicine and Pharmacy-, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.213",
    "filters": {
      "actSubs": ["Amoxicillin / Clavulanic acid", "Amoxicillin", "Ceftriaxone", "Piperacillin / Tazobactam", "Ceftazidime", "Cefepime"],
      "indication": [],
      "statedClass": ["Beta-Lactam Antibiotics"],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["101 - 500"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Prescribed antineoplastic agents in paediatric patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A117.1",
    "authors": "V Alonso Castro, B López Centeno, I Martín Casasempere, D Alioto, A Gil Martín, M Segura Bedmar, A Aranguren Oyarzábal, MJ Calvo Alcántara",
    "institution": "Servicio Madrileño de Salud, Subdirección General de Farmacia y Productos Sanitarios, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.254",
    "filters": {
      "actSubs": ["Vincristine", "Cyclophosphamide", "Cytarabine", "Mercaptopurine", "Carboplatinum", "Dactynomicin", "Pegaspargase", "Bevacizumab", "Ifosfamide"],
      "indication": [],
      "statedClass": ["Antineoplastic Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study"],
      "setting": ["Hospital"],
      "ward": ["Oncology", "Haematology"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": ["501 - 1000"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of antiplatelet agent prescribing in patients on direct oral anticoagulant",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A75.2",
    "authors": "AS Larock, A Spinewine, P Laloux, P Eucher, C Hanet",
    "institution": "CHU UCL Namur- Namur Thrombosis and Haemostasis Centre- Universite Catholique de Louvain, Pharmacy, Yvoir, Belgium. CHU UCL Namur- Namur Thrombosis and Haemostasis Centre- Université Catholique de Louvain, Pharmacy, Yvoir, Belgium. Louvain Drug Research Institute- Clinical Pharmacy Research Group- Université Catholique de Louvain, Pharmacy, Brussels, Belgium. CHU UCL Namur- Université Catholique de Louvain, Neurology, Yvoir, Belgium. CHU UCL Namur- Université Catholique de Louvain, Cardiac- Vascular and Thoracic Surgery, Yvoir, Belgium. CHU UCL Namur- Université Catholique de Louvain, Cardiology, Yvoir, Belgium",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.167",
    "filters": {
      "actSubs": ["Acetylsalicylic acid", "Clopidogrel"],
      "indication": [],
      "statedClass": ["Antiplatelet Agents", "Direct Oral Anticoagulants"],
      "typeOfMedical": [],
      "studyDesign": ["Cohort Study", "Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Belgium"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Stewardships of hepatitis c virus patients in prisons",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A108.1",
    "authors": "MD Gil-Sierra, F Tellez-Perez, E Rios-Sanchez, MDP Briceño-Casado, S Fenix-Caballero, C Martinez-Diaz, EJ Alegre-Del Rey, C Palomo-Palomo, J Diaz-Navarro, JF Lopez-Vallejo, JM Borrero-Rubio",
    "institution": "Hospital Universitario de Puerto Real, Pharmacy, Puerto Real, Spain. Hospital Universitario de Puerto Real, Internal Medicine Service, Puerto Real, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.234",
    "filters": {
      "actSubs": ["Glecaprevir / Pibrentasvir", "Glecaprevir", "Pibrentasvir", "Sofosbuvir / Velpatasvir", "Sofosbuvir", "Velpatasvir", "Elbasvir / Grazoprevir", "Elbasvir", "Grazoprevir", "Ledipasvir / Sofosbuvir", "Ledipasvir"],
      "indication": ["Hepatitis C", "Acquired Immunodeficiency Syndrome (AIDS)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Dupilumab treatment discontinuation due to limiting adverse effects: a case report",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A85.2",
    "authors": "A Rodríguez Ferreras, L Ordóñez Fernández, I Maray Mateos, C Álvarez Asteinza, E Lázaro López, B Zarate Tamames, Á Pieras López, L Velasco Roces, A Lozano Blázquez",
    "institution": "Hospital Universitario Central De Asturias, Hospital Pharmacy, Oviedo, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.188",
    "filters": {
      "actSubs": ["Dupilumab", "Cyclosporine", "Methotrexate", "Omalizumab", "Levocabastine"],
      "indication": ["Dermatitis (Atopic)", "Conjunctivitis"],
      "statedClass": ["Corticosteroids"],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Eczema Area and Severity Index", "Numeric Rating Scale (NRS)", "Dermatology Life Quality Index"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": ["vigilance"],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Persistence of an antiretroviral therapy in human immunodeficiency virus patients in a tertiary level hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A111.3",
    "authors": "A Pinilla Rello, H Navarro Aznarez, A Magallón Martínez, B Abad Bañuelos, Á Arias Sánchez, MP Olier Martínez, A Gasso Sánchez, MR Abad Sazatornil",
    "institution": "Universitary Miguel Servet Hospital, Hospital Pharmacy, Zaragoza, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.242",
    "filters": {
      "actSubs": ["Emtricitabine / Tenofovir disoproxil", "Emtricitabine", "Tenofovir", "Lamivudine / Abacavir", "Abacavir", "Lamivudine"],
      "indication": ["Acquired Immunodeficiency Syndrome (AIDS)"],
      "statedClass": ["Integrase Inhibitors", "Protease Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Transversal Study", "Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["501 - 1000"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Health outcomes using direct-acting antiviral drugs for the treatment of patients with hepatitis C virus and F0–F1 liver fibrosis stage",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A110.2",
    "authors": "M Martín López, B Hernández Muniesa, A Ontañón Nasarre, A Pou Alonso, N Herrero Muñoz, M García Gil",
    "institution": "Hospital Universitario de Fuenlabrada, Pharmacy, Fuenlabrada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.239",
    "filters": {
      "actSubs": ["Ledipasvir / Sofosbuvir", "Ledipasvir", "Sofosbuvir", "Elbasvir / Grazoprevir", "Elbasvir", "Grazoprevir", "Ombitasvir / Paritaprevir / Ritonavir / Dasabuvir", "Ombitasvir", "Paritaprevir", "Ritonavir", "Dasabuvir", "Glecaprevir / Pibrentasvir", "Glecaprevir", "Pibrentasvir", "Sofosbuvir / Velpatasvir", "Velpatasvir", "Ombitasvir / Paritaprevir / Ritonavir"],
      "indication": ["Hepatitis C", "Fibrosis (Liver)"],
      "statedClass": ["Direct Acting Antivirals"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Sacubitril/valsartan (Entresto) in real life: an observational study in a hospital centre",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A78.1",
    "authors": "A Rajkumar, J Lemonnier, M Gautier, JL Georges, F Samdjee, C Courtin",
    "institution": "Versailles Hospital, Pharmacy Unit, Le Chesnay, France. Versailles Hospital, Cardiology Unit, Le Chesnay, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.172",
    "filters": {
      "actSubs": ["Sacubitril / Valsartan", "Sacubitril", "Valsartan"],
      "indication": ["Heart Failure"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Cardiology"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["New York Heart Association (NYHA) Classification"],
      "studyLength": ["6 months - 1 year"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Analysis of drug prescriptions of incompatible drugs through drug utilisation review",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A177.2",
    "authors": "H Kim, S Min, S Yu, Y Jung, H Jeong",
    "institution": "Seoul Veterans Hospital- Korea Veterans Health Service, Department of Pharmacy, Seoul, South Korea",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.382",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Antidiabetics", "Genitourinary Organ And Rectal Agents", "Non-Steroidal Anti-Inflammatory Drugs", "Cardiovascular Drugs"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["501 - 1000"],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["South Korea"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Quality of the empiric antibiotic treatment in community-acquired pneumonia",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A90.1",
    "authors": "S Conde, MD Belles, C Raga, M Tripiana, T Cebolla, M Juan, R Ferrando",
    "institution": "Hospital General Universitario de Castellón, Hospital Pharmacy, Castellón, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.197",
    "filters": {
      "actSubs": ["Ceftriaxone", "Levofloxacin"],
      "indication": ["Pneumonia (Community Acquired)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine", "Pneumology"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Pneumonia Severity Index of Fine Score", "Chi-Square (χ2) Test", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Efficacy and safety of artemisinine derivatives in the treatment of malaria",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A93.2",
    "authors": "D Gonzalez Vaquero, MA Castro Vida, J Urda Romacho, A Martos Rosa, F Avila Cabrera, M Aznar García, P Acosta Robles",
    "institution": "Agencia Pública Empresarial Sanitaria Hospital de Poniente, Pharmacy Department, El Ejido, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.204",
    "filters": {
      "actSubs": ["Artemisinin", "Piperaquine / Dihydroartemisin", "Artesunate"],
      "indication": ["Malaria"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Impact of clinical pharmacist-vancomycin monitoring on patient safety outcome",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A88.1",
    "authors": "R Al-ruwaisan, R Bahmaid, N Albanyan",
    "institution": "King Fahad Medical City, Pharmacy Services Administration, Riyadh. KSA, Saudi Arabia",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.193",
    "filters": {
      "actSubs": ["Vancomycin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Cohort Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Saudi Arabia"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Impact of pharmaceutical interview in patient acceptance of insulin glargine’s biosimilar 100UI/ml",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A71.1",
    "authors": "M Malassigné, M Megne-Wabo, V Rigalleau, K Mohammedi, F Xuereb, D Breilh",
    "institution": "Bordeaux University Hospital, Pharmacy Department, Bordeaux, France. Bordeaux University Hospital, Diabetology Department, Bordeaux, France. University of Bordeaux, Inserm 1034 – Pharmacokinetics and Pharmacodynamics PK/PD, Bordeaux, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.157",
    "filters": {
      "actSubs": ["Insulin glargine"],
      "indication": [],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Diabetology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Optimisation of antipsychotic treatment in a patient undergoing dialysis: a case report",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A151.1",
    "authors": "C González Martín, J Ruiz Gutierrez, A Diez Alcantara, T Delgado Expósito, M Ruiz de Hoyos, A Pujol-Xicoy Gimferrer",
    "institution": "Sanatorio Esquerdo Psiquiatria. Hestia Alliance, Pharmacy Department, Madrid, Spain. Agencia Española de Medicamentos y Productos Sanitarios, Pharmacology and Clinical Assessment Division, Madrid, Spain. Servicio Madrileño de Salud, Primary Care Pharmacy, Majadahonda, Spain. Sanatorio Esquerdo Psiquiatria. Hestia Alliance, Department of Psychiatry, Madrid, Spain. Hospital Hestia Madrid. Hestia Alliance, Pharmacy Department, Madrid, Spain. Hestia Alliance. Chief Pharmacist, Pharmacy Department, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.324",
    "filters": {
      "actSubs": ["Risperidone", "Zuclopenthixol"],
      "indication": ["Schizoaffective Disorder", "Chronic Kidney Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series", "Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Anticoagulation therapy in haemodialysis – a clinical pharmacist experience in a primary care team",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A76.2",
    "authors": "A Szabó, Á Haris, S Dolgos, I Cseh",
    "institution": "Szent Margit Hospital, Central Pharmacy Department, Budapest, Hungary. Szent Margit Hospital, Nephrology Department, Budapest, Hungary",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.169",
    "filters": {
      "actSubs": ["Heparin", "Acetylsalicylic acid", "Dalteparin", "Clopidogrel", "Erythropoietin"],
      "indication": [],
      "statedClass": ["Low Molecular Weight Heparins", "Oral Anticoagulants", "Non-Steroidal Anti-Inflammatory Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Cohort Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Hungary"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Effectiveness and use of off-label treatments in a general hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A182.2",
    "authors": "A Murgadella Sancho, B Gracia Garcia, A Morales Triado, N San Juan Martínez",
    "institution": "Hospital Moisès Broggi, Pharmacy, Sant Joan Despí, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.392",
    "filters": {
      "actSubs": ["Rituximab", "Botulinum Toxin", "Immunoglobulin"],
      "indication": ["Nephrotic Syndrome", "Systemic Lupus Erythematosus", "Sjögren Syndrome", "Achalasia", "Spasmodic Dysphonia", "Myasthenia Gravis", "Encephalitis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Neurology", "Nephrology", "Digestive Medicine", "Ophthalmology", "Otorhinolaryngology"],
      "numPatients": [],
      "numPrescriptions": ["51 - 100"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Development of pharmacist medication review in paediatric discharge process",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A195.2",
    "authors": "M Solano, M Jeannin, R Anxionnat, AL Clairet, S Limat",
    "institution": "University Hospital of Besançon, Pharmacy Department, Besancon, France. University Hospital of Besançon, Paediatric Unit, Besancon, France. University of Bourgone Franche Comte, Inserm 1098, Besancon, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.420",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Paediatrics"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["6 months - 1 year"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "The use of oral apremilast for the treatment of plaque psoriasis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A82.2",
    "authors": "MC Sánchez Argaiz, B Cancela Díez, S Sadyrbaeva Dolgova, R Álvarez Sánchez, MR Cantudo Cuenca",
    "institution": "San Agustín Hospital, Hospital Pharmacy, Linares Jaén, Spain. Virgen de Las Nieves University Hospital, Hospital Pharmacy, Granada, Spain. Campus de la Salud Hospital, Hospital Pharmacy, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.182",
    "filters": {
      "actSubs": ["Apremilast"],
      "indication": ["Psoriasis (Moderate to Severe Plaque)", "Psoriatic Arthropathy"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Psoriasis Area and Severity Index (PASI)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Pharmacist-led medicine reconciliation at diabetes outpatient clinic",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A70.1",
    "authors": "C Camilleri, L Azzopardi, L Grech",
    "institution": "University of Malta, Pharmacy Department, Msida, Malta",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.155",
    "filters": {
      "actSubs": ["Metformin"],
      "indication": [],
      "statedClass": ["Statins"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital", "Community Pharmacy"],
      "ward": ["Diabetes Outpatient Clinic"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Malta"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "A qualitative study on how clinical pharmacists preform medication reconciliation in the emergency department",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A181.1",
    "authors": "MK Moan Ingebrigtsen, J Kutschera Sund, M Winge, HT Bell",
    "institution": "Levanger Hospital Pharmacy, Central Norway Hospital Pharmacy Trust, Levanger, Norway. Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway. Central Norway Hospital Pharmacy Trust, Central Norway Hospital Pharmacy Trust, Trondheim, Norway. Faculty of Nursing and Health Sciences, Nord University, Levanger, Norway",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.389",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": [],
      "numPrescriptions": ["51 - 100"],
      "criteriaMethod": ["Systematic Text Condensation"],
      "studyLength": [],
      "country": ["Norway"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Natalizumab: a review of its use in the management of multiple sclerosis, experience in a university hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A133.1",
    "authors": "S Oprea, S Negres",
    "institution": "Bucharest University Emergency Hospital, Pharmacy, Bucharest, Romania. University of Medicine and Pharmacy Carol Davila, Pharmacology and Clinical Pharmacy Department-, Bucharest, Romania",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.286",
    "filters": {
      "actSubs": ["Natalizumab"],
      "indication": ["Multiple Sclerosis", "Progressive Multifocal Leukoencephalopathy"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Expanded Disability Status Scale"],
      "studyLength": [],
      "country": ["Romania"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Patient with complicated fungal endocarditis: a case report",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A105.1",
    "authors": "J Bellegarde, L Hasseine, E Demonchy, K Risso, C Ichai, H Quintard, EM Maiziere, R Collomp, V Mondain, F Lieutier",
    "institution": "CHU Nice, Pharmacy, Nice, France. CHU Nice, Mycology Laboratory, Nice, France. CHU Nice, Infectious Diseases Department, Nice, France. CHU Nice, Intensive Care Unit, Nice, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.228",
    "filters": {
      "actSubs": ["Caspofungin", "Flucytosine", "Amphotericin", "Fluconazole"],
      "indication": ["Endocarditis"],
      "statedClass": ["Echinocandins"],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "DDI-predictor: a novel clinical pharmacy decision-making tool for dose adaptation?",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A181.2",
    "authors": "F Moreau, N Simon, M Tod, B Decaudin, P Odou",
    "institution": "CHU Lille, Institut de Pharmacie, Lille, France. Univ. Lille, EA 7365 – Grita – Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Lille, France. Université Lyon 1- Faculté de Médicine Lyon-Sud-Charles Mérieux, Emr 3738, Oullins, France. Groupement Hospitalier Nord- Hospices Civils de Lyon, Pharmacy, Lyon, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.390",
    "filters": {
      "actSubs": [],
      "indication": ["Cirrhosis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["More than 1000"],
      "criteriaMethod": [],
      "studyLength": ["More than 2 years - 5 years"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": ["pharmacogenetics"],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Analysis of an epidemiological model for the treatment of hepatitis C virus in co-infected HIV/HCV drug addictions via parenteral",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A193.1",
    "authors": "MT Brieva Herrero, I Reyes Torres, M Sáez-Torres de Vicente, P López López, M Frias Casas, A Rivero Juarez",
    "institution": "Instituto Maimónides de Investigación Biomédica de Cordoba Imibic, Clinical Virology and Zoonosis Research Group, Córdoba, Spain. Hospital Univeritario Reina Sofia, Hospital Pharmacist, Cordoba, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.415",
    "filters": {
      "actSubs": [],
      "indication": ["Hepatitis C", "Acquired Immunodeficiency Syndrome (AIDS)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Dynamic Modeling"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Statin overuse? Evaluation of statin initiation for primary prevention during hospitalisation between two neighbouring countries in europe in high-risk patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A80.2",
    "authors": "D Haider, B Arthofer, P Drofenik, N Gr&zcaron;ini&ccaron;, C Haider, M Petre, A Pointinger, M Ravnikar, I Schneider, T Tomši&ccaron;",
    "institution": "Sozialmedizinisches Zentrum Süd – KFJ Spital, Hospital Pharmacy, Vienna, Austria. Klinikum Wels-Grieskirchen, Hospital Pharmacy, Wels, Austria. UKC Maribor, Hospital Pharmacy, Maribor, Slovenia. UKC Ljubljana, Hospital Pharmacy, Ljubljana, Slovenia. Kepler Universitätsklinikum Linz, Hospital Pharmacy, Linz, Austria. SB Novo Mesto, Hospital Pharmacy, Novo Mesto, Slovenia",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.177",
    "filters": {
      "actSubs": [],
      "indication": ["Cardiovascular Disease", "Diabetes Type II (Mellitus)"],
      "statedClass": ["Statins"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Systematic Coronary Risk Evaluation"],
      "studyLength": [],
      "country": ["Austria", "Slovenia"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Pre-anaesthesia best possible medication history for orthopaedic surgery-programmed patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A190.1",
    "authors": "A Renaudin, V Delannoy, M Knight, C Roux, JM Kinowski, H Richard",
    "institution": "University Hospital of Nimes, Clinical Pharmacy Department, Nimes, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.409",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Orthopaedic Surgery"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": ["preopMedication"],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Real-world effectiveness of evolocumab and alirocumab at 12 months of treatment",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A80.1",
    "authors": "M Gomez Zamora, P Rovira Torres, A Jimenez Portilla, M Ortiz, A Gomez Lobon, MM Santandreu Esterlich, E Rodriguez Campos, O Delgado Sanchez, JR Urgeles Planella",
    "institution": "Hospital Universitario Son Espases, Pharmacy, Palma de Mallorca, Spain. Hospital Universitario Son Espases, Endocrinology, Palma de Mallorca, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.176",
    "filters": {
      "actSubs": ["Evolocumab", "Alirocumab", "Ezetimibe"],
      "indication": ["Hypercholesterolaemia", "Cardiovascular Disease"],
      "statedClass": ["Proprotein Convertase Subtilisin / Kexin Type 9 Enzyme (PCSK9) Inhibitors", "Statins"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Parenteral nutrition-associated cholestasis as an early-onset adverse effect in adult patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A178.2",
    "authors": "P López-Méndez, F Fernández-Fraga, M Moreno-García, N Ibañez-Heras, T Molina-García",
    "institution": "Hospital Universitario de Getafe, Pharmacy Department, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.384",
    "filters": {
      "actSubs": [],
      "indication": ["Cholestasis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Longitudinal Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Chi-Square (χ2) Test"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Lack of hepatitis C virus uptake in HIV/HCV co-infected patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A193.2",
    "authors": "MT Brieva Herrero, I Reyes Torres, M Sáez-Torres de Vicente, P López López, M Frias Casas, A Rivero Juárez",
    "institution": "Instituto Maimónides de Investigación Biomédica de Cordoba Imibic, Clinical Virology and Zoonosis Research Group, Córdoba, Spain. Hospital Univeritario Reina Sofia, Hospital Pharmacist, Cordoba, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.416",
    "filters": {
      "actSubs": ["Ribavirin"],
      "indication": ["Hepatitis C", "Acquired Immunodeficiency Syndrome (AIDS)"],
      "statedClass": ["Direct Acting Antivirals", "Pegylated Interferons (PEG-IFN)"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Cohort Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": ["Logistic Regression Analysis", "Multivariate Analysis"],
      "studyLength": ["More than 1 year - 2 years"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Implementation of an empirical antibiotic treatment guide: impact on antiobitic prescription in an emergency department",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A86.2",
    "authors": "L Otero millan, A Perez-Landeiro, C Casanova martinez, MT Perez-Rodriguez, L Martinez Lamas, A Blanco Rodicio, K Lorenzo Lorenzo, L Perez Rodriguez, G Piñeiro Corrales",
    "institution": "Hospital Álvaro Cunqueiro, Pharmacy, Vigo, Spain. Hospital Álvaro Cunqueiro, Internal Medicine, Vigo, Spain. Hospital Álvaro Cunqueiro, Microbiology, Vigo, Spain. Hospital Álvaro Cunqueiro, Emergency, Vigo, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.190",
    "filters": {
      "actSubs": ["Amoxicillin / Clavulanic acid", "Levofloxacin"],
      "indication": [],
      "statedClass": ["Quinolones", "Cephalosporins", "Carbapenems"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Fisher’s Exact Test"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Clinical experience of new lipid-lowering therapies: evolocumab and alirocumab",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A81.1",
    "authors": "MP Monforte Gasque, I Varela Martínez, CA Moncín Torres",
    "institution": "Hospital Royo Villanova, Pharmacy, Zaragoza, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.178",
    "filters": {
      "actSubs": ["Evolocumab", "Alirocumab"],
      "indication": ["Hypercholesterolaemia", "Cardiovascular Disease"],
      "statedClass": ["Proprotein Convertase Subtilisin / Kexin Type 9 Enzyme (PCSK9) Inhibitors", "Statins"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Rescue of patients infected with hepatitis C virus not responding to interferon-free therapies",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A112.2",
    "authors": "M Sáez-Torres de Vicente, MD López Malo de Molina, T López-Viñau López, L García Martinez",
    "institution": "Hospital Reina Sofía, Pharmacy, Córdoba, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.244",
    "filters": {
      "actSubs": ["Ledipasvir / Sofosbuvir", "Ledipasvir", "Sofosbuvir", "Ribavirin", "Sofosbuvir / Daclatasvir", "Daclatasvir", "Ombitasvir / Paritaprevir / Ritonavir / Dasabuvir", "Ombitasvir", "Paritaprevir", "Ritonavir", "Dasabuvir", "Sofosbuvir / Simeprevir", "Simeprevir", "Sofosbuvir / Velpatasvir / Voxilaprevir", "Velpatasvir", "Voxilaprevir", "Glecaprevir / Pibrentasvir", "Glecaprevir", "Pibrentasvir"],
      "indication": ["Hepatitis C"],
      "statedClass": ["Direct Acting Antivirals"],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Patients in clinical trials and their treatment: did the prescription support a first-line information tool?",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A167.1",
    "authors": "A Carmona, A Cransac, J Paris, C Brun, L Porcher, M Boulin, C Pernot",
    "institution": "CHU Francois Mitterrand, Pharmacy, Dijon, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.359",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Skin protection and prevention of cutaneous mycosis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A82.1",
    "authors": "C Léger, E Delandre, A Durand, A Chaupin-Prieur, L Caumette",
    "institution": "Centre Hospitalier des Vallées de L’Ariège, Pharmacie, Saint-Jean de Verges, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.181",
    "filters": {
      "actSubs": ["Econazole"],
      "indication": ["Mycosis", "Candidaemia", "Dermatitis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Geriatrics"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Mann-Whitney U Test"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Impact of the electronic prescription in an emergency department",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A167.2",
    "authors": "C Casanova Martínez, A Pérez-Landeiro, L Otero Millán, L Pérez Rodríguez, K Lorenzo Lorenzo, B Leboreiro Enríquez, G Piñeiro Corrales",
    "institution": "Hospital Álvaro Cunqueiro, Servicio Farmacia, Vigo, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.360",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Pharmacist interventions in neonatal intensive care unit and associated cost avoidance and cost savings",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A178.1",
    "authors": "Y Kim, J Rho, Y Suh, K Choi, E Lee, E Lee, CW Choi",
    "institution": "Seoul National University Hospital- Bundang, Department of Pharmacy, Seongnam-si- Gyeonggi-do, South Korea. Seoul National University, College of Pharmacy, Seoul, South Korea",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.383",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Neonatal Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["South Korea"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Biosimilars’ utilisation under hospital pharmacy management policy",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A133.2",
    "authors": "S Poitier, F Machado, A Figueira, B Vandewalle, V Andreozzi, J Félix, J Feio",
    "institution": "Centro Hospitalar e Universitário de Coimbra, Hospital Pharmacy, Coimbra, Portugal. Exigo Consultores, Market Intelligence, Lisbon, Portugal. Exigo Consultores, Quantitative Methods, Lisbon, Portugal. Exigo Consultores, Director, Lisbon, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.287",
    "filters": {
      "actSubs": ["Etanercept", "Infliximab", "Rituximab"],
      "indication": [],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["501 - 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Time to perform medication reconciliation at admission in a neurology unit: comparison between proactive and retroactive processes",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A182.3",
    "authors": "C Dubrou, V Nail, T Horowitz, V Mira, JP Azulay, G Hache",
    "institution": "University Hospitals of Marseille, Pharmacy, Marseille, France. University Hospitals of Marseille, Neurology, Marseille, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.393",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Neurology"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Clinical experience of optimising co-administration therapy of low-dose allopurinol with low-dose thiopurines in inflammatory bowel disease patients attending a virtual pharmacist clinic",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A137.2",
    "authors": "F Fuertes, S Abdel-Aziz, D Bullas",
    "institution": "Barnsley Hospital NHS Foundation Trust, Pharmacy, Barnsley, UK. Barnsley Hospital NHS Foundation Trust, Gastroenterology, Barnsley, UK",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.296",
    "filters": {
      "actSubs": ["Allopurinol", "Azathioprine", "Mercaptopurine"],
      "indication": ["Inflammatory Bowel Disease", "Crohn’s Disease", "Ulcerative Colitis"],
      "statedClass": ["Thiopurines", "Xanthine Oxidase Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["United Kingdom"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "A theoretically based cross-sectional survey on the behaviours and experiences of clinical pharmacists caring for chronic kidney disease patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A159.2",
    "authors": "F Al Raiisi, F Al Raiisi, D Stewart, C Ashley, M Fahmy, S Cunningham",
    "institution": "Robert Gordon University, Pharmacy and Life Sciences, Aberdeen, UK. University College of London, School of Pharmacy, London, UK. Oman College of Health Sciences, Pharmacy College, Muscat, Oman",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.342",
    "filters": {
      "actSubs": [],
      "indication": ["Chronic Kidney Disease", "Anemia", "Mineral and Bone Disorder"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Bristol Online Survey Tool", "Theoretical Domains Framework"],
      "studyLength": [],
      "country": ["United Kingdom"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Cost-minimisation analysis of maintenance therapy of antineutrophil cytoplasm antibody-associated vasculitides",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A124.2",
    "authors": "AB Guisado Gil, M Muñoz Burgos, FJ Bautista Paloma, FJ Garcia Hernandez, B Santos Ramos",
    "institution": "Hospital Universitario Virgen del Rocio, Hospital Pharmacy, Seville, Spain. Hospital Universitario Virgen del Rocio, Internal Medicine, Seville, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.270",
    "filters": {
      "actSubs": ["Rituximab"],
      "indication": ["Vasculitides"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Cost Minimisation Analysis (CMA)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Therapeutic drug monitoring: are we getting it right and optimising therapy?",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A171.3",
    "authors": "P Firman",
    "institution": "Logan Hospital, Pharmacy, Meadowbrook, Australia. The University of Queensland, School of Pharmacy, Woolloongabba, Australia",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.369",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Australia"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Efficacy and safety of anakinra and canakinumab for the treatment of IL-36R antagonist deficiency",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A144.1",
    "authors": "M Sáez-Torres de Vicente, PJ Gómez Arias, J Hernández Parada, J Ruano Ruiz, F Gómez García, B Isla Tejera",
    "institution": "Hospital Reina Sofía, Pharmacy, Córdoba, Spain. Hospital Reina Sofía, Dermatology, Córdoba, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.309",
    "filters": {
      "actSubs": ["Anakinra", "Canakinumab"],
      "indication": ["Deficiency of the Interleukin-36 Receptor Antagonist"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Scoping Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Ceftobiprole in empirical treatment of bone and joint infections: survey of the prescriptions, respect of the protocol and economic evaluation over 6 months",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A90.2",
    "authors": "M Debailleul, J Di Paolo, S Genay, H Dezeque, E Senneville, S Putman, H Migaud, C Loiez, B Decaudin, P Odou",
    "institution": "Institut de Pharmacie- Chu Lille, Nord, Lille, France. Institut de Pharmacie- Chu Lille- Ea 7365 Grita Faculté De Pharmacie- Université Lille, Nord, Lille, France. Centre Hospitalier Lille- Centre de Référence Des Infections Ostéoarticulaires Complexes Crioac- Lille-Tourcoing, Nord, Lille, France. Service Des Maladies Infectieuses- Centre Hospitalier de Dron- Tourcoing- Université de Lille- Lille- Centre De Référence Des Infections Ostéoarticulaires Complexes Crioac- Lille-Tourcoing, Nord, Lille-Tourcoing, France. Clinique D’orthopaédie- Chu de Lille- Université de Lille, Nord, Lille, France. Clinique D’orthopaédie- Chu Lille- Centre de Référence des Infections Ostéoarticulaires Complexes Crioac- Lille-Tourcoing, Nord, Lille, France. Institut de Microbiologie- Chu de Lille – Université de Lille, Nord, Lille, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.198",
    "filters": {
      "actSubs": ["Ceftobiprole", "Daptomycin", "Cefepime"],
      "indication": ["Bone and/or Prosthetic Infections"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["6 months - 1 year"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": ["pharmacogenetics"],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Implementation of an integrated software for clinical trials management and automated preparation of investigational drugs in a hospital pharmacy",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A185.1",
    "authors": "A Ortenzi, MS De Meo, S Leoni, LL Borgiani, M Federici, F Vagnoni, D Paolucci, GB Ortenzi, MC Mosconi, T Terenzi, A Marinozzi",
    "institution": "Ospedali Riuniti Ancona, Hospital Pharmacy, Ancona, Italy. Loccioni Group, Humancare, Ancona, Italy. University of Camerino, Pharmacology, Camerino, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.398",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Gravimetric Analysis", "Photographic Recognition"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": ["personalized"],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Therapeutic drug monitoring of tyrosine kinase inhibitors: key to personalised medicine in oncology",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A156.1",
    "authors": "K Chetouane, I Debrix",
    "institution": "Tenon Hospital, Pharmacy, Paris, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.335",
    "filters": {
      "actSubs": ["Afatinib", "Osimertinib", "Gefitinib", "Erlotinib", "Palbociclib", "Cabozantinib", "Nintedanib", "Pazopanib", "Regorafenib", "Sunitinib"],
      "indication": [],
      "statedClass": ["Tyrosine Kinase Inhibitors", "Anti-Vascular Endothelial Growth Factor Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": ["personalized"],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Place of clinical pharmacist in the management of patients undergoing bariatric surgery",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A191.1",
    "authors": "A Rivet, N Retur, A Mendjel, J Gugenheim, T Dantin, R Collomp",
    "institution": "Centre Hospitalo-Universitaire de Nice, Pharmacy, Nice, France. Centre Hospitalo-Universitaire de Nice, General and Digestive, Nice, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.411",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Oral Anticoagulants", "Antihypertensives", "Vitamin Supplements", "Non-Steroidal Anti-Inflammatory Drugs"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital", "Community Pharmacy"],
      "ward": ["Digestive Surgery"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Study of the use of tapentadol",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A147.1",
    "authors": "MT López Mancha, R Sánchez del Moral, MB Contreras Rey, E Rodríguez Molins, J Estaire Gutiérrez, MM Romero Alonso",
    "institution": "Infanta Elena Hospital, Pharmacy, Huelva, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.316",
    "filters": {
      "actSubs": ["Tapentadol"],
      "indication": ["Chronic Pain Syndrome", "Polyarthritis", "Fibromyalgia", "Migraine", "Parkinson’s Disease"],
      "statedClass": ["Analgesics"],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine", "Orthopaedic Surgery", "Traumatology", "Neurology", "Urology", "Palliative Care"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": ["painManagement"],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Quality of life of patients with moderate-to-severe atopic dermatitis undergoing out-patient treatment with dupilumab",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A85.1",
    "authors": "I Casas Hidalgo, A Rodríguez Delgado, ÁS Raquel, A Madrid Paredes",
    "institution": "Hospital Universitario San Cecilio, Farmacia Hospitalaria, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.187",
    "filters": {
      "actSubs": ["Dupilumab"],
      "indication": ["Dermatitis (Atopic)", "Anxiety", "Depression"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["Less than 10"],
      "numPrescriptions": [],
      "criteriaMethod": ["Dermatology Life Quality Index", "Hospital Anxiety and Depression Scale (HADS)", "Scoring Atopic Dermatitis (SCORAD) Index"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Anticholinergical risk in chronic complex patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A163.3",
    "authors": "ADP Boix Montañés, I Torre Lloveras, O Carrascosa Piquer",
    "institution": "Hospital Espirit Sant, Pharmacy Department, Barcelona, Spain. Hospital Dos de Maig, Pharmacy Department, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.351",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Anticholinergics", "Benzodiazepines", "Antidepressants", "Opioids", "Diuretics", "Antispasmodics (Urinary)", "Corticosteroids"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study", "Cross-Sectional Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": ["101 - 500"],
      "criteriaMethod": ["Anticholinergic Risk Scale", "Anticholinergic Burden Calculator", "Charlson Comorbidity Index", "STOPP/START Criteria"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "The effect of continuation of home medication by hospitalised patients on medication waste and patient satisfaction, a multicentre, quasi-experimental study with a pre-post design",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A199.1",
    "authors": "L Van Herpen-Meeuwissen, B Maat, B Van den Bemt, H Van Onzenoort",
    "institution": "Radboud University Medical Centre, Pharmacy, Nijmegen, The Netherlands. Radboud Institute For Health Sciences, Pharmacy, Nijmegen, The Netherlands. Elisabeth-Tweesteden Hospital, Pharmacy, Tilburg, The Netherlands. Sint Maartenskliniek, Pharmacy, Nijmegen, The Netherlands. Amphia Hospital, Pharmacy, Breda, The Netherlands",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.428",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Quasi-Experimental Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Student's T-test"],
      "studyLength": ["Less than 3 months"],
      "country": ["Netherlands"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": ["homeCare"],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of the degree of adherence to the intravenous treatment of ambulatory patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A183.1",
    "authors": "S Martínez-Pérez, M Llinares Esquerdo, AM Sanchez Garcia, AC Murcia Lopez, L Soriano Irigaray, A Navarro Ruiz",
    "institution": "Hospital General Universitario de Elche, Pharmacy, Elche, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.394",
    "filters": {
      "actSubs": ["Infliximab", "Tocilizumab", "Belimumab"],
      "indication": ["Rheumatoid Arthritis", "Crohn’s Disease", "Systemic Lupus Erythematosus"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Longitudinal Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Hypothesis Testing", "Chi-Square (χ2) Test"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Medication and confusion in acute hospital older patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A180.1",
    "authors": "V Marvin, E Ward, E Whiting",
    "institution": "Chelsea and Westminster Hospital, Pharmacy Dept, London, UK. Imperial College, Medical School, London, UK",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.387",
    "filters": {
      "actSubs": [],
      "indication": ["Confusion"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study", "Cohort Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["United Kingdom"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "The impact of multidisciplinary collaboration in optimising the prescription of antibiotics in a paediatric hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A84.2",
    "authors": "H Attjioui, A Cheikh, M Lazrak, O Hamdaoui, Z Aliat, S Yaniss, A Benomar, H Mefetah, M Bouatia",
    "institution": "Mohammed V University-faculty Of Medicine And Pharmacy Of Rabat, Chis, Rabat, Morocco. Abulcasis University, Faculty of Pharmacy, Rabat, Morocco. Paediatric Hospital, Pharmacy, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.186",
    "filters": {
      "actSubs": ["Ceftazidime", "Imipenem / Cilastatin", "Vancomycin", "Amikacin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Gastroenterology", "Endocrinology", "Neurology", "Neonatal Intensive Care", "Child Intensive Care", "Infectious Disease"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Medication reconciliation and pharmacotherapeutic review in an orthogeriatric unit of a central hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A164.2",
    "authors": "R Branco, S Duque, R Andrade, E Viegas, G Consciência, L Campos, F Falcao",
    "institution": "HSFX – Centro Hospitalar Lisboa Ocidental, Hospital Pharmacy, Lisbon, Portugal. HSFX – Centro Hospitalar Lisboa Ocidental, Orthogeriatric Unit- Internal Medicine, Lisbon, Portugal. Lisbon University, Faculty of Medicine, Lisbon, Portugal. Lisbon University, Faculty of Pharmacy, Lisbon, Portugal. HSFX – Centro Hospitalar Lisboa Ocidental, Ortogeriatric Unit- Orthopaedics, Lisbon, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.353",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Cardiovascular Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Orthogeriatric Unit"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Beers Criteria", "STOPP/START Criteria"],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "A fully integrated clinical trial-like system to manage and monitor persistence in planned hepatitis C treatment",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A108.2",
    "authors": "I Gomes1, A Figueira, C Sequeira, S Ferreira da Silva, F Machado, P Figueiredo, E Rabadão, V Andreozzi, J Félix, J Feio",
    "institution": "Centro Hospitalar e Universitário de Coimbra, Hospital Pharmacy, Coimbra, Portugal. Centro Hospitalar e Universitário de Coimbra, Gastroenterology Department, Coimbra, Portugal. Centro Hospitalar e Universitário de Coimbra, Infectious Disease Department, Coimbra, Portugal. Exigo Consultores, Quantitative Methods, Lisbon, Portugal. Exigo Consultores, Administration, Lisbon, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.235",
    "filters": {
      "actSubs": ["Sofosbuvir"],
      "indication": ["Hepatitis C"],
      "statedClass": ["Direct Acting Antivirals"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["501 - 1000"],
      "numPrescriptions": [],
      "criteriaMethod": ["Kaplan-Meier Method", "Cox Proportional Hazards Regression Analysis", "Pill Count Method"],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Drug cost saving resulting from metastatic melanoma clinical trials",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A121.1",
    "authors": "FJ García Moreno, E González-Haba Peña, MN Sánchez Fresneda, E García Martín, S García Sánchez, B Marzal Alfaro, R Collado Borrell, A Mur Mur, A Herranz Alonso, M Sanjurjo Sáez",
    "institution": "Hospital General Universitario Gregorio Marañón, Pharmacy Department, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.262",
    "filters": {
      "actSubs": [],
      "indication": ["Melanoma"],
      "statedClass": ["Oral Anticancer Drugs", "BRAF Inhibitors", "MEK Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Pharmacoeconomic analysis of the management of gaucher disease in a paediatrics hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A164.1",
    "authors": "H Attjioui, C Adade, Z Aliat, A Cheikh, H Mefetah, M Bouatia",
    "institution": "Mohammed V University-Faculty of Medicine and Pharmacy of Rabat, Chis, Rabat, Morocco. Paediatric Hospital, Pharmacy, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.352",
    "filters": {
      "actSubs": ["Taliglucerase alfa"],
      "indication": ["Gaucher Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Descriptive Study", "Analytical Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["Less than 10"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": ["pharmacoeconomy"],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": ["enzymeSubstrate"],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "How pharmacists can improve patients’ care management in subcutaneous antipsoriatic biologic therapy",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A134.2",
    "authors": "H Benoist, A Dinahet, C Clement, G Saint-Lorant",
    "institution": "Caen University Hospital, Pharmacy, Caen, France. Caen University Hospital, Dermatology, Caen, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.289",
    "filters": {
      "actSubs": [],
      "indication": ["Psoriasis"],
      "statedClass": ["Biologicals"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Dermatology"],
      "numPatients": ["Less than 10"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": ["nursesReccomend"],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Impact of the pharmaceutical recommendations for the improvement in antibiotics prescription",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A99.2",
    "authors": "C Notario Dongil, A Marcos de la Torre, MT Gomez Lluch, M Malañon Pardo, J Martinez Mayordomo, JL Sanchez Serrano, P Araque Arroyo",
    "institution": "Hospital General la Mancha Centro, Hospital Pharmacy Service, Alcazar de San Juan, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.217",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Antibiotics", "Beta-Lactam Antibiotics", "Quinolones", "Aminoglycosides", "Glycopeptides", "Macrolides", "Sulfonamides"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine", "Emergency Department", "Surgical Unit", "Urology", "Oncology", "Haematology", "Digestive Medicine", "Pneumology", "Traumatology", "Intensive Care", "Otorhinolaryngology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": ["deprescribing"],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effectiveness and safety of omalizumab in chronic idiopathic urticaria",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A153.2",
    "authors": "MDP Briceño Casado, MD Gil-Sierra, E Rios-Sanchez, S Fenix-Caballero, M Camean-Castillo, JC Garciadeparedes-Esteban, C Martinez-Diaz, J Diaz-Navarro, EJ Alegre-Del Rey, FJ Salmeron-Navas, JM Borrero-Rubio",
    "institution": "Hospital Universitario Puerto Real, Hospital Pharmacy, Cadiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.330",
    "filters": {
      "actSubs": ["Omalizumab"],
      "indication": ["Urticaria"],
      "statedClass": ["Antihistamines", "Corticosteroids", "Antileukotriene Agents"],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Urticaria Activity Score (UAS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "A simulation pilot study of health optimisation for patients with bipolar disorders: an emerging role for clinical pharmacists as decision coaches",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A195.1",
    "authors": "LM Seljeflot, HD Nguyen, Ø Eiring",
    "institution": "Hospital Pharmacy Enterprise South-Eastern Norway, Hospital Pharmacy Enterprise Gjoevik, Gjoevik, Norway. University of Glasgow, School of Computing Science, Singapore, Singapore. Norwegian Institute of Public Health- Oslo, Innlandet Hospital Trust, Brumunddal, Norway",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.419",
    "filters": {
      "actSubs": [],
      "indication": ["Bipolar Disorder"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Literature Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Norway", "Singapore"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Tolerance to chemoradiotherapy treatment: comparing capecitabine with 5-fluorouracil in neoadjuvant therapy for stage II–III rectal cancer",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A126.2",
    "authors": "L Perez Cordon, S Marin Rubio, J Delgado Rodriguez, T Gurrera Roig, L Campins Bernadas, M Camps Ferrer",
    "institution": "Hospital de Mataro, Pharmacy, Mataro, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.274",
    "filters": {
      "actSubs": ["Capecitabine", "Florourasil (5-FU)"],
      "indication": ["Colorectal Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Prescription of fall-risk-increasing drugs in patients suffering a fall with major lesions during admission at an intermediate care centre",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A170.1",
    "authors": "AM De Andrés, E Romano, M García-Salmones, LM Pérez, M Inzitari",
    "institution": "Parc Sanitari Pere Virgili, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.365",
    "filters": {
      "actSubs": ["Quetiapine"],
      "indication": [],
      "statedClass": ["Cardiovascular Drugs", "Psychotropics", "Non-Steroidal Anti-Inflammatory Drugs", "Opioids", "Anti-Epileptics", "Benzodiazepines"],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": ["101 - 500"],
      "criteriaMethod": ["STATA"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": ["endOfLife"],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Medication counselling by clinical pharmacists in newly grafted renal transplant recipients",
    "url": "CHU Caen, Pharmacy, Caen, France",
    "authors": "A Landry, I Goyer, G Saint-Lorant, M Baudon-Lecame, C Chatron",
    "institution": "CHU Caen, Pharmacy, Caen, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.311",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Nephrology"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Morisky Medication Adherence Scale"],
      "studyLength": ["3 months - 5 months"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Adequacy of the prescription of parenteral nutrition in neonatology",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A157.2",
    "authors": "A Pintado, C Fernandez Cuerva, JJ Alcaraz Sanchez, C Gallego Fernandez, I Muñoz Castillo",
    "institution": "Hospital Regional Universitario Malaga, Farmacia Hospitalaria, Malaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.338",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": ["More than 1000"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Linezolid usage and cost analysis after a hospital transfer",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A188.1",
    "authors": "E Lázaro López, A Rodríguez Ferreras, A Pieras López, L Velasco Roces, A Lozano Blázquez",
    "institution": "Hospital Universitario Central de Asturias, Hospital Pharmacy, Oviedo, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.405",
    "filters": {
      "actSubs": ["Linezolid"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Defined Daily Dose (DDD)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "The effectiveness of enzyme replacement therapy in the management of gaucher disease",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A155.2",
    "authors": "H Attjioui, A Cheikh, Z Aliat, M Lazrak, I Bennani, H Mefetah, M Bouatia",
    "institution": "Mohammed V University-Faculty of Medicine and Pharmacy of Rabat, Chis, Rabat, Morocco. Abulcasis University, Pharmacy, Rabat, Morocco. Paediatric Hospital, Pharmacy, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.334",
    "filters": {
      "actSubs": [],
      "indication": ["Gaucher Disease", "Hepatosplenomegaly", "Haematological Disorder"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["Less than 10"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": ["enzymeSubstrate"],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Impact of pharmaceutical care in the rational use of daptomycin",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A97.1",
    "authors": "B Martin Cruz, M Mañes Sevilla, B Santiago Gallego, B Bertrán de Lis Bartalomé, B Rubio Cebrián, E Maroto Garcia, EP Gomez Caballero, I Soto Baselga, J Solis Olivares, MI Bernias Dominguez, C Moriel Sanchez",
    "institution": "Hospital Universitario de Mostoles, Hospital Pharmacy, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.212",
    "filters": {
      "actSubs": ["Daptomycin"],
      "indication": ["Skin and Soft Tissue Infection", "Bacteraemia", "Endocarditis"],
      "statedClass": ["Statins"],
      "typeOfMedical": [],
      "studyDesign": ["Interventional Study", "Prospective Study", "Longitudinal Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["6 months - 1 year"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effectiveness and safety study of nivolumab in the second line of advanced nonsquamous non-small cell lung cancer",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A118.1",
    "authors": "M Camean-Castillo, C Martinez-Diaz, MD Gil-Sierra, MP Briceño-Casado, FJ Salmeron-Navas, S Fenix-Caballero, J Diaz-Navarro, E Rios-Sanchez, EJ Alegre-Del Rey, JM Borrero-Rubio",
    "institution": "H.U. Puerto Real, Pharmacy, Cádiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.256",
    "filters": {
      "actSubs": ["Nivolumab"],
      "indication": ["Non-Small Cell Lung Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Kaplan-Meier Method"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Adherence of patients receiving antibiotic therapy after hospitalisation",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A98.2",
    "authors": "EE Nagy, N Gyimesi, A Bor, L Fényes, A Süle",
    "institution": "Péterfy Hospital and Trauma Centre, Department of Pharmacy, Budapest, Hungary. Péterfy Hospital and Trauma Centre, Department of Septic Surgery, Budapest, Hungary",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.215",
    "filters": {
      "actSubs": ["Amoxicillin / Clavulanic acid", "Cefuroxime", "Ciprofloxacin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Chi-Square (χ2) Test"],
      "studyLength": [],
      "country": ["Hungary"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": ["telepharmacy"],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Intravenous immunoglobulins use for children’s neurological and neurodevelopmental disorders",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A115.2",
    "authors": "F Bossacoma Busquets, T Lozano Andreu, Na Julia Palacios, J Arrojo Suarez, A Comes Escoda, M Sánchez Celma, A Deya Martinez, L Alsina Manrique de Lara",
    "institution": "Hospital Sant Joan de Déu, Pharmacy, Esplugues de Llobregat, Spain. Hospital de Bellvitge, Pharmacy, Barcelona, Spain. Hospital Sant Joan de Déu, Neurology, Esplugues de Llobregat, Spain. Hospital Sant Joan de Déu, Immunology, Esplugues de Llobregat, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.250",
    "filters": {
      "actSubs": ["Immunoglobulin (IVIg)"],
      "indication": ["Neurodevelopmental Disorders", "Guillain-Barré Syndrome", "Myasthenia Gravis", "Encephalomyelitis", "Epilepsy", "Ataxia Telangiectasia", "Acute Cerebellitis", "Encephalitis", "Hypogammaglobulinaemia", "Opsoclonus Myoclonus Syndrome"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Neurology"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Quality of intratect: in vitro evaluation of biological activities",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A115.1",
    "authors": "C Schmidt, K Winterling, CC Heinz, M König, V Braun, S Kistner, M Germer",
    "institution": "Biotest AG, Translational Research, Dreieich, Germany. Biotest AG, Investigational and Applied Biosciences, Dreieich, Germany. Biotest AG, Bioanalysis, Dreieich, Germany. Biotest AG, Preclinical Research, Dreieich, Germany",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.249",
    "filters": {
      "actSubs": ["Immunoglobulin (IVIg)"],
      "indication": ["Chronic Inflammatory Demyelinating Polyneuropathy"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Germany"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Adequacy of systematic antifungal agent prescriptions in a teaching hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A104.2",
    "authors": "F Barge, C Dubreuil, T Gastinne, J Caillon, I Rouiller-Furic, D Navas, JF Huon",
    "institution": "Nantes Teaching Hospital, Clinical Pharmacy, Nantes, France. Nantes Teaching Hospital, Haematology, Nantes, France. Nantes Teaching Hospital, Bacteriology, Nantes, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.227",
    "filters": {
      "actSubs": [],
      "indication": ["Invasive Fungal Infection"],
      "statedClass": ["Antifungals (Systemic)", "Antifungal Azoles"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Paediatric Haematology – Oncology", "Haematology", "Intensive Care"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": ["51 - 100"],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": ["antibioticProphylaxis"],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of the standard dosage regimen of voriconazole in a paediatric and adult population through therapeutic drug monitoring",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A106.1",
    "authors": "P Boada, P Más-Serrano, R Nald-Molina, A Ramon-Lopez, A Raymundo, S Bernabeu, G Riera, A Pascual, M Díaz-González, J Selva",
    "institution": "Hospital General Universitario de Alicante, Pharmacy Department, Alicante, Spain. Universidad Miguel Hernandez de Alicante, Pharmacy and Biopharmaceutical Division- Faculty of Pharmacy, Alicante, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.230",
    "filters": {
      "actSubs": ["Voriconazole"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": ["antibioticProphylaxis"],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "The piramid study: patients treated by myeloma oral medication have a bad compliance",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A134.1",
    "authors": "N Allaire, JF Huon, P Nizet, C Dubreuil, V Burgeot, I Rouiller, L Flet, M Tching-Sin",
    "institution": "CHU Nantes, Pharmacy, Nantes, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.288",
    "filters": {
      "actSubs": ["Thalidomide", "Lenalidomide", "Pomalidomide"],
      "indication": ["Multiple Myeloma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study", "Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Morisky Medication Adherence Scale", "Univariate Analysis"],
      "studyLength": ["6 months - 1 year"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of adherence to inhaled medications in chronic obstructive pulmonary disease",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A175.1",
    "authors": "D Hachemi, N Bagur, M Knight, C Roux, H Richard, F Dubois",
    "institution": "Pharmacie Caremeau, Gard, Nimes 30029, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.376",
    "filters": {
      "actSubs": [],
      "indication": ["Chronic Obstructive Pulmonary Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Girerd's Questionnaire"],
      "studyLength": ["Less than 3 months"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Estimating the economic impact of pharmacist-led prescription order validation of opioid prescriptions in a tertiary university hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A148.2",
    "authors": "S Wuyts, PJ Cortoos, K Vanhaecht, C Ligneel, H Collier, A Dupont, P Cornu",
    "institution": "UZ Brussel, Pharmacy, Brussels, Belgium. UZ Brussel, Clinical Pharmacology and Pharmacotherapy, Brussels, Belgium. Kuleuven, Leuven Insititute for Healthcare Policy, Leuven, Belgium",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.319",
    "filters": {
      "actSubs": ["Fentanyl", "Hydromorphone", "Methadone", "Morphine", "Oxycodone", "Piritramide"],
      "indication": [],
      "statedClass": ["Opioids"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["More than 1000"],
      "criteriaMethod": ["Sensitivity Analysis"],
      "studyLength": [],
      "country": ["Belgium"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Influence of pharmacological interactions in hepatitis C treatment selection in opiate-dependent patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A114.1",
    "authors": "A Zurutuza, MP Carmona, D García, J Landa, T Gonzalez, P Pascual, G Lopez, L Lombera, C Ripa, MP Bachiller, MJ Gayan",
    "institution": "Donostia University Hospital, Pharmacy, San Sebastian, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.247",
    "filters": {
      "actSubs": ["Glecaprevir / Pibrentasvir", "Glecaprevir", "Pibrentasvir", "Metamizole", "Oxcarbazepine", "Sofosbuvir / Velpatasvir", "Sofosbuvir", "Velpatasvir", "Ethinylestradiol"],
      "indication": ["Hepatitis C"],
      "statedClass": ["Proton-Pump Inhibitors", "Statins", "Antipsychotics", "Protease Inhibitors", "Antiplatelet Agents"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Child–Pugh Score"],
      "studyLength": ["6 months - 1 year"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Value of the clinical pharmacist in the pharmacokinetic monitoring of antimicrobials: health outcomes",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A88.2",
    "authors": "MM Alañon Pardo, MC Conde García, C Notario Dongil, A Marcos de la Torre, D Fraga Fuentes, N Andrés Navarro",
    "institution": "Hospital General Mancha Centro, Pharmacy, Alcázar de San Juan, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.194",
    "filters": {
      "actSubs": ["Vancomycin", "Gentamicin"],
      "indication": ["Urinary Tract Infection", "Osteoarticular Infection"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Bayesian Population Pharmacokinetic Approach"],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": ["antibioticProphylaxis"],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effect of dedicated pharmacist intervention in neurocritical care unit: before and after participating in multidisciplinary rounds",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A192.2",
    "authors": "E Sa1, AJ Kim, Y Cho, EJ Cho, E Lee, R Sandy Jeong",
    "institution": "Seoul National University, Department of Pharmacy, Seoul, South Korea. Ehwa Womans University, Department of Pharmacy, Seoul, South Korea",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.414",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Neurocritical Care Unit", "Intensive Care"],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["South Korea"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effectiveness and safety of nab-paclitaxel in patients with metastatic adenocarcinoma of the pancreas in a real-world setting",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A127.1",
    "authors": "I Plo Seco, P Sanmartin Fenollera, P Roldan Navarro, JJ Martinez Simon, I Oterino Moreira, P Toro Chico, M Perez Encinas",
    "institution": "Hospital Universitario Fundacion Alcorcón, Hospital Pharmacy, Alcorcon, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.275",
    "filters": {
      "actSubs": ["Nab-paclitaxel", "Gemcitabine"],
      "indication": ["Adenocarcinoma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "The primary efficacy endpoint for alirocumab, reductions in low-density lipoprotein cholesterol",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A81.3",
    "authors": "J Polo García, J Preciado Goldaracena, N Larrea Goñi, R de la Riva Bohigas, JA Illodo Becerra, A Rodriguez Esquiroz, M Coma Punset, P Aldave Cobos, B Larrayoz Sola, M Sarobe Carricas",
    "institution": "Complejo Hospitalario de Navarra, Farmacia, Pamplona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.180",
    "filters": {
      "actSubs": ["Alirocumab"],
      "indication": ["Hypercholesterolaemia", "Dyslipidaemia", "Coronary Artery Disease", "Stroke (Ischemic)", "Peripheral Arterial Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Safety and effectiveness of obinutuzumab in chronic lymphocytic leukaemia: our experience",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A119.2",
    "authors": "C Fernandez Cuerva, C Ortega de la Cruz, JC del Rio Valencia, B Mora Rodriguez, I Muñoz Castillo",
    "institution": "Hospital Regional Universitario de Málaga, Servicio de Farmacia, Málaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.259",
    "filters": {
      "actSubs": ["Obinotuzumab", "Chlorambucil", "Allopurinol"],
      "indication": ["Leukaemia (Chronic Lymphocytic)"],
      "statedClass": ["Corticosteroids", "Antipyretics", "Antihistamines"],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["Less than 10"],
      "numPrescriptions": [],
      "criteriaMethod": ["Cumulative Illness Rating Scale (CIRS)", "Common Terminology Criteria for Adverse Events"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Experience of dual targeting use of neoadjuvant HER2-positive breast cancer",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A123.2",
    "authors": "E Mateos Egido, AM Álamo Medina, M Lombardero Pin, ME Luján Lopez, D Fernandez Vera",
    "institution": "Complejo Hospitalario Universitario Insular-Materno Infantil, Pharmacy, Las Palmas de Gran Canaria, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.267",
    "filters": {
      "actSubs": ["Pertuzumab", "Trastuzumab", "Paclitaxel", "Florourasil (5-FU)", "Epirubicin", "Cyclophosphamide", "Carboplatinum", "Docetaxel"],
      "indication": ["Breast Cancer (HER2 Positive)"],
      "statedClass": ["Taxanes"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Eastern Cooperative Oncology Group (ECOG) Performance Status", "Miller-Payne Criteria (MPC)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": ["radiopharmaceuticals"],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "The impact of a ward-based pharmacy technician service",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A179.1",
    "authors": "E Lynch, J O’Fynn, C O’Riordan, C Bogue, D Lynch, S McCarthy, K Murphy",
    "institution": "University College Cork, School of Pharmacy, Cork, Ireland. University College Cork and Cork University Hospital, School of Pharmacy and Pharmacy Department, Cork, Ireland. Cork University Hospital, Pharmacy Department, Cork, Ireland",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.385",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Ireland"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": ["highRisk"],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Acculturation of prescribers to recommendations on the management of clostridium difficile infections two years’ after an antimicrobial stewardship programme in a university hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A163.2",
    "authors": "H Benoist, A Flatres, G Saint-Lorant",
    "institution": "Caen University Hospital, Pharmacy, Caen, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.350",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Antibiotics", "Proton-Pump Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Teriflunomide and dimethylfumarate in patients with relapsing-remitting multiple sclerosis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A132.1",
    "authors": "S Izquierdo Munoz, AM López Gónzalez, ME Cárdaba García, L Enriquez Olivar, E Queipo García, MT Sánchez Sánchez",
    "institution": "Hospital Clínico Universitario de Valladolid, Servicio de Farmacia, Valladolid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.284",
    "filters": {
      "actSubs": ["Teriflunomide", "Dimethylfumarate", "Interferon Beta", "Glatiramer acetate"],
      "indication": ["Multiple Sclerosis"],
      "statedClass": ["Immune-Modulators"],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Observational Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Creation of an innovative and attractive training programme for prescribers to promote the correct use of fluoroquinolones",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A103.1",
    "authors": "F Theron1, S Carret, S Ley, JY Chastenet, S Ousseini, J Niel",
    "institution": "Centre Hospitalier D’Ussel, Pharmacie, Ussel, France. Centre Hospitalier D’Ussel, Service Maladies Infectieuses, Ussel, France. Centre Hospitalier D’Ussel, Qualite et Gestion Des Risques, Ussel, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.224",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Quinolones"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": ["mobileVR"],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "A revision of prescribing pump inhibitor prescriptions in internal medicine and addictology department",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A68.1",
    "authors": "C Bons, J Renaud, L Langlumé, A Le Quellec, I Bertchansky, D Rosant, C Breuker, I Roch-Torreilles",
    "institution": "CHU Montpellier, Pharmacy Centre, Montpellier, France. CHU Montpellier, Internal Medicine, Montpellier, France. CHU Montpellier, Addictology, Montpellier, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.150",
    "filters": {
      "actSubs": ["Acetylsalicylic acid"],
      "indication": ["Ulcer (Peptic)", "Gastroesophageal Reflux"],
      "statedClass": ["Proton-Pump Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine", "Addictology"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Comparative analysis of effectiveness between a patient-controlled analgesia morphine device and a sublingual sufentanil tablet system",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A148.1",
    "authors": "D Serrano, S Roig, J Fernandez, P Alonso",
    "institution": "Pharmcist, Hospital Pharmacy – Centro Medico Teknon, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.318",
    "filters": {
      "actSubs": ["Morphine", "Sufentanil"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Sublingual Sufentanil Tablet System", "Patient Controlled Analgesia Morphine Device"],
      "studyDesign": ["Observational Study", "Prospective Study", "Comparative Study"],
      "setting": ["Hospital"],
      "ward": ["Neurosurgery", "Gynaecology"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Visual Analogue Scale", "Statistical Package for the Social Sciences (SPSS)", "Student's T-test", "Mann-Whitney U Test"],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": ["painManagement"],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Palbociclib combined with hormonal therapy for metastatic breast cancer treatment",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A129",
    "authors": "F Sanchez Rubio, MV Lerma Gaude, M Diaz Rangel, J Marco del Rio, E Adrover Cebrian, A Valladolid Walsh",
    "institution": "Complejo Hospitalario Universitario de Albacete, Pharmacy, Albacete, Spain. Complejo Hospitalario Universitario de Albacete, Oncology, Albacete, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.279",
    "filters": {
      "actSubs": ["Palbociclib"],
      "indication": ["Breast Cancer (HR Positive / HER2 Negative Metastatic)"],
      "statedClass": ["Cyclin-Dependent Kinases 4/6 Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Eastern Cooperative Oncology Group (ECOG) Performance Status", "Response Evaluation Criteria In Solid Tumours (RECIST)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Use of prohemostatic drugs in massive haemorrhage episodes",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A163.1",
    "authors": "N Báez, M Alonso Moreno, H Rodríguez Ramallo, MD Rincon Ferrari, V Orellana, M Muñoz Burgos, JL Pérez Blanco",
    "institution": "Hospital Universitario Virgen del Rocío, Pharmacy, Seville, Spain. Hospital Universitario Virgen del Rocío, Intensive Care Unit, Seville, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.349",
    "filters": {
      "actSubs": ["Fibrinogen", "Tranexamic acid", "Prothrombin complex concentrate"],
      "indication": ["Haemorrhage"],
      "statedClass": ["Prohemostatic Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Tumour necrosis factor inhibitors: utility of pharmacokinetics monitoring in inflammatory bowel disease management",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A142.2",
    "authors": "M Llinares, S Martinez Perez, M Pomares Bernabeu, L Soriano Irigaray, A Garcia Monsalve, A Navarro Ruiz",
    "institution": "Hospital General Universitario de Elche, Hospital Pharmacist, Elche, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.306",
    "filters": {
      "actSubs": ["Infliximab", "Adalimumab"],
      "indication": ["Inflammatory Bowel Disease", "Crohn’s Disease", "Ulcerative Colitis"],
      "statedClass": ["Tumor Necrosis Factor (TNF) Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Bayesian Population Pharmacokinetic Approach"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Antimicrobial point prevalence survey",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A184.2",
    "authors": "M Nunez-Nunez, F Anguita-Santos, R Alvarez-Sanchez, I Vallejo",
    "institution": "Hospital San Cecilio, Pharmacy, Granada, Spain. Hospital San Cecilio, Infectious Diseases, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.397",
    "filters": {
      "actSubs": ["Amoxicillin / Clavulanic acid"],
      "indication": ["Urinary Tract Infection", "Pneumonitis", "Skin and Soft Tissue Infection"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": ["antibioticProphylaxis"],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Lidocaine 5% plaster: is it worth the pain?",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A146.2",
    "authors": "M Chouchana, E Moutel, E Ducret, O Chauvel, F Plassart, JL Pons",
    "institution": "Centre Hospitalier Victor Dupouy, Pharmacy, Argenteuil, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.314",
    "filters": {
      "actSubs": ["Lidocaine hydrochloride"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Palliative Care", "Geriatrics"],
      "numPatients": [],
      "numPrescriptions": ["101 - 500"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": ["painManagement"],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Does antibiotic consumption predict the incidence density of healthcare-associated infections?",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A100.2",
    "authors": "A Peric1, S Vezmar Kova&ccaron;evi&ccaron;2, B Milenkovi&ccaron;3, V Šuljagi&ccaron;4",
    "institution": "Military Medical Academy – Faculty of Medicine, Sector of Pharmacy, Belgrade, Serbia. Faculty of Pharmacy- University of Belgrade, Department of Pharmacokinetics and Clinical Pharmacy, Belgrade, Serbia. Military Medical Academy, Sector of Pharmacy, Belgrade, Serbia. Military Medical Academy- Medical Faculty, Department of Healthcare-Related Infection Control, Belgrade, Serbia",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.219",
    "filters": {
      "actSubs": [],
      "indication": ["Healthcare-Associated Infections"],
      "statedClass": ["Cephalosporins", "Aminoglycosides", "Quinolones", "Carbapenems", "Glycopeptides"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Defined Daily Dose (DDD)"],
      "studyLength": [],
      "country": ["Serbia"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Collaboration with the ophthalmology service in a public residential care home",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A154.2",
    "authors": "MB de-la-Nogal-Fernandez1, P Soler-Bartrina2, AV Sanchez-Ferreiro2, BC Lopez-Virtanen3, SDC Vazquez-Troche3, J Valdueza-Beneitez3, V Martinez-Fernandez3, M Noguerol-Cal3, H Casas-Agudo3, M Rodriguez-Maria3, R Mitchell4",
    "institution": "Hospital El Bierzo, Hospital Pharmacy, Ponferrada, Spain. Hospital El Bierzo, Servicio de Oftalmologia, Ponferrada, Spain. Hospital El Bierzo, Servicio de Farmacia, Ponferrada, Spain. Hospital del Bierzo, Fisioterapia, Ponferrada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.332",
    "filters": {
      "actSubs": ["Tobramycin", "Dexamethasone", "Diclofenac", "Latanoprost", "Hyoscine", "Tolterodine", "Hydroxyzine", "Topiramate"],
      "indication": ["Glaucoma", "Cataract"],
      "statedClass": ["Carbonic Anhydrase Inhibitors", "Alpha 1 Adrenergic Receptor Antagonists", "Beta-Blockers", "Prostaglandin Analogues", "Lubricants", "Anticholinergics", "Antidepressants", "Antipsychotics"],
      "typeOfMedical": [],
      "studyDesign": ["Transversal Study"],
      "setting": ["Hospital"],
      "ward": ["Ophthalmology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": ["endOfLife"],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Analysis of intra-patient variability of plasmatic levels of tacrolimus in early maintenance of renal post-transplant",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A138.1",
    "authors": "S Garcia Garcia, DS Oleas Vega, MB Aller Hernández, I Torres Rodriguez, BO Chamoun Huacón, E Pericas Bosch, JB Montoro Ronsano",
    "institution": "Vall d’Hebron Hospital, Pharmacy Service, Barcelona, Spain. Vall d’Hebron Hospital, Nephrology Service, Barcelona, Spain. Vall d’Hebron Hospital, Artificial Intelligence Information Service, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.297",
    "filters": {
      "actSubs": ["Tacrolimus"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Fisher–Snedecor F Distribution", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of the safety of inhibitors of the co-transporter 2 in a university care hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A71.2",
    "authors": "A Peláez Bejarano, E Sanchez Gomez, O Montero Pérez, P Selvi Sabater",
    "institution": "Hospital Juan Ramón Jiménez, Servicio Farmacia Hospitalaria, Huelva, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.158",
    "filters": {
      "actSubs": ["Canagliflozin", "Empagliflocin", "Dapagliflozin"],
      "indication": ["Diabetes Type II (Mellitus)"],
      "statedClass": ["Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine", "Cardiology"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Karch-Lasagna Modified Algorithm"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Avoid simultaneus prescription between linezolid and voriconazole: pharmacokinetic study",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A94.2",
    "authors": "AI Idoate, L Leache, A Aldaz",
    "institution": "Clinica Universitaria de Navarra, Pharmacy, Pamplona, Spain. Servicio Navarro de Salud, Pharmacy, Pamplona, Spain. Clinica Universidad de Navarra, Pharmacy, Pamplona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.207",
    "filters": {
      "actSubs": ["Linezolid", "Voriconazole"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": ["Less than 10"],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Palatability assessment of oral medication",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A183.2",
    "authors": "Ye Nisse, S Robert, J Wicky, S Henn-Ménétré, B Demoré",
    "institution": "Chru Nancy, Pharmacy, Vandoeuvre-Lès-Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.395",
    "filters": {
      "actSubs": ["Naftidrofuryl", "Febuxostat"],
      "indication": [],
      "statedClass": ["Antidepressants"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Palatability Score"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Dose banding – optimising doses in cetuximab or bevacizumab regimens",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A123.1",
    "authors": "S Machado, G Cainé, N Landeira, M Pereira",
    "institution": "Hospital Espírito Santo Évora- EPE, Pharmacy, Évora, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.266",
    "filters": {
      "actSubs": ["Cetuximab", "Bevacizumab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Oncology"],
      "numPatients": [],
      "numPrescriptions": ["501 - 1000"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": ["flatDoses"],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Health- related quality of life in multiple sclerosis patients treated with disease-modifying therapies",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A131.2",
    "authors": "AM Horta Hernandez, M Blanco Crespo, A Yusta Izquierdo, B Escalera Izquierdo",
    "institution": "Guadalajara University Hospital, Pharmacy Department, Guadalajara, Spain. Guadalajara University Hospital, Neurology Department, Guadalajara, Spain. Pharmacy School Alcalá University, Pharmaceutical Technology Department, Alcalá de Henares, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.283",
    "filters": {
      "actSubs": ["Natalizumab", "Fingolimod", "Dimethylfumarate", "Teriflunomide", "Interferon", "Glatiramer acetate"],
      "indication": ["Multiple Sclerosis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Health-Related Quality of Life (HRQOL)", "Physical Health Composite Score (PCS)", "Mental Health Composite Score (MCS)", "Expanded Disability Status Scale", "Multiple Sclerosis Quality of Life-54 Questionnaire", "Wilcoxon Signed Rank Test", "Student's T-test", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": ["6 months - 1 year"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Assessment of aggressive care in oncology patients at the end of life in clinical practice",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A120.2",
    "authors": "E García Martín, V Escudero Vilaplana, R Collado Borrell, E González-Haba Peña, B Marzal Alfaro, B Fox, Á Hoyo Muñoz, PA Martínez Ortega, MÁ Amor García, A Herranz Alonso, M Sanjurjo Saéz",
    "institution": "General University Hospital Gregorio Marañon, Pharmacy Department, Madrid, Spain. General University Hospital Gregorio Marañon, Oncology Department, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.261",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Antineoplastic Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Longitudinal Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["STATA"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": ["endOfLife"],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Impact of a team of clinical pharmacists in a paediatric surgery unit: results after 6 months",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A189.1",
    "authors": "AS Remoué Fanuel, C Louet, D Navas, JF Huon, J Mocquard, E Corbineau",
    "institution": "CHU Nantes, Pharmacy, Nantes, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.407",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Nervous System Drugs", "Respiratory System Drugs", "Anti-Infective Drugs"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Paediatric Surgery"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["6 months - 1 year"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Screening for painful diabetic neuropathy",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A166.1",
    "authors": "R Bs, H Ghada, S Yasmine, K Mohamed Amine, D Mehdi, Y Mohamed Ali",
    "institution": "Military Hospital Hmpit Tunis, Internal Pharmacy, Tunis, Tunisia. Faculty of Pharmacy, Department of Pharmacology, Monastir, Tunisia",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.356",
    "filters": {
      "actSubs": ["Metformin"],
      "indication": ["Neuropathy (Peripheral)", "Diabetes Type II (Mellitus)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Analytical Study"],
      "setting": ["Hospital"],
      "ward": ["Endocrinology"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["DN4 Assessment Tool"],
      "studyLength": ["Less than 3 months"],
      "country": ["Tunisia"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Are patients and healthcare professionals willing to exchange the price of treatments to choose a biosimilar? experience based on the delphi method",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A194.2",
    "authors": "C Gary, A Schiavon De Jodar, T Deljehier, F Xuereb, K Bouabdallah, A Pigneux, N Milpied, D Breilh",
    "institution": "University Hospital of Bordeaux, Pharmacy and Haematology, Pessac, France. University Hospital of Bordeaux, Pharmacy, Pessac, France. University Hospital of Bordeaux, Haematology, Pessac, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.418",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Haematology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Delphi Method"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Impact of pharmaceutical interventions in parenteral nutrition",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A165.2",
    "authors": "M Brito, A Alcobia",
    "institution": "Hospital Garcia de Orta, Pharmacy, Almada, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.355",
    "filters": {
      "actSubs": [],
      "indication": ["Refeeding Syndrome", "Catheter Associated Infections"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": ["101 - 500"],
      "criteriaMethod": ["Harris Benedict Equation"],
      "studyLength": ["6 months - 1 year"],
      "country": ["Portugal"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": ["nursesReccomend"],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Impact of medication reconciliation in patients on admission to an expert centre for parkinson’s disease",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A149.2",
    "authors": "V Nail, C Dubrou, M Dulac, JP Azulay, G Hache",
    "institution": "University Hospitals of Marseille, Pharmacy, Marseille, France. University Hospitals of Marseille, Neurology, Marseille, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.321",
    "filters": {
      "actSubs": [],
      "indication": ["Parkinson’s Disease"],
      "statedClass": ["Nervous System Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["More than 1 year - 2 years"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": ["history"]
    }
  },
  {
    "title": "Evaluation of exit prescriptions using computerised provider order-entry system for outpatients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A156.2",
    "authors": "M Abbes, J Nakab, S Berdah, F Bernard, P Rossi, N Colombini",
    "institution": "Hôpital Nord de Marseille, Pharmacie à Usage Intérieur, Marseille, France. Hôpital Nord de Marseille, Chirurgie Digestive, Marseille, France. Hôpital Nord de Marseille, Médicine Interne et Gériatrie, Marseille, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.336",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Digestive Surgery", "Internal Medicine", "Geriatrics"],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": ["history"]
    }
  },
  {
    "title": "Antifibrotics in idiopathic pulmonary fibrosis management: pirfenidone and nintedanib",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A125.2",
    "authors": "M Muñoz Burgos, M Mejias Trueba, T Desongles Corrales",
    "institution": "Hospital Universitario Virgen del Rocio, Hospital Pharmacy, Seville, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.272",
    "filters": {
      "actSubs": ["Pirfenidone", "Nintedanib"],
      "indication": ["Fibrosis (Pulmonary)"],
      "statedClass": ["Antifibrotics"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": ["history"]
    }
  },
  {
    "title": "Choosing the right wound dressing for the right pressure ulcer: the development of a colour-based chart helping healthcare providers",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A166.2",
    "authors": "E Calzavara, L Gambitta, E Galfrascoli, P Richelmi, MLA Medaglia",
    "institution": "ASST Fatebenefratelli-Sacco- P.O. Fatebenefratelli e oftalmico, Pharmacy Unit, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.357",
    "filters": {
      "actSubs": [],
      "indication": ["Ulcer (Pressure)"],
      "statedClass": [],
      "typeOfMedical": ["Wound Dressings"],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": ["nursesReccomend"],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of knowledge of patients with inflammatory bowel disease treated by the reference product concerning biosimilars: role of clinical pharmacists",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A135.2",
    "authors": "E Coget1, P Laffont-Lozes, V Velasco Gonzalvo1, D Huc, G Pineton de Chambrun, R Altwegg, P Blanc, GP Pageaux, D Rosant, C Breuker",
    "institution": "CHU Saint-Eloi, Pharmacy, Montpellier, France. CHU Saint-Eloi, Gastroenterology, Montpellier, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.292",
    "filters": {
      "actSubs": [],
      "indication": ["Inflammatory Bowel Disease", "Crohn’s Disease", "Ulcerative Colitis"],
      "statedClass": ["Biosimilars", "Monoclonal Antibodies"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Gastroenterology"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["6 months - 1 year"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Economic impact over the past 4 years associated with biological therapy optimisation in rheumatic diseases patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A134.3",
    "authors": "I Cavada Carranza, FJ Alonso-Zazo, ME Martínez-Núñez, R Vázquez-Sánchez, J Sánchez-Rubio-Ferrández, Á Aragón-Díez, JM Rodríguez-Heredia, T Molina-García",
    "institution": "Hospital Universitario de Getafe, Pharmacy Department, Madrid, Spain. Hospital Universitario de Getafe, Rheumatology Department, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.290",
    "filters": {
      "actSubs": ["Abatacept", "Adalimumab", "Certolizumab", "Etanercept", "Golimumab", "Secukinumab", "Tocilizumab", "Ustekinumab"],
      "indication": ["Rheumatoid Arthritis", "Spondyloarthropathy", "Psoriatic Arthropathy"],
      "statedClass": ["Biologicals"],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": ["501 - 1000"],
      "criteriaMethod": ["Disease Activity Score-28 (DAS28) for Rheumatoid Arthritis", "Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effectiveness of meropenem treatment in critical patients: pharmacokinetic study",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A95.1",
    "authors": "AI Idoate, A Aldaz",
    "institution": "Clinica Universitaria de Navarra, Pharmacy, Pamplona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.208",
    "filters": {
      "actSubs": ["Meropenem"],
      "indication": [],
      "statedClass": ["Carbapenems"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study", "Cohort Study"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Pharmacokinetic / Pharmacodynamic (PK/PD) Efficacy Index", "Sawchuk – Zaske Method", "STATA", "Propensity Score Matching"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": ["safetyProfile"],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "An evaluation of a pharmacist-managed paediatric toxicology consultation service",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A175.2",
    "authors": "A Higazy, O Alsoukhni, S Aly",
    "institution": "Hamad Medical Corporation, Pharmacy, Doha, Qatar",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.377",
    "filters": {
      "actSubs": ["Paracetamol", "Charcoal"],
      "indication": [],
      "statedClass": ["Vitamin Supplements"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Paediatric Emergency Centre"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Descriptive Statistics"],
      "studyLength": [],
      "country": ["Qatar"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Analysis of clinical pharmacist interventions carried out in an intensive care unit",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A191.2",
    "authors": "T Rodríguez Martínez, V Dominguez Leñero, MA Meroño Saura, A Gómez Gil, S Clavijos Bautista, M Pascual Barriga, C Fernández Zamora, T Alonso Domínguez, M Soria Soto, J Sánchez Lucas",
    "institution": "Hospital Universitario Morales Meseguer, Servicio de Farmacia, Murcia, Spain. Hospital Universitario Los Arcos del Mar Menor, Servicio de Farmacia, Murcia, Spain. Hospital Universitario Morales Meseguer, Servicio de Medicina Interna, Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.412",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Anti-Infective Drugs", "Cardiovascular Drugs", "Blood and Haematopoietic Derivatives"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": ["safetyProfile"],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Evaluation of health outcomes of daratumumab in monotherapy in adult patients with relapsed refractory multiple myeloma",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A116.2",
    "authors": "C Alarcon-Payer, JE Martínez-de la Plata, S Cano Domínguez, ME Clavero Sánchez, R Ríos Tamayo, M Jurado Chacón, A Jiménez Morales",
    "institution": "Hospital Universitario Virgen de las Nieves, Servicio de Farmacia, Granada, Spain. Hospital Universitario Virgen de las Nieves, Servicio de Haematología, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.252",
    "filters": {
      "actSubs": ["Daratumumab", "Montelukast"],
      "indication": ["Multiple Myeloma"],
      "statedClass": ["Proteasome Inhibitors", "Immune-Modulators"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["More than 2 years - 5 years"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Mapping antibiotic use patterns in a septic orthopaedic ward",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A93.3",
    "authors": "N Gyimesi, A Bor, L Fényes, A Dobák, A Süle",
    "institution": "Péterfy Hospital and Trauma Centre, Department of Pharmacy, Budapest, Hungary. Péterfy Hospital and Trauma Centre, Septic Orthopaedic Ward, Budapest, Hungary. Péterfy Hospital and Trauma Centre, Department of Microbiology, Budapest, Hungary",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.205",
    "filters": {
      "actSubs": ["Amoxicillin / Clavulanic acid", "Cefuroxime", "Ciprofloxacin", "Clindamycin", "Ceftriaxone", "Vancomycin", "Linezolid", "Tigecycline"],
      "indication": [],
      "statedClass": ["Antibiotics (Systemic)", "Beta-Lactam Antibiotics"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Septic Orthopaedic", "Microbiology Department"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Defined Daily Dose (DDD)", "Prescribed Daily Dose (PDD)"],
      "studyLength": [],
      "country": ["Hungary"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Chemotherapy treatment in colorectal cancer patients older than 70 years at a tertiary hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A116.3",
    "authors": "JJ Alcaraz Sanchez, JC del Río Valencia, R Tamayo Bermejo, I Muñoz Castillo",
    "institution": "Hospital Regional Universitario de Málaga, Hospital Pharmacy, Málaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.253",
    "filters": {
      "actSubs": ["Oxaliplatinum", "Capecitabine", "Florourasil (5-FU)", "Calcium Folinate", "Cetuximab", "Bevacizumab", "Irinotecan"],
      "indication": ["Colorectal Cancer"],
      "statedClass": ["Epidermal Growth Factor Receptor (EGFR) Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Eastern Cooperative Oncology Group (ECOG) Performance Status"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Rituximab use in children, a single hospital experience",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A158.1",
    "authors": "M Pallares Borras, A Comes Escoda, F Bossacoma Busquets, AD Madrid Aris, M Sánchez Celma, J Arrojo Suarez, J Vinent Genestar, A Martínez Deyà, L Alsina Manrique de Lara",
    "institution": "Hospital Sant Joan de Déu, Pharmacy, Esplugues de Llobregat, Spain. Hospital Sant Joan de Déu, Nephrology, Esplugues de Llobregat, Spain. Hospital Sant Joan de Déu, Clinical Immunology, Esplugues de Llobregat, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.339",
    "filters": {
      "actSubs": ["Rituximab"],
      "indication": ["Nephrotic Syndrome", "Lymphoma (non-Hodgkin)", "Neuroblastoma", "Anemia (Hemolytic)", "Leukaemia", "Hemophagocytic Syndrome", "Thrombocytopenic Purpura", "Juvenile Idiopathic Arthritis", "Systemic Lupus Erythematosus", "Vasculitides", "Encephalitis", "Epstein-Barr Virus Infection", "Stevens–Johnson Syndrome"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Nephrology", "Oncology", "Haematology", "Rheumatology", "Neurology", "Infectious Disease"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Multi-state model to estimate the optimal duration of first-line chemotherapy in advanced gastric cancer: data from the national registry agamenon",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A117.2",
    "authors": "A Arias, FJ Alvarez Manceñido, AM Martínez Torrón, A Rodriguez Palomo, MÁ Alaguero Calero, G Aguado, M Sánchez Cánovas, N Martínez Lago, C Hernández Pérez, A Lozano-Blázquez",
    "institution": "Hospital Universitario Central de Asturias, Hospital Pharmacy, Oviedo, Spain. Hospital Universitario Gregorio Marañon, Medical Oncology, Madrid, Spain. Hospital Universitario Morales Meseguer, Medical Oncology, Murcia, Spain. Complejo Hospitalario Universitario de A Coruña, Medical Oncology, A Coruña, Spain. Hospital Universitario Nuestra Señora de Candelaria, Medical Oncology, Santa Cruz de Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.255",
    "filters": {
      "actSubs": ["Platin"],
      "indication": ["Gastric Cancer"],
      "statedClass": ["Fluoropyrimidines"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Multi-State Markov Model", "Aalen - Johansen Estimator"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Impact of implementing a global collaborative physician-pharmacist strategy on prophylactic antibiotic practices in a university hospital centre",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A100.1",
    "authors": "A Pardo, R Demeester, M Rivolta, M Joris, S Stenuit",
    "institution": "Marie Curie Civil Hospital – Chu Charleroi, Pharmacy, 6042 Lodelinsart, Belgium. Marie Curie Civil Hospital – Chu Charleroi, Infectious Diseases, 6042 Lodelinsart, Belgium. University of Mons, Mathematics, 7000 Mons, Belgium. Marie Curie Civil Hospital – Chu Charleroi, Cardiothoracic Surgery, 6042 Lodelinsart, Belgium",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.218",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Penicillins"],
      "typeOfMedical": [],
      "studyDesign": ["Quasi-Experimental Study", "Retrospective Study", "Observational Study", "Transversal Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Multivariate Analysis", "Wald Test", "Chi-Square (χ2) Test", "Student's T-test", "Welch's T-Test"],
      "studyLength": [],
      "country": ["Belgium"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": ["antibioticProphylaxis"],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Is there still a place for chloral hydrate syrup in hospital?",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A146.3",
    "authors": "O El Hamdaoui, A Raghani, A Rhars, Y Elalaoui, Y Bensouda",
    "institution": "Faculty of Medicine and Pharmacy- Mohammed V University- Rabat- Morocco, Hospital Pharmacy- Specialty Hospital, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.315",
    "filters": {
      "actSubs": ["Chloral Hydrate", "Midazolam"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": ["pharmacoeconomy"],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Scoping review on the use of canakinumab and anakinra in interleukin-1 antagonist receptor deficiency",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A144.2",
    "authors": "J Hernandez Parada, JA Ruano Ruiz, M Sáez-Torres de Vicente, PJ Gómez Arias, F Gómez García, B Isla Tejera",
    "institution": "Reina Sofía University Hospital, Departmen of Pharmacy, Córdoba, Spain. Reina Sofía University Hospital/University of Cordoba, Department of Dermatology/Immune-Mediated Inflammatory Skin Diseases Group, Córdoba, Spain. Reina Sofía University Hospital, Deparment of Pharmacy, Córdoba, Spain. Reina Sofía University Hospital/University of Cordoba, Department of Pharmacy/Immune-Mediated Inflammatory Skin Diseases Group, Córdoba, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.310",
    "filters": {
      "actSubs": ["Canakinumab", "Anakinra", "Acitretin", "Methotrexate", "Cyclosporine", "Immunoglobulin (IVIg)", "Azathioprine", "Thalidomide", "Etanercept"],
      "indication": ["Deficiency of the Interleukin-1 Receptor Antagonist"],
      "statedClass": ["Interleukin-1 Receptor Antagonists", "Corticosteroids", "Antibiotics", "Antifungals", "Immune-Modulators"],
      "typeOfMedical": [],
      "studyDesign": ["Scoping Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Impact of hospital-city communication based on the multiprofessional and collaborative development of the discharge letter on the continuity of patients’ medication management-city study",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A172.1",
    "authors": "L Geneletti, S Chanoine, M Lugosi, B Allenet, L Bouilet, P Bedouch, A Deroux",
    "institution": "Grenoble University Hospital, Internal Medicine Unit, Grenoble, France. Grenoble University Hospital, Pharmacy Department, Grenoble, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.370",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Cluster Randomized Trials"],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Sensitivity Analysis", "STOPP/START Criteria"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Safety profile of apremilast in psoriasis and psoriatic arthritis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A142.1",
    "authors": "I Mendoza Acosta, M Blanco Crespo, M Torralba Gonzalez de Suso, AM Horta Hernandez",
    "institution": "Guadalajara University Hospital, Pharmacy Department, Guadalajara, Spain. Guadalajara University Hospital, Research Department, Guadalajara, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.305",
    "filters": {
      "actSubs": ["Apremilast", "Methotrexate", "Acitretin", "Cyclosporine", "Adalimumab", "Etanercept"],
      "indication": ["Psoriasis", "Psoriatic Arthropathy"],
      "statedClass": ["Biologicals"],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Dabrafenib and trametinib: combination therapy for metastatic melanoma",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A118.2",
    "authors": "C Carriles Fernandez, A Arias, C Rosado María, I Zapico García, B Zarate Tamames, R Menárguez Blanc, A Lozano-Blázquez",
    "institution": "Hospital Universitario Central de Asturias, Pharmacy, Oviedo, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.257",
    "filters": {
      "actSubs": ["Dabrafenib", "Trametinib"],
      "indication": ["Melanoma"],
      "statedClass": ["BRAF Inhibitors", "MEK Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Kaplan-Meier Method", "STATA"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": ["pharmacogenetics"],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of pharmacists’ input in anticoagulation clinic reviewing direct oral anticoagulants initiated in a secondary care hospital in london",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A75.1",
    "authors": "A Grover, P Wright, S Antoniou, C Jagjot",
    "institution": "Barts Health NHS Trust, Cardiology- Pharmacy, London, UK",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.166",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Direct Oral Anticoagulants"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Cockcroft–Gault Creatinine Clearance"],
      "studyLength": [],
      "country": ["United Kingdom"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Interactions between alternative therapies and products in clinical trial in onco-haematology",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A130.2",
    "authors": "A Toulemonde, C Bensoussan, C Davoine, F Cartier, I Madelaine",
    "institution": "Hôpital St. Louis, Pharmacy, Paris, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.281",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Herbal Medicines", "Oral Anticancer Drugs"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Haematology", "Onco-Dermatology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Retreatment of patients with hepatitis C virus infection after virological failure to direct-acting antivirals",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A110.1",
    "authors": "C Burgui, R Juanbeltz, J Castilla, B Larrayoz, M Sarobe, A Perez, A Aguinaga, Jm Zozaya, M Gracia-Ruiz de Alda, R San Miguel",
    "institution": "Ciber Epidemiologia y Salud Publica Ciberesp, Hospital Pharmacy, Pamplona, Spain. Instituto de Salud Publica de Navarra-Idisna-Ciber Epidemiología y Salud Pública Ciberesp, Transmissible Disease and Vaccination, Pamplona, Spain. Navarra Hospital Complex-Idisna, Hospital Pharmacy, Pamplona, Spain. Navarra Hospital Complex-Ciber Epidemiología Y Salud Pública Ciberesp, Microbiology, Pamplona, Spain. Navarra Hospital Complex, Microbiology, Pamplona, Spain. Navarra Hospital Complex-Idisna, Gastroenterology and Hepatology, Pamplona, Spain. Navarra Hospital Complex, Infectious Disease, Pamplona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.238",
    "filters": {
      "actSubs": ["Ombitasvir / Paritaprevir / Ritonavir / Dasabuvir", "Ombitasvir", "Paritaprevir", "Ritonavir", "Dasabuvir", "Ribavirin", "Ledipasvir / Sofosbuvir", "Ledipasvir", "Sofosbuvir", "Sofosbuvir / Daclatasvir", "Daclatasvir", "Sofosbuvir / Velpatasvir", "Velpatasvir", "Glecaprevir / Pibrentasvir", "Glecaprevir", "Pibrentasvir", "Elbasvir / Grazoprevir", "Elbasvir", "Grazoprevir", "Ombitasvir / Paritaprevir / Ritonavir", "Sofosbuvir / Velpatasvir / Voxilaprevir", "Voxilaprevir", "Sofosbuvir / Simeprevir", "Simeprevir"],
      "indication": ["Hepatitis C", "Acquired Immunodeficiency Syndrome (AIDS)"],
      "statedClass": ["Direct Acting Antivirals"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["METAVIR Score"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": ["pharmacogenetics"],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evolution of nonoccupational postexposure prophylaxis use since 2010 in a third-level hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A107.2",
    "authors": "L Garcia, FJ Bécares, MÁ Arias, C de Gorostiza, A Cordero, B Ardizone, E Tortajada",
    "institution": "Hospital Universitario Fundación Jiménez Díaz, Hospital Pharmacy, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.233",
    "filters": {
      "actSubs": [],
      "indication": ["Acquired Immunodeficiency Syndrome (AIDS)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Prevalence and relationship between hypovitaminosis D and insulin resistance in obese patient candidates for bariatric surgery",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A72.2",
    "authors": "D Blánquez Martínez, M Hayon Ponce, P Nieto Gómez, ÁS Raquel, X Diaz Villamarin, C Garcia Fernandez, C Davila Fajardo",
    "institution": "Hospital Universitario San Cecilio, Farmacia Hospitalaria, Granada, Spain. Hospital Universitario San Cecilio, Endocrinología y Nutrición, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.160",
    "filters": {
      "actSubs": [],
      "indication": ["Hypovitaminosis D", "Diabetes Type II (Mellitus)", "Insulin Resistance", "Metabolic Syndrome"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Nutrition Unit", "Endocrinology"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Homeostatic Model Assessment for Insulin Resistance (HOMA-IR)", "Statistical Package for the Social Sciences (SPSS)", "Univariate Linear Regression Test"],
      "studyLength": ["Less than 3 months"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Optimising of antibiotic prophylaxis at cardiac surgery clinic",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A86.1",
    "authors": "S Gregor, K Chrapkova, M Hojny, J Maly",
    "institution": "Department of Hospital Pharmacy, Institute of Clinical and Experimental Medicine, Prague, Czech Republic. Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Kralove, Charles University, Czech Republic",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.189",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Cardiac Surgery"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Czech Republic"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": ["antibioticProphylaxis"],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Access to ‘fondo AIFA 5%’ as an instrument supporting the sustainability in a shared clinical management of rare and difficult-to-treat diseases",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A169.2",
    "authors": "G Valinotti, M Scaldaferri, M Tonelli, P Crosasso, MR Chiappetta, F Cattel",
    "institution": "Città Della Salute e Della Scienza di Torino, Pharmacy, Torino, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.364",
    "filters": {
      "actSubs": ["Eculizumab", "Tocilizumab", "Belinostat", "Ibrutinib", "Ruxolitinib", "Venetoclax", "5-azacitidine", "Sorafenib", "Interferon (Pegylated)", "Pembrolizumab", "Bortezomib"],
      "indication": ["Glomerulonephritis", "Hypoparathyroidism", "Lymphoma (T-Cell)", "Arteritis", "Neuroblastoma", "Scleroderma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["51 - 100"],
      "criteriaMethod": [],
      "studyLength": ["More than 1 year - 2 years"],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": ["orphan"],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Analysis of adaptation to a protocol of use of the PCSK9 inhibitors",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A81.2",
    "authors": "D Yáñez Feria, P Selvi Sabater, A Pelaez Bejarano, O Montero Pérez, MD Santos Rubio",
    "institution": "Hospital Juan Ramon Jimenez, Pharmacy, Huelva, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.179",
    "filters": {
      "actSubs": ["Evolocumab", "Alirocumab"],
      "indication": ["Atherosclerosis", "Cardiovascular Disease"],
      "statedClass": ["Proprotein Convertase Subtilisin / Kexin Type 9 Enzyme (PCSK9) Inhibitors", "Statins"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": ["history"]
    }
  },
  {
    "title": "Assessment of the medication error rate pre-prescription during the medication reconciliation process",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A169.1",
    "authors": "V Chevalet1, O Gleizes, L Hammi, A Rieutord, R Sterpu, G Bussone, R Fior, N Curatolo",
    "institution": "Hôpital Antoine Béclère, Service Pharmacie, Clamart, France. Hôpital Antoine Béclère, Service Médicine Aigue Polyvalente, Clamart, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.363",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Interventional Study", "Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": ["history"]
    }
  },
  {
    "title": "Cost minimisation study: switch vial to pen in geriatrics",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A70.2",
    "authors": "I Castanié, C Vert, P Puyo, AS Mange, A Pages, C Mccambridge, P Cestac",
    "institution": "CHU Toulouse, Pharmacy Department, Toulouse, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.156",
    "filters": {
      "actSubs": ["Insulin glargine"],
      "indication": [],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Geriatrics"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Wilcoxon Signed Rank Test"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effectiveness of glecaprevir/pibrentasvir in real-world clinical practice for chronic hepatitis C infection",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A112.1",
    "authors": "M Rodriguez-Reyes, JM Sotoca-Momblona, M Mensa-Vendrell, D Soy-Muner",
    "institution": "Hospital Clínic, Pharmacy Department, Barcelona, Spain. Hospital Plató, Pharmacy Department, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.243",
    "filters": {
      "actSubs": ["Glecaprevir / Pibrentasvir", "Glecaprevir", "Pibrentasvir"],
      "indication": ["Hepatitis C", "Fibrosis (Liver)"],
      "statedClass": ["Direct Acting Antivirals"],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Adjusted Morbidity Groups"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": ["pharmacogenetics"],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Analysis of the methodology to communicate potentially inappropriate prescriptions in inpatients to an internal medicine service of a third-level hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A190.2",
    "authors": "M Fernandez, E Carmona, J Cordero, L Rendón de Lope, MA Colmenero, L Alvarez, MA Calleja",
    "institution": "Hospital Universitario Virgen Macarena, Pharmacy, Sevilla, Spain. Hospital Universitario Virgen Macarena, Internal Medicine, Sevilla, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.410",
    "filters": {
      "actSubs": ["Digoxin"],
      "indication": [],
      "statedClass": ["Non-Steroidal Anti-Inflammatory Drugs", "Antibiotics", "Insulins", "Proton-Pump Inhibitors", "Low Molecular Weight Heparins"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["STOPP/START Criteria", "Beers Criteria"],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Appropriate use of antifungals: impact of an antifungal stewardship programme on the clinical outcome of candidaemia in a university hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A105.2",
    "authors": "H Benoist, S Rodier, A de la Blanchardiere, J Bonhomme, P Thibon, G Saint-Lorant",
    "institution": "Caen University Hospital, Pharmacy, Caen, France. Caen University Hospital, Infectious Diseases, Caen, France. Caen University Hospital, Microbiology, Caen, France. Caen University Hospital, Cpias Normandie, Caen, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.229",
    "filters": {
      "actSubs": [],
      "indication": ["Candidaemia"],
      "statedClass": ["Antifungals", "Echinocandins"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["More than 2 years - 5 years"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "GLP-1 agonist liraglutide as add-on therapy in type 2 diabetes",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A69.3",
    "authors": "D Blánquez Martínez, M Hayon Ponce, I Casas Hidalgo, X Diaz Villamarin, ÁS Raquel, P Nieto Gómez, C Davila Fajardo",
    "institution": "Hospital Universitario San Cecilio, Farmacia Hospitalaria, Granada, Spain. Hospital Universitario San Cecilio, Endocrinología y Nutrición, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.154",
    "filters": {
      "actSubs": ["Liraglutide"],
      "indication": ["Diabetes Type II (Mellitus)"],
      "statedClass": ["Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists", "Antidiabetics"],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Endocrinology"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)", "Student's T-test"],
      "studyLength": ["6 months - 1 year"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Perioperative management of antirheumatic medication in real practice: is mismanagement related to post-surgical complications?",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A143.2",
    "authors": "P Ranz Ortega, R Vázquez-Sánchez, ME Martínez-Núñez, T Molina-García",
    "institution": "Hospital Universitario de Getafe, Pharmacy, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.308",
    "filters": {
      "actSubs": [],
      "indication": ["Rheumatoid Arthritis", "Rheumatological Diseases", "Spondyloarthropathy", "Psoriatic Arthropathy", "Postoperative Infection"],
      "statedClass": ["Immune-Suppressors", "Biologicals", "Disease Modifying Anti-Rheumatic Drugs", "Glucocorticoids", "Tumor Necrosis Factor (TNF) Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Binary Logistic Regression Analysis", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": ["preopMedication"],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "An evaluation of gastrointestinal prophylaxis in elderly patients on aspirin therapy",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A69.1",
    "authors": "A Sant, J Falade, D Dobla",
    "institution": "University College London, School of Pharmacy, London, UK. North Middlesex University Hospital NHS Trust, Pharmacy Department, London, UK",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.152",
    "filters": {
      "actSubs": ["Acetylsalicylic acid", "Lansoprazole"],
      "indication": ["Gastrointestinal Injury", "Ulcer (Peptic)", "Helicobacter Pylori Infection"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Cardiology", "Geriatrics"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["United Kingdom"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "A comparison of clinical pharmacy activity between two methods of clinical pharmacy service delivery in an acute psychiatric hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A180.2",
    "authors": "P McGee, G Carroll, N Doyle",
    "institution": "Beaumont Hospital, Pharmacy Department, Dublin, Ireland",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.388",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Quantitative Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["Ireland"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Daratumumab (darzalex) for the treatment of multiple myeloma in a third-level hospital: variability of use and effectiveness",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A131.1",
    "authors": "S Gonzalez Suarez, AR Rubio Salvador, AA García Sacristán, A Dominguez Barahona, R López Álvarez, C Blázquez Romero, N Labrador Andújar, P Moya Gómez",
    "institution": "Hospital Virgen de la Salud, Hospital Pharmacy, Toledo, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.282",
    "filters": {
      "actSubs": ["Daratumumab", "Lenalidomide", "Dexamethasone", "Bortezomib"],
      "indication": ["Multiple Myeloma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Haematology"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Pharmacist interventions: the success of an antimicrobial stewardship team",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A160.2",
    "authors": "H Duarte, G Costa, S Azevedo, V Andreozzi, J Felix, M Coelho, A Alcobia",
    "institution": "Garcia Orta Hospital, Pharmacy, Almada, Portugal. Hospital Garcia de Orta, Pharmacy, Almada, Portugal. Exigo Consultores, Statistics Department, Lisboa, Portugal. Exigo Consultores, Statistics, Lisboa, Portugal. Hospital Garcia de Orta, Antimicrobial Stewardship Team, Almada, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.344",
    "filters": {
      "actSubs": [],
      "indication": ["Urinary Tract Infection"],
      "statedClass": ["Carbapenems", "Quinolones"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": ["The R Project for Statistical Computing"],
      "studyLength": ["More than 1 year - 2 years"],
      "country": ["Portugal"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": ["errors"],
      "administrative": ["administrative"],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evolution over time of antiretrovirals",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A109.1",
    "authors": "S Hernandez Rojas, MDP Díaz Ruiz, JA de León Gil, M Miguelez Morales, M Suarez Gonzalez, A Estévez López, J Merino Alonso, E Ramos Santana, JA Martín Conde",
    "institution": "Hospital Nuestra Señora de la Candelaria, Hospital Pharmacy, Santa Cruz de Tenerife, Spain. Hospital Nuestra Señora de la Candelaria, Internal Medicine, Santa Cruz de Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.236",
    "filters": {
      "actSubs": ["Emtricitabine / Tenofovir disoproxil / Rilpivirine", "Emtricitabine", "Tenofovir disoproxil", "Rilpivirine", "Emtricitabine / Tenofovir disoproxil / Efavirenz", "Efavirenz", "Darunavir / Ritonavir", "Ritonavir", "Darunavir", "Abacavir / Dolutegravir / Lamivudine", "Abacavir", "Dolutegravir", "Lamivudine", "Emtricitabine / Tenofovir disoproxil / Elvitegravir / Cobicistat", "Elvitegravir", "Cobicistat", "Emtricitabine / Tenofovir alafenamide / Elvitegravir / Cobicistat", "Tenofovir alafenamide"],
      "indication": ["Acquired Immunodeficiency Syndrome (AIDS)"],
      "statedClass": ["Antiretrovirals", "Integrase Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Longitudinal Study", "Descriptive Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["501 - 1000"],
      "numPrescriptions": [],
      "criteriaMethod": ["Descriptive Statistics"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Oral ketamine in unmanageable chronic pain: a case report",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A146.1",
    "authors": "I Martínez Aguirre, U Blazquez Urtizberea, MM Alvarez Lavin, M Alonso Diez, JA Dominguez Menendez, A Llona Armada, A Aguirrezabal Arredondo",
    "institution": "OSI Bilbao Basurto, Hospital Pharmacy, Bilbao, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.313",
    "filters": {
      "actSubs": ["Ketamine", "Fentanyl"],
      "indication": ["Neuropathic Pain"],
      "statedClass": ["Opioids", "Analgesics", "Antiinflamatory Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Clinical Global Impressions Scale (CGI)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": ["painManagement"],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],  
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Extended infusion of meropenem in a neonate with complicated klebsiella pneumoniae meningitis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A96.1",
    "authors": "MG Lopez Ramos, Á Pertierra Cortada, A Alarcón Allen, N Carreras Blesa, B Palenzuela Afonso, S Luque Pardos, S Grau Cerrato, R Farré Riba",
    "institution": "Hospital Sant Joan de Déu, Pharmacy, Esplugues de Llobregat Barcelona, Spain. Hospital Sant Joan de Déu, Neonatology, Esplugues de Llobregat Barcelona, Spain. Hospital del Mar, Pharmacy, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.210",
    "filters": {
      "actSubs": ["Meropenem"],
      "indication": ["Meningitis", "Ventriculitis"],
      "statedClass": ["Carbapenems"],
      "typeOfMedical": ["External Ventricular Drain", "Ventriculoperitoneal Shunt"],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Community pharmacy-based eGFR screening for early detection of chronic kidney disease in high-risk patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A187.1",
    "authors": "J Papastergiou, M Omran, B Van Den Bemt",
    "institution": "University of Toronto, Leslie Dan Faculty of Pharmacy, Toronto, Canada. St. Maartenskliniek Nijmegen, Department of Pharmacy, Nijmegen, The Netherlands",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.402",
    "filters": {
      "actSubs": [],
      "indication": ["Chronic Kidney Disease", "Diabetes Type II (Mellitus)", "Hypertension", "Cardiovascular Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Community Pharmacy"],
      "ward": [],
      "numPatients": ["501 - 1000"],
      "numPrescriptions": [],
      "criteriaMethod": ["Estimated Glomerular Filtration Rate (eGFR)", "Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) Equation"],
      "studyLength": ["6 months - 1 year"],
      "country": ["Netherlands", "Canada"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "A systematic review of pharmacist input in the screening, management and prevention of metabolic syndrome",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A197.1",
    "authors": "R Aladawi, A Tonna, D Stewart, C Ryan",
    "institution": "Robert Gordon University, School of Pharmacy and Life Sciences, Aberdeen, UK. Trinity College Dublin, Pharmacy School, Dublin, Ireland",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.424",
    "filters": {
      "actSubs": [],
      "indication": ["Metabolic Syndrome"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital", "Community Pharmacy"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["United Kingdom", "Ireland"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Analysis and improvement of professionnal practices: prescription’s evaluation of proton pump inhibitors in oral routes",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A68.2",
    "authors": "A Heim1, L Pereira, M Marchand, M Bonnefous, JM Sénard, V Duhalde, B Juillard Condat, P Cestac",
    "institution": "University Hospital, Comédims, Toulouse, France. University Hospital, Observatory of Drugs- Medical Devices and Therapeutique Innovation, Toulouse, France. University Hospital, Clinical Digestive, Toulouse, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.151",
    "filters": {
      "actSubs": [],
      "indication": ["Liver Failure", "Ulcer (Peptic)", "Gastrointestinal Perforation"],
      "statedClass": ["Proton-Pump Inhibitors", "Non-Steroidal Anti-Inflammatory Drugs", "Anticoagulants"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": ["10 - 50"],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Biosimilar rituximab – a year beyond",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A187.2",
    "authors": "M Pereira, G Costa, S Domingos-Camões, A Alcobia",
    "institution": "Hospital Garcia de Orta, Pharmacy, Almada, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.403",
    "filters": {
      "actSubs": ["Rituximab"],
      "indication": ["Rheumatoid Arthritis"],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Pertinence of the prescription of stress ulcer prophylaxis in intensive care medicine",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A69.2",
    "authors": "J Piubellini, A Schneider, P Eckert, F Sadeghipour, P Voirol",
    "institution": "CHUV, Pharmacy, Lausanne, Switzerland. CHUV, Adult Intensive Care Medicine, Lausanne, Switzerland",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.153",
    "filters": {
      "actSubs": ["Esomeprazole"],
      "indication": ["Ulcer (Stress)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Switzerland"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Erlotinib in non-small-cell lung cancer without epidermal growth factor receptor activating mutations",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A124.1",
    "authors": "D Yáñez Feria, IM Carrion Madroñal, MT Garrido Martinez, O Montero Pérez, MD Santos Rubio",
    "institution": "Juan Ramon Jimenez Hospital, Pharmacy, Huelva, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.269",
    "filters": {
      "actSubs": ["Erlotinib"],
      "indication": ["Non-Small Cell Lung Cancer"],
      "statedClass": ["Taxanes", "Platinum Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Eastern Cooperative Oncology Group (ECOG) Performance Status"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Sublingual and enteric tacrolimus whole blood levels in an intensive care unit",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A137.1",
    "authors": "L Doménech, JM Guiu Segura, JB Montoro Ronsano",
    "institution": "Vall d’Hebron University Hospital, Pharmacy Department, Barcelona, Spain. Consorci de Salut I Social de Catalunya, Pharmacy Department, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.295",
    "filters": {
      "actSubs": ["Tacrolimus"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Pharmacogenetics as a tool in dose adjustment of immunosuppressive drugs: a case report",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A136.2",
    "authors": "M Debailleul, H Henry, G Lepeut, B Hennart, B Decaudin, P Mathurin, P Odou",
    "institution": "Institut de Pharmacie- CHU Lille, Nord, Lille, France. Institut de Pharmacie- CHU Lille- EA 7365 Grita Faculté de Pharmacie- Université de Lille, Nord, Lille, France. Service des Maladies de L’Appareil Digestif- CHU Lille, Nord, Lille, France. Unité Fonctionnelle de Toxicologie- CHU Lille, Nord, Lille, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.294",
    "filters": {
      "actSubs": ["Mycophenolate", "Prednisone", "Tacrolimus", "Caspofungin", "Meropenem", "Cyclosporine"],
      "indication": ["Cirrhosis", "Ascites", "Encephalopathy", "Varices (Esophageal)", "Portal Hypertension"],
      "statedClass": ["Immune-Suppressors"],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series", "Literature Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": ["pharmacogenetics"],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Establishment of a pharmaceutical standardised interview concerning biosimilars of infliximab in the daycare clinic of a gastroenterology department for patients affected by inflammatory bowel disease",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A136.1",
    "authors": "E Coget, P Laffont-Lozes, V Velasco Gonzalvo, D Huc, G Pineton de Chambrun, R Altwegg, P Blanc, GP Pageaux, D Rosant, C Breuker",
    "institution": "CHU Saint-Eloi, Pharmacy, Montpellier, France. CHU Saint-Eloi, Gastroenterology, Montpellier, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.293",
    "filters": {
      "actSubs": ["Infliximab"],
      "indication": ["Inflammatory Bowel Disease", "Crohn’s Disease", "Ulcerative Colitis"],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Gastroenterology"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Comparative analysis between originator and biosimilar infliximab according to trough levels in patients with inflammatory bowel disease",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A140.2",
    "authors": "M Gil Candel, C Iniesta Navalon, M Onteniente Candela, N Salar Valverde, C Pastor Mondejar, L Rentero Redondo, C Caballero Requejo, E Urbieta Sanz",
    "institution": "Hospital General Universitario Reina Sofia, Hospital Pharmacy, Murcia, Spain. Hospital Comarcal del Noroeste, Hospital Pharmacy, Caravaca de la Cruz Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.302",
    "filters": {
      "actSubs": ["Infliximab"],
      "indication": ["Inflammatory Bowel Disease", "Crohn’s Disease"],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["ELISA Immunoassay", "Chi-Square (χ2) Test", "Student's T-test", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Switch from clarithromycin to azithromycin – one option to optimise macrolide use through clinical pharmacists",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A87.1",
    "authors": "C Querbach",
    "institution": "Klinikum Rechts der Isar der Tum München, Pharmacy, München, Germany",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.191",
    "filters": {
      "actSubs": ["Clarithromycin", "Azithromycin"],
      "indication": [],
      "statedClass": ["Macrolides"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Germany"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Analysis of the discrepancies found in the reconciliation of concomitant medication in a cohort of elderly patients infected with HIV",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A192.1",
    "authors": "L Ruiz Gonzalez, A Lazaro Lopez, Al Alvarez Nonay, M Lavandeira Perez, I Mendoza Acosta, M Rodriguez Zapata",
    "institution": "Hospital Universitario de Guadalajara, Pharmacy Service, Guadalajara, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.413",
    "filters": {
      "actSubs": [],
      "indication": ["Acquired Immunodeficiency Syndrome (AIDS)"],
      "statedClass": ["Antiretrovirals", "Vitamin Supplements", "Psycholeptics", "Antacids"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": ["6 months - 1 year"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": ["history"]
    }
  },
  {
    "title": "8 years’ evolution of antipsychotics prescriptions in a mental health public institution",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A150.1",
    "authors": "R Bellay, C Barbazan, B Langree, N Marie",
    "institution": "Centre Hospitalier Guillaume Regnier, Pharmacie, Rennes, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.322",
    "filters": {
      "actSubs": ["Loxapine", "Olanzapine", "Cyamemazine", "Risperidone", "Paliperidone", "Clozapine", "Haloperidol", "Flupentixol", "Zuclopenthixol"],
      "indication": [],
      "statedClass": ["Antipsychotics"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Defined Daily Dose (DDD)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Clinical impact evaluation of implementing antibiotherapy control of more than 7 days",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A98.1",
    "authors": "Y Moutaouakkil, Y Tadlaoui, Y Atbib, B Adouani, A Bennana, Y Cherrah, J Lamsaouri, Y Bousliman",
    "institution": "Pharmacy Pole-Military Hospital of Instruction Mohammed V Rabat, Department of Pharmacology – Toxicology- University Mohammed V- Faculty of Medicine and Pharmacy-, Rabat, Morocco. Pharmacy Pole-Military Hospital of Instruction Mohammed V Rabat, Department of Pharmacy Clinic- University Mohammed V- Faculty of Medicine and Pharmacy-, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.214",
    "filters": {
      "actSubs": [],
      "indication": ["Osteoarticular Infection", "Urinary Tract Infection", "Pulmonary Infection", "Skin and Soft Tissue Infection", "Gastrointestinal Infection", "Endocarditis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["51 - 100"],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Morocco"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Assessment of medication reconciliation in chronic complex patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A162.2",
    "authors": "A Andres Rosado, T Gomez Lluch, S Lorenzo Gimenez, LA Pedraza Cezon",
    "institution": "Hospital Universitario del Tajo, Pharmacy, Aranjuez Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.348",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": ["history"]
    }
  },
  {
    "title": "Clinical experience with dalbavancin in a tertiary hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A162.1",
    "authors": "M Nuñez Nuñez, A Ruiz Sancho, M Moya-Martin, I Vallejo Rodriguez, ÁS Raquel, J Cabeza Barrera",
    "institution": "Hospital Virgen San Cecilio, UGC Farmacia, Granada, Spain. Hospital Campus de la Salud, UGC Enfermedades Infecciosas, Granada, Spain. Hospital Universitario Virgen Macarena, UGC Farmacia, Seville, Spain. Hospital Campus de la Salud, UGC Farmacia, Granada, Spain. Hospital San Cecilio, UGC Farmacia, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.347",
    "filters": {
      "actSubs": ["Dalbavancin"],
      "indication": ["Osteoarticular Infection", "Bloodstream Infection", "Skin and Soft Tissue Infection", "Endocarditis"],
      "statedClass": ["Lipoglycopeptides"],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Influence of time and storage conditions in the stability of neonatal total parenteral nutrition admixtures",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A185.2",
    "authors": "L Otero Millan1, N Lago Rivero, C Vazquez Lopez, JL Legido Soto, G Piñeiro Corrales, A Blanco Rodicio, M Alonso Iglesias, S Lopez Gonzalez, C Costas Carrera, MC Pascual Rubin, C Perez Rego",
    "institution": "Hospital Álvaro Cunqueiro, Pharmacy, Vigo, Spain. Universidad de Vigo, Física Aplicada, Vigo, Spain. Hospital Álvaro Cunqueiro, Emergency, Vigo, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.399",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Laser Diffraction Analysis", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Postoperative pain management and pain referred by adult patients 24 hours after surgery and one month after discharge",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A147.2",
    "authors": "P Martinez Ortega, A Gimenez-Manzorro, A Ribed-Sanchez, A de Lorenzo-Pinto, E Garcia-Martin, S Garcia-Sanchez, MA Amor-Garcia, FJ Garcia-Moreno, A Melgarejo-Ortuño, A Herranz-Alonso, M Sanjurjo-Saez",
    "institution": "Hospital General Universitario Gregorio Marañon, Pharmacy Department, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.317",
    "filters": {
      "actSubs": ["Acetaminophen", "Dipyrone"],
      "indication": [],
      "statedClass": ["Analgesics", "Non-Steroidal Anti-Inflammatory Drugs", "Opioids"],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Descriptive Study", "Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Emergency Department", "General Surgery"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Numeric Verbal Scale (NVS)"],
      "studyLength": ["6 months - 1 year"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": ["preopMedication"],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": ["painManagement"],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Safety and effectiveness of trastuzumab emtansin in locally advanced or metastatic HER2 positive breast cancer",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A126.1",
    "authors": "M Mejias Trueba, R Jiménez Galán, M Muñoz Burgos, AB Guisado Gil, MD Vega Coca, L Abdel Kader Martin, S Flores Moreno",
    "institution": "Hospital Universitario Virgen del Rocío, Farmacia Hospitalaria, Seville, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.273",
    "filters": {
      "actSubs": ["Trastuzumab emtansine", "Trastuzumab", "Pertuzumab", "Capecitabine", "Lapatinib"],
      "indication": ["Breast Cancer (HER2 Positive)"],
      "statedClass": ["Taxanes"],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Kaplan-Meier Method", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": ["pharmacogenetics"],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of the satisfaction of the implementation of a pharmaceutical letter of hospital discharge transmitted to patients and community health professionals",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A194.1",
    "authors": "J Salgues, L Viault, M Cosson, L Lohan-Descamps, D Rosant, I Roch-Torreilles, M Villiet, R Goulabchand, P Fesler, A Le Quellec, C Breuker",
    "institution": "University Hospital Centre of Montpellier, Pharmacy Unit, Montpellier, France. University Hospital Centre of Montpellier, Internal Medicine Unit Saint Eloi, Montpellier, France. University Hospital Centre of Montpellier, Internal Medicine Unit Lapeyronie, Montpellier, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.417",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Enoxaparin dose adjustment in the elderly – the intervention of the clinical pharmacist",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A165.1",
    "authors": "M Brito, A Alcobia",
    "institution": "Hospital Garcia de Orta, Pharmacy, Almada, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.354",
    "filters": {
      "actSubs": ["Enoxaparin", "Protamine"],
      "indication": ["Acute Kidney Injury", "Chronic Kidney Disease", "Hematoma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Prospective Study", "Longitudinal Study"],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["Portugal"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Aging with HIV: optimising pharmacotherapy beyond interactions",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A107.1",
    "authors": "J Gallardo-Anciano, Y Gonzalez-Perez, ME Calvo-Aragüete, JR Blanco-Ramos",
    "institution": "Hospital Universitario San Pedro, Hospital Pharmacy, Logroño, Spain. Hospital Universitario San Pedro, Department of Infectious Diseases, Logroño, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.232",
    "filters": {
      "actSubs": [],
      "indication": ["Acquired Immunodeficiency Syndrome (AIDS)"],
      "statedClass": ["Fall-Risk Increasing Drugs (FRIDS)", "Antipsychotics", "Antidepressants", "Benzodiazepines", "Diuretics (Loop)", "Opioids", "Antiepileptics", "Antiretrovirals", "Anticholinergics"],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Medication Regimen Complexity Index", "Anticholinergic Risk Scale", "Drug Burden Index Score", "STOPP/START Criteria"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Analysis of the use of omalizumab in oral tolerance induction for high-risk food allergies in children",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A132.2",
    "authors": "M Larrosa García, I Jimenez-Lozano, C Blasco-Valero, C Canete-Ramirez, MT Garriga-Baraut, BM Garcia-Palop, BR Vila-Indurain, S Clemente-Bautista, MJ Cabanas-Poy",
    "institution": "Vall d’Hebron University Hospital, Clinical Pharmacy, Barcelona, Spain. Vall d’Hebron University Hospital, Paediatric Allergology, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.285",
    "filters": {
      "actSubs": ["Omalizumab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effectiveness and safety of radium-223 chloride in bone-metastatic castration-resistant prostate cancer",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A158.2",
    "authors": "JJ Martínez Simón, MA Asensio Ruíz, C Sobrino Jiménez, M Soria Soto, A Abella Tarazona, F Moreno Ramos, AM Gómez Pedrero, MT Martínez Martínez, M Pérez Encinas",
    "institution": "Hospital Universitario Fundación Alcorcón, Hospital Pharmacy, Alcorcón, Spain. Hospital General Universitario Virgen de la Arrixaca, Radiopharmacy, Murcia, Spain. Hospital Universitario la Paz, Hospital Pharmacy, Madrid, Spain. Hospital General Universitario Morales Meseguer, Hospital Pharmacy, Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.340",
    "filters": {
      "actSubs": ["Radium-223 dichloride"],
      "indication": ["Prostate Cancer (Metastatic Castration Resistant)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Eastern Cooperative Oncology Group (ECOG) Performance Status", "Kaplan-Meier Method"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": ["radiopharmaceuticals"],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Use of ustekinumab in refractory patients of psoriasis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A83.1",
    "authors": "MD Gil-Sierra, E Rios-Sanchez, MDP Briceño-Casado, S Fenix-Caballero, C Martinez-Diaz, C Palomo-Palomo, EJ Alegre-Del Rey, J Diaz-Navarro, JF Lopez-Vallejo, M Camean-Castillo, JM Borrero-Rubio",
    "institution": "Hospital Universitario de Puerto Real, Pharmacy, Puerto Real, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.183",
    "filters": {
      "actSubs": ["Ustekinumab", "Etanercept", "Adalimumab", "Infliximab", "Adalimumab", "Efalizumab", "Etanercept"],
      "indication": ["Psoriasis (Moderate to Severe Plaque)"],
      "statedClass": ["Tumor Necrosis Factor (TNF) Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Psoriasis Area and Severity Index (PASI)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "The practice of using dexmedetomidine in a paediatric intensive care unit: retrospective chart review",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A153.1",
    "authors": "D Almutairi, M Aljeraisy",
    "institution": "King Abdulaziz Medical City, Pharmacy, Riyadh, Saudi Arabia",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.329",
    "filters": {
      "actSubs": ["Dexmedetomidine", "Midazolam"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Paediatric Intensive Care"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Saudi Arabia"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Ruxolitinib as salvage therapy in paediatric patients with steroid-refractory graft-versus-host disease",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A130.1",
    "authors": "E Serramontmany, B Renedo Miro, M Oliveras Arenas, MJ Carreras Soler, MI Benitez Carabante, M Roch Santed, MQ Gorgas Torner",
    "institution": "Vall d’Hebron University Hospital, Pharmacy Service, Barcelona, Spain. Vall d’Hebron University Hospital, Paediatric Oncohaematology, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.280",
    "filters": {
      "actSubs": ["Ruxolitinib", "Infliximab", "Posaconazole"],
      "indication": ["Graft Versus Host Disease"],
      "statedClass": ["Corticosteroids", "Immune-Suppressors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["Less than 10"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Follow-up of recommendations on dose adjustment of ceftolozane/tazobactam in renal failure",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A102.1",
    "authors": "M Rodriguez-Reyes, E López-Suñé, E Calvo-Cidoncha, M Tuset-Creus, C Codina-Jané, A Soriano-Viladomiu",
    "institution": "Hospital Clínic, Pharmacy Department, Barcelona, Spain. Hospital Clínic, Infectious Diseases Department, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.222",
    "filters": {
      "actSubs": ["Ceftolozane / Tazobactam", "Ceftolozane", "Tazobactam"],
      "indication": ["Respiratory Tract Infection", "Urinary Tract Infection", "Intra-abdominal Infection"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "How well is the target concentration of vancomycin achieved in intensive care unit patients?",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A94.1",
    "authors": "P Hansson, A Peyravi Latif",
    "institution": "Uppsala University Hospital, Pharmacy Department, Uppsala, Sweden",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.206",
    "filters": {
      "actSubs": ["Vancomycin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care", "Neurocritical Care Unit"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": ["101 - 500"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Sweden"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Assessing medication adherence and condition-related knowledge of heart failure patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A170.2",
    "authors": "I Debono, L Grech, RG Xuereb, LM Azzopardi",
    "institution": "University of Malta, Pharmacy, Msida, Malta. Mater Dei Hospital, Cardiology, Msida, Malta",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.366",
    "filters": {
      "actSubs": [],
      "indication": ["Heart Failure"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cohort Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Treatment Adherence Questionnaire (TAQ)"],
      "studyLength": ["Less than 3 months"],
      "country": ["Malta"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Efficacy, safety and acceptance of treatment with alirocumab or evolocumab in patients with dyslipidaemia",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A78.2",
    "authors": "I Monge, P Acin, E Navarrete-Rouco, L Recasens, J Pedro-Botet, A Oliveras, E González-Colominas, S Luque, S Grau",
    "institution": "Hospital de Mar, Pharmacy, Barcelona, Spain. Hospital de Mar, Cardiology, Barcelona, Spain. Hospital de Mar, Endocrinology, Barcelona, Spain. Hospital de Mar, Nephrology, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.173",
    "filters": {
      "actSubs": ["Alirocumab", "Evolocumab", "Ezetimibe"],
      "indication": ["Dyslipidaemia"],
      "statedClass": ["Proprotein Convertase Subtilisin / Kexin Type 9 Enzyme (PCSK9) Inhibitors", "Lipid Lowering Agents"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Fisher’s Exact Test", "Mann-Whitney U Test"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Current state of retreatment of hepatitis C infection in patients whom prior therapy failed in a hepatitis referral centre",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A111.1",
    "authors": "JF Meyer, C San, V Siorat, S Kabiche, JE Fontan",
    "institution": "Hôpital Jean Verdier, Pharmacy, Bondy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.240",
    "filters": {
      "actSubs": ["Sofosbuvir", "Daclatasvir", "Ledipasvir", "Velpatasvir", "Elbasvir / Grazoprevir", "Elbasvir", "Grazoprevir", "Paritaprevir", "Ombitasvir", "Ritonavir", "Ombitasvir / Paritaprevir / Ritonavir", "Ombitasvir / Paritaprevir / Ritonavir / Dasabuvir", "Dasabuvir", "Simeprevir", "Sofosbuvir / Simeprevir", "Sofosbuvir / Velpatasvir", "Glecaprevir / Pibrentasvir", "Glecaprevir", "Pibrentasvir", "Sofosbuvir / Velpatasvir / Voxilaprevir", "Voxilaprevir"],
      "indication": ["Hepatitis C", "Acquired Immunodeficiency Syndrome (AIDS)", "Hepatitis B", "Cirrhosis"],
      "statedClass": ["Direct Acting Antivirals", "Non-Structural Protein 5A (NS5A) Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Hepatology"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": ["pharmacogenetics"],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effectiveness and safety of the early switch from intravenous to oral antibiotics treatment in the pneumology ward",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A99.1",
    "authors": "D Echeverria-Esnal, J Martinez-Casanova, M Dominguez-Alvarez, C Estirado, MP Ausin, E Balcells, C Martin-Ontiyuelo, P Acin, E Navarrete Rouco, J Gea, S Grau",
    "institution": "Hospital Del Mar, Pharmacy, Barcelona, Spain. Hospital Del Mar, Respiratory, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.216",
    "filters": {
      "actSubs": ["Amoxicillin / Clavulanic acid", "Amoxicillin", "Clavulanic acid", "Trimethoprim / Sulfamethoxazole", "Trimethoprim", "Sulfamethoxazole", "Clindamycin", "Azithromycin"],
      "indication": ["Hypertension", "Diabetes Type II (Mellitus)", "Chronic Obstructive Pulmonary Disease", "Cardiopulmonary Disease", "Pneumonitis", "Asthma"],
      "statedClass": ["Antibiotics", "Antibiotics (Oral)", "Antibiotics (Systemic)", "Quinolones"],
      "typeOfMedical": [],
      "studyDesign": ["Quasi-Experimental Study"],
      "setting": ["Hospital"],
      "ward": ["Pneumology"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Dosing of platinum and taxanes in obese patients: a systematic review",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A121.2",
    "authors": "A Casas, B Torroba, B Tapia, MA Garcia-Del-Barrio",
    "institution": "Clinica Universidad de Navarra, Hospital Pharmacy, Pamplona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.263",
    "filters": {
      "actSubs": ["Cisplatinum", "Carboplatinum", "Oxaliplatinum", "Paclitaxel", "Docetaxel", "Nab-paclitaxel"],
      "indication": [],
      "statedClass": ["Platinum Drugs", "Taxanes"],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Prevalence of polypharmacy in patients with human immunodeficiency virus infection",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A111.2",
    "authors": "C Orallo Luna, J Fra Yáñez, L Becerra Ingerto, L Gómez de Segura Iiriarte, N González Sánchez, P Puente Martín, M Lamas Lopez",
    "institution": "Hospital Universitario San Agustín, Hospital Pharmacy, Avilés- Asturias, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.241",
    "filters": {
      "actSubs": [],
      "indication": ["Acquired Immunodeficiency Syndrome (AIDS)"],
      "statedClass": ["Antiretrovirals", "Anxiolytics", "Hypnotics", "Antihypertensives", "Lipid Lowering Agents", "Antidepressants"],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Reorganisation in hospital outpatient drug delivery: any progress?",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A177.1",
    "authors": "E Jouhanneau, I Girault, H Perrier, A Bruel, S Bourg, A Deboes, G Ligneul, M Raoul, I Taine, S Toutain, D Bruel",
    "institution": "Centre Hospitalier du Mans, Pharmacy, Le Mans, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.381",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Plan-Do-Check-Act (PDCA) Cycle"],
      "studyLength": ["Less than 3 months"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Role of the pharmacist in the evaluation of the prescriptive appropriateness in antibiotic therapy as a ‘single dose’ ",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A102.2",
    "authors": "P Sorice, L Armillei, G Di Florio, F Gasbarri, S Rossetti, S Corridoni, A Costantini",
    "institution": "Hospital Santo Spirito Pescara, Hospital Pharmacy, Pescara, Italy. Hospital Santo Spirito Pescara, Hospital Pharmacy – Trainee, Pescara, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.223",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Antibiotics"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": ["history"]
    }
  },
  {
    "title": "Evaluation of systemic antibiotics and antifungal use in an intensive paediatric care unit: a five-year study in a french university hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A173.2",
    "authors": "A Solal, C Bouchand, A Guerin, M Postaire, S Cisternino, F Moulin",
    "institution": "Hôpital Universitaire Necker Enfants Malades, Pharmacie, Paris, France. Hôpital Universitaire Necker Enfants Malades, Réanimation Paédiatrique, Paris, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.373",
    "filters": {
      "actSubs": ["Imipenem", "Imidazole", "Levofloxacin", "Amoxicillin / Clavulanic acid", "Amoxicillin", "Clavulanic acid", "Amphotericin", "Voriconazole", "Caspofungin", "Flucytosine", "Micafungin", "Fluconazole", "Oxacillin"],
      "indication": [],
      "statedClass": ["Antibiotics (Systemic)", "Antifungals", "Cephalosporins"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": ["Paediatric Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Defined Daily Dose (DDD)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": ["antibioticProphylaxis"],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Rituximab in the treatment of primary glomerulonephritis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A122.1",
    "authors": "M Lamas Lopez, C Orallo Luna, J Fra Yañez, L Becerra Injerto, A Fernández González, N González Sánchez, P Puente Martínez",
    "institution": "Hospital Universitario San Agustín, Servicio de Farmacia Hospitalaria, Avilés, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.264",
    "filters": {
      "actSubs": ["Rituximab"],
      "indication": ["Glomerulonephritis", "Glomerulonephritis (Primary)", "Nephropathy", "Glomerulosclerosis", "Minimal Change Disease"],
      "statedClass": ["Corticosteroids", "Immune-Suppressors"],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of intra-patient variability of the tacrolimus plasmatic levels in different periods after liver transplant",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A139.1",
    "authors": "S Garcia Garcia, C Dopazo Taboada, MB Aller Hernández, I Bilbao Aguirre, E Pericas Bosch, JB Montoro Ronsano",
    "institution": "Vall d’Hebron Hospital, Pharmacy Service, Barcelona, Spain. Vall d’Hebron Hospital, Hepatolobiliar Surgery Service, Barcelona, Spain. Vall d’Hebron Hospital, Artificial Intelligence Information Service, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.299",
    "filters": {
      "actSubs": ["Tacrolimus"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Analysis of Variance (ANOVA)", "Kruskal-Wallis H Test", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Experience with omalizumab in the treatment of uncontrolled persistent asthma",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A154.1",
    "authors": "JJ Martínez Simón, EA Álvaro Alonso, I Plo Seco, S Prieto Moix, M Pérez Encinas",
    "institution": "Hospital Universitario Fundación Alcorcón, Hospital Pharmacy, Alcorcón, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.331",
    "filters": {
      "actSubs": ["Omalizumab"],
      "indication": ["Asthma"],
      "statedClass": ["Corticosteroids"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Asthma Control Test", "Asthma Quality of Life Questionnaire"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Adherence to treatment in older adults admitted to an acute geriatric unit and associated factors",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A174.2",
    "authors": "M Gutiérrez-Valencia, M Castresana-Elizondo, MP Monforte-Gasque, E Lacalle-Fabo, J Alonso-Renedo, N Martínez-Velilla",
    "institution": "Complejo Hospitalario de Navarra, Pharmacy Department, Pamplona, Spain. Hospital Reina Sofía, Pharmacy Department, Tudela, Spain. Hospital San Juan de Dios, Pharmacy Department, Zaragoza, Spain. Complejo Hospitalario de Navarra, Geriatric Department, Pamplona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.375",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Multicompartment Compliance Aids (MCAs)"],
      "studyDesign": ["Cross-Sectional Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Acute Geriatric Unit"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Morisky – Green Questionnaire", "Multivariate Logistic Regression Analysis", "Charlson Comorbidity Index", "Barthel Index"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Apremilast adherence in patients with psoriasis and psoriatic arthritis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A84.1",
    "authors": "X Fernández-Sala, E González-Colominas, E Navarrete Rouco, O Ferrández, N Carballo, R Gonzalez, L Tarrasón, E Beltrán, F Gallardo, M Ferran, S Grau",
    "institution": "Hospital del Mar, Pharmacy Department, Barcelona, Spain. Hospital del Mar, Rheumatology Department, Barcelona, Spain. Hospital del Mar, Dermatology Department, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.185",
    "filters": {
      "actSubs": ["Apremilast"],
      "indication": ["Psoriasis", "Psoriatic Arthropathy"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Univariate Analysis"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "A new breath for clozapine …",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A150.2",
    "authors": "A Chane-Kene, F Plassart, O Chauvel, C Lamisse, JL Pons",
    "institution": "Victor Dupouy Hospital Centre, Pharmacy, Argenteuil, France. Victor Dupouy Hospital Centre, Psychiatry, Argenteuil, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.323",
    "filters": {
      "actSubs": ["Clozapine", "Risperidone"],
      "indication": ["Schizophrenia", "Dementia"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Adherence and effectiveness of PCSK9 inhibitors in routine clinical practice",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A79.2",
    "authors": "P Gabaldón Garnica, C Sobrino Jiménez, F Moreno Ramos, L González del Valle, C Jiménez Vicente, A Herrero Ambrosio",
    "institution": "Hospital Universitario La Paz, Pharmacy, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.175",
    "filters": {
      "actSubs": ["Alirocumab", "Evolocumab"],
      "indication": ["Hypercholesterolaemia", "Cardiovascular Disease", "Statin Intolerance"],
      "statedClass": ["Proprotein Convertase Subtilisin / Kexin Type 9 Enzyme (PCSK9) Inhibitors", "Monoclonal Antibodies", "Cholesterol Lowering Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Descriptive Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Clinical impact of genomic biomarkers predictors of response and the therapeutic strategy in patients with myelodysplastic syndrome associated with del(5q)",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A160.1",
    "authors": "C Alarcón Payer, A Jiménez Morales, C García Collado, F Hernández Mohedo, M Jurado Chacón",
    "institution": "Hospital Universitario Virgen de las Nieves, Servicio de Farmacia, Granada, Spain. Hospital Universitario Virgen de las Nieves, Servicio de Haematología, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.343",
    "filters": {
      "actSubs": ["Lenalidomide"],
      "indication": ["Myelodysplastic Syndrome"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Next Generation Sequencing (NGS)"],
      "studyLength": ["More than 2 years - 5 years"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": ["pharmacogenetics"],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": ["personalized"],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Local assessment of the impact of pharmacist-led medication reconciliation on hospitalised elderly patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A184.1",
    "authors": "S Nobili, SE Campbell Davies, E Galfrascoli, C Tinelli, M Picca, P Marino, G Muserra, M Medaglia",
    "institution": "Fatebenefratelli e Oftalmico Hospital – Asst Fatebenefratelli Sacco, Hospital Pharmacy, Milan, Italy. S. Matteo Hospital, Epidemiology Department, Pavia, Italy. Macedonio Melloni Hospital- Asst Fatebenefratelli Sacco, Medicine Ward, Milan, Italy. Fatebenefratelli e Oftalmico Hospital- Asst Fatebenefratelli Sacco, Medicine Ward, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.396",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["STATA", "Student's T-test", "Chi-Square (χ2) Test"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Insulin prescription analysis in a third-level hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A72.1",
    "authors": "E Elvira Ladrón de Guevara, Verdejo Reche, B Tauste Hernández, E Martinez Velasco, F Sierra García, E Tejedor Tejada",
    "institution": "C.H.Torrecárdenas, Pharmacy, Almeria, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.159",
    "filters": {
      "actSubs": ["Insulin glargine", "Insulin degludec"],
      "indication": ["Diabetes Type II (Mellitus)", "Hyperglycaemia"],
      "statedClass": ["Insulins"],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Observational Study", "Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Assessment of clinical pharmacist interventions in an intensive care unit",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A171.1",
    "authors": "M Valera Rubio, M Gómez Delgado, A Puerto Morlán, C Estaun, I Moya-Carmona, JM Fernández Ovies",
    "institution": "Hospital Virgen de la Victoria, Hospital Pharmacy, Málaga, Spain. Hospital Virgen de la Victoria, Intensive Medicine, Málaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.367",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Insulins"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": ["nursesReccomend"],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Off-label uses of bevacizumab in ophthalmology in a moroccan university hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A155.1",
    "authors": "O El Hamdaoui, H Elorch, F Rahmaoui, Y Bensouda, Y Elalaoui",
    "institution": "Faculty of Medicine and Pharmacy- Mohammed V University- Rabat- Morocco-, Hospital Pharmacy- Specialty Hospital., Rabat, Morocco. Faculty of Medicine and Pharmacy- Mohammed V University- Rabat- Morocco-, Department of Ophthalmology. Specialty Hospital., Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.333",
    "filters": {
      "actSubs": ["Bevacizumab", "Ranibizumab"],
      "indication": ["Diabetic Macular Oedema", "Age Related Macular Degeneration", "Retinal Vein Occlusion"],
      "statedClass": ["Monoclonal Antibodies"],
      "typeOfMedical": ["Prefilled Syringes"],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Ophthalmology"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Optical Coherence Tomography"],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Lipid modification therapy for primary prevention of cardiovascular disease",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A79.1",
    "authors": "S Fhadil, P Wright, M Khuu, B Hazelrigg, A Jung, O Ruthsatz, S Antoniou",
    "institution": "Barts Health NHS Trust, Pharmacy, London, UK. Purdue University, Pharmacy, West Lafayette, USA",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.174",
    "filters": {
      "actSubs": ["Atorvastatin"],
      "indication": ["Cardiovascular Disease", "Acute Coronary Syndrome"],
      "statedClass": ["Lipid Lowering Agents", "Statins"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Cardiovascular Risk Score (QRISK2)"],
      "studyLength": ["Less than 3 months"],
      "country": ["United Kingdom", "USA"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Impact of antimicrobial stewardship programme on carbapenems resistance and consumption in a tertiary hospital: a before-and-after interventional study",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A96.2",
    "authors": "T Lopez Viñau Lopez, M Saez-Torres de Vicente, I Gracia-Ahufinger, L García-Martinez, J Torre-Cisneros",
    "institution": "Hospital Reina Sofía, Pharmacy Unit, Córdoba, Spain. Hospital Reina Sofía, Microbiology Unit, Córdoba, Spain. Hospital Reina Sofía, Infectious Diseases Unit, Córdoba, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.211",
    "filters": {
      "actSubs": ["Meropenem", "Imipenem"],
      "indication": [],
      "statedClass": ["Carbapenems"],
      "typeOfMedical": [],
      "studyDesign": ["Interventional Study", "Quasi-Experimental Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Defined Daily Dose (DDD)", "Student's T-test", "Chi-Square (χ2) Test", "Statistical Package for the Social Sciences (SPSS)", "ATC/DDD Index"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": ["deprescribing"],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of intra-patient variability of the tacrolimus plasmatic levels in the different periods of the kidney post-transplant",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A138.2",
    "authors": "S Garcia Garcia, DS Oleas Vega, MB Aller Hernández, I Torres Rodriguez, BO Chamoun Huacón, E Pericas Bosch, JB Montoro Ronsano",
    "institution": "Vall d’Hebron Hospital, Pharmacy Service, Barcelona, Spain. Vall d’Hebron Hospital, Nephrology Service, Barcelona, Spain. Vall d’Hebron Hospital, Artificial Intelligence Information Service, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.298",
    "filters": {
      "actSubs": ["Tacrolimus"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)", "Analysis of Variance (ANOVA)", "Fisher–Snedecor F Distribution"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A202.1",
    "authors": "R Mesa Expósito, MDP Díaz Ruiz, M Suárez González, E Tevar Afonso, MA Navarro Dávila, A González Rodríguez, F Pérez Hernández, CL Diaz Diaz, I González García, FJ Merino Alonso",
    "institution": "Hospital Nuestra Señora de la Candelaria, Pharmacy, Santa Cruz de Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.434",
    "filters": {
      "actSubs": ["Obeticholic acid", "Ursodeoxycholic acid"],
      "indication": ["Cirrhosis (Primary Biliary)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["Less than 10"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Iatrogenic hypoglycaemia: frequency and impact on quality of life among type 2 diabetes mellitus patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A202.2",
    "authors": "K Ben Jeddou, A Abbassi, H Sakly, E Ben Mrad, K Khiari, Z Ouahchi",
    "institution": "University Hospital of Bizerte, Pharmacy, Bizerte, Tunisia. University Hospital of Charles Nicolle, Pharmacy, Tunis, Tunisia. University Hospital of Charles Nicolle, Internal Medicine, Tunis, Tunisia",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.435",
    "filters": {
      "actSubs": ["Glucagon", "Glucose"],
      "indication": ["Hypoglycaemia (Iatrogenic)", "Diabetes Type II (Mellitus)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": ["Endocrinology", "Emergency Department"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["EuroQol-5D", "EuroQol Visual Analogue Scale (EQ-VAS)", "Analysis of Variance (ANOVA)", "Chi-Square (χ2) Test"],
      "studyLength": [],
      "country": ["Tunisia"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "A qualitative analysis of barriers to medication adherence in uncontrolled diabetes – focus on insulin and suggestions for practice improvements",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A202.3",
    "authors": "M Jaam, A Awaisu, M Abdul Hadi, MI Mohamed Izham, N Kheir",
    "institution": "Qatar University, Clinical Pharmacy and Practice, Doha, Qatar. De Montfort University, Leicester School of Pharmacy, Leicester, UK. University of Auckland, School of Pharmacy Faculty of Medical and Health Sciences, Auckland, New Zealand",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.436",
    "filters": {
      "actSubs": [],
      "indication": ["Diabetes Type II (Mellitus)"],
      "statedClass": ["Insulins"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Qatar", "New Zealand", "United Kingdom"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Observational study of the evolution of blood glucose levels after the change to insulin degludec",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A203.1",
    "authors": "ML Moya-Martin, C Castillo-Martin, M Fernandez-Gonzalez, C Donoso-Rengifo, L Rendón de Lope, J Cordero-Ramos, M Murillo-Izquierdo, MD Alvarado-Fernandez, S Santana-Martinez, E Romero-Carreño",
    "institution": "Hospital Universitario Virgen Macarena, Pharmacy, Seville, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.437",
    "filters": {
      "actSubs": ["Insulin glargine", "Insulin degludec"],
      "indication": ["Hypoglycaemia", "Diabetes Type I (Juvenile)", "Diabetes Type II (Mellitus)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Safety and efficacy of fast-acting insulin added to total parenteral nutrition",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A203.2",
    "authors": "M Aznar Garcia, J Canto Mangana, D Rubio Calvo, A Martos Rosa, A Jofré Peralta, F Ávila Cabrera, J Urda",
    "institution": "Empresa Pública Hospital de Poniente, Pharmacy, El Ejido Almería, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.438",
    "filters": {
      "actSubs": [],
      "indication": ["Hyperglycaemia"],
      "statedClass": ["Insulins (Rapid-Acting)"],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Critical Care Unit"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Use of substitute enzymatic treatment and substrate reduction in gaucher disease",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A204.1",
    "authors": "V González Rosa, MI Sierra Torres, S Fernández Espínola, M Zaragoza Rascón, M Pajares Alonso",
    "institution": "Hospital Serrania Ronda, Servicio de Farmacia, Ronda Málaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.439",
    "filters": {
      "actSubs": ["Miglustat", "Velaglucerase alfa", "Imiglucerase"],
      "indication": ["Gaucher Disease", "Hepatosplenomegaly", "Anemia", "Thrombopaenia"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["Less than 10"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": ["enzymeSubstrate"],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Sebelipase alfa as enzyme replacement therapy in three paediatric patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A204.2",
    "authors": "C Jimenez Nunez, J Alvarez Criado, T Perez Robles, P Gabaldon Garnica, C Jimenez Vicente, M Moreno Palomino, P Lucena Martinez, A Herrero Ambrosio",
    "institution": "Hospital Universitario la Paz, Hospital Pharmacy, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.440",
    "filters": {
      "actSubs": ["Sebelipase alfa"],
      "indication": ["Lysosomal Acid Lipase Deficiency", "Fibrosis (Liver)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": ["enzymeSubstrate"],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "CYP2C19 SNP’s influence on clopidogrel response in peripheral artery disease patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A205.1",
    "authors": "X Díaz-Villamarín, CL Dávila-Fajardo, D Blánquez-Martínez, E Fernández-Gómez, A Antúnez-Rodríguez, ÁS Raquel",
    "institution": "Farmacia Hospital San Cecilio, Pharmacy, Granada, Spain. Genyo, Genomics Unit, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.441",
    "filters": {
      "actSubs": ["Clopidogrel"],
      "indication": ["Peripheral Arterial Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Univariate Analysis", "Multivariate Analysis", "Survival Analysis"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": ["pharmacogenetics"],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "CYP2C19 SNP’s influence on clopidogrel response in cerebrovascular disease patients: final results",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A205.2",
    "authors": "X Díaz-Villamarín, CL Dávila-Fajardo, D Blánquez-Martínez, E Fernández-Gómez, A Antúnez-Rodríguez, ÁS Raquel",
    "institution": "Farmacia Hospital San Cecilio, Pharmacy, Granada, Spain. Genyo, Genomics Unit, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.442",
    "filters": {
      "actSubs": ["Clopidogrel"],
      "indication": ["Cerebrovascular Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Univariate Analysis", "Multivariate Analysis", "Survival Analysis"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": ["pharmacogenetics"],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Manipulation of warfarin tablets in paediatric care: do we give the right dose?",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A206.1",
    "authors": "J Brustugun, E Birkedal AAS, I Tho, K Bjerknes",
    "institution": "Hospital Pharmacy Enterprises- South Eastern Norway, Sao- Rikshospitalet, Oslo, Norway. School of Pharmacy- University of Oslo, Pharmaceutics, Oslo, Norway. Hospital Pharmacy Enterprises- South Eastern Norway, Hospital Pharmacy- Lørenskog, Lørenskog, Norway",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.443",
    "filters": {
      "actSubs": ["Warfarin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Ultra High Performance Liquid Chromatography (UHPLC)"],
      "studyLength": [],
      "country": ["Norway"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Venous thromboembolic events and total hip or knee arthroplasty: incidence and associated factors",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A206.2",
    "authors": "A Etangsale, B Kadri, C Balouzet, E Snobbert, S Pargade, S Camps",
    "institution": "Institut Mutualiste Montsouris, Paris, Paris 14th, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.444",
    "filters": {
      "actSubs": ["Rivaroxaban", "Dabigatran"],
      "indication": ["Venous Thromboembolism"],
      "statedClass": ["Low Molecular Weight Heparins"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["501 - 1000"],
      "numPrescriptions": [],
      "criteriaMethod": ["Fisher’s Exact Test"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Impact of therapeutic patient education in the prevention and treatment of venous thromboembolism in patients with cancer",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A207.1",
    "authors": "L Le Meur, I Benzidia, A Hij, I Madelaine, C Frere, L Deville, D Farge",
    "institution": "Saint Louis Hospital, Pharmacy, Paris, France. Saint Louis Hospital, Internal Medicine, Paris, France. Pitié-Salpétrière Hospital, Biological Haematology, Paris, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.445",
    "filters": {
      "actSubs": ["Tinzaparin sodium"],
      "indication": ["Venous Thromboembolism", "Thrombosis (Cancer-Associated)", "Breast Cancer", "Lung Cancer", "Thrombosis (Catheter-Related)", "Thrombosis (Deep Vein)", "Pulmonary Embolism"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Prescriptions of direct oral anticoagulants in patients admitted",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A207.2",
    "authors": "S Ruiz Garcia, E Alañón Plaza, A Calvo García, I Cidoncha Muñoz, M Ruiz López, C Martínez Nieto, A Ibáñez Zurriaga, A Morell Baladrón",
    "institution": "Hospital Universitario la Princesa, Farmacia Hospitalaria, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.446",
    "filters": {
      "actSubs": ["Apixaban", "Dabigatran", "Rivaroxaban", "Acenocoumarol"],
      "indication": ["Atrial Fibrillation"],
      "statedClass": ["Direct Oral Anticoagulants"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Novel oral anticoagulants vs vitamin K antagonists: a cost analysis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A208.1",
    "authors": "M Tonelli, DA Barila’, E Caiazza, M Scaldaferri, F Cattel",
    "institution": "A.O.U. Città Della Salute e Della Scienza di Torino, Hospital Pharmacy, Turin, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.447",
    "filters": {
      "actSubs": ["Warfarin", "Dabigatran", "Rivaroxaban"],
      "indication": ["Haemorrhage", "Anemia"],
      "statedClass": ["Vitamin K Antagonists", "Novel Oral Anticoagulants"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Drug interaction between noacs and itraconazole: an italian district analysis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A208.2",
    "authors": "E Viglione, M Lecis, S Strobino, G Ceravolo",
    "institution": "ASL TO3, Hospital Pharmacy, Rivoli, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.448",
    "filters": {
      "actSubs": ["Itraconazole", "Apixaban", "Edoxaban", "Rivaroxaban", "Dabigatran", "Acetylsalicylic acid"],
      "indication": [],
      "statedClass": ["Novel Oral Anticoagulants"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Unfavourable outcomes of blood transfusions in hospitalised anaemic patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A208.3",
    "authors": "A Alcobia, A Soares, MF Delerue, H Pereira, H Mansinho, J Félix, M Afonso-Silva, M Vargas Gomes, M Amorim, M Plácido, S Rabiais, V Andreozzi",
    "institution": "Hospital Garcia de Orta, Pharmaceutical Services, Almada, Portugal. Hospital Garcia de Orta, Internal Medicine, Almada, Portugal. Hospital Garcia de Orta, Cardiology, Almada, Portugal. Hospital Garcia de Orta, Haemato-Oncology, Almada, Portugal. Exigo Consultores, Director, Lisbon, Portugal. Exigo Consultores, Outcomes Research, Lisbon, Portugal. Exigo Consultores, Quantitative Department, Lisbon, Portugal. Exigo Consultores, Quantitative Department and Research and Innovation, Lisbon, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.449",
    "filters": {
      "actSubs": ["Iron sucrose", "Ferric carboxymaltose"],
      "indication": ["Anemia"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Cohort Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": ["Logistic Regression Analysis"],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Implementation and monitoring of a protocol for the use of intravenous iron",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A209.1",
    "authors": "LS Diego, AM Tamara, CL Isabel, CM Isabel, FG Maria Elisa",
    "institution": "Hospital Santa Bárbara, Pharmacy, Soria, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.450",
    "filters": {
      "actSubs": ["Ferric carboxymaltose", "Iron sucrose"],
      "indication": ["Anemia"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine", "Gastroenterology"],
      "numPatients": [],
      "numPrescriptions": ["101 - 500"],
      "criteriaMethod": ["Ganzoni Equation for Iron Deficiency Anemia"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Implementation of parenteral nutrition prescribing software in a neonatal intensive care unit",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A209.2",
    "authors": "A Abbassi, N Hasni, E Bokri, M Mseddi, E Ben Hamida",
    "institution": "Hospital Charles Nicolle, Tunis, Tunisia. Faculty of Pharmacy, Monastir, Tunisia. Neonatology, Hospital Charles Nicolle, Tunis, Tunisia",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.451",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Comparative Study"],
      "setting": ["Hospital"],
      "ward": ["Neonatal Intensive Care", "Neonatal Unit"],
      "numPatients": [],
      "numPrescriptions": ["51 - 100"],
      "criteriaMethod": ["PSPP (GNU Project)"],
      "studyLength": ["3 months - 5 months"],
      "country": ["Tunisia"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Switching from individualised nutrition to standardised or commercialised nutrition in newborns: are there any possibilities?",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A210.1",
    "authors": "YE Nisse, B Vidal, M Lux, JM Hascoet, B Demoré",
    "institution": "Chru Nancy, Pharmacy, Vandoeuvre-Lès-Nancy, France. Maternité Régionale Universitaire, Pharmacy, Nancy, France. Maternité Régionale Universitaire, Neonatalogy, Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.452",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": ["More than 1000"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": ["personalized"],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Safety evaluation of injectable potassium chloride prescriptions in hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A210.2",
    "authors": "JB Taouk, B Taouk, M Diracca, E Pieri, S Gayetty, F Raymond, C Nassibian, S Salini",
    "institution": "Centre Hospitalier Notre-Dame de la Miséricorde, Pharmacy, Ajaccio, France. Centre Hospitalier Universitaire Reims, Pharmacy, Reims, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.453",
    "filters": {
      "actSubs": ["Potassium chloride"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Transversal Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": ["youngPharma"],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Pharmacogenetic testing for personalisation of statin therapy",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A211.1",
    "authors": "J Cerdá Iñesta, F Wirth, G Zahra, RG Xuereb, C Barbara, A Serracino-Inglott",
    "institution": "Department of Pharmacy, Faculty of Medicine and Surgery. University of Malta, Msida, Malta. Molecular Diagnostics Unit, Department of Pathology- Mater Dei Hospital, Msida, Malta. Cardiac Catheterisation Suite, Department of Cardiology- Mater Dei Hospital, Msida, Malta",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.454",
    "filters": {
      "actSubs": ["Simvastatin", "Rosuvastatin"],
      "indication": ["Myopathy"],
      "statedClass": ["Statins"],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Real-Time Polymerase Chain Reaction"],
      "studyLength": [],
      "country": ["Malta"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": ["pharmacogenetics"],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": ["personalized"],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "An evaluation of the pharmacist intervention in intravenous mixtures’ stability",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A211.2",
    "authors": "E Rodríguez Molíns, Y Labeaga, B Rodriguez de Castro, B Fernández González, R Pampín Sánchez",
    "institution": "Cabueñes Hospital, Hospital Pharmacy, Gijón, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.455",
    "filters": {
      "actSubs": ["Dopamine", "Nitroglycerin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["51 - 100"],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": ["nursesReccomend"],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Adequate digoxin dosage in patients with digitalis toxicity",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A212.1",
    "authors": "JJ Martínez Simón, A Martín Suárez, AM Gómez Pedrero, M Pérez Encinas",
    "institution": "Hospital Universitario Fundación Alcorcón, Hospital Pharmacy, Alcorcón, Spain. Universidad De Salamanca, Department of Pharmacy and Pharmaceutical Technology, Salamanca, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.456",
    "filters": {
      "actSubs": ["Digoxin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["STOPP/START Criteria", "Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) Equation"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": ["highRisk"],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Medication errors – a cause for major cardiovascular events in an emergency department",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A212.2",
    "authors": "MA Neag, DM Prunea, IC Bocsan, MF Neag, A Catinean, AD Buzoianu",
    "institution": "’Iuliu Hatieganu’ University of Medicine and Pharmacy, Department of Pharmacology- Toxicology and Clinical Pharmacology- Faculty of Medicine, Cluj-Napoca, Romania. Institute of Oncology ‘Prof. Dr. Ion Chiricuta’, Pharmacy, Cluj-Napoca, Romania. ‘Iuliu Hatieganu’ University of Medicine and Pharmacy, Department of Internal Medicine – Faculty of Medicine, Cluj-Napoca, Romania",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.457",
    "filters": {
      "actSubs": [],
      "indication": ["Cardiovascular Disease", "Stroke", "Hypertension", "Acute Coronary Syndrome"],
      "statedClass": ["Anticoagulants", "Antiplatelet Agents"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Romania"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Pulmonary arterial hypertension drugs: epidemiological analysis concerning an italian district",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A213.1",
    "authors": "M Lecis, E Viglione, S Strobino, G Ceravolo",
    "institution": "Asl TO3, Hospital Pharmacy, Rivoli, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.458",
    "filters": {
      "actSubs": [],
      "indication": ["Hypertension (Pulmonary Arterial)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Impact of a safety alert with valsartan in a health management area",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A213.2",
    "authors": "ST Maria Isabel, V Gonzalez Rosa, S Fernandez Espinola",
    "institution": "Hospital Serranía de Málaga, Farmacia Hospitalaria, Ronda, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.459",
    "filters": {
      "actSubs": ["Valsartan", "Losartan", "Telmisartan", "Candesartan"],
      "indication": [],
      "statedClass": ["Angiotensin II Receptor Blockers (ARBs)"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effectiveness and safety of tolvaptan and urea for the treatment of severe symptomatic hyponatraemia: a case series",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A213.3",
    "authors": "FI Maria Belen, M Valera Rubio, MI Sierra Torres, C Estaun, I Moya-Carmona, JM Fernández Ovies",
    "institution": "Hospital Universitario Virgen de la Victoria, Hospital Pharmacy, Málaga, Spain. Hospital de la Serrania, Hospital Pharmacy, Ronda, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.460",
    "filters": {
      "actSubs": ["Tolvaptan", "Urea"],
      "indication": ["Hyponatraemia", "Heart Failure", "Syndrome of Inappropriate Antidiuretic Hormone Secretion"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series", "Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["Less than 10"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "The governance of PCSK9-inhibitors for the treatment of primary hypercholesterolaemia: appropriateness analysis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A214.1",
    "authors": "MR Garreffa, C Zito, S Esposito, C Monopoli, MD Naturale, AE de Francesco",
    "institution": "Azienda Ospedaliero-Universitaria ‘Mater Domini’, Unit of Pharmacy, Catanzaro, Italy. University of ‘Magna Graecia’, School of Specialization in Hospital Pharmacy, Catanzaro, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.461",
    "filters": {
      "actSubs": ["Ezetimibe"],
      "indication": ["Hypercholesterolaemia"],
      "statedClass": ["Proprotein Convertase Subtilisin / Kexin Type 9 Enzyme (PCSK9) Inhibitors", "Statins"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Grading of Recommendations Assessment, Development and Evaluation (GRADE) Approach"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effectiveness and safety of evolocumab in real clinical practice",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A214.2",
    "authors": "MV Villacañas Palomares, A Colón Lopez de Dicastillo, I Gutiérrez Pérez, F Uriarte Estefania, R Santos del Prado, S Lorenzo Martin, E Parra Alonso",
    "institution": "Hospital de Sierrallana, Servicio de Farmacia, Torrelavega, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.462",
    "filters": {
      "actSubs": ["Evolocumab"],
      "indication": ["Atherosclerosis"],
      "statedClass": ["Statins"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Do we know which antibiotics should be avoided in our patients? Antibiotic allergy survey among hospitalised patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A215.1",
    "authors": "R Benko, T Vivien, M Maria, D Peter, V Reka, B Reka, S Gyongyver",
    "institution": "University of Szeged, Clinical Pharmacy, Szeged, Hungary",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.463",
    "filters": {
      "actSubs": [],
      "indication": ["Anaphylaxis"],
      "statedClass": ["Antibiotics", "Antibiotics (Systemic)", "Penicillins", "Sulfonamides", "Anti‐Bacterial Agents"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["Hungary"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "A two-year retrospective analysis of adverse drug reactions with fluoroquinolone and quinolone antibiotics",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A215.2",
    "authors": "V Borsi1, M Del Lungo2, L Giovannetti1, MG Lai1, M Parrilli1",
    "institution": "Azienda Usl Toscana Centro, Pharmacovigilance, Florence, Italy. University of Florence, Dept. of Neurosciences- Psychology- Drug Research and Child Health Neurofarba- Section of Pharmacology and Toxicology, Florence, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.464",
    "filters": {
      "actSubs": ["Ciprofloxacin", "Flumequine", "Levofloxacin", "Lomefloxacin", "Moxifloxacin", "Norfloxacin", "Ofloxacin", "Pefloxacin", "Prulifloxacin", "Rufloxacin", "Cinoxacin", "Nalidixic acid", "Pipemidic acid"],
      "indication": ["Urinary Tract Infection", "Respiratory Tract Infection"],
      "statedClass": ["Quinolones"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Pharmacovigilance Department"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": ["vigilance"],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Administration protocol for penicillin G in a patient with a severe reaction to betalactams and abdominal actinomycosis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A216.1",
    "authors": "E Izquierdo, A Lazaro-Cebas, A Carreño-Ocaña, N Blanca-Lopez, FJ Ruano-Perez, A Such-Diaz, P Tejedor-Prado, EA Alvaro-Alonso, A Santiago-Perez, MG Canto-Diez, I Escobar-Rodriguez",
    "institution": "Infanta Leonor Hospital, Pharmacy, Madrid, Spain. Infanta Leonor Hospital, Allergology, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.465",
    "filters": {
      "actSubs": ["Penicillin G", "Ceftriaxone", "Norepinephrine", "Adrenaline", "Salbutamol"],
      "indication": ["Actinomycosis (Abdominal)", "Anaphylaxis"],
      "statedClass": ["Beta-Lactam Antibiotics", "Corticosteroids"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effectiveness of computerised decision support system-based intervention in antimicrobial use: the HIGEA project",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A216.2",
    "authors": "CG Rodriguez-Gonzalez, E Chamorro-de Vega, S Ibañez-Garcia, ML Martin-Barbero, JL de la Rosa, A Herranz-Alonso, M Sanjurjo-Saez",
    "institution": "Hospital General Universitario Gregorio Marañon. Instituto de Investigacion Sanitaria Gregorio Marañon, Pharmacy, Madrid, Spain. Yerbabuena Software, It Department in Information System, Malaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.466",
    "filters": {
      "actSubs": ["Linezolid", "Fluconazole"],
      "indication": [],
      "statedClass": ["Penicillins", "Cephalosporins", "Quinolones", "Antifungal Azoles", "Carbapenems"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Linezolid and serotonin syndrome",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A217.1",
    "authors": "R Seisdedos, P Lopez",
    "institution": "Hospital Universitario Puerto Real, Farmacia, Puerto Real, Spain. Hospital de Tomelloso, Farmacia, Tomelloso, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.467",
    "filters": {
      "actSubs": ["Linezolid", "Fentanyl", "Tramadol", "Pethidine", "Sertraline", "Venlafaxine", "Citalopram"],
      "indication": ["Serotonin Syndrome"],
      "statedClass": ["Serotonergic Agents", "Opioids", "Antidepressants"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Analysis of the medication treatment of community-acquired pneumonia treated in the community and having resulted in hospitalisation",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A217.2",
    "authors": "C Trouilleux, H Faure, H Poujol, C Lechiche, G Leguelinel-Blache, A Sotto",
    "institution": "CHU Carémeau, Pharmacie, Nîmes, France. CH Cognac, Pharmacie, Cognac, France. CHU Carémeau, Service De Maladies Infectieuses et Tropicales, Nîmes, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.468",
    "filters": {
      "actSubs": [],
      "indication": ["Pneumonia (Community Acquired)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital", "Community Pharmacy"],
      "ward": ["Emergency Department"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Polypharmacy and deprescribing in HIV-infected elderly population",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A218.1",
    "authors": "S Gallardo, J Pardo, P March, G Garreta, C Sangrador, J Nicolás",
    "institution": "Hospital Universitario Mutua Terrassa, Pharmacy, Terrassa, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.469",
    "filters": {
      "actSubs": ["Oxycodone"],
      "indication": ["Acquired Immunodeficiency Syndrome (AIDS)"],
      "statedClass": ["Anticholinergics", "Sulfonylureas", "Antihistamines", "Antipsychotics", "Bisphosphonates", "Cholinesterase Inhibitors", "Non-Steroidal Anti-Inflammatory Drugs", "Proton-Pump Inhibitors", "Hypnotics", "Sedatives", "Selective Serotonin Reuptake Inhibitors (SSRIs)", "Antidepressants (Tricyclic)"],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Descriptive Study", "Transversal Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Descriptive Statistics", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": ["deprescribing"],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Analysis of human immunodeficiency virus postexposure prophylaxis in a third-level hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A218.2",
    "authors": "C Estaun, I Moya-Carmona, E Sánchez-Yañez, JM Fernández-Ovies",
    "institution": "Hospital Virgen de la Victoria- Málaga, Pharmacy, Malaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.470",
    "filters": {
      "actSubs": ["Emtricitabine", "Tenofovir disoproxil", "Raltegravir", "Emtricitabine / Tenofovir disoproxil", "Darunavir / Ritonavir", "Darunavir", "Ritonavir", "Lopinavir / Ritonavir", "Lopinavir", "Emtricitabine / Tenofovir disoproxil / Elvitegravir / Cobicistat", "Elvitegravir", "Cobicistat"],
      "indication": ["Acquired Immunodeficiency Syndrome (AIDS)"],
      "statedClass": ["Antiretrovirals"],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Observational Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Safety and effectiveness of HIV post-exposure prophylaxis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A219.1",
    "authors": "A Fernandes, A Brito, L Lourenço, S Domingos, A Alcobia",
    "institution": "Hospital Garcia de Orta, Pharmacy, Almada, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.471",
    "filters": {
      "actSubs": ["Raltegravir", "Emtricitabine / Tenofovir disoproxil", "Emtricitabine", "Tenofovir disoproxil"],
      "indication": ["Acquired Immunodeficiency Syndrome (AIDS)"],
      "statedClass": ["Antiretrovirals"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": ["101 - 500"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Glecaprevir/pibrentasvir association for chronic hepatitis C virus infection: results in health",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A219.2",
    "authors": "MD Gil-Sierra, E Rios-Sanchez, F Tellez-Perez, MDP Briceño-Casado, S Fenix-Caballero, C Martinez-Diaz, J Diaz-Navarro, C Palomo-Palomo, EJ Alegre-del Rey, M Camean-Castillo, JM Borrero-Rubio",
    "institution": "Hospital Universitario de Puerto Real, Pharmacy, Puerto Real, Spain. Hospital Universitario de Puerto Real, Internal Medicine Service, Puerto Real, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.472",
    "filters": {
      "actSubs": ["Glecaprevir / Pibrentasvir", "Glecaprevir", "Pibrentasvir"],
      "indication": ["Hepatitis C (Chronic)", "Fibrosis (Liver)", "Cirrhosis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine", "Infectious Disease"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Real-life direct-acting antivirals effectiveness comparative study in HIV-hepatitis C virus coinfected patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A220.1",
    "authors": "L Margusino-Framiñan, C Mondelo-Garcia, V Gimenez-Arufe, N Fernandez-Bargiela, C Fernandez-Oliveira, S Rotea-Salvo, P Cid-Silva, A Mena-de-Cea, I Rodriguez-Osorio, I Martin-Herranz, A Castro-Iglesias",
    "institution": "Complexo Hospitalario Universitario A Coruña, Pharmacy, A Coruña, Spain. Complexo Hospitalario Universitario A Coruña, Infectious Diseases, A Coruña, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.473",
    "filters": {
      "actSubs": ["Ledipasvir / Sofosbuvir", "Ledipasvir", "Sofosbuvir", "Ribavirin", "Sofosbuvir / Daclatasvir", "Daclatasvir", "Sofosbuvir / Velpatasvir", "Velpatasvir"],
      "indication": ["Acquired Immunodeficiency Syndrome (AIDS)", "Hepatitis C (Chronic)", "Cirrhosis", "Fibrosis (Liver)", "Hepatocarcinoma"],
      "statedClass": ["Direct Acting Antivirals"],
      "typeOfMedical": [],
      "studyDesign": ["Comparative Study", "Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": ["Descriptive Statistics", "Fisher’s Exact Test", "Mann-Whitney U Test"],
      "studyLength": ["More than 2 years - 5 years"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": ["pharmacogenetics"],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Efficacy and safety of cidofovir in the treatment of laryngeal papillomatosis: case reports",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A220.2",
    "authors": "M Navarro, A Puebla, E Tevar, R Mesa, L Diaz, A Ocaña, M Viña, I Plasencia, I Gonzalez, J Merino",
    "institution": "Hospital Nuestra Señora de Candelaria, Pharmacy, Santa Cruz de Tenerife, Spain. Hospital San Rafael, Pharmacy, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.474",
    "filters": {
      "actSubs": ["Cidofovir"],
      "indication": ["Papillomatosis (Laryngeal)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["Less than 10"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Modification on fasting lipid and renal parameters in patients switching from tenofovir disoproxil to tenofovir alafenamide",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A221.1",
    "authors": "P Taberner Bonastre, L Vallez Valero, SM Cano Marrón, T Puig Ganau, B Amoros Folguera, FI Torres Bondia, JA Schoenenberger Arnaiz",
    "institution": "Hospital Universitario Santa Maria, Hospital Pharmacy, Lleida, Spain. Hospital Universitario Arnau De Vilanova De Lleida, Pharmacy, Lleida, Spain. Hospital Universitario Arnau De Vilanova De Lleida, Infectious Diseases, Lleida, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.475",
    "filters": {
      "actSubs": ["Tenofovir disoproxil", "Tenofovir alafenamide", "Emtricitabine / Tenofovir disoproxil / Elvitegravir / Cobicistat", "Emtricitabine / Tenofovir alafenamide / Elvitegravir / Cobicistat"],
      "indication": ["Acquired Immunodeficiency Syndrome (AIDS)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Student's T-test", "Wilcoxon Signed Rank Test", "Pearson Correlation Coefficient", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Comorbidities, polypharmacy and adherence in geriatric HIV patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A221.2",
    "authors": "JM Vinuesa Hernando, M Gimeno Gracia, T Salvador Gómez, MDP Pardo Jario, MA Alcacera, S Gamarra Calvo, FJ Campos Montellano, B Bonaga Serrano, AJ Frutos Perez-Surio",
    "institution": "Hospital Clínico Universitario Lozano Blesa, Pharmacy, Zaragoza, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.476",
    "filters": {
      "actSubs": [],
      "indication": ["Acquired Immunodeficiency Syndrome (AIDS)", "Hypertension", "Diabetes Type II (Mellitus)", "Dyslipidaemia", "Central Nervous System Disorders"],
      "statedClass": ["Antiretrovirals"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Aseptic meningitis induced by intravenous immunoglobulin",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A221.3",
    "authors": "M Domínguez Bachiller, MI Barcia Martin, AM Martin de Rosales, M Pérez Encinas",
    "institution": "Hospital Universitario Fundación Alcorcon, Hospital Pharmacy, Alcorcon, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.477",
    "filters": {
      "actSubs": ["Immunoglobulin (IVIg)"],
      "indication": ["Meningitis (Aseptic)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Karch-Lasagna Modified Algorithm"],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Safety profile of sunitinib in real clinical practice",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A222.1",
    "authors": "A Alcala Soto, C Puivecino Moreno, R Gazquez Perez, A Varas Perez, V Sanchez-Matamoros Piazza, L Jimenez Pichardo, V Vazquez Vela, JF Sierra Sanchez, R Gavira Moreno, MT Gomez de Travecedo Y Calvo",
    "institution": "Hospital Universitario Jerez de la Frontera, Pharmacy Service, Jerez de la Frontera-Cádiz, Spain. Hospital San Juan Grande, Pharmacy Service, Jerez De La Frontera-Cádiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.478",
    "filters": {
      "actSubs": ["Sunitinib"],
      "indication": ["Renal Cell Cancer", "Gastrointestinal Stromal Tumor", "Pancreatic Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Efficacy and safety of panitumumab in metastatic colorectal cancer treatment",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A222.2",
    "authors": "MS Aldirra-Taha, A Planas-Giner, MÁ Pérez-Quirós, R Rodriguez Mauriz, N Almendros Abad, L Borras Trias, C Segui Solanes, N Rudi Sola",
    "institution": "Hospital General de Granollers, Hospital Pharmacy, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.479",
    "filters": {
      "actSubs": ["Panitumumab"],
      "indication": ["Colorectal Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Response Evaluation Criteria In Solid Tumours (RECIST)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Nivolumab flat dose, clinical-ethical and economic implications",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A223.1",
    "authors": "FN Beretta, D Zenoni, DB Bonzi, V Martinelli",
    "institution": "Università Degli Studi di Milano, Scuola di Specializzazione in Farmacia Ospedaliera, Milano, Italy. Asst Bergamo Est, Farmacia Interna, Alzano Lombardo, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.480",
    "filters": {
      "actSubs": ["Nivolumab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": ["flatDoses"],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": ["vigilance"],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Real-world safety and tolerability of the recently commercialised palbociclib",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A223.2",
    "authors": "A Colón López de Dicastillo, I Gutiérrez Pérez, V Villacañas Palomares, F Uriarte Estefanía, S Lorenzo Martín, R Santos del Prado, E Parra Alonso",
    "institution": "Hospitales Sierrallana Y Tres Mares, Pharmacy Service, Torrelavega, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.481",
    "filters": {
      "actSubs": ["Palbociclib", "Fulvestrant"],
      "indication": ["Breast Cancer (HR Positive / HER2 Negative Metastatic)"],
      "statedClass": ["Aromatase Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["Less than 10"],
      "numPrescriptions": [],
      "criteriaMethod": ["Common Terminology Criteria for Adverse Events"],
      "studyLength": ["6 months - 1 year"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Atezolizumab: efficacy and safety in advanced non-small cell lung cancer",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A224.1",
    "authors": "D Fernandez, C Otero, A Álamo, E Mateos, M Lombardero, ME Lujan, D Dorta, A Dominguez",
    "institution": "Complejo Hospitalario Insular Materno-Infantil de Gran Canaria, Pharmacy, LAS Palmas de Gran Canaria, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.482",
    "filters": {
      "actSubs": ["Atezolizumab"],
      "indication": ["Non-Small Cell Lung Cancer"],
      "statedClass": ["Platinum Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Eastern Cooperative Oncology Group (ECOG) Performance Status", "Descriptive Statistics", "Statistical Package for the Social Sciences (SPSS)", "Kaplan-Meier Method", "Common Terminology Criteria for Adverse Events"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Toxicity with 5-fluorouracil and irinotecan: interest of genotyping in patient care",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A224.2",
    "authors": "M Gallard, J Arcizet, B Dalifard, M Laplace, V Moulin, B Lefranc",
    "institution": "GH La Rochelle Ré Aunis, Pharmacy, La Rochelle, France. GH La Rochelle Ré Aunis, Oncology Unit, La Rochelle, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.483",
    "filters": {
      "actSubs": ["Florourasil (5-FU)", "Irinotecan"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": ["pharmacogenetics"],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": ["personalized"],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Analysis of cardiovascular events associated with carfilzomib in patients with multiple refractory myeloma",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A225.1",
    "authors": "D Garcia, G Lizeaga Cundin, MJ Garcia de Andoin Barandiaran, A Zurutuza Lopez, J Landa Alberdi, T Gonzalez Fernandez, A Lizardi Mutuberria, M Urretavizkaya Anton, L Leunda Eizmendi, MA Aranguren Redondo, MP Bachiller Cacho",
    "institution": "University Hospital of Donostia, Pharmacist, San Sebastian, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.484",
    "filters": {
      "actSubs": ["Carfilzomib", "Bortezomib", "Cyclophosphamide", "Dexamethasone", "Lenalidomide"],
      "indication": ["Multiple Myeloma", "Hypertension (Pulmonary Arterial)", "Diabetes Type II (Mellitus)", "Dyslipidaemia", "Heart Failure", "Atrial Fibrillation", "Ischaemia (Transient)"],
      "statedClass": ["Diuretics", "Corticosteroids"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Cardiology"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "The error room: a fun training tool for the pharmaceutical chemotherapy unit",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A225.2",
    "authors": "M Jaffuel, J Mangavelle, S Vernardet, I Lefort",
    "institution": "Centre Hospitalier D’ardèche Nord, Pharmacie, Annonay, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.485",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Adaptation of prophylaxis against varicella–zoster virus in patients with multiple myeloma",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A226.1",
    "authors": "I Larrosa Espejo, C Tallon Martinez, E Roson Sanchez, G Hernando Llorente, M Molinero Muñoz, M Saenz de Tejada Lopez, JM Martinez Sesmero",
    "institution": "Clinico San Carlos Hospital, Pharmacy Service, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.486",
    "filters": {
      "actSubs": ["Daratumumab", "Carfilzomib", "Acyclovir"],
      "indication": ["Multiple Myeloma", "Chronic Kidney Disease", "Glomerulopathy (Chronic)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Haematology"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": ["personalized"],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": ["antibioticProphylaxis"],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Nivolumab in lung cancer: from weight-based to flat dosing",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A226.2",
    "authors": "V Leclerc, E Cartet, S Demir, S Luciani, E Pont",
    "institution": "Centre Hospitalier Pierre Oudot, Pharmacy Department, Bourgoin-Jallieu, France. Centre Hospitalier Pierre Oudot, Pneumology Department, Bourgoin-Jallieu, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.487",
    "filters": {
      "actSubs": ["Nivolumab"],
      "indication": ["Non-Small Cell Lung Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": ["flatDoses"],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Does palbociclib mean neutropaenia?",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A226.3",
    "authors": "A Perez Contel, L Soriano-Gutierrez, VJ de Pedro Ambrosio, P Miralles-Albors, G Puig Comas, S Fernandez-Molina, M Gomez-Valent",
    "institution": "Consorci Corporacio Sanitaria Parc Tauli, Pharmacy, Sabadell, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.488",
    "filters": {
      "actSubs": ["Palbociclib"],
      "indication": ["Neutropenia"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Oncology"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Safety between the use of commercial and generic imatinib: is the excipient relevant?",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A227.1",
    "authors": "MA Perez Quiros, M Cortés-Sansa, A Planas-Giner, MS Aldirra-Taha, R Rodriguez-Mauriz, N Almendros-Abad, L Borras-Trias, C Seguí-Solanes, N Rudi-Sola",
    "institution": "Granollers General Hospital, Pharmacy, Granollers Barcelona, Spain. Granollers General Hospital, Hematology, Granollers Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.489",
    "filters": {
      "actSubs": ["Imatinib", "Nilotinib", "Bosutinib"],
      "indication": ["Leukaemia (Chronic Myeloid)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Olaparib and niraparib safety profile in the clinical practice of a tertiary-level hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A227.2",
    "authors": "A Pinilla Rello, H Navarro Aznarez, A Magallón Martínez, B Abad Bañuelos, O Pereira Blanco, A Casajus Navasal, MR Abad Sazatornil, A Herrero Ibañez",
    "institution": "Universitary Miguel Servet Hospital, Hospital Pharmacy, Zaragoza, Spain. Universitary Miguel Servet Hospital, Oncology Service, Zaragoza, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.490",
    "filters": {
      "actSubs": ["Olaparib", "Niraparib"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Transversal Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Measuring adherence to european society of cardiology guidelines for patients treated with trastuzumab",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A228.1",
    "authors": "R Rainone, O Gleizes, S Foucher, A Rieutord",
    "institution": "Antoine-Béclère Hospital AP-HP, Pharmacy, Clamart, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.491",
    "filters": {
      "actSubs": ["Trastuzumab", "Epirubicin"],
      "indication": ["Hypertension"],
      "statedClass": ["Beta-Blockers", "Angiotensin Converting Enzyme (ACE) Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Cyclin dependent kinases 4/6 inhibitors: new options in hr+ her2- breast cancer",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A228.2",
    "authors": "J Ramos Rodríguez, S Hernández Rojas, I González Perera, MM Viña Romero, GJ Nazco Casariego, FJ Merino Alonso, S García Gil, B Del Rosario García, L Cantarelli, F Gutiérrez Nicolás",
    "institution": "Hospital Universitario de Canarias, Pharmacy, Santa Cruz De Tenerife, Spain. Hospital Universitario Nuestra Señora de la Candelaria, Pharmacy, Santa Cruz De Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.492",
    "filters": {
      "actSubs": ["Palbociclib", "Ribociclib"],
      "indication": ["Breast Cancer (HR Positive / HER2 Negative Metastatic)"],
      "statedClass": ["Cyclin-Dependent Kinases 4/6 Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Common Terminology Criteria for Adverse Events"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Immunotherapy and toxicity: experience in a third-level hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A229.1",
    "authors": "J Ramos Rodríguez, S García Gil, B Del Rosario García, L Cantarelli, GJ Nazco Casariego, GA González de la Fuente, J González García, MM Viña Romero, F Gutiérrez Nicolás",
    "institution": "Hospital Universitario de Canarias, Pharmacy, Santa Cruz de Tenerife, Spain. Hospital Universitario Nuestra Señora de la Candelaria, Pharmacy, Santa Cruz de Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.493",
    "filters": {
      "actSubs": ["Nivolumab", "Pembrolizumab", "Ipilimumab"],
      "indication": ["Non-Small Cell Lung Cancer", "Melanoma", "Bladder Cancer", "Lymphoma (Hodgkin)", "Head and Neck Cancer", "Kidney Cancer", "Colorectal Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Determination of genetic polymorphisms of the dihydropyrimidine dehydrogenase gene in real clinical practice: posological individualisation",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A229.2",
    "authors": "MD Alvarado Fernández, M Murillo Izquierdo, J Cordero Ramos, L Rendón de Lope, MDLCDonoso Rengifo, ML Moya Martin",
    "institution": "Hospital Virgen Macarena, Pharmacy, Seville, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.494",
    "filters": {
      "actSubs": [],
      "indication": ["Colorectal Cancer", "Gastric Cancer", "Pancreatic Cancer", "Head and Neck Cancer"],
      "statedClass": ["Fluoropyrimidines"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Common Terminology Criteria for Adverse Events"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": ["pharmacogenetics"],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": ["personalized"],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Raltitrexed as an end-of-life treatment in patients with metastatic colorectal cancer",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A230.1",
    "authors": "A Rodríguez Ferreras, I Zapico García, E Lázaro López, C Álvarez Asteinza, I Maray Mateos, R Menárguez Blanc, A Arias Martínez, A Lozano Blázquez",
    "institution": "Hospital Universitario Central de Asturias, Hospital Pharmacy, Oviedo, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.495",
    "filters": {
      "actSubs": ["Raltitrexed"],
      "indication": ["Colorectal Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Palliative Care"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": ["endOfLife"],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "More risk of neutropaenia in obese patients treated with paclitaxel?",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A230.2",
    "authors": "R Rodriguez Mauriz, N Almendros-Abad, MA Pérez-Quirós, MA Aldirra-Taha, A Planas-Giner, L Borràs Trias, C Segui Solanes, N Rudi Sola",
    "institution": "Hospital General de Granollers, Pharmacy Department, Granollers, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.496",
    "filters": {
      "actSubs": ["Paclitaxel"],
      "indication": ["Neutropenia", "Breast Cancer", "Lung Cancer", "Ovarian Carcinoma", "Endometrial Cancer", "Pharyngeal Cancer", "Cervical Cancer", "Gastric Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Common Terminology Criteria for Adverse Events"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Intensive monitoring of afatinib – case report",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A231.1",
    "authors": "AS Santos, M Lobo Alves, P Cavaco, E Viegas, F Falcão",
    "institution": "Hospital de São Francisco Xavier – Centro Hospitalar de Lisboa Ocidental, Pharmacy, Restelo, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.497",
    "filters": {
      "actSubs": ["Afatinib", "Vinorelbine"],
      "indication": ["Non-Small Cell Lung Cancer (EGFR-Mutated)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": ["vigilance"],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Manic symptomatology induced by alectinib: a case report",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A231.2",
    "authors": "L Zampogna1, G Lo Cricchio1, L Gambitta1, E Togliardi1, L Ventura1, A Grecchi2, D Di Benedetto3",
    "institution": "Asst Santi Paolo E Carlo, Ospedale San Carlo Borromeo- U.O. Farmacia, Milano, Italy. Asst Santi Paolo E Carlo, Ospedale San Carlo Borromeo- U.O. Psichiatria, Milano, Italy. Asst Santi Paolo E Carlo, Asst Santi Paolo E Carlo- U.O. Farmacia, Milano, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.498",
    "filters": {
      "actSubs": ["Alectinib", "Valproic acid", "Aripiprazole", "Lithium carbonate", "Lorazepam", "Olanzapine"],
      "indication": ["Non-Small Cell Lung Cancer (ALK Positive)", "Bipolar Disorder"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series", "Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Psychiatry"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": ["vigilance"],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "The other side of immunotherapy: safety and toxicity management in clinical practice",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A231.3",
    "authors": "E Zhan Zhou, MI Barcia Martin, P Toro Chico, X Mielgo Rubio, M Perez Encinas",
    "institution": "Hospital Universitario Fundación Alcorcón, Pharmacy Service, Alcorcón, Spain. Hospital Universitario Fundación Alcorcón, Medical Oncology Service, Alcorcón, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.499",
    "filters": {
      "actSubs": ["Nivolumab", "Pembrolizumab"],
      "indication": ["Non-Small Cell Lung Cancer", "Bladder Cancer", "Kidney Cancer"],
      "statedClass": ["Immune Checkpoint Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Detection of adverse neuropsychiatric reactions associated with abiraterone and enzalutamide treatments in the hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A232.1",
    "authors": "AM Valle Díaz de La Guardia, R Álvarez Sánchez, A Jiménez, E González",
    "institution": "Hospital Universitario Virgen de Las Nieves, Farmacia Hospitalaria, Granada, Spain. Hospital Universitario San Cecilio, Farmacia Hospitalaria, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.500",
    "filters": {
      "actSubs": ["Abiraterone", "Enzalutamide"],
      "indication": ["Prostate Cancer (Metastatic Castration Resistant)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Adherence to disease-modifying therapies in spanish patients with multiple sclerosis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A232.2",
    "authors": "E Ramírez Herráiz, R Morillo Verdugo, R Fernández-del Olmo, M Roig Bonet, M Valdivia García",
    "institution": "Hospital Universitario de La Princesa, Farmacia Hospitalaria, Madrid, Spain. Hospital Universitario de Valme, Farmacia Hospitalaria, Sevilla, Spain. Roche, Market Access, Madrid, Spain. Fundation, Projects and Innovation, Barcelona, Spain. Fundation, Health Area, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.501",
    "filters": {
      "actSubs": [],
      "indication": ["Multiple Sclerosis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Morisky – Green Questionnaire"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Influence of pathology in injection pain reduction with a new formulation of original adalimumab",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A233.2",
    "authors": "J Martínez-Casanova, P Acin, N Carballo, R Gonzalez, E Navarrete Rouco, C Perez García, E Gonzalez-Colominas, L Tarason, S Grau, O Ferrández",
    "institution": "Hospital del Mar, Pharmacy, Barcelona, Spain. Hospital del Mar, Rheumatology, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.503",
    "filters": {
      "actSubs": ["Adalimumab"],
      "indication": ["Psoriasis"],
      "statedClass": ["Antidepressants", "Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Visual Analogue Scale"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": ["painManagement"],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of the effectiveness and safety of vedolizumab for the treatment of inflammatory bowel disease",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A234.1",
    "authors": "MÁ Amor, E Lobato-Matilla, Á Giménez-Manzorro, X García-González, E García-Martín, A Melgarejo-Ortuño, JL Revuelta-Herrero, PA Martínez-Ortega, C Ortega-Navarro, A Herranz-Alonso, M Sanjurjo-Sáez",
    "institution": "Servicio de Farmacia, Hospital General Universitario Gregorio Marañón, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.504",
    "filters": {
      "actSubs": ["Vedolizumab"],
      "indication": ["Inflammatory Bowel Disease", "Crohn’s Disease", "Ulcerative Colitis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["The Mayo Score for Ulcerative Colitis", "Harvey-Bradshaw Index (HBI) for Crohn's Disease"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Acute promyelocytic leukaemia after infliximab therapy in a crohn’s disease patient: a case report and a review of the literature",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A234.2",
    "authors": "L Camuffo, MV Lucatelli, G Pieri, C Bacci, G Inzalaco, R Puzziferri, C Di Carlo, M Fazio",
    "institution": "Humanitas Research Hospital, Pharmacy, Rozzano, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.505",
    "filters": {
      "actSubs": ["Infliximab", "Azathioprine", "Adalimumab", "Ustekinumab", "Arsenic trioxide", "Tretinoin"],
      "indication": ["Leukaemia (Acute Promyelocytic)", "Crohn’s Disease", "Rheumatoid Arthritis", "Ankylosing Spondylitis"],
      "statedClass": ["Corticosteroids", "Tumor Necrosis Factor (TNF) Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series", "Literature Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Mucormycosis induced by inappropiate use of oral corticoids – a case report",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A235.1",
    "authors": "M Ferris Villanueva, S Martin Clavo, E Garcia Lobato, C Redondo Galan, A Cinza Gonzalez, MDLOCerezo Arias, JF Rangel Mayoral, E Ferris Villanueva",
    "institution": "University Hospital Complex of Badajoz, Hospital Pharmacy, Badajoz, Spain. University Hospital Complex of Badajoz, Maxillofacial and Oral Surgery, Badajoz, Spain. University Hospital Complex of Badajoz, Intensive Care, Badajoz, Spain. San Juan de Dios Hospital, Hospital Pharmacy, Seville, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.506",
    "filters": {
      "actSubs": ["Dexamethasone", "Amphotericin", "Isavuconazole", "Daptomycin", "Amikacin", "Clindamycin"],
      "indication": ["Mucormycosis", "Hypertension (Pulmonary Arterial)", "Dyslipidaemia", "Hepatitis (Acute)", "Fasciitis (Necrotizing)"],
      "statedClass": ["Corticosteroids (Oral)"],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series", "Observational Study", "Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Canakinumab in familial mediterranean fever and secondary amyloidosis: a case report",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A235.2",
    "authors": "V González Rosa, MI Sierra Torres, S Fernández Espínola, M Zaragoza Rascón, M Pajares Alonso",
    "institution": "Hospital Serrania Ronda, Servicio de Farmacia, Ronda Málaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.507",
    "filters": {
      "actSubs": ["Canakinumab", "Colchicine", "Acetaminophen", "Anakinra", "Etanercept", "Darbepoetin"],
      "indication": ["Familial Mediterranean Fever", "Amyloidosis", "Chronic Kidney Disease", "Hypertension", "Heart Failure", "Anemia", "Neutrophilia"],
      "statedClass": ["Interleukin-1 Receptor Antagonists"],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Introduction of biosimilar etanercept: an italian district analysis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A236.1",
    "authors": "M Lecis, E Viglione, S Strobino, G Ceravolo",
    "institution": "ASL TO3, Hospital Pharmacy, Rivoli, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.508",
    "filters": {
      "actSubs": ["Etanercept"],
      "indication": [],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Switching biologic treatments: experience of a regional hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A236.2",
    "authors": "A Retamero, D Grados, M Cucurell, X Sanchez, RM Pares, J Serrais, D Ferrandez",
    "institution": "Consorci Sanitari de L’anoia, Pharmacy, Igualada, Spain. Consorci Sanitari de L’anoia, Reumatology, Igualada, Spain. Consorci Sanitari de L’anoia, Dermatology, Igualada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.509",
    "filters": {
      "actSubs": ["Infliximab", "Etanercept"],
      "indication": ["Rheumatoid Arthritis", "Spondyloarthropathy", "Psoriatic Arthropathy", "Psoriasis", "Crohn’s Disease", "Ulcerative Colitis"],
      "statedClass": ["Biologicals", "Biosimilars", "Tumor Necrosis Factor (TNF) Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)", "Chi-Square (χ2) Test"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Cost-effectiveness of biosimilar etanercept in clinical practice use",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A237.1",
    "authors": "S Ruiz Garcia, E Ramírez Herraiz, A Calvo García, C Martínez Nieto, A Morell Baladrón",
    "institution": "Hospital Universitario La Princesa, Farmacia Hospitalaria, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.510",
    "filters": {
      "actSubs": ["Etanercept", "Methotrexate"],
      "indication": ["Rheumatoid Arthritis"],
      "statedClass": ["Biosimilars", "Biologicals", "Disease Modifying Anti-Rheumatic Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Disease Activity Score-28 (DAS28) for Rheumatoid Arthritis"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Morphine overdose from error infusion rate with intravenous pump: feedback experience and action plan",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A237.2",
    "authors": "M Papus, M Jaffuel, J Mangavelle, S Vernardet, I Lefort",
    "institution": "Centre Hospitalier D’ardèche Nord, Pharmacie, Annonay, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.511",
    "filters": {
      "actSubs": ["Morphine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Syringe Pumps"],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Association of Litigation and Risk Management (ALARM)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "The use of fentanyl sublingual tablets in a hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A238.1",
    "authors": "C Juez, AC Viney, E Conesa Nicolas, S Nuñez Redondo, A Lloret Llorca, CN Garcia Matillas, G Sarrió Montes, MH Garcia Lagunar, A Chica Marchal, MDM Sanchez Catalicio, MC Gonzalez Perez-Crespo",
    "institution": "Hospital Universitario Santa Lucia, Hospital Pharmacy, Cartagena- Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.512",
    "filters": {
      "actSubs": ["Fentanyl"],
      "indication": ["Lung Cancer", "Colorectal Cancer", "Pancreatic Cancer", "Breast Cancer", "Diabetic Foot", "Ischaemia"],
      "statedClass": ["Opioids"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Anaesthesia", "Vascular Angiology", "Rheumatology"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": ["painManagement"],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "A study on risk factors eliciting opioid adverse reactions in elderly males",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A238.2",
    "authors": "JY Kim, YJ Jung, H Jeong",
    "institution": "Veterans Health Service Medical Centre, Pharmacy, Seoul, South Korea",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.513",
    "filters": {
      "actSubs": ["Oxycodone", "Codeine"],
      "indication": [],
      "statedClass": ["Opioids", "Gamma Aminobutyric Acid (GABA) Analogues"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["South Korea"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Δ-9-tetrahydrocannabinol (sativex) for the treatment of multiple sclerosis spasticity: evaluation of effectiveness and safety",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A239.1",
    "authors": "F Ferrante, G Polito, M Ferraro",
    "institution": "Ospedale ‘F. Spaziani’, U.O. Farmacia, Frosinone, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.514",
    "filters": {
      "actSubs": ["Cannabidiol", "Delta-9-tetrahydrocannabinol"],
      "indication": ["Multiple Sclerosis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Cohort Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Expanded Disability Status Scale", "Numeric Rating Scale (NRS)"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Development and validation of quality indicators for benzodiazepine use in general and mental health hospitals: shortcomings of available reimbursement data",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A239.3",
    "authors": "N Pijpen, F Desplenter, P Cosemans, A Ghekiere, K Cornelis, C Ligneel, H Collier, PJ Cortoos",
    "institution": "UZ Brussel, Pharmacy, Brussels, Belgium. University Psychiatric Hospitals Katholieke Universiteit Leuven Campus Kortenberg, Pharmacy, Kortenberg, Belgium. Zorgnet-Icuro, Quality and Safety Ggz – Az, Brussels, Belgium. Agentschap Zorg En Gezondheid, Gespecialiseerde Zorg, Brussels, Belgium. Intermutualistisch Agentschap, Ima-Aim, Brussels, Belgium",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.516",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Benzodiazepines"],
      "typeOfMedical": [],
      "studyDesign": ["Literature Review"],
      "setting": ["Hospital"],
      "ward": ["Psychiatry"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Belgium"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Risk of QT interval prolongation in older patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A240.1",
    "authors": "I Gumiel Baena, GC Maria Dolores, SQ Virginia, CS Marina, SFDS Raquel, RÁ Adrián",
    "institution": "University Hospital Puerta de Hierro Majadahonda, Pharmacy, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.517",
    "filters": {
      "actSubs": ["Duloxetine", "Trazodone", "Azithromycin", "Levofloxacin", "Rivastigmine", "Domperidone", "Amiodarone", "Famotidine"],
      "indication": ["Cardiovascular Disease"],
      "statedClass": ["Psychotropics", "Selective Serotonin Reuptake Inhibitors (SSRIs)", "Antidepressants (Tricyclic)", "Antipsychotics", "Antibiotics", "Antiarrhythmics", "Antihistamines"],
      "typeOfMedical": [],
      "studyDesign": ["Transversal Study", "Descriptive Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Metabolic disorders in patients treated with second-generation antipsychotics: an opportunity for pharmaceutical intervention",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A240.2",
    "authors": "A Melgarejo-Ortuño, ME Lobato-Matilla, JL Revuelta-Herrero, A De Lorenzo-Pinto, X García-González, E García-Martín, MA Amor-García, S García-Sánchez, PA Martínez-Ortega, A Herranz-Alonso, M Sanjurjo-Sáez",
    "institution": "Hospital General Universitario Gregorio Marañon, Servicio de Farmacia, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.518",
    "filters": {
      "actSubs": ["Clozapine", "Olanzapine", "Quetiapine", "Ziprasidone", "Paliperidone", "Risperidone"],
      "indication": ["Metabolic Syndrome", "Schizophrenia", "Depression"],
      "statedClass": ["Antipsychotics (Second-Generation)", "Antihypertensives", "Lipid Lowering Agents"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Psychiatry"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Prevalence of aspiration pneumonia following antipsychotics: a large population study",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A241.1",
    "authors": "M Miarons Font, S Marín Rubio, L Perez Cordon, J Delgado Rodriguez, L Campins Bernadàs, D López Faixó",
    "institution": "Mataró Hospital, Pharmacy Department, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.519",
    "filters": {
      "actSubs": [],
      "indication": ["Pneumonia (Aspiration)"],
      "statedClass": ["Antipsychotics"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Inappropiate use of hydroxycine",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A241.2",
    "authors": "R Seisdedos, P López",
    "institution": "Hospital Universitario Puerto Real, Farmacia, El Puerto de Santa María, Spain. Hospital de Tomelloso, Farmacia, Tomelloso, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.520",
    "filters": {
      "actSubs": ["Hydroxyzine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["101 - 500"],
      "criteriaMethod": ["Beers Criteria", "Descriptive Statistics"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": ["history"]
    }
  },
  {
    "title": "Development of alzheimer’s disease and exposition to benzodiazepines: a cohort study in a health region of catalonia between 2002 and 2015",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A242.1",
    "authors": "FI Torres-Bondia, G Piñol-Ripoll, J De Batlle-Garcia, M Buti-Sole, L Galvan-Santiago",
    "institution": "Hospital Universitario Santa María de Lleida, Pharmacy, Lleida, Spain. Hospital Universitario Santa María de Lleida, Cognitive Disorders Unit, Lleida, Spain. IRB/Lleida, Translational Research In Respiratory Medicine Research Group/Irblleida, Lleida, Spain. Institut Català de La Salut, Clinical Evaluation Unit, Lleida, Spain. Servei Català de La Salut, Pharmacy, Lleida, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.521",
    "filters": {
      "actSubs": ["Zoplicona", "Zolpidem"],
      "indication": ["Alzheimer’s Disease"],
      "statedClass": ["Benzodiazepines"],
      "typeOfMedical": [],
      "studyDesign": ["Cohort Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": ["Defined Daily Dose (DDD)", "Chi-Square (χ2) Test", "Logistic Regression Analysis", "Cox Proportional Hazards Regression Analysis"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Prevalence of prescription of antipsychotic polypharmacy in a psychiatric hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A242.2",
    "authors": "J Velasco, M Martinez de Guzman, MA de Concepcion Salesa",
    "institution": "Hospital Psiquiatrico Roman Alberca, Servicio de Farmacia, El Palmar, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.522",
    "filters": {
      "actSubs": ["Clotiapine", "Levomepromazine", "Zuclopenthixol", "Haloperidol", "Clozapine", "Olanzapine", "Quetiapine", "Paliperidone", "Risperidone", "Aripiprazole", "Ziprasidone", "Amisulpiride"],
      "indication": ["Schizophrenia", "Schizoaffective Disorder", "Personality Disorder", "Bipolar Disorder"],
      "statedClass": ["Antipsychotics (Long Acting Injectable)", "Antipsychotics", "Antidepressants", "Mood Stabilisers"],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": ["Acute Care Unit", "Short Stay Unit", "Half-Stay Unit"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)", "Chi-Square (χ2) Test"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Anticholinergic drugs and acetylcholinesterase inhibitors: a non-recommended combination",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A243.1",
    "authors": "M Oro Fernandez, CM Valencia Soto, JI Gutierrez Revilla, F Perez Hernandez, A Tejerina",
    "institution": "Cantabria Health Service, Unit of Medicines Reconciliation, Santander, Spain. Cantabria Health Service, Chief of the Pharmaceutical Management Service, Santander, Spain. Cantabria Health Service, Director of Health Assistance, Santander, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.523",
    "filters": {
      "actSubs": ["Rivastigmine", "Donepezil", "Galantamine", "Quetiapine", "Trazodone"],
      "indication": ["Cognitive Disorder", "Alzheimer’s Disease", "Dementia"],
      "statedClass": ["Anticholinergics", "Acetylcholinesterase Inhibitors", "Nervous System Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Charlson Comorbidity Index", "Anticholinergic Burden Calculator", "Global Impairment Scale (GDS-FAST)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": ["endOfLife"],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Asthma in the moroccan population",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A243.2",
    "authors": "R Nejjari, Y Elaissaoui, A Tebaa, SB Rachida",
    "institution": "Faculty of Medicine and Pharmacy, Pharmacognosy, Rabat, Morocco. Antipoison and Pharmacovigilance Centre of Morocco, Pharmacovigilance Department, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.524",
    "filters": {
      "actSubs": [],
      "indication": ["Asthma"],
      "statedClass": ["Glucocorticoids", "Beta-2-Adrenoreceptor Agonists (Inhaled)", "Beta-2-Adrenoreceptor Agonists"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": ["vigilance"],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Profile and complexity level of clinical trials in the pharmacy service",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A244.1",
    "authors": "R Gazquez Perez, A Alcala Soto, C Puivecino Moreno, L Pichardo Jiménez, A Varas Pérez, V Sánchez-Matamoros Piazza, JF Sierra Sánchez, P Gómez Germá, C Mora Herrera, MT Gómez de Travecedo y Calvo",
    "institution": "Hospital Universitario Jerez de La Frontera, Pharmacy Service, Jerez de La Frontera Cádiz, Spain. Hospital San Juan Grande, Pharmacy, Jerez de La Frontera Cádiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.525",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Oncology", "Nephrology", "Haematology", "Pneumology", "Infectious Disease", "Cardiology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Characterisation of pre-filled syringe use in an acute care setting: costs and advantages",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A244.2",
    "authors": "A Harvey",
    "institution": "BD, Health Economics and Outcomes Research, Research Triangle Park- NC- 27709, USA",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.526",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Prefilled Syringes"],
      "studyDesign": ["Literature Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["USA"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Use of excipients in oral liquid commercial medicines in a children’s hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A245.1",
    "authors": "D Gavrus Ion, F Bossacoma Busquets, MA Romo Murillo, JM Catala Foguet, A Diaz Cambron, M Sánchez Celma, M Villaronga Flaqué, JA Cuartero Lozano, J Vinent Genestar, R Farre Riba",
    "institution": "Hospital Sant Joan de Déu, Pharmacy, Esplugues de Llobregat, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.527",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Oral Liquid Medicines"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Key stakeholders, perspectives on medication safety practices and error reporting in qatar – an exploratory sequential mixed-method study",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A246.1",
    "authors": "P Abdulrouf, B Thomas, W Elkassem, M Alhail",
    "institution": "Hamad Medical Corporation, Assistant Director – Pharmacy Executive Office, Doha, Qatar. Hamad Medical Corporation, Clinical Pharmacy Specialist – Pharmacy Executive Office, Doha, Qatar. Hamad Medical Corporation, Executive Director – Pharmacy Executive Office, Doha, Qatar",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.529",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Hospital Survey on Patient Safety Culture", "Framework Approach"],
      "studyLength": [],
      "country": ["Qatar"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Triple whammy interaction: improving patients’ safety",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A246.2",
    "authors": "N Alzueta, MC Celaya, MT Acin, A Echeverría, C Fontela, L Sanz, N Gómez, ML Fernandez, A López, J Garjón",
    "institution": "Navarre Health Service, Pharmacy Subdirection, Pamplona, Spain. Navarre Health Service, Complejo Hospitalario de Navarra. Nephrology Department, Pamplona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.530",
    "filters": {
      "actSubs": [],
      "indication": ["Acute Kidney Injury"],
      "statedClass": ["Angiotensin Converting Enzyme (ACE) Inhibitors", "Angiotensin II Receptor Blockers (ARBs)", "Diuretics", "Non-Steroidal Anti-Inflammatory Drugs"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": ["deprescribing"],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Using a customised medication verification tool on admission to hospital in psychiatric patients to reduce clinically relevant medication discrepancies",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A247.1",
    "authors": "V Akrum, B Maat, N Veth",
    "institution": "Elisabeth-Tweesteden Hospital, Clincal Pharmacy, Tilburg, The Netherlands. Elisabeth-Tweesteden Hospital, Medical Psychiatry Unit, Tilburg, The Netherlands",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.531",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Psychiatry"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) Index"],
      "studyLength": [],
      "country": ["Netherlands"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": ["history"]
    }
  },
  {
    "title": "Impact of robotics on patient safety and productivity",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A247.2",
    "authors": "M Al Nemari, E Zayed, A Bin Dous, A Malhani, N Al Banyan, A Al Rassan, M Faqehi, P Sharma, Am Al Faadhel, A Al Sarheed, M Gashi",
    "institution": "King Fahad Medical City, Supervisor- Pharmacy Informatics and Automation, Riyadh, Saudi Arabia. King Fahad Medical City, Pharmacist, Riyadh, Saudi Arabia. King Fahad Medical City, Assistant Pharmacist, Riyadh, Saudi Arabia. Six Sigma, Master Black Belt, Riyadh, Saudi Arabia. King Fahad Medical City, Riyadh, Saudi Arabia",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.532",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Six Sigma Approach"],
      "studyLength": [],
      "country": ["Saudi Arabia"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Public perceptions and concerns including medication awareness in lifestyle health campaigns",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A248.1",
    "authors": "F Alhomoud, K Alameer, Z Almousa, M Almatar, W Alzlaiq, F Alhomoud",
    "institution": "Imam Abdulrahman Bin Faisal University, Department of Pharmacy Practice- College of Clinical Pharmacy, Dammam, Saudi Arabia. Imam Abdulrahman Bin Faisal University, College of Clinical Pharmacy, Dammam, Saudi Arabia",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.533",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Saudi Arabia"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": ["mobileVR"],
      "Printing3D": [],
      "socialMedia": ["socialMedia"],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Less-chron for deprescribing in nursing home residents",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A248.2",
    "authors": "MC Sánchez Argaiz, MR Cantudo Cuenca, S Guijarro Herrera, R Alvarez Sánchez, B Muñoz Cejudo",
    "institution": "San Agustín Hospital, Hospital Pharmacy, Linares Jaén, Spain. Virgen de Las Nieves University Hospital, Hospital Pharmacy, Granada, Spain. Campus de La Salud Hospital, Hospital Pharmacy, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.534",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Digestive System Drugs", "Blood and Cardiovascular System Drugs", "Nervous System Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["List Evidence-based Deprescribing For Chronic Patients Criteria (LESS-CHRON)", "Charlson Comorbidity Index"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": ["endOfLife"],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": ["deprescribing"],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Antimicrobial treatment inadequacy in an emergency department",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A248.3",
    "authors": "F Oltra Hostalet, M Nuñez Nuñez, M Moya-Martin, Ás Raquel",
    "institution": "Hospital Universitario Virgen Macarena, Ugc Urgencias, Seville, Spain. Hospital Universitario San Cecilio de Granada, Ugc Farmacia, Granada, Spain. Hospital Universitario Virgen Macarena, Pharmacy, Seville, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.535",
    "filters": {
      "actSubs": ["Ertapenem", "Levofloxacin"],
      "indication": ["Pneumonitis", "Urinary Tract Infection", "Respiratory Tract Infection (Lower)"],
      "statedClass": ["Antimicrobial Agents"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": [],
      "numPrescriptions": ["101 - 500"],
      "criteriaMethod": ["Point Prevalence Survey", "Multivariate Analysis", "Logistic Regression Analysis"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Pharmacological study of HIV patients entered into the hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A249.1",
    "authors": "AM Valle Díaz de la Guardia, R Álvarez Sánchez, A Jiménez",
    "institution": "Hospital Universitario Virgen de Las Nieves, Farmacia Hospitalaria, Granada, Spain. Hospital Universitario San Cecilio, Farmacia Hospitalaria, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.536",
    "filters": {
      "actSubs": ["Darunavir", "Salmeterol"],
      "indication": ["Acquired Immunodeficiency Syndrome (AIDS)"],
      "statedClass": ["Antiretrovirals", "Cardiovascular Drugs", "Respiratory System Drugs", "Protease Inhibitors", "Benzodiazepines"],
      "typeOfMedical": [],
      "studyDesign": ["Literature Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "Investigating error reporting rates by all pharmacy staff in the pharmacy department of a general hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A249.2",
    "authors": "S Amarneh, B Olsburgh, R Levy",
    "institution": "Laniado Hospital, Pharmaceutical Services, Netanya, Israel. Laniado Hospital, Pharmacy Department, Netanya, Israel",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.537",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["6 months - 1 year"],
      "country": ["Israel"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Effectiveness and toxicity profile analysis of antifibrotic agents in idiopathic pulmonary fibrosis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A250.1",
    "authors": "M Arrieta, C García, JM Caro, M González, C Rosas, JM Ferrari",
    "institution": "Hospital Universitario 12 de Octubre, Pharmacy, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.538",
    "filters": {
      "actSubs": ["Nintedanib", "Pirfenidone"],
      "indication": ["Fibrosis (Pulmonary)"],
      "statedClass": ["Antifibrotics"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Student's T-test", "STATA"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Focusing audits on patient safety",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A250.2",
    "authors": "A Attard, F Wirth, C Muscat, LM Azzopardi, A Serracino-Inglott",
    "institution": "University of Malta- Faculty of Medicines and Surgery, Department of Pharmacy, Msida- Malta, Malta",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.539",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Malta"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": ["highRisk"],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": ["coldChain"],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Aspirin and novel oral anticoagulants: reporting of adverse drug reactions",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A251.1",
    "authors": "J Attard, J Vella Szijj, A Serracino Inglott",
    "institution": "University of Malta, Department of Pharmacy, Msida, Malta",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.540",
    "filters": {
      "actSubs": ["Acetylsalicylic acid", "Apixaban", "Dabigatran", "Rivaroxaban"],
      "indication": [],
      "statedClass": ["Novel Oral Anticoagulants"],
      "typeOfMedical": [],
      "studyDesign": ["Comparative Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Malta"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": ["vigilance"],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Procedure for paediatric emergency and results of a survey on use",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A251.2",
    "authors": "I Barbato, B Esposito, V Cristiano",
    "institution": "Aos Dei Colli, Farmacia, Napoli, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.541",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Endotracheal Tubes", "Catheters", "Nasogastric Tubes"],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Broselow Tape Method"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Computerised physician order entry systems and related clinical decision support tools in inpatient care – barriers of cost-effectiveness",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A252.2",
    "authors": "R Bella, A Langer, M Csanádi, A Zemplényi, L Botz",
    "institution": "University of Pécs, Department of Pharmaceutics, Pécs, Hungary. Eötvös Lóránd University, Department of Health Policy and Health Economics, Budapest, Hungary. University of Pécs, Health Management Directorate, Pécs, Hungary",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.543",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Hungary"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of the form’s quality of medical prescriptions from public hospitals and private clinics",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A253.1",
    "authors": "S Bennis, M Alami Chentoufi, H Ouhaddouch, L Yachi, A Cheikh, M Bouatia",
    "institution": "Mohammed V University- Faculty of Medicine and Pharmacy- Rabat- Morocco, Mohammed V University- Faculty of Medicine And Pharmacy- Rabat- Morocco, Casablanca, Morocco. Mohammed V University- Faculty of Medicine and Pharmacy- Rabat- Morocco, Mohammed V University- Rabat- – Faculty of Medicine and Pharmacy- Rabat- Morocco, Rabat, Morocco. Mohammed V University- Faculty of Medicine and Pharmacy- Rabat- Morocco, Mohammed V University- Faculty of Medicine and Pharmacy- Rabat- Morocco, Rabat, Morocco. Abulcasis University-Faculty of Pharmacy- Rabat- Morocco, Abulcasis University-Faculty of Pharmacy- Rabat- Morocco, Rabat, Morocco. Mohammed V University-Faculty of Medicine and Pharmacy- Analytical Chemistry- Paediatric Hospital- Rabat- Morocco, Mohammed V University-Faculty of Medicine and Pharmacy- Analytical Chemistry- Paediatric Hospital- Rabat- Morocco., Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.544",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Transversal Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": ["101 - 500"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Risk assessment of elemental impurties for manufacturing the drug substance (ICH Q3D)",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A253.2",
    "authors": "S Bennis, L Yachi, H Ouhaddouch, M Alami Chentoufi, A Cheikh, M Bouatia",
    "institution": "Mohammed V University -Faculty of Medicine and Pharmacy- Rabat- Morocco, Mohammed V University -Faculty of Medicine and Pharmacy- Rabat- Morocco, Casablanca, Morocco. Mohammed V University -Faculty of Medicine and Pharmacy- Rabat- Morocco, Mohammed V University -Faculty of Medicine and Pharmacy- Rabat- Morocco, Rabat, Morocco. Abulcasis University-Faculty of Pharmacy- Rabat- Morocco, Abulcasis University-Faculty of Pharmacy- Rabat- Morocco, Rabat, Morocco. Mohammed V University-Faculty of Medicine and Pharmacy- Analytical Chemistry- Paediatric Hospital- Rabat- Morocco, Mohammed V University-Faculty of Medicine and Pharmacy- Analytical Chemistry- Paediatric Hospital- Rabat- Morocco, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.545",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "How to secure medication self-management in hospitalised postpartum women?",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A254.1",
    "authors": "H Benoist, I Goyer, G Saint-Lorant",
    "institution": "Caen University Hospital, Pharmacy, Caen, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.546",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Analgesics"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Postpartum Unit"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": ["selfMedication"],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Evaluation of pharmaceutical interventions performed on medication errors detected in the prescription",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A254.2",
    "authors": "C Carriles Fernandez, B Zarate Tamames, M Alaguero Calero, Á Pieras López, A Arias, R Menárguez Blanc, A Lozano-Blázquez",
    "institution": "Hospital Universitario Central de Asturias, Pharmacy, Oviedo, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.547",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"],
      "history": []
    }
  },
  {
    "title": "‘patient experience’ for improving patient clinical pathways in an oncology day hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A255.1",
    "authors": "C Chatain, M Durand, N Curatolo, S Morellec, S Barthier, A Rieutord, A Decottignies",
    "institution": "Antoine Béclère Hospital, Pharmacy, Clamart, France. Bicetre Hospital, Quality, Le Kremlin-Bicêtre, France. Antoine Béclère Hospital, Ambulatory Care Centre, Clamart, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.548",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": ["youngPharma"],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Analysis and evaluation of a renal function-based dosage adjustment system at a university hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A255.2",
    "authors": "KS Choi, L Eunsook, R Sandy Jeong",
    "institution": "Seoul National University Bundang Hospital, Department of Pharmacy, Seongnam, South Korea. Ewha Womans University, Division of Life and Pharmaceutical Sciences and College of Pharmacy, Seoul, South Korea",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.549",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["H2-Receptor Antagonists", "Antimicrobial Agents"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["South Korea"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Preventing medication errors regarding high-alert medication",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A255.3",
    "authors": "MT López Mancha, R Sánchez del Moral, MB Contreras Rey, E Rodriguez Molins, MM Romero Alonso, J Estaire Gutiérrez",
    "institution": "Infanta Elena Hospital, Pharmacy, Huelva, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.550",
    "filters": {
      "actSubs": ["Heparin", "Potassium chloride", "Methotrexate"],
      "indication": [],
      "statedClass": ["Oral Anticoagulants", "Insulins"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": ["highRisk"],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "A preliminary survey on daily drug intake in older patients in compliance with eahp policy statement on an ageing society",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A256.2",
    "authors": "E Di Martino, A Provenzani, P Polidori",
    "institution": "Ismett, Clinical Pharmacy, Palermo, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.552",
    "filters": {
      "actSubs": ["Betamethasone", "Iopromide", "Ranolazine", "Levofloxacin", "Cefuroxime", "Amoxicillin / Clavulanic acid", "Amoxicillin", "Clavulanic acid", "Paracetamol", "Nintedanib", "Tacrolimus"],
      "indication": ["Cardiovascular Disease"],
      "statedClass": ["Vitamin Supplements", "Herbal Medicines", "Antihypertensives"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": ["vigilance"],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Application of international geriatric criteria according to EAHP policy statement on an ageing society",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A257.1",
    "authors": "E Di Martino, A Provenzani, P Polidori",
    "institution": "Ismett, Clinical Pharmacy, Palermo, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.553",
    "filters": {
      "actSubs": [],
      "indication": ["Cardiovascular Disease", "Cancer", "Chronic Obstructive Pulmonary Disease", "Asthma"],
      "statedClass": ["Proton-Pump Inhibitors", "Muscarinic Antagonist", "Opioids", "Beta-Blockers", "Beta-2-Adrenoreceptor Agonists (Inhaled)"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Cohort Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Beers Criteria", "STOPP/START Criteria", "Improving Prescribing in the Elderly Tool (IPET)"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Surveillance and monitoring of patient falls in a hospital setting by the hospital pharmacist: focus on patient-related risk factors and drug therapy",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A256.1",
    "authors": "E Di Martino, D Leonardi Vinci, P Polidori",
    "institution": "Ismett, Clinical Pharmacy, Palermo, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.551",
    "filters": {
      "actSubs": ["Furosemide", "Omeprazole", "Insulin lispro", "Tramadol"],
      "indication": [],
      "statedClass": ["Fall-Risk Increasing Drugs (FRIDS)", "Cardiovascular Drugs", "Hypoglycaemics", "Proton-Pump Inhibitors", "Laxatives", "Opioids", "Anxiolytics"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": ["preopMedication"],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Quality assessment within french fire and rescue services pharmacies in the north of france: development and evaluation of a self-assessment tool",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A257.2",
    "authors": "V Ducatez, C Gerard, V Legrand de Ginji, M Le Jouan, E Alavoine",
    "institution": "French Fire and Rescue Services of North County, Pharmacy, Lille, France. French Fire and Rescue Services of Oise County, Pharmacy, Beauvais, France. Public Hospitals of Paris Ap-Hp, Omedit, Paris, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.554",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Quantitative Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Peripheric intravenous perfusion in anaesthesia: securing medical treatment is also about the proper use of medical devices",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A258.1",
    "authors": "F Duwicquet, N Avez-Platteeuro, B Luyssaert",
    "institution": "Groupe Hospitalier Seclin-Carvin, Pharmacy, Seclin, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.555",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Catheters", "Infusion Warmers"],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Operating Room"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Failure modes, effects and criticality analysis: application to a hospital pharmacy",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A258.2",
    "authors": "MA El Wartiti, W Enneffah, A Cheikh, M Abouatia, J Lamsaouri, J Taoufik, A Bennana",
    "institution": "Mohammed V Military Teaching Hospital – Faculty of Medicine and Pharmacy of Rabat, Pharmacy, Rabat, Morocco. Cheikh Zaid International University Hospital – Abulcasis International University of Health Sciences, Pharmacy, Rabat, Morocco. Rabat Children’s Hospital – Faculty of Medicine and Pharmacy of Rabat, Pharmacy, Rabat, Morocco. Faculty of Medicine and Pharmacy of Rabat, Pharmacy, Rabat, Morocco. Cheikh Khalifa Ben Zayed Hospital – Faculty of Medicine and Pharmacy of Rabat, Pharmacy, Casablanca, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.556",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Failure Mode, Effects and Criticality Analysis (FMECA)"],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  },
  {
    "title": "Quality and risk management in hospitals: evaluation of implantable medical devices’ traceability process",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A259.1",
    "authors": "W Enneffah, MA El Wartiti, A Cheikh, M Abouatia, J Lamsaouri, J Taoufik, A Bennana",
    "institution": "Mohammed V Military Teaching Hospital – Faculty of Medicine and Pharmacy of Rabat, Pharmacy, Rabat, Morocco. Cheikh Zaid International University Hospital – Abulcasis International University of Health Sciences, Pharmacy, Rabat, Morocco. Children’s Hospital of Rabat – Faculty of Medicine and Pharmacy of Rabat, Pharmacy, Rabat, Morocco. FACULTY OF MEDICINE AND PHARMACY OF RABAT, PHARMACY, RABAT, Morocco. Cheikh Khalifa Ben Zayed Hospital – Faculty of Medicine and Pharmacy of Rabat, Pharmacy, Casablanca, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.558",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Implantable Medical Devices", "Parietal Reinforcement Plates", "Implantable Staples"],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Operating Room", "Gynaecology", "Urology", "Visceral Surgery"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["6 months - 1 year"],
      "country": ["Morocco"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": ["history"]
    }
  },
  {
    "title": "Medications and falls in the elderly: an epidemiological study in a french hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A259.2",
    "authors": "A Etangsale, R Ratiney",
    "institution": "Centre Hospitalier Universitaire René Muret, Seine Saint Denis, Sevran, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.559",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Hypotensive Agents", "Diuretics", "Benzodiazepines"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": [],
      "history": []
    }
  }
]